WO2022230590A1 - Drug feeder and drug dispensing unit - Google Patents

Drug feeder and drug dispensing unit Download PDF

Info

Publication number
WO2022230590A1
WO2022230590A1 PCT/JP2022/016202 JP2022016202W WO2022230590A1 WO 2022230590 A1 WO2022230590 A1 WO 2022230590A1 JP 2022016202 W JP2022016202 W JP 2022016202W WO 2022230590 A1 WO2022230590 A1 WO 2022230590A1
Authority
WO
WIPO (PCT)
Prior art keywords
medicine
weight
container
drug
powdered medicine
Prior art date
Application number
PCT/JP2022/016202
Other languages
French (fr)
Japanese (ja)
Inventor
千晴 浅岡
克朗 吉川
有 宮本
亮輔 深森
潤 堀井
雅彦 粕屋
Original Assignee
株式会社湯山製作所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2022049908A external-priority patent/JP2022169440A/en
Priority claimed from JP2022049907A external-priority patent/JP2022169439A/en
Priority claimed from JP2022049906A external-priority patent/JP7345092B2/en
Application filed by 株式会社湯山製作所 filed Critical 株式会社湯山製作所
Priority to KR1020237025091A priority Critical patent/KR20240004218A/en
Priority to CN202280020256.1A priority patent/CN117120013A/en
Publication of WO2022230590A1 publication Critical patent/WO2022230590A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/30Devices or methods for controlling or determining the quantity or quality or the material fed or filled
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B37/00Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
    • B65B37/04Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged by vibratory feeders
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B37/00Supplying or feeding fluent-solid, plastic, or liquid material, or loose masses of small articles, to be packaged
    • B65B37/16Separating measured quantities from supply
    • B65B37/18Separating measured quantities from supply by weighing

Definitions

  • the present invention relates to a medicine feeder for weighing and taking out a predetermined amount of powdered medicine.
  • the drug feeder of the present invention is suitably used as a device for supplying powdered drugs to a powdered drug dispensing device.
  • the present invention also relates to a drug dispensing device incorporating a drug feeder.
  • the drug dispensing devices disclosed in Patent Documents 2 and 3 employ a drug feeder in which a drug container and a container mounting device are combined.
  • the container placement device has a horizontal vibrating member and weight measuring means for measuring the weight of the drug container. Then, the drug container is placed on the vibrating member, the vibrating member is vibrated, and the drug is discharged little by little from the powdered drug discharging portion, and the discharged amount of the drug is detected by the weight measuring means.
  • the drug containers disclosed in Patent Literatures 2 and 3 have a substantially quadrangular prism shape and are installed in the container placing device in a horizontal posture.
  • a substantially quadrangular prism-shaped drug container is horizontally placed on a container mounting device, and when combined as a drug feeder, the drug container has a length in the horizontal direction of and low height.
  • a robot transports a drug container to a predetermined position, and the robot opens and closes the lid of the drug container.
  • Patent Document 4 discloses a powder medicine supply device used in a powder medicine packaging machine.
  • powdered medicine is stored in each of a plurality of cassettes, and the powdered medicine is discharged from the cassette after the cassette is moved to the supply position.
  • the cassette has a screw, a shutter that closes a discharge port consisting of a cylindrical tip, and a stirring blade that rotates together with the screw, and the shutter is configured to be forcibly maintained in a closed state by a spring.
  • the screw presses the shutter, and the shutter moves against the biasing force of the spring, thereby opening the discharge port.
  • the rotation of the screw and the stirring blade causes the powder to flow toward the discharge port.
  • powdered medicine is ejected from the cassette.
  • the powder medicine supply device of Patent Document 4 movement of the cassette to the supply position and movement from the supply position are automatically executed.
  • the powdered medicine feeder in this powdered medicine supply apparatus discharges the powdered medicine by rotating the stirring blade and the screw, and does not discharge the powdered medicine by vibration (by vibrating the entire cassette).
  • the powder feeder is formed by an actuator in the feed position and one cassette, the actuator merely supplying power to the screw of the cassette. That is, the cassette has all the mechanisms for discharging the powder medicine.
  • the movement of the shutter in the closing direction is made by a spring. In other words, the shutter is opened by temporarily applying a force in the opening direction to the shutter that always maintains the closed state. Close the shutter. In other words, the opening degree of the shutter is not adjusted.
  • JP-A-2000-85703 Japanese Patent Application Laid-Open No. 2018-35001 WO2015/076267/A1 JP-A-7-132135
  • Patent Documents 2 and 3 have a problem that they occupy a large area when installed.
  • the medicine dispensers disclosed in Patent Documents 2 and 3 have a problem that the number of parts is large.
  • Patent Documents 2 and 3 disclose a drug dispensing device that transports a drug container by a robot and opens and closes the lid of the drug container. There was a problem that it was difficult to introduce to small-scale pharmacies. Also, in order to solve such problems, when considering a device in which the robot mechanism is eliminated and the drug container is manually placed at a predetermined position, the mechanism for opening and closing the lid is made as compact as possible and provided in another member. , there was a desire to reduce the size of the entire apparatus.
  • the medicine dispensing device disclosed in Patent Document 4 has room for improvement from the viewpoint of finely adjusting the discharge amount of the medicine with a simple structure.
  • One aspect of the present invention for solving the above-described problems is a drug container containing a powdered drug, a container holding section for holding the drug container, and directly or indirectly measuring the weight of the drug container.
  • weight measuring means for discharging the powdered medicine from the medicine container by vibrating the medicine container, and capable of detecting the discharged amount of the powdered medicine by the weight measuring means
  • the medicine container comprises: The powdered medicine discharging part discharges the powdered medicine to the outside, and further comprises an opening/closing member for opening and closing the powdered medicine discharging part, and further comprising an opening/closing mechanism part, wherein the opening/closing mechanism part applies a force directly or indirectly to the opening/closing member. and moves at least a part of the opening/closing member to open/close the powdered medicine discharge section. It is a drug feeder that applies force.
  • the opening/closing mechanism that opens and closes the opening/closing member applies force to the opening/closing member to open/close it, so it is possible to finely control the opening/closing operation of the opening/closing member. Accordingly, by adjusting the degree of opening of the powdered medicine discharge part (the degree of opening, or the degree of opening), it is possible to finely adjust the discharge amount. That is, compared with the case where the discharge amount is adjusted only by adjusting the vibration amount, it is possible to finely adjust the discharge amount.
  • the medicament container is manually retainable in the container holding portion, is manually removable from the container holding portion, and removes the medicament container from the container holding portion.
  • the drug container separates from the container holding portion and the opening/closing mechanism portion.
  • the degree of opening of the powdered medicine discharge section can be adjusted stepwise when the powdered medicine discharge section is placed in the open state.
  • the powdered medicine discharge part is a slit extending in an oblique direction
  • the opening/closing member includes a closing wall that moves below the powdered medicine discharge part, and the closing wall extends in the width direction of the medicine container.
  • the opening/closing member moves in the closing direction, the overlapping portion between the closing wall and the powdered medicine discharge section increases, and the effective opening width for discharging the powdered medicine in the powdered medicine discharge section becomes smaller. It is desirable to be
  • the container holding portion has a vertical wall, the vertical wall is vibrated by the vibrating means, and the drug container is fixed to the vertical wall and vibrated.
  • the drug feeder can be placed vertically, and the area occupied can be reduced. That is, there is an effect that a considerable amount of powdered medicine can be accommodated, and the area occupied when installed is small.
  • the drug container has a large-area side surface and a small-area side surface, is taller than it is wide, and has a side portion of the bottom surface and/or a side surface near the bottom surface for discharging the powdered medicine. and a partition member having an opening in the vicinity of the bottom surface. It is desirable that the powdered medicine thus obtained moves between the partition plate and the bottom to reach the powdered medicine discharge section.
  • the medicine container adopted in this aspect has a narrow width and a high height. Therefore, the width of the container is narrow even though it can contain drugs equivalent to those of conventional drug containers.
  • the medicine feeder of this aspect has a narrow width, and many medicine feeders can be arranged in a small space.
  • the powdered medicine discharge part has a slit shape extending in an oblique direction.
  • the drug container has a large-area side surface and a small-area side surface, is taller than its width, and can open the large-area side surface, and the drug container is
  • the medicine container is detachable from the container holding part, and the powder medicine is filled with the large-area side surface opened in a state in which the medicine container is removed from the container holding part.
  • an eaves-like temporary receiving plate is provided in the middle portion of the drug container in the height direction.
  • the weight of the powdered medicine in the upper layer can be supported by the temporary receiving plate, and the powdered medicine in the lower layer is not pressed. Therefore, movement of the powdered medicine is less likely to be hindered when the medicine container is vibrated.
  • a locking mechanism may be provided to lock the opening/closing member in a state where the powdered medicine discharge section is closed, and the locking mechanism may be released by holding the drug container in the container holding section. desirable.
  • the drug is less likely to spill when the drug container is removed from the container holding portion.
  • the container holding portion has a vertical wall, the vertical wall has a holding portion-side engaging portion, and the drug container is engaged by the holding portion-side engaging portion so that the drug container is
  • the drug container is held by the container holding portion, the drug container has an engaging portion, and the container holding portion has a detachment assisting member that engages with the engaging portion and presses the drug container in a direction to detach from the container holding portion. is desirable.
  • the drug container can be easily removed from the container holding portion.
  • the medicine container has a powdered medicine passage connected to the powdered medicine discharge part, the powdered medicine moves in the powdered medicine passage and is discharged from the powdered medicine discharge part, and the powdered medicine passage has a ceiling wall.
  • the opening/closing member has a projecting portion that projects toward the powdered medicine passage when the powdered medicine discharge portion is closed, and the ceiling wall has a partition that projects downward into the dispersion passage, It is desirable that the projecting portion reaches the vicinity of the partition portion when the opening/closing member closes the powdered medicine discharge portion.
  • the opening/closing member when the opening/closing member is opened, the drug is less likely to spill from the powdered drug discharge part. Furthermore, according to this aspect, it is possible to prevent the powdered medicine from splashing out from the powdered medicine passage while the medicine is being dispensed.
  • a weight member is provided, and lifting means is provided for lifting and lowering at least one of the weight member, the weight measuring means, and the drug container, and the load of the weight member is applied to the weight measuring means. It is preferable to compare a state in which the load of the weight member is applied and a state in which the load of the weight member is not applied to the weight measuring means for calibration and/or failure detection of the weight measuring means.
  • the drug container has a vibration detection sensor that detects its own vibration.
  • An invention relating to a medicine dispensing device is a medicine dispensing device that takes out a predetermined amount of powdered medicine from a medicine container, divides it into a predetermined number, packs it individually, and discharges it.
  • a plurality of drug feeders according to any one of the above are installed in the vicinity of the distribution tray, and the powdered drug is discharged from the drug container and put into the drug charging groove of the distribution tray.
  • the conventional drug dispensing device described above has room for improvement in that it is difficult to reduce the size of the entire device and that the operation of dispensing powdered medicine is completed more quickly. That is, in the medicine dispensing device described above, when the execution of the powdered medicine dispensing operation is determined, the powdered medicine is dispensed after moving the medicine container from the storage position to the dispensing position. In other words, it takes time to transport the medicine container, and there is room for improvement in terms of speeding up the operation of dispensing the powdered medicine.
  • one aspect of the related invention of the present invention for solving such problems is a drug container in which powdered drugs in an amount larger than one dose to be dispensed are allocated one to one, and containing powdered drugs,
  • a plurality of drug feeders having a mounting table for holding drug containers, a vibrating device for vibrating the drug containers, and a distribution plate having an input groove for holding powdered drugs and rotated by power, and a plurality of drug feeders. is fixed around a distribution tray, a drug feeder is selected from among a plurality of drug feeders, and one dose of powdered drug is dispensed from the selected drug feeder to the distribution tray. It is a device.
  • one aspect of the above-mentioned related invention has a distribution dish provided with an annular drug feeding groove and rotated by power, and a plurality of drug feeders, wherein the drug feeders are drug containers containing powdered drugs, a loading member for holding the drug container; and a powdered drug discharging means for discharging the powdered drug from the drug container.
  • the drug feeders are drug containers containing powdered drugs, a loading member for holding the drug container; and a powdered drug discharging means for discharging the powdered drug from the drug container.
  • one or a plurality of drug feeders are selected from among the drug feeders, and a predetermined amount of powdered drug is dispensed from the selected drug feeder to a distribution tray.
  • a drug feeder that can be suitably employed in a drug dispensing device that does not have a robot mechanism, and a drug dispensing device equipped with such a drug feeder.
  • FIG. 2 is a perspective view of the periphery of a distribution plate of the medicine dispensing device of Fig. 1;
  • 1 is a perspective view of a drug feeder of an embodiment of the invention;
  • FIG. 4 is a perspective view showing the drug feeder of FIG. 3 with information reading means omitted;
  • FIG. 5 is a perspective view of the drug feeder observed from a direction different from that of FIG. 4;
  • Fig. 10 is a perspective view of the feeder body of the drug feeder with the drug container removed from the holding member;
  • FIG. 4 is a side view of the feeder main body of the drug feeder with the drug container removed from the holding member.
  • FIG. 8 is a side view of the feeder main body showing a model of FIG. 7;
  • FIG. 7 is a perspective view of the feeder body of the drug feeder, with the drug container removed from the holding member and observed from a direction different from that in FIG. 6 ;
  • FIG. 10 is a perspective view of the feeder main body, with the drug container removed from the holding member, observed from a different direction from FIGS. 6 and 9, showing an enlarged outline of the shutter opening/closing mechanism.
  • FIG. 4 is an exploded perspective view of a holding member of the feeder body;
  • FIG. 4 is an exploded perspective view of a holding member of the feeder body;
  • FIG. 4 is an exploded perspective view of the holding member of the feeder body exploded in more detail; (a), (b), and (c) are an explanatory view showing a state from mounting the drug container to the feeder body to discharging the powdered drug, and an enlarged cross-sectional view of a part thereof.
  • 10A is a perspective view of the engaging member of the feeder body shown in FIG. 10, and FIG. (b) is an explanatory diagram showing a state where the engaging piece of the feeder body is retracted into the opening on the left side, and an explanatory diagram showing a state where the engaging piece of the feeder body protrudes from the opening on the right side. is.
  • (a) is a perspective view of the drug container with the lid member opened, and (b) is a front view thereof.
  • FIG. 4 is a perspective view showing a posture when filling powdered medicine into a medicine container.
  • (a), (b), and (c) are front views of the lid portion of the drug container, showing how the lid member is fixed to the container body.
  • (a) is a diagram showing the periphery of the clamping piece with the lid member closed in the drug container described above, the left diagram being a perspective view and the right diagram being a plan view.
  • (b) is a diagram showing the periphery of a clamping piece with the lid member closed in a drug container according to an embodiment different from (a), the left diagram being a perspective view and the right diagram being a plan view.
  • FIG. 4 is an exploded perspective view of the shutter of the drug container; FIG.
  • FIG. 4A is an explanatory view showing the operation of the shutter of the medicine container, where (a) is a perspective view with the shutter closed, and (b) is a perspective view with the shutter open.
  • FIG. 10 is a perspective view showing a state in which the engaging portion of the transmission member of the drug container is engaged with the engaging portion of the shutter opening/closing mechanism; It is an explanatory view showing the positional relationship between the medicine feeder and the distribution tray.
  • (a) is an explanatory diagram showing the spread of the powdered medicine when the shutter is fully opened and the medicine is dropped onto the distribution tray
  • (b) is an explanatory diagram showing the spread of the powdered medicine when the shutter is half-opened and the medicine is dropped onto the distribution tray.
  • FIG. 1 is a bottom view of the drug container when the shutter is fully opened
  • (b) is a bottom view of the drug container when the shutter is half-opened
  • (c) is a bottom view of the drug container when the shutter is closed.
  • (d) is a perspective view of the lower part of the container body and the shutter.
  • (a) is a perspective view showing a state in which a sealing member different from that in FIG. 19 is attached to the shutter member, and shows a state seen from below.
  • (b) is a perspective view showing the sealing member of (a)
  • (c) is a bottom view showing the sealing member of (a).
  • FIG. 26 is a bottom view showing a drug container employing the sealing member shown in FIG. 25, (a) showing a state in which the shutter is fully opened, (b) showing a state in which the shutter is slightly opened, and (c). , indicates that the shutter is closed.
  • FIG. 10 is a bottom view of a drug container according to an embodiment different from the above-described embodiment, where (a) shows a state in which the shutter is fully opened, (b) shows a state in which the shutter is slightly opened, and (c). indicates that the shutter is closed.
  • Fig. 10 is a front view of a drug feeder according to another embodiment of the invention; Fig.
  • FIG. 10 is a perspective view showing the inside of a drug container according to still another embodiment of the present invention, where (a) shows a state in which the shutter of the second partition is closed, and (b) shows a state in which the shutter of the second partition is open; Indicates status.
  • FIG. 30 is an explanatory view showing an opening/closing mechanism of a shutter employed in the medicine container shown in FIG. 29;
  • Fig. 10 is a perspective view of the periphery of the distribution tray of the drug dispensing device according to another embodiment of the present invention;
  • FIG. 4 is an explanatory view showing the positional relationship between the distribution tray and the powdered medicine charging hopper, where (a) shows a state in which the powdered medicine has been sprinkled on the distribution tray, and (b) shows a state in which the disk of the scraping device is placed in the distribution tray. and (c) shows how the powdered medicine is scraped out from the distribution dish.
  • FIG. 10 is a perspective view showing a drug container according to an embodiment different from the above-described embodiment, where (a) shows how the lid member is closed, and (b) shows how the lid member is opened; show.
  • 33(a) is a perspective view showing the medicine container of FIG. 33(a) viewed from another direction, and (b) is a bottom view schematically showing the medicine container of (a).
  • FIG. 33(a) is a cross-sectional view showing the drug container of FIG. 33(a), showing a state in which the lid member and other portions are cut along different cutting planes.
  • Figure 33(a) is an exploded perspective view of the drug container of Figure 33(a);
  • FIG. 37 shows the partition member of FIG. 36, where (a) is a perspective view from below and (b) is a front view; (a) is a plan view schematically showing a medicine feeder and a distribution tray in FIG. 2, and (b) is a perspective view showing a state in which the posture of the tablet hand-dispensing device in FIG. 1 is changed.
  • FIG. 1 is a side view showing a modeled medicine feeder of the second embodiment, and (b) is an exploded perspective view of the shutter opening/closing mechanism.
  • (a), (b), and (c) of the drug feeder of the second embodiment are explanatory diagrams showing how the drug container is attached to the feeder main body.
  • (a), (b), and (c) of the drug feeder of the second embodiment are explanatory diagrams showing how the drug container is removed from the feeder main body.
  • (a) is a cross-sectional view showing a drug container of a third embodiment, and (b) is a cross-sectional view near the shutter when the shutter is open.
  • FIG. 10 is a front view of a drug feeder according to still another embodiment of the present invention, where (a) shows a state in which a drug container is attached to the feeder body, and (b) shows a state in which the drug container is removed from the feeder body; Indicates status.
  • Fig. 10 is a front view of a feeder body according to still another embodiment of the present invention, where (a) shows the state of the feeder body when the drug container is attached to the feeder body, and (b) shows the feeder body when the drug container is attached to the feeder body; 2 shows the state of the feeder body when removed from the body.
  • FIG. 11 is an exploded perspective view of the shutter of the drug container of the third embodiment;
  • FIG. 46 shows the partition member of FIG.
  • FIG. 45 where (a) is a perspective view from below and (b) is a front view; It is a figure which shows the modification of a partition member, (a) is the perspective view, (b) is sectional drawing of the horizontal part of a partition plate.
  • 1 is a front view of an electronic display; FIG. It is a perspective view of the medicine dispensing device showing a modification of the upper lid, (a) shows a state in which the cover is closed, and (b) shows a state in which the cover is opened. It is a perspective view of the drug dispensing device showing another modification of the upper lid, (a) shows a state in which the cover is closed, and (b) shows a state in which the cover is opened.
  • FIG. 5 is a perspective view showing a state in which the weight calibration unit of FIG. 4 is viewed from another direction;
  • FIG. 52 is an exploded perspective view of the weight calibration unit of FIG. 51; It is a figure which shows the upper guide member of FIG. 51, (a) is a perspective view observed from the downward side, (b) is sectional drawing.
  • 5A to 5C are explanatory diagrams schematically showing the operation when the weight calibration unit shown in FIG. 4 shifts from the first state to the second state, and shifts in the order of (a) to (c).
  • 53A is a perspective view showing a weight according to an embodiment different from FIG. 52
  • FIG. 53B is a perspective view showing a weight support member according to an embodiment different from FIG.
  • (a) is an explanatory view schematically showing a drug feeder according to a further different embodiment
  • (b) is a schematic diagram showing how the drug feeder in (a) shifts from the first state to the second state. It is an explanatory diagram schematically shown.
  • 3A is a perspective view of a calibration instrument that can be attached to the scraping device of FIG. 2, and FIG. ) is an explanatory diagram showing an exploded calibration instrument.
  • 58(a) is an explanatory diagram schematically showing how a weight member is supported by the calibration instrument shown in FIG. 57
  • FIG. 58(b) is a diagram showing a vibration-side horizontal movement of the weight member by the calibration instrument shown in FIG. FIG.
  • FIG. 10 is an explanatory view schematically showing how the device is placed on the part; It is explanatory drawing which shows typically the medicine feeder which concerns on further another embodiment, (a) shows a 1st state, (b) shows a 2nd state.
  • (a) is an explanatory diagram schematically showing a state in which a weight correcting unit according to still another embodiment is adopted in a drug dispensing device.
  • (b) is an explanatory view schematically showing the periphery of one weight member when the left figure is in the first state, and the right figure is one weight member when in the second state. It is an explanatory view showing the periphery typically.
  • FIG. 10 is an explanatory view schematically showing the main part of the medicine dispensing device according to still another embodiment, showing how powdered medicine is discharged from the medicine feeder to the distribution tray and failure detection operation is executed.
  • FIG. 62 is a diagram showing how the medicine dispensing device shown in FIG. 61 performs a failure detection operation different from that in FIG. 61;
  • FIG. 4 is an explanatory diagram schematically showing a specific procedure of discharging operation for discharging powdered medicine from a medicine feeder to a distribution tray, and the discharging operation is executed in the order of (a) to (k).
  • 9A is a perspective view showing a simpler model of the container supporting portion shown in FIG. 8, and
  • FIG. 9B is a perspective view showing a simpler model of the medicine container shown in FIG.
  • FIG. 65 is a circuit diagram of the vibration detection sensor of FIG. 64; (a) is a logic table showing the inspection mode when inspecting the vibration state of the medicine feeder, and (b) is a circuit diagram for switching the vibration detection sensor, showing connection of each switch when the inspection mode is N. (c) is a circuit diagram for switching the vibration detection sensor and shows the connection state of each switch when the inspection mode is F1.
  • the drug dispensing device 1 according to the embodiment of the present invention will be further described below.
  • the vertical positional relationship is based on the normal installation state (state shown in FIG. 1).
  • the outline and rough operation of the drug dispensing device 1 will be described first, and then each member and device will be described in detail.
  • the drug dispensing device 1 of this embodiment is surrounded by a housing 2, and the interior is divided into a tablet hand-dispensing area 300, a powdered medicine division area 301, and a medicine packaging area 302. ing.
  • the housing 2 has an upper lid 3 as shown in FIG.
  • the upper lid 3 is attached to the main body of the housing 2 with a hinge (not shown).
  • a tablet manual distribution device 303 is provided in the tablet manual distribution area 300 .
  • This tablet hand-dispensing device 303 is positioned above a distribution plate 6, a medicine feeder 5, etc., which will be described later. Since the tablet manual distributing device 303 is well known, a detailed description thereof will be omitted.
  • the medicine packaging area 302 incorporates a medicine packaging device 305 as conceptually shown in FIG.
  • the medicine packaging device 305 is a machine for packaging medicines for each dose, and has a packing paper supply device 306 (packaging paper feeding section) and a packing device 308 (sealing section).
  • the drug packaging device 305 is also provided with a powdered drug charging hopper 310 above the packaging device 308 for charging the drug.
  • a powdered drug charging hopper 310 is shown at a position away from the distribution tray 6 for drawing purposes, the upper end of the powdered medicine charging hopper 310 is actually within the equipment storage opening 15 of the distribution tray 6 .
  • the drug packaging device 305 is used by attaching roll paper to the attachment portion of the main body (not shown) of the packaging paper supply device 306 .
  • the roll paper is formed by winding a band-shaped packing paper (wrapping paper) around a tubular core member to form a roll.
  • the roll paper of the present embodiment is a roll of packaging paper that is folded in two and has a strip shape.
  • the medicine packaging device 305 has a printing mechanism (printing section) (not shown). In the drug packaging device 305, the packaging paper fed out from the roll paper is introduced into the printing mechanism, and information such as the patient name, drug name, date and time of administration (information related to prescription and information related to the drug to be provided) is printed. .
  • the packaging sheet on which the predetermined information is printed is opened upward.
  • the medicine (powder medicine) dropped (supplied) from the powder medicine introduction hopper 310 is received.
  • the packaging paper containing the drug is introduced into the sealing section (packaging device 308) and sealed in the vertical and horizontal directions by the sealing section to sequentially package the received drugs.
  • a drug package containing a single dose of drug is formed, and the drug package is transported to the outside of the apparatus.
  • a drug packaging band is formed in which a plurality of drug packages are continuously packed, and the band is conveyed to the outside of the apparatus.
  • the drug packaging band one or more individual drug packages may be formed and delivered to the outside of the apparatus.
  • the above-described horizontal direction is the delivery direction (delivery direction) of the packaging paper
  • the vertical direction is the direction crossing (perpendicular to) the delivery direction of the packaging paper.
  • an identifier may be attached to the core member of the roll paper described above.
  • the identifier is information that can individually identify the roll paper (information on the manufacturer, etc. (manufacturer name, etc.), information on the date of manufacture, etc., type of roll paper wound around the core, order number, shipping date , customer information of the delivery destination, the model name and model code of the packaging machine to which the roll paper is attached, other IDs, etc.), and may be, for example, a memory such as an IC tag.
  • a code such as a one-dimensional code (bar code) or a two-dimensional code may be used, and when a code is employed, it may be attached to a label.
  • the packaging paper supply device 306 an operation is executed to check with the device to be loaded, that is, to determine whether or not the predetermined roll paper is to be loaded into the device correctly. good too. Further, information for identifying that the roll paper is unused may be stored in the identifier, and an operation for determining whether the roll paper is unused may be executed when the roll paper is loaded. Further, information regarding the remaining amount of packaging paper when the roll paper (packaging paper roll) is attached to the main body of the packaging paper supply device 306 may be stored. Further, when the packaging operation of packaging the medicine is executed, the remaining amount at an appropriate time during the packaging operation may be stored. Information about this remaining amount may be stored, for example, during the packaging operation. In addition, after the packaging operation, the remaining amount at the end of the packaging operation may be stored. That is, when operating the medicine dispensing device 1, information about the remaining amount may be stored at appropriate timing.
  • the powdered medicine division area 301 is an area where the distribution tray 6 is installed, and the medicine feeder 5 and the cleaning device 7 are arranged around it.
  • a scraping device 8 is provided in the powdered medicine dividing area 301 .
  • the distribution pan 6 and scraping device 8 are well known and will be briefly described.
  • the distribution plate 6 is a disk-shaped member provided with a medicine injection groove 13 (injection groove), which is also referred to as a "concave groove".
  • the drug introduction groove 13 surrounds the outer edge of the distribution plate 6 in an annular shape.
  • the distribution plate 6 is provided with an equipment storage opening 15 in the center. In addition, in FIG. 2, most of them are covered with a lid.
  • the above-described powdered medicine charging hopper 310 is installed in the equipment storage opening 15 .
  • the distribution dish 6 can be rotated at a constant speed. It can also be rotated by a predetermined angle.
  • the raking device 8 has a rotary plate 12 (see FIG. 2) at the tip of a raking arm 17 (see FIG. 57(b), etc.). Specifically, a mounting base 255 (see FIG. 57(b), etc.) that can be rotated by a motor is provided at the tip of the scraping arm 17, and a scraping plate or the like (not shown) is attached to the mounting base 255. ) is mounted thereon. That is, the rotating plate 12 is rotated by the power of the motor. A root portion of the scraping device 8 is installed on a turntable (not shown) in the equipment storage opening 15 of the distribution plate 6 . A scraping arm 17 of the scraping device 8 protrudes from the center of the distribution plate 6 .
  • the scraping device 8 can be turned as a whole by rotating the turntable. Also, the scraping arm 17 can swing vertically. Note that the scraping device 8 may be one in which the turntable is not provided, the whole is not swivel, and the scraping arm 17 is swingable.
  • the upper opening serving as the drug input port of the powdered drug input hopper 310 is positioned inside the distribution plate 6 . That is, the distribution tray 6 continues in an annular (annular) fashion outside the powdered medicine charging hopper 310, and the powdered medicine charging hopper 310 is located in an area surrounded by the distribution tray 6 in a plan view.
  • the scraping device 8 is also positioned inside the distribution plate 6 . When the powdered medicine on the distribution tray 6 is scraped out by the scraping device 8 and put into the powdered medicine charging hopper 310 , the powdered medicine is scraped out toward the inside of the distribution tray 6 .
  • the rotary plate 12 is rotated to move the scraping plate so as to move the powdered medicine on the distribution tray 6 to the inside of the distribution tray 6 (the scraping plate moves from the outer edge side to the inner edge side of the distribution tray 6). rotating plate 12 so as to move in the transverse direction).
  • the scraping device 8 is provided inside the distribution tray 6 and the powdered medicine is scraped out toward the inside of the distribution tray 6, thereby reducing the number of members outside the distribution tray 6.
  • the drug feeder 5 has a feeder section 22 provided with a weight calibration section 21.
  • the drug feeder 5 also has an information read/write means 66 (see FIG. 3) capable of reading and writing information to and from an information storage means 65 (see FIG. 4), which will be described later. 4 to 10, the feeder section 22 has a medicine container 20 containing powdered medicine and a feeder body 10 holding the medicine container 20.
  • the feeder body 10 is mechanically divided into a container support portion 23, a weight measurement portion 24, and a base portion 26.
  • FIG. shown in FIG.
  • the container support section 23 has a support base 27, a vibrating member 16 (container holding section), and vibrating means 30a and 30b.
  • the vibrating means 30a and 30b are piezoelectric elements and have a plate shape.
  • the vibrating member 16 and vibrating means 30a and 30b are also vibrating devices for vibrating the drug container 20. As shown in FIG.
  • the support base 27 and the vibrating member 16 are both "L" shaped members having a horizontal portion and a vertical wall portion. That is, the support table 27 has a support-side horizontal portion 30 and a support-side vertical wall portion 31, as shown in FIGS.
  • the vibration member 16 also functions as a container holding portion, and has a vibration-side horizontal portion 32 and a vibration-side vertical wall portion 33 (vertical wall).
  • the vibration-side vertical wall portion 33 is provided with an engaging portion (holding portion-side engaging portion, which is a groove-shaped engaging portion 48 (trapezoidal engaging portion 47) described later) that engages with the drug container 20.
  • Two pieces (holding portion side engaging portions) 50 are provided.
  • the support base 27 and the vibrating member 16 are connected by two vibrating means 30a and 30b. There is substantially no contact between the vibration-side horizontal portion 32 and the support-side horizontal portion 30 . Therefore, when the vibrating means 30a and 30b are energized, the vibrating member 16 vibrates.
  • a weight measurement section 24 is arranged below the container support section 23 .
  • the weight measurement unit 24 includes weight measurement means 25 and vibration isolation means 18 .
  • the weight measuring means 25 is a known load cell.
  • the vibration isolation means 18 has a vibration isolation member 28 .
  • a detecting portion of the weight measuring means 25 is connected to the container supporting portion 23 (the supporting base 27, the vibrating member 16, and the vibrating means 30a and 30b). Further, the base portion 26 supports the upper members (the support base 27, the vibrating member 16, and the vibrating means 30a and 30b) via the vibration isolating member 28 of the weight measuring portion 24. As shown in FIG.
  • the weight of container support portion 23 is detected by weight measuring means 25 .
  • the weight of the anti-vibration means 18 hangs on the base portion 26 but does not hang on the weight measuring means 25 . Therefore, the weight of the container support portion 23 (the support base 27, the vibrating member 16, the vibrating means 30a and 30b) is detected by the weight measuring means 25. FIG. (which is measurable).
  • the drug container 20 is a container filled with powdered medicine, and has a rectangular parallelepiped shape with substantially square side surfaces.
  • the drug container 20 is surrounded by a front wall 35, a rear wall 36, left and right side walls 37, a top wall 38 and a bottom wall 40, as shown in FIGS.
  • An openable and closable powdered medicine discharge part 11 is located near the front wall 35 of the medicine container 20 at the bottom wall 40 .
  • there are engagement portions (engagement groove 130 and engagement recess 131, see FIG. 6) on the vertical sides and lower portion of the rear wall 36 .
  • the medicine container 20 is filled with powdered medicine and fixed to the feeder body 10 as shown in FIGS. That is, the back wall 36 of the drug container 20 is in contact with the vibration side vertical wall portion 33 (vertical wall) of the vibrating member 16 serving as the container holding portion, and the back wall 36 side of the bottom wall 40 of the drug container 20 is in contact with the vibration side horizontal portion 32 . , most of the drug container 20 is fixed to the feeder body 10 in a cantilevered state. In other words, the vibration-side horizontal portion 32 is also a mounting member (mounting table) on which at least part of the drug container 20 is mounted.
  • the engaging portion of the medicine container 20 engages with two engaging portions (a groove-shaped engaging portion 48 (trapezoidal engaging portion 47 holding portion side engaging portion) described later) of the vibrating member 16, respectively. These are two of the pieces (holding portion side engaging portions) 50, and are engaged with the pieces (see FIG. 10). Therefore, the drug container 20 is integrated with the vibrating member 16 and vibrates together with the vibrating member 16 .
  • information storage means 65 is attached to one of the two left and right side walls 37 (see FIG. 4).
  • Information on the drug container 20 (information on the powdered medicine contained in the drug container 20) is stored in the information storage means 65 .
  • information storage means 65 stores identification information (information such as drug name and various codes) that identifies the stored medicine, and remaining amount information about the current remaining amount of the stored medicine.
  • the information stored in the information storage means 65 is information that can be used in association with prescription data and the like. It becomes possible to perform a specified operation.
  • This information storage means 65 may be a memory such as an IC tag. Also, a code such as a one-dimensional code (bar code) or a two-dimensional code may be used, and when a code is employed, it may be attached to a label.
  • the medicine feeder 5 has the information reading/writing means 66 (see FIG. 3) capable of reading and writing information to/from the information storage means 65, as described above.
  • an RFID reader/writer is employed as the information reading/writing means 66, and information can be read from/to the information storage means 65 by wireless communication.
  • An operation of reading the cassette information from the information storage means 65 and an operation of writing (rewriting) the remaining amount after dispensing the powdered medicine from the medicine container 20 are possible.
  • the cassette information is information about the drug container 20 described above, and includes, for example, the drug name and remaining amount.
  • the information reading/reading means 66 is located outside the information storage means 65 when the medicine container 20 is attached to the feeder main body 10, and is arranged at a position slightly separated from the information storage means 65 (see FIGS. 3 and 5). See Figure 4). In place of the information reading/writing means 66, it is conceivable to provide an information reading means, an information writing means, etc. capable of reading and writing information respectively.
  • the weight calibration section 21 detects whether or not the weight measuring means 25 is normal.
  • the weight calibration unit 21 includes a weight 42 (weight member, weight for calibration), a weight mounting member 43 (weight receiver) on which the weight 42 is mounted, and a weight for lifting the weight 42 into the air. It has a support member 45 (see FIG. 51).
  • the weight placement member 43 is fixed to the container support portion 23 of the feeder body 10 via an attachment member. Therefore, the weight of the weight mounting member 43 is added to the weight measuring means 25.
  • the weight support member 45 is arranged so that a load is applied to the base portion 26 of the feeder body 10 (see FIGS. 51 and 52). The weight of the weight support member 45 is therefore not added to the weight measuring means 25 .
  • the drug container 20 has a front wall 35 side (see FIG. 6 and the like) protruding toward the distribution plate 6 , and the powdered drug discharge section 11 is positioned directly above the drug introduction groove 13 .
  • the medicine container 20 of each medicine feeder 5 is filled with different medicines in advance. Then, based on a prescription (prescription data, which is information about prescription), a specific drug feeder 5 is driven, and powdered drugs are put into the distribution tray 6 . Specifically, according to a signal from a control device (not shown), a current of a constant frequency is applied to the vibrating means 30a and 30b of a specific drug feeder 5 to generate vibration, and the vibrating member 16 (container holding portion) is caused by this vibration. to vibrate. In addition, the distribution plate 6 is rotated before and after the start of vibration.
  • the weight of the medicine container 20 is measured before and after the start of the vibration.
  • the weight of the medicine container 20 is obtained by subtracting a certain value from the weight detected by the weight measuring means 25 . More specifically, the weight of the drug container 20 is calculated from the weight detected by the weight measuring means 25 by the member including the container supporting portion 23 and part of the weight calibrating portion 21 (the load is applied to the weight measuring means 25). material) is subtracted.
  • the weight of the medicine container 20 before the powdered medicine is discharged is stored as the original weight G.
  • the weight of the drug container 20 is constantly monitored. That is, the current weight of the drug container 20 is monitored as the current weight g.
  • the drug container 20 vibrates together.
  • the drug container 20 is provided with two engaging portions (a groove-shaped engaging portion 48 (trapezoidal engaging portion 47 holding portion side engaging portion) described later). 10) of the vibrating member 16, and the degree of close contact with the vibrating member 16 is high. 20 vibrates at the same frequency as vibrating member 16 . As a result, the powdered medicine stored in the medicine container 20 slowly moves toward the powdered medicine discharging part 11 side.
  • the powdered medicine falls from the powdered medicine discharge part 11 and enters the medicine input groove 13 of the distribution plate 6 below.
  • the weight of the medicine container 20 decreasing The fact that the powdered medicine is falling is confirmed by the weight of the medicine container 20 decreasing. That is, in this embodiment, the current weight of the medicine container 20 is continuously monitored as the current weight g even while the powdered medicine is falling from the medicine container 20 .
  • the original weight G of the drug container 20 immediately after being placed on the vibrating member 16 is compared with the current weight g, and the falling amount H of the powdered medicine (the discharged amount of the powdered medicine, G minus g) is always calculated. Then, the vibration of the vibrating member 16 is stopped when the total dropping amount H of the powder medicine reaches the desired weight.
  • the rotating plate 12 of the scraping device 8 is dropped into the medicine charging groove 13 of the distribution plate 6.
  • the distribution plate 6 is rotated by an angle corresponding to the number of distribution, and the powdered medicine for one dose is collected on the front side of the rotary plate 12.
  • the rotating plate 12 is rotated, and the powdered medicine is scraped out of the distribution tray 6 by a scraping plate (not shown) and put into the powdered medicine feeding hopper 310 .
  • the powdered medicine dropped from the powdered medicine feeding hopper 310 is packaged by the medicine packaging device 305 for each dose.
  • the medicine dispensing device 1 of the present embodiment is capable of packaging the medicine by one dose in the same manner as a well-known medicine dispensing device. Further, the container support portion 23 functions as powdered medicine discharge means for discharging the powdered medicine from the medicine container 20 .
  • the series of drug discharge operations described above is performed while the weight 42 is lifted by the weight support member 45 of the weight calibration unit 21 . Therefore, the weight of the weight 42 is not detected by the weight measuring means 25 .
  • the weight supporting member 45 is operated to place the weight 42 on the weight placing member 43 (details will be described later). As a result, the weight of the weight 42 is applied to the weight measuring means 25, and the weight of the weight 42 is detected.
  • the weight measuring means 25 is normal if the increase in the detected weight due to the weight 42 being placed is equal to the value of the weight of the weight 42 stored in advance.
  • the weight measuring means 25 is out of order. That is, in calibrating the weight measuring means 25, a weight obtaining step is performed to obtain an increase in the detected weight (the weight of the weight 42) due to placing the weight 42 thereon.
  • Feeder body 10 The feeder body 10 is divided into the container support portion 23, the weight measuring means 25, and the base portion 26, as described above. Further, the container support section 23 has a support base 27, a vibrating member 16 (container holding section), and vibrating means 30a and 30b.
  • the external shape of the vibrating member 16 is as shown in FIGS. 4 to 12, and is substantially "L" shaped. That is, the vibration member 16 has a vibration-side horizontal portion 32 and a vibration-side vertical wall portion 33 as a vertical wall.
  • the vibration-side vertical wall portion 33 has a body portion 63 made of metal and a lining member 46 made of resin.
  • the lining member 46 has a substantially rectangular plate shape as a whole, and has an engaging portion 47 on the surface side.
  • the engaging portion 47 has a trapezoidal shape that is close to a rectangle when viewed from the front. However, there is a bulging portion 58 at the bottom of one oblique side.
  • a dovetail groove-shaped engaging portion (holding portion-side engaging portion) 48 is provided on a side corresponding to the oblique side of the trapezoidal shape.
  • each recess 132 forms an inclined surface 133 .
  • the inclined surface 133 is inclined such that the lower side is closer to the back side than the upper side.
  • the inclined surface 133 functions as a seating surface for mounting the vibrating means 30a and 30b.
  • a substantially rectangular opening 51 is provided on the front surface of the engaging portion 47 and in the lower portion thereof.
  • An engaging piece 50 is accommodated in the opening 51 .
  • the engaging piece 50 is connected to the loading/unloading mechanism and projects from the opening 51 .
  • the vibration-side horizontal portion 32 is a plate-like member made of metal.
  • a shutter opening/closing mechanism 55 (opening/closing mechanism portion) is provided on one side portion of the vibration-side horizontal portion 32, as shown in FIGS.
  • the shutter opening/closing mechanism 55 is an opening/closing mechanism for discharging a fixed amount of powdered medicine from the medicine container 20 .
  • the shutter opening/closing mechanism 55 is composed of an engagement piece holding portion 56 and an arm 57 as shown in FIGS. It also has a power unit that operates (linearly moves) the arm 57 . This power unit is composed of a motor and the like.
  • the engaging piece holding portion 56 has a substantially rectangular parallelepiped shape, and has a concave portion that serves as an engaging portion 60 on the upper surface thereof.
  • One end of the arm 57 is connected to the engagement piece holding portion 56 , and the other end is accommodated in the vibration-side vertical wall portion 33 . And it is connected to the loading/unloading mechanism described above.
  • the feeder body 10 of this embodiment has an engaging member 210 (see the left diagram of FIG. 14(a)), the upper portion of which constitutes an engaging piece 50. do. That is, the engaging member 210 has an upper engaging piece forming portion 210a that forms the engaging piece 50, a lower contact portion 210b, and an intermediate portion 210c that connects them.
  • the engaging member 210 is constantly urged in the direction from the support-side vertical wall portion 31 toward the vibration-side vertical wall portion 33 by an urging member such as a coil spring.
  • the engaging piece holding portion 56 has a pressing projection portion 56a (see the right figure in FIG. 14(a)) on its side surface.
  • the engagement piece holding portion 56 is positioned near the vibration side vertical wall portion 33, as shown in the left diagram of FIG. It is pressed in a direction toward the wall portion 33 .
  • the engaging member 210 is pressed against the urging force, and the engaging piece 50 is recessed into the opening 51 .
  • the engaging piece holding portion 56 is moved away from the vibration-side vertical wall portion 33, the engaging member 210 is pressed by the biasing member as shown in the right diagram of FIG. is moved, and the engagement piece 50 protrudes from the opening 51 .
  • the engaging member 210 moves within the groove (recess) formed in the vibration-side horizontal portion 32 .
  • the external shape of the support base 27 is as shown in FIGS. 12 and 13, and is substantially "L" shaped. That is, the support base 27 has a support-side horizontal portion 30 and a support-side vertical wall portion 31 .
  • the support-side vertical wall portion 31 also has an inclined surface (not shown) on the front side thereof, and the inclined surface functions as a seat surface for mounting the vibrating means 30a and 30b.
  • a vibrating member 16 is mounted on a support base 27 , and a vibrating horizontal portion 32 is on a supporting horizontal portion 30 .
  • the convex side of the vibration-side vertical wall portion 33 faces the concave side of the support-side vertical wall portion 31 .
  • the concave side of the support-side vertical wall portion 31 and the convex side of the vibration-side vertical wall portion 33 are connected by two vibrating means 30a and 30b. Both of the vibrating means 30a and 30b are attached so that the support-side vertical wall portion 31 side is upward and the vibrating-side vertical wall portion 33 side is downward. There is substantially no contact between the vibration-side horizontal portion 32 and the support-side horizontal portion 30 .
  • the weight measurement unit 24 includes weight measurement means 25 and vibration isolation means 18 .
  • the vibration isolation means 18 is composed of a vibration isolation frame 135 and a vibration isolation member 28 .
  • the anti-vibration frame 135 has a high frame 136 and a support base 137, as shown in FIG.
  • the high frame 136 has anti-vibration member attachment plates 140 arranged in parallel.
  • the support base portion 137 is provided at a position below the high portion frame 136 between the anti-vibration member mounting plates 140 .
  • the vibration isolating members 28 are attached to the four corners of the vibration isolating member mounting plate 140 on the lower side.
  • the weight measuring means 25 is fixed on the support base portion 137 . Since the support base 137 is located below the high frame 136, most of the weight measuring means 25 is located below the high frame 136, but the upper surface of the weight measuring means 25 is located above the high frame 136. It is positioned above the frame 136 .
  • the base portion 26 is a plate-like member made of metal, and has a recess in the center.
  • a container supporting portion 23 is fixed to the upper surface of the weight measuring means 25 of the weight measuring portion 24 .
  • the support-side horizontal portion 30 of the container support portion 23 is fixed to the upper surface of the weight measuring means 25 projecting from the high portion frame 136 .
  • a vibration isolating member 28 of the weight measuring section 24 is installed on the base section 26 .
  • what is placed on the upper surface of the weight measuring means 25 is the container supporting portion 23 (the supporting table 27, the vibrating member 16, and the vibrating means 30a and 30b). can be accurately measured.
  • the feeder body 10 of this embodiment has a container holding portion that holds the drug container 20 and an upright support portion (support side vertical wall portion 31). wall portion 33), and vibrating means 30a and 30b are provided between the support portion and the vertical member.
  • the feeder main body 10 of this embodiment has vibrating means 30 a and 30 b on one side of the drug container 20 . That is, the medicine container 20 and the vibrating means 30a, 30b are arranged side by side. Therefore, compared to a layout in which the vibrating means 30a and 30b are located under the drug container 20, the drug container 20 can be placed at a lower position, and the powdered drug discharging portion 11 of the drug container 20 can be brought closer to the distribution plate 6. , can reduce splashing of powdered medicine.
  • the drug container 20 has a sealable container body 70 . 6 and 15, the drug container 20 has a partition plate 68 (partition member), a rectifying member 72, and a shutter structure portion 73 inside.
  • the external shape of the container body 70 is an elongated box-like member when viewed from the front side (the powdered medicine discharge section 11 side) with respect to the orientation of the feeder body 10 attached to the container support portion 23 .
  • the container main body 70 is a rectangular parallelepiped with a substantially square side surface. That is, the drug container 20 has a large-area side surface 61 and a small-area side surface 62, and the height H is high with respect to the width W.
  • the container body 70 is surrounded by a front wall 35 , a rear wall 36 , left and right side walls 37 , a top wall 38 and a bottom wall 40 .
  • the front wall 35 and the rear wall 36 are small area side surfaces 62 and are vertically long rectangles.
  • the left and right side walls 37 have a rectangular shape close to a square, and are large-area side surfaces 61 .
  • the top wall 38 and bottom wall 40 are rectangular.
  • the rear wall 36 is provided with a pair of engaging grooves 130 and one engaging recess 131 as shown in FIGS.
  • the engaging grooves 130 are vertical grooves that open inward along the left and right vertical sides of the back wall 36 .
  • the engagement recess 131 is a depression provided in the lower portion of the rear wall 36 .
  • the slope of the end of the missing portion 77 is a combination of a steep slope portion 150 and a gentle slope portion 151 .
  • the container body 70 is composed of a box portion 71 with one side open and a lid member 75 .
  • the box portion 71 constitutes five walls of the container body 70 excluding one side wall.
  • a packing (not shown) is attached to the opening of the box portion 71 .
  • An engaging portion 81 is provided on the opening side of the front wall 35 of the box portion 71 as shown in FIG.
  • the lid member 75 constitutes one of the walls of the container body 70 (the large-area side surface 61).
  • the lid member 75 is swingably attached to the back wall 36 of the box portion 71 via a hinge 120 (see FIG. 15(a)).
  • a tightening member 76 is provided on the free end side of the lid member 75 .
  • the tightening member 76 employs toggle-type tightening means, and includes a tightening piece 78 that can swing via a hinge 121 (see FIG. 15(a)).
  • An engaging recess 80 is provided inside the tightening piece 78 .
  • the tightening piece 78 has a substantially triangular prism-like outer shape, and the thickness decreases toward the free end side.
  • the tightening piece 78 has an inclined surface on the side opposite to the front wall 35 side in the closed state. It adheres without gaps.
  • a notch portion 78a is formed on the free end side of the tightening piece 78, and the portion adjacent to the notch portion 78a (the portion located on the base end side of the tightening piece 78) is the front wall 35. A minute gap (not shown) is formed between them. Then, a part of an external device or jig is inserted into this gap from the notch portion 78a, and the posture of the tightening piece 78 is changed to release the tightened state.
  • the cutout portion 78a and the gap adjacent to the cutout portion 78a are sized so that a general adult's finger cannot be inserted therein.
  • a drug container that assumes that the tightened state (locked state) is manually released may be employed.
  • This medicament container differs from the medicament container 20 described above in that a clamping piece 278 is provided. Therefore, in the tightened state, a gap 279 is formed between the tightening piece 278 and the front wall 35 as shown in FIG. 18(b).
  • This gap 279 is a relatively large gap, and is of a size that a general adult's finger can easily enter. More specifically, when the clamping piece 278 in the clamped state is viewed from above, half or more of the edge portion of the clamping piece 278 on the side of the front wall 35 is located away from the front wall 35 .
  • the gap 279 is widest on the free end side of the tightening piece 278 (upper side in FIG. 18), and gradually increases toward the base end side (lower side in FIG. 18). narrow.
  • the tightened state (locked state) can be released by the user inserting a finger into the gap 279 to change the posture of the tightening piece 278 .
  • the partition plate 68 (partition member) is formed by bending a belt-like plate, and as shown in FIG. have.
  • the partition plate 68 (partition member) has a horizontal portion 146 in the central portion, a large inclined portion 143 and a small inclined portion 145 formed on both sides thereof, and contact wall portions 141 and 142 formed on both sides thereof. is.
  • the horizontal portion 146 assumes a horizontal posture when installed in the container body 70, and is provided with a large number of small holes (openings) 146.
  • the small hole (opening) 146 employed in this embodiment has a slit shape extending in the width W direction of the container body 70 .
  • the large inclined portion 143 and the small inclined portion 145 are portions inclined toward the horizontal portion 146 when installed on the container body 70 , and the large inclined portion 143 is longer than the small inclined portion 145 .
  • the inclination angles of the inclined portions 143 and 145 are the same.
  • the contact wall portions 141 and 142 are portions that assume a vertical posture when installed on the container body 70 .
  • the rectifying member 72 is a coil-shaped member.
  • the shutter structure 73 is composed of a guide member 90, a shutter member 91 (opening/closing member), a transmission member 92, and a biasing member 93, as shown in FIG.
  • the guide member 90 is a member having a concave side surface, and has an upper horizontal wall 95, a lower horizontal wall 96, and a back wall 97 connecting the two.
  • the shutter member 91 has a closing wall 110, a guide wall portion 111, a connecting wall 112, and a stopper wall 113, as shown in FIGS.
  • a sealing member (packing) is attached to a position above the closing wall 110 .
  • the closing wall 110 assumes a horizontal position when installed.
  • Closing wall 110 has a hypotenuse 138 .
  • the guide wall portion 111 is a wall surface parallel to the closing wall 110 .
  • the connecting wall 112 is a vertical wall that connects the guide wall portion 111 and the closing wall 110 .
  • a concave shape is formed by the closing wall 110 , the connecting wall 112 and the guide wall portion 111 .
  • the stopper wall 113 is a small wall vertically rising from the free end side of the guide wall portion 111 .
  • the transmission member 92 is a stick-shaped member. In this embodiment, it is made of an elongated metal plate. A shutter-side mounting portion 118 is provided at one end of the transmission member 92 . A notch portion 115 is provided at the other end of the transmission member 92 , and a portion ahead of the notch portion 115 serves as an engaging portion 116 . The transmission member 92 is integrated with the shutter member 91 by attaching the shutter side attachment portion 118 to the shutter member 91 .
  • the biasing member 93 is a spring.
  • the partition plate 68 (partition member) and the rectifying member 72 are housed inside the container body 70 .
  • the shutter structure 73 is mostly inside the container body 70 and only the transmission member 92 extends along the outer surface of the container body 70 .
  • the partition plate 68 (partition member) is configured such that the contact wall portion 142 is fixed inside the front wall 35 of the container body 70 and the contact wall portion 141 is fixed inside the rear wall 36 of the container body 70, and the container It is fixed to the body 70 .
  • the inclined portions 143 and 145 and the horizontal portion 146 of the partition plate 68 (partition member) are suspended from the front wall 35 and the rear wall 36 of the container body 70 as if they were suspended therefrom.
  • the large inclined portion 143 of the partition plate 68 (partition member) is located from the front wall 35 to the center of the container body 70 .
  • the horizontal portion 146 is in the vicinity of the bottom wall 40 of the container body 70, but is not in contact with the bottom wall 40, and a powdered drug passage 117 is formed between the two through which the powdered drug passes.
  • the shutter structure portion 73 is accommodated on the lower side of the large inclined portion 143 .
  • the guide member 90 of the shutter structure 73 is arranged with the back wall 97 facing the rear wall 36 side.
  • the shutter member 91 is oriented such that a concave portion formed by the closing wall 110 , the connecting wall 112 and the guide wall portion 111 is engaged with the concave portion of the guide member 90 . That is, the lower surface of the guide wall portion 111 of the shutter member 91 is in contact with the lower horizontal wall 96 of the guide member 90 . Also, the closing wall 110 of the shutter member 91 is in contact with the outside of the bottom wall 40 of the container body 70 .
  • the biasing member 93 is located between the inner surface of the front wall 35 of the container body 70 and the stopper wall 113 of the shutter member 91 and biases the shutter member 91 toward the inner wall 97 of the guide member 90 .
  • the transmission member 92 is located outside the container body 70 as described above and extends along the side wall toward the rear wall 36 side.
  • the transmission member 92 is integrated with the shutter member 91 , and when the transmission member 92 is slid in the front-rear direction of the container body 70 , the shutter member 91 also linearly moves.
  • the recessed portion of the shutter member 91 is in contact with the guide member 90 and the container body 70, and is restricted by these to move linearly.
  • the closing wall 110 of the shutter member 91 covers the missing portion 77 in the lower portion of the container body 70 and closes the missing portion, which is the opening through which the powdered medicine is discharged. Block 77.
  • the closing wall 110 of the shutter member 91 leaves the inclined side of the missing portion 77 in the lower portion of the container body 70 (the oblique side on the side of the back wall 36 ). opens at the bottom.
  • the opening end of the missing portion 77 of the container body 70 (the portion of the missing portion 77 on the front wall 35 side of the bottom wall 40) is inclined, and the free end of the shutter member 91 is also an inclined side 138, so that the powdered medicine
  • the opening that serves as the discharge portion 11 is a slit 148 in an oblique posture as shown in FIGS. 24(a) and 24(b).
  • the drug feeder 5 of this embodiment can adjust the degree of opening of the width of the slit 148, and the degree of opening can be changed (control to adjust the degree of opening) based on a signal from a control device (not shown). ing. This control is also control of the moving distance of the transmission member 92 .
  • the degree of opening of the slit 148 may be changed according to (based on) the type of drug to be discharged from the drug container 20 (the type of powdered drug, flowability, particle size, etc.) and the discharge amount of the drug. .
  • the shutter member 91 is pressed by a biasing member 93 in a direction in which the powdered medicine discharge portion 11 is closed, and the powdered medicine discharge portion 11 is opened by moving the transmission member 92 toward the front wall 35 side.
  • a plurality of drug feeders 5 are arranged side by side around the distribution tray 6 as shown in FIG.
  • the drug feeders 5 are all oriented normal to the distribution dish 6 . Since the drug feeder 5 of this embodiment has a narrow width, a large number of drug feeders can be arranged in a narrow area. Therefore, a large number of them can be arranged around the distribution plate 6. - ⁇ In this embodiment, six drug feeders 5 are radially arranged in the front half circumference portion of the distribution plate 6 .
  • the drug feeder 5 of this embodiment supports the back wall 36 of the drug container 20 in a cantilever manner with the vibration-side vertical wall portion 33 of the feeder main body 10, most of the drug container 20 is supported by the feeder main body. It protrudes from 10 in a cantilevered manner. As shown in FIGS. 22 and 23, the position of the powdered medicine discharge portion 11 provided on the front wall 35 side of the medicine container 20 is the position right above the medicine introduction groove 13 of the distribution plate 6 .
  • the powdered medicine discharge part 11 has a slit shape and is inclined with respect to the medicine container 20 . 22 and 23, the powdered medicine discharge part 11 spreads in the width A direction of the medicine feeding groove 13. As shown in FIGS.
  • the medicine container 20 of each medicine feeder 5 is filled with different medicines in advance.
  • the medicine container 20 is removed from the feeder main body 10, and the medicine container 20 is laid flat as shown in FIG.
  • the cover member 75 is opened, and powdered medicine is filled from the large-area side surface 61 side of the medicine container 20 .
  • the lid member 75 is closed to make the inside of the drug container 20 hermetically sealed.
  • the drug container 20 is attached to the feeder main body 10 as shown in FIG.
  • the feeder main body 10 is in a standby state as shown in FIG. 13(a).
  • the loading/unloading mechanism of the feeder main body 10 is in the retracted posture, and the engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51 .
  • the arm 57 of the shutter opening/closing mechanism 55 is drawn toward the vibration-side vertical wall portion 33 , and the engagement piece holding portion 56 is located near the vibration-side vertical wall portion 33 .
  • the drug container 20 pulls the transmission member 92 toward the rear wall 36 to block the opening at the bottom of the container body 70 .
  • the vibration-side vertical wall portion 33 has a trapezoidal engaging portion 47, and a dovetail-shaped engaging portion (holding portion-side engaging portion) 48 is provided on a side corresponding to the oblique side of the trapezoidal shape.
  • the rear wall 36 of the container body 70 has a pair of engaging grooves 130 . Therefore, by inserting the rear wall 36 of the drug container 20 from above along the vibration-side vertical wall portion 33 of the feeder body 10 , the engagement groove 130 of the container body 70 is engaged with the engagement portion 48 of the vibration-side vertical wall portion 33 . can be engaged. At this time, since the engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51, it does not interfere with inserting the drug container 20. As shown in FIG.
  • the engaging portion 116 of the transmission member 92 is engaged with the engaging piece holding portion 56 of the feeder body 10 as shown in FIG. 13(b).
  • the dovetail groove-shaped engaging portion 48 functions as a guide for regulating the moving direction of the drug container 20 as described above. Therefore, the drug container 20 can be attached only by moving the drug container 20 along the engaging portion 48, and the engagement between the engaging portion 116 of the transmission member 92 and the engaging piece holding portion 56 can be achieved. It becomes possible. In other words, the drug container 20 is mounted without performing fine positioning for engaging the engaging portion 116 of the transmission member 92 and the engaging piece holding portion 56 (without being conscious of the work for engaging). It becomes possible to engage naturally only by doing.
  • a specific drug feeder 5 is selected and driven based on the prescription.
  • the selected drug feeder 5 has the loading/unloading mechanism in a protruding posture, and the engaging piece 50 of the vibration-side vertical wall portion 33 protrudes from the opening 51 as shown in FIG. 13(c).
  • the engagement piece 50 of the vibration-side vertical wall portion 33 engages with the engagement recess 131 of the back wall 36 of the medicine container 20 , and the medicine container 20 is firmly fixed to the vibration member 16 .
  • the engagement piece holding portion 56 moves toward the front wall 35, the transmission member 92 slides forward, and the shutter member 91 moves forward. It is moved to open the powdered medicine discharge part 11 at the bottom of the container body 70 .
  • the vibrating member 16 starts to vibrate, and the drug container 20 vibrates together as described above.
  • the drug container 20 is firmly joined to the vibrating member 16 by the engaging portions provided at two locations, and the degree of close contact with the vibrating member 16 is high. vibrates at the same frequency as the vibrating member 16 .
  • a partition plate 68 partition member
  • a space (powder medicine passage 117 ) through which the powder medicine passes is secured in the lower part of the partition plate 68 . Therefore, the powdered medicine in the powdered medicine passage 117 is less likely to bear the weight of the powdered medicine on the upper side, and the powdered medicine moves easily.
  • the drug container 20 of the present embodiment Since the drug container 20 of the present embodiment has a narrow width, it is necessary to secure a volume for accommodating the powdered drug, so the height is high.
  • the pressure applied to the powdered medicine is a function that correlates with the height of the powdered medicine. Therefore, without the partition plate 68 (partition member), the powdered medicine in the vicinity of the bottom wall 40 is pressed against the powdered medicine on the upper side, and there is a concern that the movement of the powdered medicine may become difficult.
  • the weight of the powdered medicine on the upper side is supported by the partition plate 68, the powdered medicine in the vicinity of the bottom wall 40 is not pressed, and the flow due to vibration is smooth.
  • the powdered drug in the drug container 20 is agitated in the storage space above the partition plate 68 (horizontal portion 146).
  • part of the stored powdered medicine moves upward on the large inclined portion 143 and moves upward from the horizontal portion 146 toward the horizontal portion 146 .
  • the force of the powdered medicine that presses downward from above is less likely to be applied, and the powdered medicine flowing by stirring appropriately falls from the small holes (slits), so that the powdered medicine can be discharged smoothly. It becomes possible.
  • the powdered medicine in the powdered medicine passageway 117 runs short, the powdered medicine falls into the powdered medicine passageway 117 from a small hole 147 provided in the horizontal portion 146, and the powdered medicine passageway 117 is replenished with the powdered medicine.
  • replenishment of the powdered medicine to the powdered medicine passage 117 is performed only from the horizontal portion 146 .
  • the horizontal portion 146 is horizontally closer to the rear wall 36 than to the front wall 35 and away from the discharge portion.
  • the front side in the advancing direction of the powder medicine has a wider space. Specifically, the height of the space is increased. Therefore, a space is created above the powdered medicine flowing through the powdered medicine passage 117 . Therefore, as the powdered medicine advances through the powdered medicine passage 117, the flow of the powdered medicine is rectified, laminarization progresses, and the laminarization is advanced.
  • the powdered medicine in the powdered medicine passage 117 advances toward the powdered medicine discharge section 11 side, it passes through the rectifying member 72 and passes through the gaps between the wires of the coil. Therefore, the drug flow is smoothed.
  • the powdered medicine drops from the powdered medicine discharging portion 11 of the shutter member 91 and enters the medicine feeding groove 13 of the distribution tray 6 below.
  • the effective opening degree can be adjusted by providing the inclined side 138 at the end face of the closing wall 110 . That is, in the medicine feeder 5 of this embodiment, the shape of the powdered medicine discharge part 11 is slit-shaped and inclined with respect to the container body 70 . Therefore, as described above, the powdered medicine discharge portion 11 is widened in the width A direction of the medicine introduction groove 13 . Since the powdered medicine spreads in the direction of the width A of the medicine feeding groove 13 and falls, it falls evenly in the direction of the width A of the medicine feeding groove 13 . Therefore, when the powdered medicine is collected in a later step, the gathered powdered medicine is less likely to collapse.
  • the slope of the end of the cutout portion 77 of the container body 70 is a combination of a steep slope portion 150 and a gentle slope portion 151 . Therefore, as shown in FIG. 24(a), by increasing the amount of movement of the closing wall 110, the powder can be dropped from the entire width of the bottom wall 40 (see FIG. 23(a)). On the other hand, when the amount of movement of the closing wall 110 is small as shown in FIG. The width becomes narrow (see FIG. 23(b)). When it is necessary to discharge a large amount of powdered medicine, as shown in FIGS. 23(b) and 24(b), the amount of movement of the closing wall 110 is reduced to drop the powdered medicine from a narrow width.
  • the vibration of the vibrating member 16 is stopped.
  • the loading/unloading mechanism of the feeder main body 10 is operated to the retraction side.
  • the engagement piece holding portion 56 moves toward the rear wall 36
  • the transmission member 92 slides rearward
  • the shutter member 91 moves
  • the opening at the bottom of the container body 70 closes.
  • the loading/unloading mechanism of the feeder main body 10 assumes the retracted posture, and the engagement piece 50 of the vibration-side vertical wall portion 33 disengages from the engagement concave portion 131 of the medicine container 20 .
  • the bottom portion (bottom surface) of the internal space of the drug container 20 in the above-described embodiment that is, the bottom portion (bottom surface) of the powdered medicine passage 117 (see FIGS. 15 and 16) connected to the powdered medicine discharge portion 11 may be inclined.
  • the bottom surface may be an inclined surface that is inclined so that the height decreases toward one side in the width direction of the drug container 20 . That is, the two left and right side walls 37 are sloped surfaces that are inclined so as to become lower from one side to the other side.
  • the powdered medicine when discharging the powdered medicine, the powdered medicine tends to gather on one side in the width direction of the medicine container 20, so that even when discharging a small amount of the powdered medicine, accurate and stable discharge is possible. It is also conceivable to form the bottom surface so as to slope downward toward the powdered medicine discharge portion 11 . That is, in a direction perpendicular to the width direction in a plan view, it may be formed so as to have a downward slope from one end side to the other end side.
  • the shutter member 91 described above may be fitted with a seal member 250 as shown in FIG.
  • the seal member 250 has an upright plate-like mounting piece portion 251 and a flat plate portion 280 projecting outward from one main surface of the mounting piece portion 251, which are integrally formed.
  • the attachment piece 251 extends obliquely as shown in FIG. 25(c). Note that the oblique directions refer to the width direction of the drug container 20 (horizontal direction in FIG. 25(c)) and the flow direction of the powdered medicine during discharge (vertical direction in FIG. 25(c)) in plan view. and the direction of inclination.
  • the flat plate portion 280 has a first protruding piece portion 260, a second protruding piece portion 261, and a third protruding piece portion 262 from one side to the other side in the width direction of the medicine container 20 (left and right direction in FIG. 25(c)). are divided into In the following description of the sealing member 250, the width direction of the drug container 20 (horizontal direction in FIG. 25(c)) is also referred to as the lateral direction, and the flow direction of the powder medicine (vertical direction in FIG. 25(c)) is referred to as the front-rear direction. Also called At this time, let the downward direction of FIG.25(c) be the front.
  • the first projecting piece portion 260, the second projecting piece portion 261, and the third projecting piece portion 262 are projecting lengths from the attachment piece portion 251, and are perpendicular to the main surface of the attachment piece portion 251 (Fig. 25(c) ) in the direction indicated by the arrow X) is different. Specifically, the projection length is increased in the order of the first projecting piece portion 260, the second projecting piece portion 261, and the third projecting piece portion 262. As shown in FIG. Therefore, the projecting end surface of the first projecting piece portion 260 and the projecting end surface of the second projecting piece portion 261 are continuous via a step.
  • the protruding end surface of the second protruding piece portion 261 is located on the rear side of the protruding end surface of the first protruding piece portion 260 in the direction orthogonal to the main surface of the mounting piece portion 251 described above.
  • the protruding end face of the third protruding piece portion 262 is located further rearward than the protruding end face of the second protruding piece portion 261 in the same direction.
  • the rearmost portion of the projecting end of the first projecting piece portion 260 (the portion indicated by P1 in the figure) and the projecting end of the third projecting piece portion 262 , the rearmost portion (the portion indicated by P2 in the figure) is at the same position in the front-rear direction. That is, the flat plate portion 280 has a shape in which a notch-shaped missing portion is formed in a plate-like body whose plan view shape is substantially trapezoidal, and a part thereof is missing.
  • the shutter member 91 moves back and forth (left and right in FIG. 26) with the sealing member 250 inserted into the internal space of the drug container 20 (powder passage 117, see FIG. 15). , the opening/closing operation of the powdered medicine discharge unit 11 is executed. Specifically, as shown in FIGS. 26(a) to 26(c), when the shutter member 91 is moved to switch between the closed state and the open state, at least a part of the third protruding piece 262 is positioned at the drug container 20. The shutter member 91 moves in a state of being constantly inserted into the interior of the . Therefore, the seal member 250 also functions as a guide when the shutter member 91 is moved.
  • the amount of movement of the shutter member 91 (closing wall 110 ) is increased to fully open the powdered medicine discharge section 11 .
  • the first protruding piece portion 260 and the second protruding piece portion 261 are arranged at a position away from the powdered medicine discharge portion 11 to the outside, while a part of the third protruding piece portion 262 is located inside the powdered medicine discharge portion 11. (inside the medicine container 20). Therefore, the powdered medicine is discharged from both the portion facing the first projecting piece 260 and the portion facing the second projecting piece 261 in the powdered medicine discharge portion 11 .
  • a part of the opening forming the powdered medicine discharge part 11 is blocked by the third protruding piece part 262 .
  • the powdered medicine falls from the space between the powdered medicine discharge portion 11 and the first projecting piece portion 260 and the space between the powdered medicine discharging portion 11 and the second projecting piece portion 261 .
  • the amount of movement of the shutter member 91 (closed wall 110) is reduced, and the powdered medicine discharge section 11 is slightly opened.
  • the first projecting piece 260 is arranged at a position away from the powdered medicine discharge part 11, part of the second projecting piece 261 and part of the third projecting piece 262 11 (inside the drug container 20).
  • the portion of the powdered medicine discharge portion 11 that faces the first projecting piece portion 260 at a distance is in a state in which the inside and outside are communicated, and the powdered medicine is discharged from this portion.
  • a part of the opening forming the powdered medicine discharge part 11 is blocked by the second protruding piece 261 and the third protruding piece 262 .
  • the powdered medicine falls from the space between the powdered medicine discharge part 11 and the first projecting piece part 260 .
  • the width of the opening effective for ejecting the powder medicine becomes small.
  • the opening area of the portion of the powdered medicine discharge portion 11 that is effective for discharging the powdered medicine is reduced.
  • the first protruding piece 260, the second protruding piece 261, and the third protruding piece 262 move inside the powdered medicine discharge part 11 ( inside the medicine container 20).
  • the powdered medicine can be pushed back from the vicinity of the powdered medicine discharging portion 11 to the back side.
  • the opening degree (opening degree) of the powdered medicine discharge section 11 is configured to be adjustable in two stages, but it may be adjustable in a plurality of stages such as three or more stages. That is, the number of projecting pieces may be four or more.
  • the degree of opening of the powdered medicine discharge unit 11 may be continuously increased or decreased according to the amount of movement of the shutter member 231 (opening/closing member).
  • the planar view shape (bottom view shape) of the closing wall 232 is substantially quadrangular (substantially rectangular) unlike the above. That is, the closing wall 232 has a shape having a length in the width direction of the drug container in plan view, and the side 232a on the rearmost side (left side in FIG. 27) extends in the same direction as the width direction of the drug container. is a side extending to In other words, it has a portion extending linearly at the rearmost portion.
  • the powdered medicine discharge part 11 extends obliquely.
  • the front end portion of the bottom wall 40 also extends obliquely in plan view.
  • the front end portion of the bottom wall 40 is also a boundary portion between the bottom wall 40 and the missing portion 77 (see FIG. 19 and the like) on the front wall 35 side.
  • the closing wall 232 is arranged at a position that does not overlap the bottom wall 40 in a plan view when it is in a fully open state as shown in FIG. 27(a).
  • the entire closing wall 232 is arranged forward of the front ends (the right ends in FIG. 27) of the powdered medicine discharge portion 11 and the bottom wall 40 .
  • the powdered medicine is discharged from the whole area of the powdered medicine discharging part 11 . That is, the powdered medicine falls from the space positioned between the powdered medicine discharge part 11 and the side 232a in plan view (bottom view).
  • a portion of the closing wall 232 is positioned below the bottom wall 40 and closes to the bottom wall 40 as shown in FIG. 27(b). They overlap in the vertical direction (the depth direction in FIG. 27(a)). At this time, in plan view, a portion of the powdered medicine discharge portion 11 (a portion of the front end portion of the bottom wall 40) is positioned forward of the side 232a, and the other portion is positioned rearward of the side 232a. .
  • the portion of the powdered medicine discharge portion 11 located on the rear side of the side 232a becomes an effective portion for discharging the powdered medicine. That is, the powdered medicine falls from the space located between the side 232a and the part located behind the side 232a. Therefore, as the shutter member 231 moves in the closing direction and the overlap between the bottom wall 40 and the closing wall 232 increases, the width of the opening effective for discharging the powder medicine becomes smaller. Conversely, as the shutter member 231 moves in the closing direction and the overlapping portion between the bottom wall 40 and the closing wall 232 becomes smaller, the opening width of the portion effective for discharging the powder medicine becomes larger.
  • the fully closed state is achieved, as shown in FIG. 27(c), the entire front ends (right ends in FIG. 27) of the powdered medicine discharge portion 11 and the bottom wall 40 are arranged forward of the side 232a. becomes.
  • the closing wall 110 of the shutter member 91 is in contact with the outside of the bottom wall 40 of the container body 70 .
  • the contour of the end surface of the closing wall 110 is a simple slanted line.
  • the closing wall 110 of the shutter member 91 may be configured to contact the inside of the bottom wall 40 of the container body 70 .
  • the closing wall 110 of the shutter member 91 is configured to be in contact with the inside of the bottom wall 40 of the container body 70 , when the closing wall 110 is closed, the end of the shutter member 91 will be in the vicinity of the opening of the bottom wall 40 of the drug container 20 . Push the powdered medicine that has reached to the back side. Therefore, the next time the closing wall 110 is opened, the powdered medicine is prevented from spilling out.
  • the partition plate 68 (partition member) is provided in the vicinity of the lower portion of the container body 70.
  • An eave-like temporary receiving plate 152 may be provided in the middle portion in the height direction of the . By providing the temporary receiving plate 152, it is possible to prevent the weight of the powdered medicine on the upper side from being applied to the powdered medicine below. An opening may be provided in the temporary receiving plate 152 .
  • a second partition 160 for partitioning the inside of the container body 70 may be provided as shown in FIG. 29(a). It is also recommended to provide a shutter 161 on the second partition 160 as shown in FIG. 29(b). The shutter 161 is manually opened and closed. By providing the second compartment 160, the first-in/first-out of the powdered medicine can be facilitated.
  • the remaining powdered medicine is dropped under the second partition 160, and then the shutter 161 is closed to separate the lower part and the upper part of the drug container. Then, powdered medicine is filled in the upper portion. After that, the shutter 161 is opened. By doing so, the new powdered medicine is piled on top of the original powdered medicine, and the old powdered medicine is discharged first.
  • the shutter 161 of the second partition 160 may be interlocked with the shutter member 91 of the powdered medicine discharge section 11 .
  • the shutter member 91 and the shutter 161 of the second partition 160 are connected by a spring 170, and the shutter member 91 and the shutter 161 of the second partition 160 are interlocked.
  • the interlocking spring 170 is desirably weaker than the spring of the biasing member 93 that biases the shutter member 91 in the closing direction. The reason for this is that when the remaining amount of powdered medicine is large, the shutter 161 of the second partition 160 may be clogged with the powdered medicine and the shutter 161 of the second partition 160 may not close.
  • the shutter 161 of the second partition 160 does not necessarily need to be fully closed. By weakening the spring 170, the shutter 161 of the second partition 160 can be in a half-open state.
  • the powdered medicine is directly filled from the side surface, but the surface on which the powdered medicine is filled is arbitrary.
  • powdered medicine may be introduced from the top side of the medicine container.
  • a medicine container 172 with an open upper surface may be used.
  • one or a plurality of feeder bodies 10 are attached with a drug container 172 having an open top side.
  • the powdered medicine input hopper 310 is installed inside the equipment storage opening 15 of the distribution tray 6 .
  • the height of the opening of the powdered medicine charging hopper 310 is slightly lower than that of the distribution plate 6 as shown in FIG.
  • the drug feeder 5 described above may employ a drug container 420 of the second embodiment as shown in FIG. 33 instead of the drug container 20 described above.
  • the drug container 420 of the second embodiment can be attached to and detached from the feeder body 10 in the same manner as the drug container 20 described above. That is, together with the feeder main body 10 described above, a drug feeder is configured.
  • This medicine container 420 is also surrounded by a front wall 435 and a rear wall 436 as small area side surfaces, two side walls 437 as large area side surfaces, a top wall 438 and a bottom wall 440 .
  • the drug container 420 is also a vertically elongated box-shaped member.
  • the back wall 436 is formed with the engaging groove 130 and the engaging concave portion (the concave portion that engages with the engaging piece 50, not shown) in the same manner as described above.
  • the medicine container 420 has an openable and closable powdered medicine discharging part 411 (see FIG. 35) at a position near the front wall 435 in the bottom wall 440 .
  • the drug container 420 also has a shutter structure portion 473 .
  • the shutter structure 473 has a shutter member 491 (opening/closing member) and a transmission member 492, as shown in FIG. 34(a). That is, it differs from the above-described embodiment in that it does not have a guide member 90 and an urging member 93 (see FIG. 19, etc.). Then, as in the above-described embodiment, the transmission member 492 linearly moves, thereby moving the shutter member 491 and opening and closing the powdered medicine discharge section 411 . That is, as in the above-described embodiment, a portion of the transmission member 492 on the side of the rear wall 436 is exposed to the outside. engage mechanism 55;
  • the medicine container 420 of this embodiment has a holding protrusion 525 that holds the intermediate portion of the transmission member 492 and a locking protrusion 526 .
  • the locking protrusion 526 forms a lock mechanism that maintains the closed state so that the powdered medicine discharging part 411 (shutter) does not open accidentally when the medicine container 420 is removed from the feeder body 10 and carried. be.
  • the holding protrusions 525 are a pair of protrusions extending in directions approaching each other from above and below. A portion of the transmission member 492 is inserted through a groove-shaped portion formed inside the holding protrusion 525 .
  • the locking protrusion 526 is a protrusion formed integrally with the flat plate-like portions of the leaf spring member 520 positioned in the front and rear, and is a plate-like portion extending in a substantially V shape in a side view between the two flat plate-like portions. be.
  • the locking protrusion 526 projects outward in the width direction of the drug container 420 in a cantilever manner together with the front and rear flat plate-like portions, and is elastically deformed together with the flat plate-like portions.
  • the locking protrusion 526 restricts unintended movement of the transmission member 492 by engaging with a notch portion (locking portion) formed above the transmission member 492 (above the engaging portion 116).
  • the engagement (locked state) between the locking protrusion 526 and the transmission member 492 is released, and the transmission member 492 becomes movable.
  • the engaging portion 60 of the engaging piece holding portion 56 see FIGS. 13 and 14
  • the transmission member 492 are connected in the same manner as described above.
  • Engagement portion 116 is engaged (a portion of transmission member 492 on the rear side of engagement portion 116 is inserted into engagement portion 60 of engagement piece holding portion 56 from above). .
  • the flat plate-like portion on the rear side (back wall 436 side) of the locking protrusion 526 is moved by the upper surface of the engaging piece holding portion 56 on which the engaging portion 60 is formed. It will be in a state of being lifted from below. As a result, the locking protrusion 526 and the flat plate portion are elastically deformed so that the locking protrusion 526 and the transmission member 492 are disengaged.
  • the lid member 475 constitutes the top wall 438 among the walls.
  • a lid member 475 is attached to a box portion 471 having an open upper surface, and the lid member 475 is swingable by means of a hinge 421 .
  • the lid member 475 is opened, powdered medicine can be filled from above, and when it is closed, the drug container 420 can be sealed.
  • the drug container 420 of the present embodiment can be filled with the powdered drug while being held by the feeder main body 10 .
  • the lid member 475 of this embodiment has a lid body portion 475a and a small lid portion 475b.
  • a small lid portion 475b is attached to the lower side of the lid main body portion 475a (the lower side when closed), and is swingable by a hinge 421.
  • the lid member 475 has an in-lid accommodating portion 527 which is a space capable of accommodating a desiccant or the like.
  • a humidity control agent is stored in the in-lid storage portion 527 of the present embodiment.
  • the in-lid accommodating portion 527 is a space formed between the lid body portion 475a and the small lid portion 475b. Specifically, when the lid member 475 is closed and the small lid portion 475b is closed, the space is located above most of the small lid portion 475b.
  • the lid member 475 has a lid-side locking piece portion 476 on the side opposite to the connecting portion with the box portion 471.
  • the lid-side locking piece 476 is connected to the front end of the lid main body 475a in a swingable state by means of a hinge 421.
  • the lid-side locking piece portion 476 has a locking projection 476a on the inner surface in an upright posture.
  • the locking projection 476 a is a projection that extends from the front side toward the back side when the lid member 475 is closed, and is a projection that can be engaged with the projection portion 600 formed on the box portion 471 .
  • the locking projection 476a and the projection 600 are engaging portions that form a pair and engage with each other.
  • the lid member 475 is in a locked state (a state in which the closed state is maintained firmly).
  • the box portion 471 is formed with an operation notch portion 601 (see FIG. 34(a)) for operating the lid member 475.
  • the operation notch 601 is positioned on the side (one side in the width direction) of the lid member 475 when the lid member 475 is in the locked state.
  • the box portion 471 is formed by inserting the partition member 606 into the box portion main body 605 from the opening on the front side, attaching the pressing plate member 607, and further attaching the shutter structure portion 473.
  • the partition member 606 has a flat plate-shaped main body portion 606a, a pressed plate portion 606b projecting upward from the upper surface of the main body portion 606a, and a straightening portion 472 (see FIG. 37) formed on the lower surface side of the main body portion 606a.
  • a powdered medicine passage 517 is formed on the lower side of the partition member 606 .
  • the powdered medicine passage 517 is a passage leading to the powdered medicine discharge portion 411 , and is surrounded by the bottom portion of the box portion 471 , the side wall lower portion, and the partition member 606 .
  • the main body part 606a has a communication hole forming part 546 on the rear wall 436 side.
  • the communicating hole forming portion 546 is a portion in which a large number of small holes (openings) 547 are provided, and in this embodiment, a long hole row is formed.
  • the row of elongated holes is formed by arranging a plurality of elongated holes in the front-rear direction. Each elongated hole penetrates the body portion 606a in the thickness direction and extends in the width direction of the drug container 20.
  • the small hole (opening) 547 employed in this embodiment has a slit shape extending in the width W direction of the container body 70 .
  • the rectifying portion 472 of the present embodiment is a group of projections composed of a plurality of projections, as shown in FIG. 37(a).
  • Each protrusion belonging to the straightening section 472 has a substantially rectangular parallelepiped outer shape and protrudes downward from the lower surface of the main body section 606a (upward from the upper surface in FIG. 37(a)).
  • each protrusion has a thickness in the width direction of the drug container 420 and has a shape extending in the front-rear direction.
  • the plurality of protrusions belonging to the straightening section 472 are arranged in a zigzag pattern.
  • the rectifying portion 472 is composed of a first projection row 472a on the front side and a second projection row 472b on the rear side (on the communication hole forming portion 546 side).
  • a plurality of (four in this embodiment) protrusions are arranged side by side in the width direction of the drug container 420 at intervals.
  • the rear portions of the protrusions belonging to the first protrusion row 472a are positioned to the sides of the front portions of the protrusions belonging to the second protrusion row 472b. Therefore, a portion of the protrusions belonging to the first protrusion row 472a is disposed between two protrusions whose rear portions belong to the second protrusion row 472b.
  • a gap is formed between the side surface of the protrusion belonging to the first protrusion row 472a and the side surface of the protrusion belonging to the second protrusion row 472b, which are arranged to face each other in the width direction of the drug container 20. .
  • the plurality of protrusions belonging to the rectifying portion 472 have different positions in the height direction of the respective lower end faces. That is, the position of the lower end surface becomes lower as the arrangement position of the protrusion approaches one end in the width direction (the right side in FIG. 10B).
  • the pressing plate member 607 has two mounting operation portions 610 and a pressing protrusion 611 (see FIG. 35).
  • the attachment operation portion 610 is a knob that is elastically deformed by being operated by the user.
  • the two attachment operation portions 610 are formed at positions separated in the width direction, and both have protrusions that protrude outward in the width direction.
  • box-side engaging portions 612 are formed on the left and right side walls of the box body 605 respectively.
  • the box-side engaging portion 612 is a hole penetrating the side wall and engages with the projecting portion of the attachment operating portion 610 .
  • the pressing plate member 607 is attached to the box body 605 by engaging the two attachment operation portions 610 and the two box side engaging portions 612 .
  • the pressing protrusion 611 is a protrusion extending from the front side to the rear side (from the right side to the left side in FIG. 35), and is the portion that contacts the pressed plate portion 606b of the partition member 606 from the front. .
  • the surface of the projecting end is in surface contact with the front surface of the pressed plate portion 606b.
  • the shutter member 491 has a closing wall 510 (see FIG. 34(b), etc.), a guide wall portion 511, and a connecting wall 512, as shown in FIG. On the other hand, the above-described stopper wall 113 (see FIG. 19, etc.) is not formed.
  • a seal member 550 is attached at a position above the closing wall 110 .
  • the closed wall 510 is positioned forward of the bottom wall 440 when the powdered drug discharge section 411 is closed. That is, a portion of the closing wall 510 does not vertically overlap the bottom wall 440 .
  • the bottom wall 440 is brought close to the powdered medicine discharge part 411 and the sealing member 550 is pressed against the powdered medicine discharge part 411 to close the powdered medicine discharge part 411 .
  • the powdered medicine discharger 411 is opened by separating the sealing member 550 forward from the powdered medicine discharger 411 . When closed, part of the sealing member 550 enters the powdered medicine passage 517 from the powdered medicine discharging portion 411 (see FIG. 35).
  • the communication hole forming portion 546 which is a plate-like portion, serves as a partition plate portion (partition member). That is, a partition plate portion (partition member) is arranged at the boundary between the storage space 613 that stores the powdered medicine and the powdered medicine passage 517 .
  • the powdered medicine passage 517 is a portion through which the powdered medicine passes when the powdered medicine is discharged. Space.
  • the bottom portion (upper surface of the bottom wall 440) of the powdered medicine passage 517 is inclined. Specifically, in the width direction of the drug container 420, it slopes downward toward one side end (in FIG. 35, the back side end in the front and back direction). Furthermore, the medicine container 420 is inclined downward toward the powdered medicine discharging part 411 in the front-rear direction (horizontal direction in FIG. 35). That is, as a whole, the powdered medicine discharge part 411 is inclined toward one end in the width direction of the medicine container 420 . Further, the lower end portions of the plurality of protrusions belonging to the rectifying portion 472 are in close contact with the bottom portion of the powdered medicine passage 517 .
  • the powdered medicine passes through the straightening section 472 , it passes between two protrusions or between one protrusion and the side wall 437 of the drug container 420 .
  • the powdered medicine passes through the rectifying section 472, it passes through a small gap (narrow flow path), smoothing the flow of the medicine.
  • the communicating hole forming portion 546 is a portion that assumes a horizontal posture when the drug container 420 is held by the feeder body 10 .
  • a large inclined portion 543 and a small inclined portion 545 are provided in a portion adjacent to the communication hole forming portion 546 serving as a partition plate.
  • the large inclined portion 543 and the small inclined portion 545 both form an inclined surface inclined toward the communication hole forming portion 546 when the drug container 420 is held by the feeder body 10 .
  • the large inclined portion 543 is longer than the small inclined portion 545 and has the same inclination angle. That is, the space between the large inclined portion 543 and the small inclined portion 545 (the lower portion of the storage space 613) converges toward the communication hole forming portion 546. As shown in FIG.
  • the medicine container 420 When the medicine is to be discharged from the medicine container 420 , the medicine container 420 is held by the feeder body 10 , the powdered medicine discharging part 411 is opened, and the medicine container 420 is vibrated. At this time, when the powdered medicine in the powdered medicine passage 517 is reduced due to the discharge, the powdered medicine in the medicine container 420 moves from the storage space 613 , which is the space above the communication hole forming portion 546 , to the powdered medicine passage 517 and toward the powdered medicine discharge portion 411 . to proceed. Then, it is discharged from the powdered medicine discharge part 411 . In this embodiment as well, the powdered medicine is agitated in the storage space 613 by vibrating the medicine container 420 .
  • part of the stored powdered medicine moves upward on the large inclined portion 543 and moves upward from the communicating hole forming portion 546 toward the communicating hole forming portion 546 side. That is, similarly to the above, it is difficult for the powdered medicine to apply a pressing force to the communication hole forming portion 546, and the powdered medicine can be discharged smoothly.
  • FIG. A medicine feeder 700 has a medicine container 701 of the third embodiment and a feeder body 702 of the second embodiment holding the medicine container 701 . Since the basic structure and function of the drug container 701 and the feeder main body 702 are the same as those of the drug containers 20, 172, 420 and the feeder main body 10 described above, only improvements will be described.
  • the feeder main body 702 of this embodiment includes a detachment assisting member 705 used when detaching the drug container 701 . Further, the feeder main body 702 has a shutter opening/closing mechanism 706 added with a function of locking the shutter 707 .
  • the drug container 701 of the third embodiment is provided with an engaging portion 710 with which the detachment assisting member 705 is engaged.
  • the drug container 701 also has a lock mechanism that maintains the closed state so that the powdered drug discharge section (shutter) 711 does not open unintentionally, but its structure is different from that of the drug container 420 described above.
  • the drug container 701 differs from the drug containers 20, 172, and 420 described above in the structure of the powdered drug discharge portion 711 and the shutter structure portion 713. As shown in FIG. This will be explained below.
  • a detachment assisting member 705 used when removing the medicine container 701 is provided on the vibration-side vertical wall portion 33 (longitudinal wall) of the vibrating member 16 (container holding portion).
  • the detachment assisting member 705 is a lever that rotates around a horizontally provided shaft 720, and has an operation portion 721 and an action portion 722.
  • the operating portion 721 has an upward arcuate shape, and has an engaging pressing portion 723 and a releasing pressing portion 725 .
  • Actuating portion 722 is a claw.
  • the operation portion 721 and the action portion 722 are connected by a substantially “L”-shaped connecting portion 726 .
  • the connection portion 726 has a vertical side portion 727 and a horizontal side portion 728 with a state in which the drug container 701 is attached to the vibrating member 16 (container holding portion) as a reference.
  • a shaft 720 is connected to the connecting portion between the vertical side portion 727 and the horizontal side portion 728 .
  • the connecting portion between the vertical side portion 727 and the horizontal side portion 728 and the outer portion functions as the seating portion 731 and is flat.
  • a biasing member 732 such as a spring is provided on the vibration-side vertical wall portion 33 (vertical wall) to always bias the detachment assisting member 705 . Specifically, the biasing member 732 presses the horizontal side portion 728 upward, biasing the detachment assisting member 705 in the rotational direction.
  • the shutter opening/closing mechanism 706 of the feeder body 702 is composed of the engagement piece holding portion 735 and the arm 57 as in the above-described embodiment.
  • a concave portion that serves as the engaging portion 60 is provided on the upper surface of the engaging piece holding portion 735 .
  • a protrusion 737 is provided on the upper surface of the engaging piece holding portion 735 .
  • Projection 737 has an inclined surface 738 . As for the inclination direction of the inclined surface 738 , the front side is lower and the rear side is higher with respect to the protruding direction side of the arm 57 .
  • a drug container 701 of the third embodiment has a lid member 475 attached to a box portion 471 having an open top, and the lid member 475 is pivoted by a hinge 421, similarly to the drug container 420 of the second embodiment described above. It is possible.
  • the drug container 701 is provided with the engaging portion 710 with which the detachment assisting member 705 engages.
  • the engaging portion 710 is a protrusion provided on the rear wall 436 .
  • the position of the engaging portion 710 is arbitrary, and may be on the side wall 437 or the bottom wall 440 .
  • the shutter structure 713 has a shutter 707, a shutter member 740 (opening/closing member), and a transmission member 741, as in the second embodiment.
  • the linear movement of the transmission member 741 causes the shutter member 740 to move and the powdered medicine discharging portion 711 to open and close.
  • a notch 742 is provided on the upper side of the transmission member 741, as in the drug container 420 of the second embodiment, as shown in FIG.
  • a forward slope 743 of the notch 742 is gentle, and a rear slope 745 is steep.
  • the drug container 701 of this embodiment also has a leaf spring member 748 and a locking protrusion 747 .
  • the leaf spring member 748 is attached to the outside in the width direction of the medicine container 701 in a cantilevered manner.
  • the locking protrusion 747 is a substantially triangular member and is integrally fixed to the leaf spring member 748 .
  • the lower surface of the locking protrusion 747 has a forward slope 750 and a rear slope 751 as shown in FIG. A front slope 750 of the locking protrusion 747 is gentle, and a rear slope 751 is steep.
  • the shutter member 740 (opening/closing member) has a protruding portion 760 that protrudes toward the drug container 701 when the powdered drug discharging portion 711 is closed.
  • the cross-sectional shape of the projecting portion 760 is substantially triangular as shown in FIG. 42, the upper surface 761 is substantially horizontal, and the lower surface 762 is an inclined surface.
  • the tip portion 763 is a substantially vertical surface.
  • the inclination angle of the lower surface 762 is 30 degrees or less. It is desirable that the angle of inclination of the lower surface 762 is smaller than the angle of repose of the powdered medicine contained in the medicine container 701 .
  • a powdered medicine passage 517 connected to a powdered medicine discharge portion 711 is provided in the medicine container 701 .
  • a partition member 620 corresponding to the ceiling wall of the powdered medicine passage 517 has a partition portion 766 projecting toward the powdered medicine passage 517 (downward) (FIGS. 42, 45, and 46).
  • the height (hanging amount) of the partition 766 is 1.2 mm to 3.0 mm, or 1/5 to 3/5 of the height of the passageway.
  • the upper surface 761 of the projecting portion 760 is extremely close to the partition member 620 corresponding to the ceiling wall of the powdered medicine passage 517 .
  • An angle D between the lower surface 762 of the protrusion 760 and the bottom surface of the powder passageway 517 is less than or equal to the repose angle of the powder.
  • the slope angle E of the tip of the powder medicine P in the traveling direction is equal to or less than the angle of repose as shown in FIG. .
  • the space between the upper surface 761 of the protruding portion 760 of the shutter member 740 and the ceiling wall of the powdered medicine passage 517 is small for the powdered medicine to enter, it is difficult for the powdered medicine to get on the upper surface 761 of the protruding portion 760, and when the shutter member 740 is opened. , the powdered medicine is less likely to spill from the upper surface 761 of the projecting portion 760 .
  • the space for the powdered medicine to enter is small between the protruding end portion 763 of the projecting portion 760 of the shutter member 740 and the partition portion 766, the powdered medicine is less likely to adhere to the protruding end portion 763 of the protruding portion 760, and when the shutter member 740 is opened, the powdered medicine is not projected. The powdered medicine is less likely to spill from the tip portion 763 of the portion 760 .
  • the feeder main body 702 is in a standby state as shown in FIG. 40(a). Specifically, the horizontal side portion 728 of the detachment assisting member 705 is pressed by the biasing member 732, and the detachment assisting member 705 is in an inclined posture as a whole.
  • the engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51 .
  • the back wall 436 of the drug container 701 is inserted along the vibration-side vertical wall portion 33 of the feeder body 702 from above.
  • the powdered medicine in the powdered medicine passage 517 of the medicine container 701 is separated from the powdered medicine discharging portion 711, and when the shutter member 740 is opened, the powdered medicine is less likely to spill.
  • the engagement groove 130 of the drug container 701 is engaged with the engagement portion (holding portion) of the vibration-side vertical wall portion 33 .
  • An engaging piece (holding portion side engaging portion) 50 of the vibration side vertical wall portion 33 is recessed in the opening 51 .
  • the acting portion 722 of the detachment assisting member 705 comes into contact with the engaging portion 710 of the drug container 701 .
  • the working portion 722 of the withdrawal assisting member 705 is pushed by the drug container 701 and rotated, the vertical side portion 727 assumes a vertical posture, and the horizontal side portion 728 assumes a horizontal posture and is removed.
  • the auxiliary member 705 assumes a stable posture.
  • the withdrawal assistance member 705 can be rotated by inserting the drug container 701, and the engagement pressing portion 723 of the operation portion 721 is pressed to assist the rotation of the withdrawal assistance member 705.
  • the horizontal side portion 728 of the detachment assisting member 705 assumes a horizontal posture as shown in FIG. 40(c). Therefore, by visually confirming that the operation portion 721 is horizontal when viewed from above, it is possible to reliably recognize that the drug container 701 is attached to the feeder main body 702 .
  • the release pressing portion 725 of the operation portion 721 is pushed as indicated by the arrow in FIG.
  • the detachment assisting member 705 rotates in the opposite direction, and the acting portion 722 of the detachment assisting member 705 rises. Therefore, the acting portion 722 engages with the engaging portion 710 of the drug container 701 to push up the drug container 701 , and the drug container 701 moves upward and is removed from the feeder main body 702 .
  • the drug container 701 can be easily removed from the feeder body 702 . That is, in the medicine dispensing device 1 of this embodiment, since the medicine feeders 5 and 700 are densely arranged, the gaps between the medicine containers 701 are small and it is difficult to insert a finger. According to the medicine feeder 700 of this embodiment, it is not necessary to insert a finger between the medicine containers 701, so the medicine containers 701 can be easily removed.
  • the engagement piece holding portion 735 moves and the projection 737 is engaged with the locking projection portion of the medicine container 701 .
  • 747 abuts.
  • the contact surface on the projection 737 side at this time is an inclined surface 738 , and as the projection 737 advances, the locking projection 747 of the medicine container 701 is pushed up against the plate spring member 748 .
  • the locking protrusion 747 attached to the leaf spring member 748 leaves the notch 742 of the transmission member 741, and the locking protrusion 747 attached to the leaf spring member 748 and the notch 742 of the transmission member 741 are separated. is disengaged.
  • the engagement piece holding portion 735 moves toward the front wall 35, the transmission member 741 slides forward, the shutter 707 moves, and the powdered medicine discharging portion 711 of the medicine container 701 opens.
  • the engaging piece 50 that engages with the drug container 20 is connected to the loading/unloading mechanism and has a structure that interlocks with the shutter opening/closing mechanism 55.
  • the engaging piece 50 is independent. It may be configured such that it appears frequently.
  • the engagement piece 50 is biased by a spring 780 in a direction in which the engagement piece 50 protrudes. be able to.
  • the engaging piece 50 can be pulled in and the drug container 20 can be removed from the feeder body without depending on the actuator of the shutter opening/closing mechanism 55 .
  • the small holes (openings) 146 provided in the container body 70 of the first embodiment and the small holes (openings) 547 provided in the container body 70 of the second embodiment are both arranged in the width W direction of the container body 70. Although it is in the shape of an elongated slit.
  • the shape of the opening is not limited to this configuration.
  • a small hole (opening) 782 shown in FIGS. 45 and 46 has a slit shape extending from the rear wall 36 side of the container body 70 to the front wall 35 .
  • the small hole (opening) 782 has an elongated triangular shape when viewed from above, and the width of the opening increases toward the front wall 35 side. According to experiments, the flow of the powder medicine became smoother by making the shape of the small holes (openings) 782 as shown in FIGS. 45 and 46 .
  • the shape of the opening is not limited to the shapes shown in FIGS.
  • the partition member 620 shown in FIG. 46 has the partition portion 766 on the lower surface as described above. Further, in the partition member 620 shown in FIG. 46, the straightening portion 621 has a columnar shape.
  • unevenness 625 may be provided on the upper surface side. According to this embodiment, it is possible to prevent the powdered medicine from being compacted in the medicine container 20 .
  • the unevenness 625 employed in this embodiment has a serrated shape or a wavy shape and has an inclination. Therefore, in the vicinity of the partition member 622, the weight of the powdered medicine itself on the upper side can be released, and the compaction of the powdered medicine in the vicinity of the partition member 622 can be suppressed.
  • the shape of the unevenness is not limited to a sawtooth shape or a wave shape, and may be, for example, a pyramid shape such as a conical triangular pyramid.
  • the drug container 20 is attached to the feeder main body 10 for use.
  • a sensor capable of detecting an object such as a photoelectric sensor or a proximity sensor, is desirable.
  • the mounting position of the sensor is arbitrary, the vibrating-side vertical wall portion 33 and the vibrating-side horizontal portion 32 of the feeder body 10 are candidates for the mounting position.
  • an RFID tag is attached to the medicine container 20 as the information storage means 65 .
  • AR markers may be provided instead of or in addition to RFID tags.
  • AR markers are pre-registered photographs, illustrations, and other graphics.
  • a label printed with an AR marker is attached to the drug container 20 at a visible position.
  • AR markers can be recognized by cameras.
  • a camera for dispensing monitoring may be installed near the medicine feeder 5 .
  • the camera is used to photograph the AR marker to identify the drug container 20 . This makes it possible to check whether the medicine container is set correctly by collating it with the medicine information based on the prescription information.
  • the RFID tag needs to ensure a detection distance, whereas the AR marker has less such restrictions.
  • the monitoring camera can also be used for photographing the AR marker, if the AR marker is adopted instead of the RFID tag, the parts for reading the RFID tag can be reduced.
  • each drug feeder 5 overlaps its center in the width direction in a plan view, and a virtual line extending in the same direction as its longitudinal direction indicates the rotation of the distribution plate 6 . It is arranged so as to overlap with the center (the point indicated by P3 in the figure). Further, in the medicine dispensing device 1 described above, one kind of powdered medicine is accommodated in the medicine container 20 of one medicine feeder 5 .
  • the medicine container 20 of one medicine feeder 5 and the predetermined powdered medicine are allocated one-to-one.
  • the drug container 20 may contain more than one dose.
  • the medicine feeder 5 to which the powdered medicine to be discharged is assigned is selected from among the plurality of medicine feeders 5, and the amount of one dose is supplied from the selected medicine feeder. It is possible to discharge powdered medicine. Further, when discharging one or more types of powdered medicine from one or more medicine feeders 5 , a predetermined amount of powdered medicine may be discharged (dispensed) from one or more selected medicine feeders 5 to the distribution tray 6 .
  • the powdered medicine in the medicine container 20 may run out in one of the medicine feeders 5 . That is, there are cases where powdered medicine, which is a consumable item, runs out.
  • the user in such a case, removes the medicine container 20 from the feeder main body 10, fills the medicine container 20 with powdered medicine, and then reinserts the medicine container 20 into the feeder main body 10. work to attach it to the In other words, when the powdered medicine runs out (or is predicted to run out) in any of the medicine feeders 5, the user who is notified of this by the notification operation or the like performs the above operation.
  • the drug container 20 when reattaching the drug container 20, the drug container 20 can be attached to another feeder body 10 in addition to the feeder body 10 to which the drug container 20 was originally attached. That is, if there is another feeder body 10 to which the medicine container 20 is not attached besides the original feeder body 10, it can be attached to that feeder body 10 as well. That is, when reattaching, the drug container 20 can be attached to any one selected from all the feeder bodies 10 that do not hold the drug container 20 at that time. As a result, the user does not have to think about where to attach the drug container 20, which facilitates the above work.
  • the powdered medicine discharge part of the medicine container can change the effective opening width (exit width of the powdered medicine) for discharging the powdered medicine.
  • the blocked portion of the opening of the powdered medicine discharge section may be changed stepwise or continuously.
  • the drug delivery device 1 described above is intended to be miniaturized.
  • the medicine dispensing device 1 described above may be provided with a gyro sensor (inclination detecting means, level). Further, based on information detected by the gyro sensor (signal transmitted from the gyro sensor), a tilt notification operation of notifying the tilt of the housing 2 may be executed.
  • This tilt notification operation is an operation for notifying that effect on the condition that the tilt of the entire device detected by the gyro sensor exceeds a specified value.
  • This operation may be an operation that is executed on the condition that the drug dispensing device 1 is powered on.
  • the medicine dispensing device 1 may be provided with a sound generating means such as a speaker, and an operation of outputting an alarm or a message may be performed.
  • a triaxial acceleration sensor as the tilt detection means.
  • a substrate on which a triaxial acceleration sensor is mounted is attached to a partition or plate that is horizontally supported inside the housing 2 .
  • a 3-axis acceleration sensor is one of inertial sensors for measuring acceleration, and can detect 3-dimensional inertial motion (translational motion in orthogonal 3-axis directions).
  • a 3-axis accelerometer can measure gravity, motion, vibration, and shock.
  • the drug dispensing device 1 is installed at a predetermined position, and the output values for each axis of the three-axis acceleration sensor after horizontal adjustment of the housing 2 are stored.
  • the triaxial acceleration sensor can detect gravitational acceleration, and gravitational acceleration is always applied in the vertical direction.
  • the detection values of the three axes change.
  • the degree of inclination of the housing 2 is calculated based on the change in the detected value, and the inclination of the housing 2 is detected. It may be displayed how to correct the posture to return to the horizontal posture. Conversely, when the change in each detected value of the three axes is less than a constant, it can be determined that the medicine dispensing device 1 is not tilted and its posture is stable.
  • the operation of discharging the powdered medicine in the medicine feeder 5 is performed by vibrating the medicine container 20 while keeping the powdered medicine discharging part 11 closed (while the shutter is closed), then opening the powdered medicine discharging part 11,
  • An operation of vibrating the drug container 20 to discharge the drug may be employed. That is, prior to the action of vibrating the drug container 20 with the powdered medicine discharge part 11 in the open state (hereinafter also referred to as the open state vibrating action), the action of vibrating the drug container 20 with the powdered drug discharge part 11 in the closed state (hereinafter referred to as the closed state) is performed. (also referred to as state oscillation operation) may be performed.
  • the closed-state vibrating action may be an action that vibrates the drug container 20 more strongly than the open-state vibrating action.
  • the medicine feeder 5 may be configured to be able to change the frequency and amplitude.
  • the closed-state vibrating action may be an action with a larger vibration amount (vibration magnitude) than the open-state vibrating action, or may be an action with a larger number of vibrations per unit time.
  • the closed-state vibrating action may be an action of vibrating the drug container 20 with the strongest vibration, that is, an action of maximizing vibration or maximizing the number of vibrations per unit time. More specifically, immediately after the medicine container 20 is filled with medicine, there may be no powdered medicine near the powdered medicine discharge section 11 .
  • the above-mentioned manual tablet distributing device 303 is a member having a substantially rectangular parallelepiped shape as a whole, and is attached in a swingable state. . That is, it is possible to change the posture between a normal posture (see FIG. 1) in which the opening of the square portion on the upper surface faces upward and an inclined posture (see FIG. 38(b)) in which the opening faces upward to the rear. . Further, as shown in FIGS. 1 and 2, the cleaning device 7 described above is arranged below the tablet manual distribution device 303 (see FIG. 1).
  • the cleaning device 7 has a suction port 7a connected to a suction device (not shown), and is a device that generates negative pressure to suck dirt (residual powdered medicine, dust, etc.) together with air.
  • the cleaning device 7 has an extension portion 7b extending inwardly from the outside of the distribution plate 6, and the extension portion 7b is formed with a suction port 7a. The cleaning device 7 cleans the distribution plate 6, and is normally in a state in which the suction port 7a faces downward.
  • the tablet hand-dispensing device 303 and the cleaning device 7 are interlocked. That is, when the attitude of the manual tablet distributing device 303 is changed from the normal attitude, which is the attitude during use, to the tilted attitude, the cleaning device 7 automatically rotates accordingly, as shown in FIG. 38(b). Specifically, this rotating operation is an operation in which the extending portion 7b rotates once, and the axis of rotation at this time is the same direction as the extending direction of the extending portion 7b. As a result, the suction port 7a faces downward, faces sideways (sideways with respect to the normal time), faces upward, and then returns to face downward.
  • the user can easily check whether or not the area around the suction port 7a of the cleaning device 7 is dirty. That is, when the user changes the attitude of the tablet hand-dispensing device 303, the change in attitude is detected by a sensor or the like (not shown), and the cleaning device 7 automatically starts rotating. By moving the cleaning device 7 in this way, it is possible to make it easier for the user to see the cleaning device 7 (it is possible to make it easier to draw the user's attention).
  • the portion around the suction port 7a which is likely to get dirty and is difficult to see in the normal posture, becomes easier to see. That is, when the area around the suction port 7a is dirty, the user can be made aware of the dirt. As a result, the user can be prompted to determine whether or not cleaning of the cleaning device 7 (maintenance of the cleaning device 7) is necessary.
  • the inside of the drug container 20 can be washed by putting water, a cleaning liquid, etc. inside the drug container 20, attaching the drug container to the feeder main body 10 in this state, and vibrating the drug container 20.
  • the upper lid 3 is provided with an electric display 800 as shown in FIG.
  • the electric display 800 has a plurality of light emitting groups 801a to 801f in which a plurality of light emitting portions 802 are arranged in a row.
  • Each luminescence group 801 a to 801 f corresponds to a drug feeder 5 in the powdered drug dividing area 301 . That is, six drug feeders 5 are installed in the powdered drug division area 301 .
  • the luminous group 801a corresponds to the drug feeder 5a
  • the luminous group 801b corresponds to the drug feeder 5b
  • the luminous group 801c corresponds to the drug feeder 5c
  • the luminous group 801d corresponds to the drug feeder 5d
  • the luminous group 801e corresponds to the drug feeder. 5e
  • luminous group 801f corresponds to drug feeder 5f.
  • the light emitting groups 801a-801f are arranged in a fan shape.
  • the light-emitting portions 802 belonging to the light-emitting group 801 are mixed with different colors and/or luminances, and are arranged stepwise so that the color or the like gradually changes from the center toward the outside. In this embodiment, the light is emitted in a lighter color toward the center and darker in color toward the outside.
  • the light-emitting group 801 is used to notify the user of the operation status of the drug dispensing device 1 by electric light.
  • the light emitting units of the light emitting group sequentially emit light according to the preparation state. Brightness and color may vary. For example, it emits light sequentially according to the temperature rise of the heater of the heat seal.
  • the tablet manual distributing device 303 is in the preparatory stage, the light emission state changes according to the preparatory stage.
  • the medicine dispensing device 1 is stopped, the fan for cooling the heater is driven, and the light-emitting units of the light-emitting group are extinguished according to the cooling condition.
  • each light emitting group may be turned off.
  • the light emission state changes according to the mounting state of the drug container 20 in each drug feeder 5 . Furthermore, a warning is issued that the drug container 20 has been forgotten to be removed. After the day's work is completed, the medicine container 20 is removed from the feeder main body 10. If the removal is forgotten, the corresponding light-emitting unit 802 of the light-emitting group 801 emits light to issue a warning. It is desirable to reduce the number of light-emitting units 802 and light-emitting groups 801 that emit light over time. The emission color and brightness may be changed.
  • the corresponding light-emitting units 802 of the light-emitting group 801 emit light in a predetermined order. For example, light may be emitted from the back to the front, or light may be emitted from a light color to a dark color.
  • the corresponding light-emitting section 802 of the light-emitting group 801 performs display different from usual. For example, in contrast to the usual case, light is emitted from the front toward the back, or light is emitted from the dark side toward the light side.
  • the corresponding light emission group 801 is in a specific light emission state.
  • all the light emitting units 802 are caused to emit red light.
  • the type of error is not limited, and may be an abnormality in the drug container 20, an abnormality in the feeder main body 10, or other abnormalities. Other abnormalities also include an abnormality in the tablet hand-dispensing device 303 .
  • the light-emitting group 801 It is desirable to cause the light-emitting group 801 to emit light depending on how the drug container 20 is attached.
  • the light emission state shown below is merely an example, and is not limited to this.
  • the corresponding light emission group 801 when the drug container 20 is not attached, the corresponding light emission group 801 is in a predetermined light emission state, and when the drug container 20 is attached, it is in a different light emission state.
  • the corresponding light emitting group 801 is turned off, and when the medicine container 20 is attached, it emits light in a pale color or in a state of low brightness.
  • the corresponding light emitting group 801 When the drug is being dispensed from the drug container 20, the corresponding light emitting group 801 is in a predetermined light emitting state, and when the dispensing from the drug container 20 is temporarily stopped, it is in a different light emitting state. For example, when the medicine is being dispensed from the medicine container 20, the corresponding light emitting group 801 of the light emitting unit 802 is lit continuously, and when the dispensing from the medicine container 20 is temporarily stopped, the corresponding light emitting group 801 flashes. When dispensing of the drug container 20 is completed, the light-emitting part 802 that has been emitting light is extinguished. When a drug container 20 is to be installed in a specific feeder body 10, the corresponding light-emitting group 801 is in a predetermined light-emitting state.
  • the light emitting group 801 may be caused to emit light in order according to the rotation of the distribution plate 6 .
  • the arc-shaped light-emitting portion 802a closest to the yuyama logo is finely divided in the same direction as the rotation direction and lights up and flashes.
  • a predetermined light emitting state may be obtained according to the situation of the medicine dispensing device 1 by a maintenance staff performing a predetermined operation.
  • the opening/closing structure of the upper lid 3 is not limited to hinges.
  • covers 616 and 617 may be provided on the upper lid 615 as shown in FIGS.
  • the cover 616 shown in FIG. 49 can be slid to the back side as shown in FIG.
  • the cover 617 shown in FIG. 50 can be slid to the front side and woven further downward as shown in FIG. 50(b). As for the cover 617 shown in FIG. 50 as well, the position of the cover 617 can be changed to partially open the upper lid 615 .
  • the drug dispensing device disclosed in Patent Document 2 includes a container storage device that stores a large number of drug containers, a robot that transports the drug containers, a container placement device that vibrates the drug containers and discharges the drugs from the drug containers, A distribution plate is built in.
  • the container placement device also has weight measuring means for measuring the weight of the drug container. Then, the required drug container is automatically selected, placed on the container placing device by the robot, and the drug container is vibrated to discharge the drug directly from the drug container to the distribution tray. While the medicine is being discharged, the weight measuring means monitors the weight of the medicine container to detect the amount of medicine discharged, and when the amount of medicine discharged reaches a predetermined amount, the vibration is stopped.
  • the robot is driven to move the medicine container onto another weight measuring means, and the weight of the medicine container is detected again by another weight detecting means.
  • This weight re-detection operation is mainly performed for the purpose of detecting a failure of the weight measuring means. That is, the weight of the drug container after drug discharge detected by the weight measuring means of the container placing device is compared with the weight of the same drug container detected by another weight detecting means. If the means are not faulty and there is a difference between the two, the weighing means may be faulty.
  • a robot is used to transfer the drug container to another weight measuring means to determine the quality of the weight measuring means, so it is essential to operate the robot.
  • the medicine dispensing device disclosed in Patent Document 2 needs to use a plurality of weight measuring means.
  • a further object of the present invention is to provide a drug feeder calibration method and a drug feeder failure detection method that do not necessarily require a robot and do not necessarily require the use of a plurality of weight measuring means.
  • One aspect of the present invention for solving the above-described problems is a drug container containing a powdered drug, a holding member for holding the drug container, and a weight for directly or indirectly measuring the weight of the drug container. and measuring means for discharging the powdered medicine from the medicine container and detecting the discharged amount of the powdered medicine by the weight measuring means, the medicine feeder having a weight member, the weight member or the weight measuring means. and a lifting means for lifting and lowering at least one of the means and the drug container, and a state in which the load of the weight member is applied to the weight measuring means and a state in which the load of the weight member is not applied to the weight measuring means.
  • a drug feeder for comparing conditions to calibrate said weighing means.
  • the drug feeder of this aspect it is possible to calibrate the weight measurement means and detect failures without necessarily requiring a robot as an external device or other weight measurement means.
  • the elevating means elevates the weight member, and it is preferable that the weight member elevates and performs the calibration.
  • the preferred aspect described above has a weight receiving portion, and the weight receiving portion is adapted to support the weight when the holding member holds the drug container and when the drug container is removed from the holding member. It is further preferred to be able to take the load of the member.
  • the weight measuring means can be calibrated both in a state in which the drug container is held and in a state in which the drug container is removed.
  • the preferred aspect described above has a measurement means inspection section formed including the weight member, the lifting means, and a weight receiving section capable of receiving the load of the weight member, and the measurement means inspection section It is further preferable that the calibration is performed, and the measuring means inspection portion is arranged at a position laterally spaced from the holding member.
  • the preferred aspect described above has a weight receiving portion
  • the lifting means includes a motor as a power source, a cam rotated by the operation of the motor, and a lifting member mounted on the cam,
  • the elevating member moves up and down as the cam rotates while maintaining a state of being placed on the cam. It is further preferable that the state in which the member is in contact with the weight receiving portion is shifted to the state in which the weight member is not in contact with the weight receiving portion.
  • the preferred aspect described above has a weight receiving portion, and the weight receiving portion is a part of the holding member, is formed at a position below the held drug container, and lifts and lowers the weight member. and switching between a state in which the weight member is placed on the weight receiving portion and the load of the weight member is applied to the weight measuring means and a state in which the weight member is separated upward from the weight receiving portion,
  • the weight member may be arranged at a position below the held drug container in each of the state of being placed on the weight receiving portion and the state of being separated upward from the weight receiving portion. More preferred.
  • the drug container can be manually held by the holding member, and the drug container held by the holding member can be manually removed.
  • Another aspect of the present invention is a drug dispensing device comprising the drug feeder described above.
  • the aspect described above has a medicine packaging unit for packaging powdered medicine, a hopper member into which the powdered medicine to be supplied to the medicine packaging unit is put, and a hopper-side weight measuring means for directly or indirectly measuring the weight of the hopper member. Then, a target amount of powdered medicine is discharged based on the detected value of the weight measuring means, and the discharged powdered medicine is put into the hopper member, and the failure is detected based on the detected value of the hopper side weight measuring means. It is preferable to
  • Another aspect of the present invention comprises a medicine container containing a powdered medicine, a holding member holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container,
  • a method for calibrating a drug feeder capable of detecting the amount of powdered medicine discharged by a weight measuring means comprising: a weight acquisition step of performing weight measurement by the weight measuring means in a state in which a load of a weight member is applied to the weight measuring means. and comparing the weight obtained in the weight obtaining step with a pre-stored weight to determine whether or not the weight measuring means is normal.
  • Another aspect of the present invention comprises a medicine container containing a powdered medicine, a holding member holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container,
  • a drug feeder failure detection method capable of detecting the amount of powdered medicine discharged by a weight measuring means, wherein the weight is measured by the weight measuring means while a load of a weight member is applied to the weight measuring means.
  • a failure detection method for a medicine feeder wherein the weight obtained in the weight obtaining step performed after the powdered medicine discharging operation is compared with the weight obtained in the weight obtaining process to determine whether or not the weight measuring means has failed during the powdered medicine discharging operation. be.
  • the powdered medicine in the operation of discharging the powdered medicine, is discharged with the powdered medicine discharging portion of the medicine container in the open state.
  • the weight of the drug container before discharging the powdered drug is obtained as the original weight before opening the powdered drug discharging portion of the drug container.
  • the present invention can provide a drug feeder that does not necessarily require a robot and does not necessarily require the use of a plurality of weight measurement means when determining the quality of the weight measurement means. Also, it is possible to provide a drug dispensing device equipped with such a drug feeder. Furthermore, it is possible to provide a drug feeder calibration method and a drug feeder failure detection method that do not necessarily require a robot and do not necessarily require the use of a plurality of weight measuring means.
  • the medicine dispensing device 1 when discharging (supplying) the powdered medicine from the medicine container 20 to the distribution tray 6, it is determined whether there is uneven discharge and whether there is an abnormality in the discharged amount. An allocation check operation is performed to determine whether the amount of one package (one dose) is correct. More specifically, when the powdered medicine is discharged, the falling amount H of the powdered medicine is constantly calculated as described above. Then, based on the falling amount H of the powdered medicine, the discharge speed (discharged amount per unit time) of the powdered medicine to the distribution tray 6 is calculated.
  • the amount of discharge per unit time deviates from the specified value, that is, when it is detected that the amount of discharge per unit of time has become extremely small or, conversely, has become extremely large, uneven discharge occurs. It is determined that Further, when discharging the powdered medicine, the weight of the powdered medicine contained in the medicine container 20 is measured before the discharge of the powdered medicine is started and after the discharge of the powdered medicine is completed. When the value obtained by subtracting the weight of powdered medicine after completion of discharging from the weight of powdered medicine before starting discharging is the same as the expected discharge amount (target discharge amount based on prescription), it is determined that there is no abnormality in the discharged amount.
  • the notification operation may be an operation in which the medicine dispensing device 1 is provided with sound generating means such as a speaker and a display device such as a display, and outputs warning sounds and voices, and displays a message. This also applies to the notification operation in the following description.
  • the weight calibration section 21 of the present embodiment includes the weight 42 and the weight placement member 43 described above, an elevating device 173 (elevating means), an upper guide member 175, and a control device 176. is doing.
  • the lifting device 173 , the upper guide member 175 , and the control device 176 are fixed to the base portion 26 (see FIG. 4) via mounting members 177 . In other words, these loads are applied to the base portion 26 .
  • the weight placing member 43 and the mounting member 177 are directly mounted to the container supporting portion 23 and the base portion 26, respectively, or indirectly via other members (see FIG. 4). At this time, the weight placement member 43 and the attachment member 177 are attached via temporary fastening elements.
  • temporary fastening element refers to a type of fastening element, and in principle refers to a fastening element that can be removed without being destroyed. , is the screw. As described above, the weight calibration unit 21 can be removed from the drug feeder 5 (detachable from the feeder main body 10).
  • the weight 42 is a metal weight having an approximately spherical outer shape, as shown in FIG.
  • the weight mounting member 43 is a member in which a flat plate-like receiving plate portion 43a and an upright plate-like mounting plate portion 43b are integrally formed.
  • the mounting plate portion 43b is a portion to be affixed to an object to be mounted (the container support portion 23 or a mounting member interposed between the container support portion 23) and has a screw hole.
  • An engagement hole portion 67 is provided in the receiving plate portion 43a.
  • the engagement hole portion 67 is a through hole having a circular opening shape, and penetrates the receiving plate portion 43a in the thickness direction (vertical direction).
  • the engagement hole 67 has a size that allows the weight support member 45 to pass through but not the weight 42 .
  • the lifting device 173 has a motor 83 serving as a power source (power section), a cam 85, a weight supporting member 45 (lifting member), and a support-side guide member 82.
  • the cam 85 is fixed to the output shaft of the motor 83 and rotates as the motor 83 operates.
  • This embodiment employs an eccentric cam in which the distance from the center of rotation to the outer peripheral surface changes in the circumferential direction.
  • the weight support member 45 is a vertically elongated substantially rectangular parallelepiped member having a recess 45a on its upper surface.
  • the recessed portion 45a is a portion on which the weight 42 is placed. In other words, it has a shape in which a part (lower part) of the weight 42 can be fitted almost exactly, and has a curved surface that comes into contact with a part of the weight 42 when the weight 42 is placed. This curved surface has a recessed depth that becomes shallower from the center toward the edge.
  • the support-side guide member 82 is a thick plate-shaped member formed to have a substantially square outer shape when viewed from above.
  • a guide hole 86 is provided in the support-side guide member 82 .
  • the guide hole 86 is a through hole that passes through the support-side guide member 82 in the thickness direction (vertical direction), and is formed to have a size that allows the weight support member 45 to be substantially just inserted therethrough.
  • the upper guide member 175 is a thick plate-like member having a thickness in the vertical direction.
  • a guide recess 88 is provided on the lower surface of the upper guide member 175 as shown in FIG.
  • the guide recessed portion 88 is a bottomed hole having a bottom portion on the upper side, and is a recessed portion that is recessed in a substantially truncated cone shape (substantially mortar shape).
  • the control device 176 is a control board that controls the operation of the weight calibration unit 21, and can transmit and receive information to and from the control device on the main body side of the medicine dispensing device 1. That is, the control device 176 has computing means such as a CPU, storage means such as a memory, and communication means such as an I/O port. Communication with an external device such as a control device on the main body side may be wired communication or wireless communication.
  • the mounting member 177 has a main body portion 63a having an upright mounting plate portion 87 and a control device mounting portion 63b. is attached to the base portion 26 with .
  • a motor 83 and a cam 85 are arranged on both sides of the mounting member 177 with the body portion 63a therebetween.
  • a motor 83 arranged on one main surface side of the main body portion 63a, and a support-side guide member 82 and an upper guide member 175 arranged on the other main surface side are attached to the main body portion 63a.
  • the support-side guide member 82 is arranged above the cam 85, and the upper guide member 175 is arranged further above it.
  • the control device mounting portion 63b of the mounting member 177 partially extends around the cam 85 as shown in FIGS.
  • the cam 85 is positioned between the motor 83 and the controller 176, as shown in FIG.
  • the weight support member 45 is placed on the cam 85 and inserted through the guide hole 86 . Further, the receiving plate portion 43a is arranged at a position spaced upward from the supporting side guide member 82, and the weight 42 is arranged above the receiving plate portion 43a. An upper guide member 175 is arranged above the weight 42 .
  • the weight calibration unit 21 operates the motor 83 to obtain the first state in which the load of the weight 42 is not applied to the receiving plate portion 43a, and the load of the weight 42 as described above.
  • the second state added to the receiving plate portion 43a can be switched.
  • the weight 42 is lifted by the weight support member 45, is positioned above the receiving plate portion 43a, and is not in contact with the receiving plate portion 43a. That is, the weight 42 does not contact the upper opening of the engaging hole 67 . In the present embodiment, at this time, a portion of the lower side of the weight 42 is positioned inside the engaging hole portion 67 . Also, in the first state, the upper portion of the weight 42 is in a state of being deeply inserted into the guide concave portion 88 of the upper guide member 175 .
  • the weight support member 45 moves downward and the weight 42 moves downward as shown in FIGS. 54(b) and 54(c). It moves downward while being placed on the member 45 . Then, a part of the weight 42 comes into contact with the upper opening of the engagement hole portion 67, and the weight 42 is placed on the receiving plate portion 43a. As a result, the first state (see FIG. 54(a)) shifts to the second state (see FIG. 54(c)). In the second state, the weight support member 45 is positioned downwardly away from the weight 42, that is, the weight 42 and the weight support member 45 are not in contact with each other, and the upper surfaces of the weight 42 and the weight support member 45 are not in contact with each other.
  • the upper portion of the weight 42 is positioned inside the guide recess 88 of the upper guide member 175 . That is, when the weight 42 moves up and down within the movable range, the upper part of the weight 42 is positioned inside the guide recess 88 and the lower part is positioned inside the engagement hole 67. state is maintained. In other words, in each of the first state, the second state, and the state in the middle of transition, the weight 42 is partly always positioned inside the guide recess 88 and partly positioned inside the engaging hole 67 . It will be in a state where it is always located inside the
  • the upper guide member 175 and the receiving plate portion 43a function as movement restricting means for restricting the range of movement of the weight 42, and also function as drop-off preventing means for preventing the weight 42 from dropping off.
  • the weight support member 45 also moves vertically within the range of movement, some portion of the weight support member 45 is positioned inside the guide hole 86 .
  • the support-side guide member 82 functions as movement restricting means for restricting the movement range of the weight support member 45, and also functions as drop prevention means for preventing the weight support member 45 from dropping off.
  • the cam 85 When shifting from the second state to the first state, the cam 85 may be rotated in the same direction as when shifting from the first state to the second state, or may be rotated in the opposite direction. may By rotating the cam 85 in this manner, the weight support member 45 (contact position between the weight support member 45 and the cam 85) moves upward, and the weight 42 is lifted and moved upward.
  • calibration of the weight measuring means 25 is an operation to determine whether the weight measuring means 25 is in a state in which the weight can be detected correctly, or whether the weight cannot be detected correctly for some reason.
  • the weight measuring means 25 on the condition that the weight of the weight 42 is correctly detected by the weight measuring means 25, it is determined that the weight measuring means 25 is in a state of being able to correctly detect the weight. That is, when the weight calibration section 21 is shifted from the first state to the second state, the load of the weight 42 is applied to the receiving plate section 43a as described above. At this time, since the weight mounting member 43 is attached to the container support portion 23, the load of the weight 42 is received by the receiving plate portion 43a, so that the weight of the weight 42 can be detected by the weight measuring means 25. .
  • the weight is measured by the weight measuring means 25 in the first state, and then the weight is measured by the weight measuring means 25 in the second state. Then, the value obtained by subtracting the detected value of the first weight measurement performed in the first state from the detected value (measured value) of the second weight measurement performed in the second state is the same as the weight of the weight 42. It is determined that the weight of the weight 42 is correctly detected on the condition that the weight is equal to the weight.
  • the following operations may be performed in the calibration without the drug container 20 attached. That is, the weight is measured by the weight measuring means 25 in the second state, and the value obtained by subtracting the basic weight from the detected value is calculated.
  • the “basic weight” is the sum of the weight of the members constituting the feeder section 22 that apply a load to the weight measuring means 25 and the weight of the weight placement member 43 .
  • the weight of the weight placing member 43 includes the weight of the other member when the weight placing member 43 is attached to the container support portion 23 via another member. Then, on the condition that the value obtained by subtracting the basic weight from the detected value is the same as the weight of the weight 42, it is determined that the weight of the weight 42 is correctly detected.
  • the weight of the weight 42 is correctly detected on the condition that the detected value is equal to the sum of the weight of the weight 42 and the basic weight.
  • the weight of the members to which a load is applied to the weight measuring means 25 the weight of the weight mounting member 43, and the weight of the weight 42 are measured in advance by another electronic balance or the like, and controlled. It may be stored in the device.
  • the weight is measured by the weight measuring means 25 in the second state, and the value obtained by subtracting the total value of the basic weight and the weight of the drug container 20 from the detected value is obtained. calculate. Then, on the condition that the calculated value is the same as the weight of the weight 42, it is determined that the weight of the weight 42 is correctly detected. At this time, it is determined that the weight of the weight 42 is correctly detected on the condition that the detected value is the same as the sum of the weight of the weight 42, the basic weight, and the weight of the medicine container 20. good.
  • the weight of the drug container 20 may be measured in advance and stored in the control device.
  • the weight of the medicine container 20 may be the sum of the weight of the medicine container 20 itself and the weight of the contained medicine when medicine (powder medicine) is contained therein.
  • the weighing means 25 of each medicine feeder 5 is automatically calibrated before the power is turned on and the work of the day is started.
  • the weight measuring means 25 of each medicine feeder 5 is automatically calibrated before the packaging operation is performed. Note that the calibration performed before execution of the packaging operation may be performed for all the medicine feeders 5, or may be performed only for the medicine feeder 5 used in the packaging operation scheduled to be performed next.
  • an operation of comparing the value obtained or calculated in the previous day's calibration with the value obtained or calculated in performing the calibration may be performed.
  • the weight value of the weight 42 calculated in the previous day's calibration is compared with the weight value of the weight 42 calculated after the power is turned on. It may be determined that there is none. Conversely, if they are not the same, it may be determined that the weight measuring means 25 of the drug feeder 5 is abnormal.
  • the medicine dispensing device 1 of the present embodiment When it is determined by calibration that the weight measuring means 25 is incapable of correctly measuring weight (the weight measuring means 25 has an abnormality), the medicine dispensing device 1 of the present embodiment performs a notification operation to notify that effect. may be executed.
  • the abnormality (failure) of the weight measuring means 25 is resolved (until the fact that the abnormality has been resolved is input by a certain operation, etc.)
  • the user may mistakenly place the medicine container 20 into the feeder body.
  • a notification operation may be performed to notify that the medicine cannot be discharged by the feeder main body 10 even if the medicine is placed (held) on the feeder body 10 .
  • This notification operation is performed each time the drug container 20 is placed on the feeder body 10 .
  • the feeder main body 10 is controlled so as not to perform the vibrating operation (set to not perform the vibrating operation).
  • the drug dispensing device 1 of the present embodiment when discharging the powdered drug from the drug container 20 to the distribution tray 6 in the packaging operation, it is possible to execute a failure detection operation for determining whether or not the weight measuring means 25 has failed. It's becoming The failure detection operation may be an operation performed in addition to the distribution check operation described above. Specifically, when discharging the powdered medicine from the medicine container 20 of the medicine feeder 5 to the distribution tray 6, the following operations may be performed. First, in the drug feeder 5 holding the drug container 20, the weight calibration section 21 is set to the first state (step 1). Then, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is obtained (step 2).
  • the weight calibration unit 21 is shifted from the first state to the second state, and an operation of detecting the weight of the weight 42 (hereinafter also referred to as preliminary weight measurement operation) is executed (step 3). Further, the weight calibration unit 21 is shifted from the second state to the first state, and the above-described operation of discharging the powdered medicine to the distribution tray 6 is executed (step 4). Also, after executing the operation of discharging the powdered medicine, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is obtained (step 5). Further, the weight calibration unit 21 is shifted from the first state to the second state, and an operation of detecting the weight of the weight 42 (hereinafter also referred to as post-weight measurement operation) is executed (step 6).
  • the weight measurement means 25 fails. determine that it did not. This makes it possible to detect an abnormality in the balance (weight measuring means 25) even in an environment where the powdered medicine scatters due to the packing operation, and by extension, an abnormality in the discharge operation of the powdered medicine (dispensing of the medicine). It can be detected whether or not In addition, according to such an operation, even when the weight 42 is aged, it is possible to perform a packaging operation with high reliability.
  • the failure detection operation is not limited to the operation performed by the weight calibration unit 21 described above, and may be an operation performed by the weight calibration units 200, 428, 521, etc., which will be described later.
  • the pre-weight measurement operation and the post-weight measurement operation may be operations of placing the weight on the medicine container and detecting the weight of the weight.
  • the configuration is not limited to the configuration in which the state in which the load of the weight is applied to the weight measuring means 25 and the state in which it is not applied are automatically switched. It is also conceivable to carry out the operation of placing and sensing the weight of the weight.
  • the amount of increase in the detected weight due to the placement of the weight 42 is obtained in each of the pre-weight measurement operation and the post-weight measurement operation, and the obtained weight (increased weight) is compare.
  • the detected value of the weight measurement performed in the second state is subtracted from the detected value of the weight measurement performed in the first state to obtain the increment. You can get the weight.
  • the increased weight may be obtained by subtracting the basic weight and the weight of the medicine container 20 from the detected value of the weight measurement performed in the second state.
  • the weight of the weight 42, the basic weight, and the total value (total weight) of the drug container 20 may be obtained and compared.
  • the present invention is not limited to this.
  • it may be a weight 153 (weight member) shown in FIG. 55(a).
  • the weight 153 has an upper portion 142a and a lower portion 142b, both of which are substantially truncated conical, and a substantially disk-shaped central portion 142c located therebetween. That is, the upper and lower sides of the weight 153 are tapered portions, and have a tapered shape in which the area of the cross section decreases as it goes upward or downward.
  • a weight support member 155 (elevating member) shown in FIG.
  • the weight support member 155 is a vertically long member having an upwardly convex curved surface on the upper end side and a downwardly convex curved surface on the lower end side, and has a substantially oval longitudinal cross-sectional shape. is.
  • the weight calibration unit 21 may be arranged on the other side, rearward (a position on the opposite side of the distribution plate 6 with the feeder unit 22 interposed therebetween, and rearward when the distribution plate 6 side is defined as the front). may be placed in In other words, it may be arranged on one side of the periphery of the feeder section 22 (the periphery including the four sides). At this time, it may be arranged at a position adjacent to the feeder section 22 or may be arranged at a position slightly separated from the feeder section 22 in the horizontal direction.
  • the user can manually hold the medicine container 20 in the feeder main body 10 . Then, the user can manually remove the drug container 20 held by the feeder main body 10 . That is, it is possible to manually replace (change) the medicine container 20 held by the feeder main body 10 .
  • the medicine feeder employed in the medicine dispensing device 1 is not limited to the one described above, and may be a medicine feeder 201 equipped with a weight calibration section 200 (measuring means inspection section) as shown in FIG.
  • the weight calibration section 200 includes an elevating device 202 (elevating means), a weight member 203 (calibration weight), and a weight receiving member 204 (weight receiving section).
  • the lifting device 202 has a motor (not shown), a gear 215 that rotates with the operation of the motor, a container lifting section 211 and a weight lifting section 212 .
  • the gear 215 is a pinion gear, and the container elevating section 211 and the weight elevating section 212 each have a gear-cut rack portion. Gears 215 are engaged with respective rack portions. Therefore, when the container raising/lowering part 211 rises, the weight raising/lowering part 212 descends, and when the container raising/lowering part 211 descends, the weight raising/lowering part 212 rises.
  • the container raising/lowering part 211 has a flat pressing piece 211a.
  • the pressing piece portion 211a is a portion that contacts the drug container 20 supported by the container support portion 23 from below.
  • the weight raising/lowering part 212 has a plate-shaped weight support part 212a. As shown in FIG. 56(b), the weight support portion 212a is provided with a support hole 230 penetrating through the weight support portion 212a in the thickness direction (vertical direction).
  • the weight member 203 has a flange portion 203a, a constricted portion 203b, and a body portion 203c in order from above.
  • the flange portion 203a has a size that cannot pass through the support hole 230, and the constricted portion 203b and the body portion 203c have sizes that allow it to pass through the support hole 230. As shown in FIG.
  • the weight receiving member 204 is a member that has a flat plate-like receiving plate portion 204a and an upright plate-like mounting plate portion 204b, and is fixed to the support base 27. As shown in FIG. 56(a), the weight receiving member 204 is a member that has a flat plate-like receiving plate portion 204a and an upright plate-like mounting plate portion 204b, and is fixed to the support base 27. As shown in FIG. 56(a), the weight receiving member 204 is a member that has a flat plate-like receiving plate portion 204a and an upright plate-like mounting plate portion 204b, and is fixed to the support base 27. As shown in FIG.
  • the weight raising/lowering part 212 is a member capable of supporting the weight member 203 in a suspended state, as shown in FIG. 56(b). That is, when the weight member 203 is inserted into the support hole 230 from above while the weight support portion 212a is positioned at a high position, the flange portion 203a is caught, and the lower surface of the flange portion 203a and the upper surface of the weight support portion 212a are aligned. Be in contact. At this time, at least part of the constricted portion 203b is positioned inside the support hole 230, most of the weight member 203 is disposed below the weight support portion 212a, and the lower surface of the weight member 203 is the receiving plate portion. 204a at a spaced position.
  • the weight member 203 is supported in a suspended state as described above and arranged at a position spaced upward from the receiving plate portion 204a. Then, the drug container 20 is placed on the vibration-side horizontal portion 32 of the vibrating member 16, and the pressing piece 211a is arranged at a position spaced downward from the drug container 20. As shown in FIG.
  • the pressing piece 211a comes into contact with the drug container 20 from below. Then, the container raising/lowering part 211 is raised as it is, thereby moving the drug container 20 upward, and the pressing piece 211 a lifts the drug container 20 .
  • the weight lifting portion 212 descends as the container lifting portion 211 rises, the weight member 203 is placed on the receiving plate portion 204a.
  • the upper surface of the weight support portion 212a is arranged at a position separated below the lower surface of the flange portion 203a. This causes a transition from the first state to the second state. Further, in the second state, the load of the weight lifting section 212 (lifting device 202) is not applied to the receiving plate section 204a (weight measuring means 25).
  • the load of weight member 203 is not applied to weight measuring means 25 and the load of medicine container 20 is applied to weight measuring means 25 .
  • the load of weight member 203 is applied to weight measuring means 25 and the load of drug container 20 is not applied to weight measuring means 25 . Therefore, by shifting to the second state, it is possible to calibrate the weight measuring means 25 . Switching between the first state and the second state can be performed automatically.
  • the gear 215 rotates in the opposite direction between the transition from the first state to the second state and the transition from the second state to the first state.
  • the drug container 20 is lifted in the second state, but the drug container 20 does not necessarily have to be lifted.
  • the weight measuring means 25 may be calibrated while the drug container 20 is being held, and the container elevating section 211 may not necessarily be provided.
  • the calibration of the weight measuring means 25, which is performed before starting work for the day, may be performed using a calibration tool 256 shown in FIG. 57(a).
  • the calibrating instrument 256 is an instrument used by being attached to the scraping device 8, and has a mounting member 257, a bearing member 252, a base member 253, and a locking member 254, as shown in FIG. 57(b).
  • the bearing member 252 is a bearing such as a ball bearing
  • the locking member 254 is a C-ring.
  • the mounting member 257 has a body portion 251a and a connecting rod portion 251b.
  • the main body portion 251a has a disk-shaped portion 263 and a peripheral wall portion 265 that continues in an annular shape.
  • the peripheral wall portion 265 is formed to protrude from the edge of the disk-shaped portion 263 to one side in the thickness direction.
  • a recessed portion (not shown) capable of accommodating the mounting base 255 of the scraping device 8 is formed in a portion surrounded by the peripheral wall portion 265 .
  • the mounting member 257 is a member mounted on the mounting base 255 described above. That is, the mounting member 257 is mounted on the mounting base 255 with the rotating plate 12 removed from the mounting base 255 .
  • the recessed portion of the mounting member 257 can fit the mounting base 255 substantially exactly inside.
  • an engaging portion (not shown) that engages with a projecting portion provided on the mounting base 255 is provided on one side portion (recess portion) of the mounting member 257 . That is, it is an engaging portion that forms a pair (engages with each other) with the projection portion that is the engaging portion on the mounting base 255 side.
  • the connecting rod portion 251b is a round rod-shaped portion, and is formed at a position opposite to the above-described recessed portion with the disc-shaped portion 263 interposed therebetween.
  • the pedestal member 253 is a member in which a weight support portion 270, a rotation preventing portion 271, and an upright plate-like connecting plate portion 272 are integrally formed.
  • the weight support portion 270 is a plate-like portion and is provided with a support hole portion 270a.
  • the support hole portion 270a penetrates the weight support portion 270 in the thickness direction (vertical direction).
  • the rotation preventing portion 271 has two plate-like members consisting of an upper plate portion 271a and a lower plate portion 271b. Both the upper plate portion 271a and the lower plate portion 271b are plate-shaped portions, and are provided so as to face each other with a space therebetween in the vertical direction.
  • the connecting plate portion 272 is continuous with the weight support portion 270 at one end in the longitudinal direction, and is continuous with the rotation preventing portion 271 at the other end.
  • the connecting plate portion 272 is provided with a connecting hole portion 272a.
  • the connecting hole portion 272a is a through hole penetrating through the connecting plate portion 272 in the thickness direction.
  • the bearing member 252 When the calibration instrument 256 is assembled, the bearing member 252 is attached to a part of the connecting plate portion 272, and the connecting rod portion 251b is inserted through the inner hole of the bearing member 252 and the connecting hole portion 272a.
  • a locking member 254 is attached to a portion of the connecting rod portion 251b that partially protrudes from the connecting hole portion 272a and is located on the distal end side in the insertion direction.
  • the base member 253 and the mounting member 257 are connected so as to be relatively rotatable. That is, it is rotatable around the connecting rod portion 251b as a rotation axis.
  • the weight supporting portion 270 When attached to the scraping device 8, as shown in FIG. 57(a), the weight supporting portion 270 is positioned on the tip side of the mounting base 255 in the extending direction of the scraping arm 17, The anti-rotation portion 271 is located on the base end side of the base 255 . At this time, the scraping arm 17 is positioned between the upper plate portion 271a and the lower plate portion 271b of the rotation preventing portion 271, and the scraping arm 17 is sandwiched between the upper plate portion 271a and the lower plate portion 271b. Become. Also, the mounting member 257 and the connecting plate portion 272 are positioned on one side of the mounting base 255 in the thickness direction.
  • the weight member 203 can be supported in a suspended state by the weight support portion 270 in the same manner as described above (see FIG. 58(a)). That is, in the calibration of the weight measuring means 25 using the calibration tool 256, the drug container 20 is previously removed from the drug feeder 5 having the weight measuring means 25 to be calibrated. Then, the turntable is rotated to turn the entire scraping device 8 (scraping arm 17 and mounting base 255). As a result, the weight member 203 is positioned above the vibration-side horizontal portion 32 as shown in FIG. 58(b).
  • the weight member 203 is placed on the vibration-side horizontal portion 32 by swinging the scraping arm 17 and moving the tip side of the scraping arm 17 downward.
  • the load of the weight member 203 is applied to the weight measuring means 25, and the weight measuring means 25 is calibrated.
  • the scraping arm 17 is swung to move the tip side of the scraping arm 17 upward, thereby supporting the weight member 203 in a suspended state and allowing the weight measuring means 25 to carry the weight.
  • a state is assumed in which no load is applied to the member 203 .
  • the entire scraping device 8 is rotated and the above operation is executed.
  • the medicine feeder employed in the medicine dispensing device 1 is not limited to the one described above, and may be a medicine feeder 405 equipped with a weight calibration section 428 (measuring means inspection section) as shown in FIG. .
  • the drug feeder 405 of this embodiment has a structure different from that of the drug feeder 5 described above in the container supporting portion 423 (holding member). That is, the vibration side horizontal portion 432 of the vibration member 416 is formed with a weight arrangement portion 443 which is a concave portion with an open top. A member placement hole 446 is formed below the weight placement portion 443 to communicate the space below the vibration member 416 with the weight placement portion 443 . Further, the support-side horizontal portion 430 of the support table 427 is also formed with a member arrangement hole 447 penetrating through the support-side horizontal portion 430 in the vertical direction.
  • the member arrangement hole 446 of the vibrating member 416 and the member arrangement hole 447 of the support base 427 are formed so that at least parts of them overlap each other in plan view.
  • a member placement space 448 is formed below the weight placement portion 443 .
  • the member placement space 448 is a space in which the lifting member 445 that is part of the lifting device 460 is arranged.
  • the elevating device 460 has an elevating member 445 and an elevating mechanism (not shown) that elevates the elevating member 445 .
  • the elevating mechanism has a motor as a power source and a conversion mechanism that converts rotary motion of the motor into linear motion.
  • the conversion mechanism may be a cam positioned below the elevating member 445, or may be a rack and pinion mechanism that combines a toothed portion provided on the elevating member 445 and a pinion gear. That is, the elevating member 445 is vertically moved by the operation of the motor.
  • an elevating mechanism is arranged below the vibrating member 416 and the support base 427 .
  • a weight measuring means (not shown) of the medicine feeder 405 is in a state where the weight of the member such as the container support portion 423 is applied, but the load of the lifting device 460 is not applied.
  • a substantially rectangular parallelepiped weight member 442 (calibration weight) is arranged in the weight arrangement portion 443 .
  • the weight placement portion 443 is positioned below the lower surface of the drug container 20 when the container support portion 423 holds the drug container 20 . At this time, the weight placement portion 443 is entirely covered with the drug container 20 on the upper side.
  • the drug feeder 405 of this embodiment has a first state (see FIG. 59A) in which the weight member 442 is arranged at a position separated from the bottom portion of the weight arrangement portion 443, and a state in which the weight member 442 It is possible to switch between a second state (see FIG. 59(b)) in which the bottom portion of 443 is contacted. By shifting the medicine feeder 405 from the first state to the second state, the weight measuring means can be calibrated. Note that the weight member 442 is arranged inside the weight arrangement portion 443 in both the first state and the second state.
  • the weight member 442 is lifted by the elevating member 445 .
  • the lower portion of the weight member 442 contacts the upper portion of the elevating member 445 , and the weight member 442 is placed on the elevating member 445 . Therefore, the load of the weight member 442 is applied to the lifting member 445 but not applied to the vibrating member 416 . That is, the load of weight member 442 is not applied to the weight measuring means of drug feeder 405, and the load of weight member 442 is not measured by the weight measuring means.
  • the lifting member 445 moves downward from the first state, the weight member 442 moves downward along with the movement of the lifting member 445 . Then, the lower portion of the weight member 442 contacts the bottom portion of the weight arrangement portion 443 from above.
  • the weight member 442 has a size (and/or shape) that cannot be inserted into the member arrangement hole 446 of the vibration member 416 from above. Therefore, when the elevating member 445 continues to move downward, the elevating member 445 is arranged at a position away from the weight member 442 downward. On the other hand, the weight member 442 is placed on the bottom portion of the weight arrangement portion 443 . This completes the transition from the first state to the second state. That is, the load of the weight member 442 is applied to the weight measuring means of the medicine feeder 405, and the load of the weight member 442 is measured by the weight measuring means.
  • the operation (calibration of weight measuring means, failure detection).
  • the weight of the drug feeder 405 is measured by the weight measuring means in the first state. After that, it is shifted to the second state, and weight measurement is performed by the weight measurement means of the medicine feeder 405 .
  • the condition is that the value obtained by subtracting the detected value of the weight measurement performed in the first state from the detected value (measured value) of the weight measurement performed in the second state is the same as the weight of the weight member 442. , it is determined that the weight of the weight member 442 is correctly detected. That is, it is determined that the weight measuring means is in a state of being able to correctly detect the weight.
  • a motor as a power source, a torque limiter, and a wire as a linear member are provided, and the wire can be used to pull a portion of the container support unit 23 upward.
  • a weight calibration unit (not shown) may be provided. That is, one end side of the wire in the longitudinal direction is attached to a member (container support section 23 or the like, hereinafter also referred to as a fixing target member) among the members constituting the feeder section 22 where a load is applied to the weight measuring means 25. fixed.
  • the motor and the torque limiter are fixed to the upper lid 4 and the lower part of the upper unit (tablet manual distributing device 303).
  • the wire is wound by operating the motor to pull the member to be fixed to which one end of the wire is fixed, thereby applying a vertically upward force to the member to be fixed.
  • a torque limiter between the motor and one end of the wire, a force of a specified magnitude is applied to the member to be fixed.
  • the detected value of the weight measuring means 25 when the pulling action is not executed and the detected value of the weight measuring means 25 while the pulling action is being executed are obtained. Then, the detected value during execution of the pulling operation is subtracted from the detected value while the pulling operation is not being executed. determine that it is in a detectable state
  • the wire may be fixed to the drug container 20 when the weight measuring means 25 is calibrated while the drug container 20 is being held. Further, in this case, the drug container 20 having the same weight is held in the measurement when the pulling operation is not performed and the measurement when the pulling operation is performed.
  • the term "medicine container 20 having the same weight” means that the weight of the drug container 20, which is the weight of the contained drug added to the weight of the drug contained therein, is the same.
  • the drug delivery device 1 of the above-described embodiment is provided with a plurality (six) of drug feeders 5, and each drug feeder 5 has its own weight calibrating section 21 individually. That is, one weight calibration unit 21 can apply a load of a weight (weight 42) to one weight measurement means 25.
  • FIG. like the weight calibration section 521 (measuring means inspection section) shown in FIG.
  • one weight calibration unit 521 is associated with a plurality of feeder units 22 to configure a drug feeder.
  • the weight calibration unit 521 of this embodiment includes a motor (not shown), a take-up pulley 501, a wire 502, a plurality of pulley members 503, and a plurality of weight members 504 (for calibration). weight).
  • the take-up pulley 501 and the pulley member 503 are fixed to the upper lid 4 or the lower part of the upper unit (tablet manual spreading device 303). Also, by operating the motor, the wire 502 can be wound by the winding pulley 501 .
  • the pulley member 503 and the weight member 504 are only partly numbered, and the other parts are omitted.
  • Separate pulley members 503 and weight members 504 are arranged above the respective feeder portions 22 .
  • the weight member 504 is arranged at a position away from the upper surface of the drug container 20 .
  • the first state in which the weight member 504 is placed and the second state in which the weight member 504 is placed on the drug container 20 can be switched.
  • the weight member 504 has an internal space 530.
  • the internal space portion 530 is a space that is open at the bottom and surrounded by a peripheral wall portion that continues in an annular shape.
  • a wire insertion hole 531 that communicates the interior space 530 with the outside is provided in the upper portion of the weight member 504 .
  • the wire insertion hole 531 is formed narrower than the internal space portion 530 .
  • a hooking member 532 is attached to the tip of the portion of the wire 502 that hangs down from the pulley member 503 .
  • the locking member 532 can be inserted into the internal space 530 from below the weight member 504 and has a size (and/or shape) that prevents it from passing through the wire insertion hole 531 .
  • the hooking member 532 is arranged in the internal space 530, and the wire 502 hanging down from the pulley member 503 extends into the internal space 530 through the wire insertion hole 531. It extends and is in a continuous state with the hooking member 532 .
  • the hooking member 532 moves downward, and the weight member 504 moves downward accordingly. Then, the lower end portion of weight member 504 comes into contact with drug container 20 from above. In this state, the locking member 532 moves further downward, so that the locking member 532 is separated downward from the upper portion of the weight member 504 in the internal space 530 and does not contact the ceiling wall portion of the internal space 530. state. As a result, the weight member 504 is placed on the medicine container 20, and the state is shifted to the second state. In the second state, the load of weight member 504 is applied to weight measuring means 25 while the load of hooking member 532 and wire 502 is not applied to weight measuring means 25 .
  • the hook member 532 moves upward and contacts the upper portion of the weight member 504 within the internal space 530 from below.
  • the weight member 504 moves upward, and the lower end portion of the weight member 504 separates upward from the drug container 20, thereby shifting to the first state. Since it is possible to shift from the first state to the second state as described above, whether or not the weight measuring means of the feeder section 22 is in a state in which the weight can be detected correctly is checked in the same manner as described above. It becomes possible to perform discriminating operations (calibration of weight measuring means, failure detection). For example, in the calibration of the weight measuring means, the weight is measured by the weight measuring means of the feeder section 22 in the first state.
  • the condition is that the value obtained by subtracting the detected value of the weight measurement performed in the first state from the detected value (measured value) of the weight measurement performed in the second state is the same as the weight of the weight member 504. , it is determined that the weight of the weight member 504 is correctly detected. That is, it is determined that the weight measuring means is in a state of being able to correctly detect the weight.
  • the weight calibration unit 521 of the present embodiment can raise and lower a plurality of weight members 504 at the same time. That is, it is possible to switch between a state in which the load of the weight member 504 is applied to each of the weight measuring means 25 of the plurality of feeder portions 22 and a state in which the weight member 504 does not apply the load to the weight measuring means 25 . be.
  • a weight holding means such as an electromagnet may be provided at the tip of the wire 502 (the tip of the portion hanging down from the pulley member 503). That is, the first state may be obtained by energizing the electromagnet to attract the weight and lifting the weight.
  • the current to the electromagnet may be stopped while the weight is placed on the drug container 20, and the weight may not be held.
  • the weight member 504 is placed on the medicine container 20 of the feeder section 22 .
  • the drug container 20 is made to function as a weight receiving portion that receives the load of the weight member 504.
  • the drug container 20 is previously removed from each feeder portion 22, and the weight member is attached to the container support portion 23. 504 may be placed.
  • the drug feeder described above may be formed so that the container support portion 23 can be moved up and down by an elevating device. At this time, the container support part 23 may be moved up and down while supporting the drug container 20 .
  • the load is not applied to the weight measuring means 25, and a large amount of pressure is applied between the lower surface of the support-side horizontal portion 30 positioned above and the weight measuring means 25.
  • a void may be formed.
  • the weight measuring means 25 can be calibrated by manually placing the weight member on the weight measuring means 25 .
  • the weight calibration section 21 is arranged on one side of the feeder section 22, and the weight 42 is placed on the weight placement member 43 to calibrate the weight measuring means 25.
  • the medicine feeder 5 that can be employed in the medicine dispensing device 1 is not limited to this.
  • an elevating device having cams arranged on both sides of the feeder section 22 is provided to move a weight member such as a weight up and down. You may switch the state arrange
  • a weight supporting member which is a member extending from one side of the feeder portion 22 to the other side and supports the weight member, is detachably formed from the main body of the lifting device. That is, when the drug container 20 is supported by the feeder main body 10, the weight supporting member is removed.
  • the weight support member may be capable of supporting the weight member in a suspended state as described above.
  • a lower weight measuring means to which the load of the plurality of drug feeders 5 is applied may be provided below the plurality of (for example, three) drug feeders 5 .
  • the weight of the drug container 20 is correctly detected in all of the plurality of drug feeders 5 . That is, the weight of each drug container 20 is measured in each drug feeder 5, and the total weight of the plurality (three) of drug containers 20 is calculated.
  • a plurality of (three) drug containers Calculate the total value of the 20 weights. Furthermore, the total value of the weights of the plurality (three) of drug containers 20 calculated based on the detection values of the plurality of weight measurement means 25 and the plurality (three) calculated based on the detection values of the lower weight measurement means is compared with the total value of the weight of the drug container 20 of As a result of the comparison operation, if there is no difference in the total value, it is determined that the weight of the drug container 20 is correctly detected by all of the plurality (three) of drug feeders 5 .
  • the weight measuring means 25 measure the weights of different weights 42 and calculate the total value thereof, and the lower weight measuring means calculates the total value of the weights of the plurality of weights 42, By comparing these, the weight measuring means 25 may be calibrated.
  • the medicine dispensing device 1 described above may construct and operate a medicine dispensing system together with an external host controller. At this time, it is possible to transmit and receive signals between the drug dispensing device 1 and the host controller. Also, the host controller is configured to have a display device such as a display. Then, when the medicine dispensing device 1 is turned on before starting work for the day (hereinafter also referred to as start of work), it may be determined whether the medicine feeder 5 needs to be calibrated.
  • each medicine feeder 5 is held in a state of holding a measurement container (measurement member). It should be noted that the weight of each container for measurement is obtained by measurement or the like performed in advance, and is stored in the control device. Then, in each drug feeder 5, a comparison operation is performed to compare the zero point of the weight measuring means 25 and the detected weight of the container for measurement. For example, in each drug feeder 5, a value is calculated by subtracting a previously stored value of the weight of the held measurement container from the detected value of the weight of the held measurement container. Subsequently, the values calculated by the comparison operations performed in each drug feeder 5 are compared.
  • the medicine dispensing device 1 transmits a signal to that effect to the host controller.
  • the host controller receives this signal, it performs a notification operation to prompt the user to calibrate the weight measuring means 25 . That is, when the values calculated by the respective medicine feeders 5 are not all the same, it is determined that the medicine feeders 5 need to be calibrated, and a notification operation to prompt the calibration of the medicine feeders 5 is performed.
  • the series of operations described above may be operations executed based on a signal transmitted from the host controller to the drug dispensing device 1 at the start of work. That is, the operation may be automatically executed by turning on the medicine dispensing device 1 .
  • a signal is periodically transmitted from the host control device such as each time the packaging operation is performed, every time the packaging operation is performed a predetermined number of times (multiple times), and every time a predetermined time elapses.
  • the measurement container may be an empty drug container 20 or a drug container 20 containing powdered medicine. That is, it may be the medicine container 20 used in the packaging operation. Further, the measurement containers held by the respective drug feeders 5 may have different weights.
  • the drug dispensing device 1 described above may be operated in a state where the power is always on. Further, even when the main body of the medicine dispensing device 1 is turned off, the medicine feeder 5 may be always turned on. In these cases, the detection value of the weight measuring means 25 of each medicine feeder 5 may be constantly monitored to detect whether or not the weight measuring means 25 is abnormal. That is, it may be determined that the weight measuring means 25 has an abnormality when the change in the value of the weight per hour is not a predicted change (eg, the specified value is not maintained).
  • a hopper-side weight measuring means 560 capable of detecting the weight of the powdered drug charging hopper 310 may be provided.
  • the hopper-side weight measuring means 560 is a part of the packaging device 308 and may be provided on a base member to which the powdered medicine charging hopper 310 is fixed. Further, when detecting the weight of the powdered medicine charging hopper 310, the detected value of the hopper-side weight measuring means 560 determines the weight of the member different from the powdered medicine charging hopper 310 among the members on which the load is applied to the hopper-side weight measuring means 560. A weight value may be obtained by subtracting the weight.
  • an upper lid member that closes the upper opening of the powdered medicine introduction hopper 310 and a lower lid member that closes the lower opening may be provided.
  • the upper lid member and the lower lid member are members capable of switching between an open state and a closed state of their respective openings.
  • the lower lid member may be provided integrally with the powdered medicine introduction hopper 310 .
  • the powdered medicine may be temporarily retained inside the powdered medicine feeding hopper 310 by putting the powdered medicine into the powdered medicine feeding hopper 310 with the lower lid member closed. At this time, the weight of the powdered medicine charged into the powdered medicine charging hopper 310 can be detected by the hopper-side weight measuring means 560 .
  • the following failure detection operation may be performed. Specifically, powdered medicine is discharged from the medicine container 20 of the medicine feeder 5 to the distribution tray 6 as described above. Around this time, the weight of a package of powdered medicine is obtained based on the prescription data. For example, when 63 g of powdered medicine is discharged to the distribution tray 6 as 21 packets, the weight of one packet of powdered medicine is 3 g (63/21). Then, one packet of the powdered medicine is put into the powdered medicine injection hopper 310 whose lower opening is closed by the lower cover member in the same manner as the normal packaging operation. Subsequently, based on the detection value of the hopper-side weight measuring means 560, the weight of the powdered medicine charged into the powdered medicine charging hopper 310 is acquired.
  • the weight of one package of powdered medicine obtained in advance and the weight of the powdered medicine put into the powdered medicine feeding hopper 310 obtained based on the hopper-side weight measuring means 560 are compared. If the result of the comparison operation is that they are the same, it is determined that the weight measuring means 25 has not failed. Conversely, if the compared weights are not the same, it is determined that the weight measuring means 25 has failed.
  • FIG. 61 if powdered medicine is discharged from one medicine feeder 5, it is determined whether or not the weight measuring means 25 of this medicine feeder 5 is out of order.
  • the weight measuring means 25 of all the medicine feeders 5 are out of order. That is, if the compared weights are the same, it is determined that the weight measuring means 25 of all of the plurality of drug feeders 5 have not failed. On the other hand, if the compared weights are not the same, it is determined that the weight measuring means 25 belonging to one or more drug feeders 5 has failed.
  • the weight of one package may be a value calculated based on the detected value of the weight measuring means 25 . That is, the total discharge amount may be calculated based on the detected value of the weight measuring means 25, and the weight of one package may be calculated from the total discharge amount.
  • a notification operation to notify that fact may be executed.
  • the notification operation may include an operation to prompt calibration of the weight measuring means 25 .
  • an operation may be executed to prompt calibration of the medicine feeder 5 determined to be out of order (or suspected to be out of order) by the failure detection operation, and belongs to the medicine dispensing device 1 (associated with the distribution tray 6).
  • an operation to prompt calibration of all drug feeders 5 may be executed.
  • the failure detection operation may be performed by stacking the powdered medicine discharged from the medicine feeder 5 to the distribution tray 6 at one point or in an extremely narrow area. That is, when this failure detection operation is started, one dose of powdered medicine is discharged from the medicine feeder 5 to the distribution tray 6 . During this time, the rotation of the distribution plate 6 is stopped, or the distribution plate 6 is rotated at a very low rotational speed. For this reason, the discharged powdered medicine is piled up at one point or in a very narrow area of the distribution tray 6 to form a powdered medicine assembly 570 .
  • the powdered medicine set 570 is a collection of powdered medicines piled up like a mountain in a narrow range that is part of the distribution tray 6 (a pile of powdered medicines).
  • one package of powdered drugs is discharged from each of them to form powdered drug aggregates 570 at a plurality of locations on the distribution tray 6 .
  • the weight of one package of the powdered medicine discharged from each medicine feeder 5, that is, the weight that becomes the target discharge amount when creating each powdered medicine group 570 is obtained.
  • the distribution tray 6 is rotated at a low speed to move one powdered drug set 570 a to a position close to the powdered drug charging hopper 310 , and then this powdered drug set 570 a is charged to the powdered drug charging hopper 310 .
  • the lower opening of the powdered medicine charging hopper 310 is kept closed, and the weight of the powdered medicine charged into the powdered medicine charging hopper 310 is obtained based on the detection value of the hopper-side weight measuring means 560 .
  • the weight of the powdered medicine (powder medicine set 570a) fed into the powdered medicine feeding hopper 310 is compared with the weight of one package that was the target discharge amount of the fed powdered medicine (target discharge amount when forming the powdered medicine set 570a). . As a result of the comparison operation, if they are the same, it is determined that the weight measuring means 25 of the medicine feeder 5 that discharged this powdered medicine was not out of order. Conversely, if they are not the same, it is determined that the weight measuring means 25 of the drug feeder 5 that has discharged this powdered drug has failed.
  • one medicine feeder 5 discharges powdered medicine with a target discharge amount of 3 g to create the powdered medicine set 570a, it is determined whether or not the weight of the powdered medicine fed into the powdered medicine feeding hopper 310 is 3 g. . Then, if it is 3 g, it is determined that the weight measuring means 25 belonging to one drug feeder 5 has not failed.
  • the lower opening of the powdered medicine charging hopper 310 is opened, and the powdered medicine (the powdered medicine set 570a) is discharged from the inside of the powdered medicine charging hopper 310.
  • the powdered medicine set 570a is discharged from the inside of the powdered medicine charging hopper 310.
  • another powdered medicine set 570b is moved to a position close to the powdered medicine feeding hopper 310, and this powdered medicine set 570b is fed into the powdered drug feeding hopper 310.
  • the lower opening of the powdered drug charging hopper 310 is closed.
  • the weight of the powdered medicine (powder medicine set 570b) fed into the powdered medicine feeding hopper 310 is acquired.
  • the weight of the powdered medicine (powder medicine set 570b) fed into the powdered medicine feeding hopper 310 and the target discharge amount of the fed powdered medicine (target discharge amount when forming the powdered medicine set 570a) for one package Compare the weight of From this, it is determined that the weight measuring means 25 of the drug feeder 5 that discharged this powdered drug was not out of order. Similarly, it is determined whether or not the weight measuring means 25 is out of order for each of the plurality of drug feeders 5 .
  • This failure detection operation is not limited to an operation targeting the weight measuring means 25 of a plurality of drug feeders 5 , and may be an operation targeting the weight measuring means 25 of one drug feeder 5 .
  • the failure detection operation described above the value (discharge amount) calculated based on the detection value of the weight measuring means 25 and the value (input amount) calculated based on the detection value of the hopper-side weight measuring means 560 are compared. Actions may be performed. Further, in the above example, the failure detection operation was performed using powdered medicine discharged from the medicine feeder 5 to the distribution tray 6 . However, the failure detection operation may use cleaning chemicals (cleaning agents), foods, excipients, etc., instead of the powdered medicine. That is, a powder different from the drug may be used. An excipient is an additive added to increase the volume before formulation, and is a so-called bulking agent.
  • food as used herein includes starch, sodium bicarbonate, and other foods that can be taken orally by humans, and the same applies to the following.
  • a container for detection operation containing these in the medicine container 20 is used.
  • This hopper attachment determination operation is an operation for determining whether or not the powdered medicine introduction hopper 310 is attached to the base member.
  • the hopper-side weight measuring means 560 detects the weight change when the powdered medicine charging hopper 310 is attached and detached. That is, based on the detection value of the hopper-side weight measuring means 560, it is determined whether or not the load of the powdered medicine charging hopper 310 is applied to the hopper-side weight measuring means 560. Then, when it is determined that the load of the powdered medicine charging hopper 310 is applied, it is assumed that the powdered medicine charging hopper 310 is attached.
  • the cleaning operation of the powdered medicine introduction hopper 310 is executed after execution of the packaging operation and before execution of the subsequent packaging operation.
  • a cleaning operation of the powdered medicine charging hopper 310 a cleaning chemical or food (hereinafter simply referred to as a cleaning agent) is charged into the powdered medicine charging hopper 310 with the lower opening closed, and then the upper opening is closed, There is a suction cleaning operation that provides suction within the powdered drug input hopper 310 .
  • the lower lid member may be opened and closed in the latter half of the suction, and at this time, air may be blown from the air nozzle to the outside of the lower lid member.
  • a dust collection operation for removing the medicine or the like adhering to the powdered medicine introduction hopper 310 by a dust collector (not shown).
  • the dust collector generates negative pressure to suck in dust together with air, and is not particularly limited, but may be equipped with a vacuum pump or a dust bag.
  • the cleaning operation there is a vibrating cleaning operation in which the powdered medicine charging hopper 310 is hit or vibrated by a vibrator, a knocker, or the like. In the cleaning operation of the drug dispensing device 1, one or more selected from a suction cleaning operation, a dust collection operation, and a vibration cleaning operation is performed.
  • the medicine dispensing device 1 of the present embodiment when performing the cleaning operation after performing the packaging operation, before the packaging operation is performed, after the packaging operation is performed (before the cleaning operation is performed), and when the cleaning operation is performed. After each execution, the operation of weighing the powdered medicine input hopper 310 is executed.
  • the value of the weight of the powdered medicine charging hopper 310 measured by the hopper-side weight measuring means 560 increases. Therefore, by acquiring the weight difference before and after the packaging operation (comparing the detected values), it is possible to determine how much powdered medicine has adhered to the powdered medicine introduction hopper 310 due to the packaging operation. In addition, by comparing the weight value before execution of the packaging operation and the value of weight after execution of the cleaning operation, it is possible to determine whether the cleaning operation was properly performed, that is, whether the powdered medicine was completely removed. can determine whether Therefore, the cleaning operation can be evaluated by comparing the detection values before the packaging operation and after the cleaning operation.
  • the drug dispensing device 1 performs a cleaning operation based on the detection value of the hopper-side weight measuring means 560 described above. For example, compare the detected values before and after the packaging operation, and if a large amount of powdered medicine is adhered, increase the amount of cleaning agent, increase the strength of hitting, and increase the number of times of hitting. , the suction strength of the dust collector is increased, the suction time is lengthened, and the like to perform the cleaning operation. Conversely, if the powdered medicine is not very attached, the cleaning operation is performed by reducing the amount of cleaning agent, weakening the strength of tapping, and so on.
  • the details of the cleaning operation to be performed (the amount of cleaning agent, the length (execution time) of various operations such as the suction operation, the number of tapping, the interval, the strength, etc.) , strength of dust collecting operation, etc.). Further, based on the detection value of the hopper-side weight measuring means 560 described above, it is determined whether or not the cleaning operation is to be performed again after the cleaning operation. When the cleaning operation is performed again, the content of the subsequent cleaning operation is also determined based on the detection value of the hopper-side weight measuring means 560 .
  • the number of times the cleaning operation is performed is determined, and the content of each cleaning operation to be performed once or multiple times is determined.
  • the number of cleaning operations to be performed may be determined whether or not the cleaning operation is to be performed continuously each time the cleaning operation is performed, or may be determined how many times to perform the cleaning operation before the first cleaning operation is performed. , the number of times to perform the cleaning operation may be determined before the second and subsequent cleaning operations are performed.
  • the contents of the cleaning operation similarly, the contents of the cleaning operation to be performed successively each time the cleaning operation is performed may be determined, or the contents of the cleaning operation may be determined at an appropriate timing.
  • cleaning evaluation information information regarding the evaluation of the already performed cleaning operation
  • the cleaning evaluation information may be information stored in association with information on the type of powdered medicine to be cleaned, information on humidity at the time of execution, information on the details of the cleaning operation performed, and the like. Then, each time the cleaning operation is performed, the cleaning operation may be performed with the content changed so as to obtain a better evaluation based on the cleaning evaluation information and related information. According to such a configuration, the longer the operation of the medicine dispensing device 1 is continued, the more the accuracy of the cleaning operation is improved.
  • the attachment determination operation is an operation for determining whether or not a member (rotary plate 12 in this embodiment) to be attached to the scraping device 8 afterward is correctly attached. Specifically, the operation of closing the lower opening of the powdered medicine charging hopper 310 and charging one package of the powdered medicine from the distribution tray 6 into the powdered medicine charging hopper 310 is executed.
  • the attachment determination operation may be an operation that is executed in parallel with the packaging operation. That is, it may be determined whether or not the rotating plate 12 is correctly mounted when the powdered medicine is put into the powdered medicine injection hopper 310 from the distribution tray 6 in the packing operation.
  • the packaging operation that is being performed may be stopped.
  • a notification operation may be performed to notify that the rotating plate 12 is not correctly mounted.
  • the attachment determination operation may be performed separately from the packing operation.
  • the powdered medicine may be discharged from the medicine feeder 5 to the distribution tray 6 before the packaging operation is performed.
  • the attachment determination operation may be an operation executed in parallel with the failure detection operation described above. That is, when the weight of the powdered medicine put into the powdered medicine feeding hopper 310 is correctly detected, it is determined that the rotating plate 12 is correctly mounted and the weight measuring means 25 of the medicine feeder 5 that has discharged this powdered medicine is not out of order. . On the other hand, if the weight of the powdered medicine is not correctly detected, it is determined that the rotating plate 12 is not properly mounted or the weight measuring means 25 of the medicine feeder 5 that has discharged the powdered medicine is out of order.
  • the medicine dispensing device 1 when discharging the powdered medicine from the medicine container 20 of the medicine feeder 5 to the distribution tray 6, as described above, prior to discharge, the preliminary weight measurement operation is performed. do. Then, the weight calibration unit 21 is shifted from the second state to the first state, and the operation of discharging the powdered medicine to the distribution tray 6 is executed. After executing the operation of discharging the powdered medicine, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is acquired. Furthermore, a post weight measurement operation is executed.
  • the operation of measuring the weight of the medicine container 20 is executed as described above. That is, the weight of the medicine container 20 is measured before and after the vibrating member 16 in the feeder section 22 starts to vibrate, and the current weight of the medicine container 20 is continuously monitored as the current weight g even while the powdered medicine is falling. Then, the original weight G and the current weight g of the drug container 20 immediately after being placed on the vibrating member 16 are compared to constantly calculate the falling amount H of the powdered medicine, and when the total falling amount H of the powdered medicine reaches the desired weight, Vibration of the vibrating member 16 is stopped.
  • the weight of the medicine container 20 before the opening provided on the lower side of the medicine container 20 is opened may be obtained as the original weight G of the medicine container 20 (it may be set as a zero point).
  • the vibration of the vibrating member 16 is stopped, and the opening of the medicine container 20 is kept open for a predetermined period of time. A waiting operation of waiting may be performed.
  • the falling amount H of the powdered medicine calculated by comparing the original weight G and the current weight g obtained after the execution of the standby operation can also be used as the amount of the powdered medicine finally discharged to the distribution tray 6 (discharge amount of the powdered medicine). good.
  • the medicine container 20 is attached to the feeder main body 10 and held, and after executing the powdered medicine discharging operation, the medicine container 20 is removed. A case of removing from the feeder main body 10 will be described in detail as an example.
  • the drug container 20 is attached to and held by the feeder body 10 (step 1, see FIG. 63(a)).
  • the weight calibration unit 21 is shifted from the first state to the second state, and the operation of detecting the weight of the weight 42 (preliminary weight measurement operation) is executed (step 2, see FIG. 63(b)).
  • the weight calibration unit 21 is shifted from the second state to the first state (step 3, see FIG. 63(c)).
  • the weight before opening the drug container 20 is acquired as the original weight G of the drug container 20, and zero point is taken (step 4, see FIG. 63(d)).
  • the drug container 20 is opened (step 5, see FIG. 63(e)).
  • the vibrating member 16 is vibrated to discharge (pay out) the powdered medicine (step 6, see FIG. 63(f)).
  • the standby operation is executed, and the original weight G and the current weight g obtained after the standby operation are compared to obtain the final discharge amount of the powder medicine (step 7, see FIG. 63(g)).
  • the opening of the drug container 20 is closed (step 8, see FIG. 63(h)).
  • the weight calibration unit 21 is shifted from the first state to the second state, and the operation of detecting the weight of the weight 42 (post weight measurement operation) is executed (step 9, see FIG. 63(i)).
  • the weight calibration unit 21 is shifted from the second state to the first state (step 10, see FIG. 63(j)).
  • the drug container 20 is removed from the feeder body 10 (step 11, see FIG. 63(k)).
  • the weight of the discharged drug is divided and packaged. There is a possibility that it will be different from the amount (emission amount that should be emitted originally). In other words, there is a possibility that the discharge amount will increase by the amount of the powdered medicine that has fallen before the zero point is taken. On the other hand, by executing the operation of discharging the powdered medicine according to the procedure described above, it becomes possible to discharge the powdered medicine more accurately.
  • invention 1 a drug container containing a powdered drug, a holding member for holding the drug container, and weight measuring means for directly or indirectly measuring the weight of the drug container, discharging the powdered drug from the drug container,
  • the drug feeder capable of detecting the discharge amount of the powdered drug by the weight measuring means, a state in which a load of the weight member is applied to the weight measurement means;
  • a drug feeder that performs calibration and/or failure detection of said weight measuring means by comparing a state in which no member load is applied to said weight measuring means.
  • invention 2 The medicine feeder according to invention 1, wherein the elevating means elevates the weight member, and the weight member elevates to perform the calibration and/or the failure detection.
  • Invention 3 having a weight receiving part, Invention 2, wherein the weight receiving portion can receive the load of the weight member in each of a state in which the holding member holds the drug container and a state in which the drug container is removed from the holding member.
  • a drug feeder as described in .
  • invention 4 a measurement means inspection unit including the weight member, the elevating means, and a weight receiving portion capable of receiving the load of the weight member;
  • the elevating means has a motor as a power source, a cam rotated by the operation of the motor, and an elevating member mounted on the cam, The elevating member moves up and down with the rotation of the cam while maintaining a state of being placed on the cam, According to any one of Inventions 2 to 4, wherein the lifting member pushes up the weight member from below, thereby shifting from a state in which the weight member is in contact with the weight receiving portion to a state in which the weight member does not contact the weight receiving portion.
  • a drug feeder according to any one of the above.
  • invention 6 having a weight receiving part,
  • the weight receiving portion is a part of the holding member and is formed at a position below the held drug container, By moving the weight member up and down, the weight member is placed on the weight receiving portion, the load of the weight member is applied to the weight measuring means, and the weight member moves upward from the weight receiving portion.
  • the separated state is switched, Invention 2, wherein the weight member is disposed at a position lower than the held drug container in each of the state of being placed on the weight receiving portion and the state of being separated upward from the weight receiving portion.
  • the drug feeder according to 3.
  • a drug dispensing device comprising the drug feeder according to any one of Inventions 1 to 7.
  • a medicine packaging unit for packaging powdered medicine for packaging powdered medicine, a hopper member into which the powdered medicine to be supplied to the medicine packaging unit is put, and a hopper-side weight measuring means for directly or indirectly measuring the weight of the hopper member, A target discharge amount of powdered medicine is discharged based on the detected value of the weight measuring means, and the discharged powdered medicine is put into a hopper member, and the failure detection is performed based on the detected value of the hopper side weight measuring means.
  • the drug delivery device 8.
  • a method for calibrating a drug feeder capable of detecting a weight acquisition step of measuring the weight by the weight measuring means with the load of the weight member applied to the weight measuring means;
  • a method of calibrating a drug feeder wherein the weight obtained in the weight obtaining step is compared with a prestored weight to determine whether or not the weight measuring means is normal.
  • a drug feeder failure detection method capable of detecting a weight acquisition step of measuring the weight by the weight measuring means with the load of the weight member applied to the weight measuring means; performing the weight acquisition step prior to the operation of discharging the powdered medicine; Further performing the weight acquisition step after the powder medicine discharging operation, The weight obtained in the weight obtaining step performed prior to the powdered medicine discharging operation is compared with the weight obtained in the weight obtaining step performed after the powdered medicine discharging operation, and the weight measuring means performs the powdered medicine discharging operation.
  • a drug feeder failure detection method for determining whether or not a drug feeder has failed.
  • invention 12 In the operation of discharging the powdered medicine, the powdered medicine is discharged by opening the powdered medicine discharging portion of the medicine container, and in the operation of detecting the amount of discharged powdered medicine, the weight of the medicine container before discharging the powdered medicine is obtained as the original weight.
  • Conventional medicine dispensers had room for improvement from the viewpoint of accurately detecting vibrations when discharging powdered medicine from the medicine feeder.
  • the present invention for solving the above-mentioned problems is a medicine which has a medicine container in which a powdered medicine is stored and a holding member which holds the medicine container, and is capable of discharging the powdered medicine from the medicine container.
  • the drug container is a drug feeder having a vibration detection sensor for detecting vibration of the drug container.
  • the drug container containing the powdered drug has a vibration detection sensor, and when discharging the powdered drug, its own vibration detection sensor can detect its own vibration. That is, it is possible to detect the vibration at the time of discharging at a position close to the powdered medicine to be discharged, and the detection accuracy can be improved.
  • the holding member has a holding-side engaging portion
  • the vibration detection sensor has a sensor-side engaging portion
  • the drug container is held by the holding member so that the holding-side engaging portion is held by the holding member. It is preferable that the joint portion and the sensor-side engaging portion are brought into contact with each other to be electrically connected, so that signals can be transmitted and received between the vibration detection sensor and other circuits.
  • a mounting detection operation for determining whether or not the drug container is held by the holding member is executed. It is further preferable to determine that the drug container is held by the holding member on the condition that the signal is input to the circuit of .
  • the vibration detection sensor is capable of detecting vibrations in a plurality of directions including the vertical direction and a direction crossing the vertical direction, and the vibration detection value in the vertical direction by the vibration detection sensor is amplified and output.
  • the value of the offset voltage that amplifies the detected value is determined based on the effect of gravity on the vibration detection sensor. It is preferable that the value of the offset voltage for amplifying the vibration detection value is the same.
  • the vibration detection sensor is an acceleration sensor.
  • Another aspect of the present invention is a drug dispensing device comprising the drug feeder described above.
  • the present invention can provide a drug feeder that can accurately detect vibrations when discharging powdered drugs. Also, it is possible to provide a drug dispensing device equipped with such a drug feeder.
  • the drug feeder 5 of the present embodiment is provided with vibration detection means 180 for detecting vibration of the drug container 20 as shown in FIG. 64 as a characteristic configuration.
  • the vibration detection means 180 has a vibration detection sensor 181 provided integrally with the medicine container 20 . By holding the drug container 20 on the container support portion 23, the vibration of the drug container 20 can be detected as an electric signal.
  • an acceleration sensor capable of detecting three-axis vibration is used as the vibration detection sensor 181 .
  • two axes extending in a direction parallel to the horizontal plane and perpendicular to each other are defined as the X axis and the Y axis
  • an axis extending in a direction perpendicular to the two axes is defined as the Z axis.
  • Y-axis, and Z-axis are defined as the vibration detection sensor 181 .
  • one axis of the three-axis acceleration sensor is in a state capable of detecting in the vertical direction (vertical direction)
  • the other axis is in a state capable of detecting in a direction parallel to the horizontal plane.
  • the vibration detecting sensor 181 has a connector contact portion 71a that contacts a connector pin 182 (holding side engaging portion, see FIG. 64(a)) provided on the vibrating member 16 (feeder body 10).
  • the connector contact portion 71a (sensor-side engaging portion) is a portion made of metal and having a flat plate-like outer shape.
  • the vibration detection sensor 181 is mounted on a substrate constituting the sensor such that the connector contact portion 71a is exposed to the outside and most of the other portions are invisible from the outside. Specifically, the connector contact portion 71a is exposed to the outside from each of the plurality of through holes provided in the back wall 36 of the drug container 20, and the other portions are attached so as not to be exposed to the outside.
  • the connector contact portion 71a of the vibration detection sensor 181 and the connector pin 182 come into contact with each other and are electrically connected. That is, the connector contact portion 71a and the connector pin 182 function as a pair of engaging portions that can be electrically connected.
  • the vibration detection sensor 181 and the control device (hereinafter, circuits on the container support portion 23 side (communication circuit, power supply circuit, signal processing circuit, etc.) are connected. circuit) are electrically connected.
  • the vibration detection sensor 181 is connected to the external circuit provided on the container support portion 23 side through the members serving as the signal line and the power supply line.
  • the connector pin 182 may be attached to the vibrating member 16 (container support portion 23) in such a manner that a part or the whole of the connector pin 182 can move in and out.
  • the vibration-side horizontal portion 32 is provided with a trigger piece that can move in and out. It is good also as a structure which protrudes. That is, it may protrude to the outside when the medicine container 20 is held.
  • the connector pin 182 is used as the holding side engaging portion, but the present invention is not limited to this.
  • the external shape of the terminal is not limited to a projecting (rod-like or needle-like) shape, and may be, for example, a plate-like portion. That is, it is sufficient that it is a terminal portion that forms a pair with the terminal portion (connector contact portion 71a) of the vibration detection sensor 181 and that is capable of electrical contact.
  • the drug feeder 5 of the present embodiment is capable of an attachment determination operation for determining whether or not the drug container 20 is correctly attached to the container support portion 23 (whether or not it is correctly held).
  • the attachment determination operation determines that the drug container 20 is properly attached to the container support portion 23 on the condition that an input voltage (input signal) is input from the vibration detection sensor 181 to the circuit on the container support portion 23 side. . Conversely, if the input voltage (input signal) is not input to the circuit on the container support portion 23 side, there is a high possibility that the connector contact portion 71a and the connector pin 182 are not in proper contact. Therefore, in this case, it is determined that the drug container 20 is not correctly attached.
  • the input voltage needs to be amplified depending on the type of acceleration sensor employed. For example, if an analog output acceleration sensor with a large scale (low detection sensitivity) is used as the vibration detection sensor 181, even if the drug container 20 vibrates at its maximum, the input voltage may change only slightly. have a nature. In this case, accurate vibration detection becomes difficult unless the input voltage is amplified. However, providing an offset voltage (offset adjustment circuit) for each of the three axes to amplify the input voltage raises a problem that the circuit configuration becomes expensive.
  • offset voltage offset adjustment circuit
  • the offset voltage for correcting each axis has variations, and may be affected by surrounding environment such as temperature characteristics and gravity.
  • As a method of preventing the offset voltage from deviating from the set value and the amplified waveform from swinging out of the measurement range it is conceivable to make the sensor substrate of the vibration detection sensor 181 capable of adjusting the volume. It is not desirable because it is necessary.
  • the maximum output voltage from the vibration detection sensor 181 is detected in the vertical direction (vertical direction) among the three sensor axes. Therefore, the offset voltage when amplifying the vibration detection sensor 181 is high as long as the amplified signal of the vibration detection sensor 181 that detects vibration in the vertical direction (vertical direction) among the three sensor axes falls within the measurement range.
  • the Z-axis which is one of the three sensor axes, is set in a state in which detection in the vertical direction (vertical direction) is possible, thereby reducing the influence of gravity during detection. That is, by reducing the error in the detected value due to the influence of gravity, the influence of the amplification including the error is reduced. Furthermore, the effect of gravity is reflected in the value of the offset voltage that corrects the detected value on the Z axis.
  • the medicine container 20 is set in advance to a state in which vibration is not performed, the Z-axis is set to a state in which vertical detection is possible, and the measurement is performed in a predetermined temperature range (for example, 0° C. to 40° C.).
  • a predetermined temperature range for example, 0° C. to 40° C.
  • the influence (magnitude of generated error, change in output voltage) per 1 g of gravity in the Z-axis detection value at a predetermined power supply voltage (for example, 3 V) is obtained.
  • the present inventor measured the Z-axis detection value (voltage measurement) under the influence of gravity of 1 g, 0 g, and -1 g when the drug feeder 5 was stationary without vibrating, the results were as shown in Table 1 below. Got.
  • the magnitude of the error in the detection value caused by the influence of the predetermined gravity and the error The post-amplification effect on the magnitude of is obtained.
  • the "effect after amplification on the magnitude of the error” is the magnitude of the error in the detected value after amplification and the amount of change in the detected value (output voltage) after amplification. According to the measurement conducted by the present inventor, it was found that the detected value after amplification changes by a maximum of about 0.2 V per 1 g of gravity.
  • the value of the offset voltage for correcting the Z-axis detection value (included in the output voltage) is determined based on the acquired amount of change in the detection value after amplification and the measurement range of the input circuit. Specifically, the value of the offset voltage is determined by adjusting the resistance values of R1 and R2 in FIG. 65 and adjusting the bias voltage.
  • the values of the offset voltages for correcting the X-axis and Y-axis detection values are set to the values described above as shown in FIG.
  • the Z-axis detection value is adjusted to the value of the offset voltage to be corrected. That is, as shown in FIG. 65, in this embodiment, an amplifier circuit (operational amplifier) is provided for correcting (amplifying) detection values for each of the three axes, ie, the X-axis, Y-axis, and Z-axis. Then, similar offset adjustment circuits (offset adjustment operational amplifiers) are used to correct the detected values of the three axes.
  • the value of the offset voltage for correcting the detected value is a value reflecting the influence of gravity as described above. Since the X-axis and Y-axis detection values are not affected by gravity, if the same offset voltage as the Z-axis detection value is used for correction, the set values will deviate from the Z-axis correction. However, since the amplitudes in the X-axis and Y-axis directions are smaller than the amplitudes in the Z-axis direction, even if the offset voltage matched to the Z-axis (even if the same bias voltage as the Z-axis is used as a reference), the measurement range will be out of range. It is unlikely that problems such as storage will occur.
  • the vibration detection sensor 181 of the present embodiment has an amplifier circuit that amplifies the output voltage, and the offset voltage for correcting the detection value of each of the three axes is an offset voltage suitable for correcting the detection value of the Z axis. matched to the voltage.
  • the maximum vibration can be detected with high accuracy by aligning the offset voltage with the axis (Z-axis) that is expected to vibrate the most.
  • the manufacturing cost increases.
  • the vibration detection means 180 may constantly monitor the vibration state for all vibration axes (X-axis, Y-axis, Z-axis). is detected, or at a regular time such as before starting work, the vibration state may be checked for all vibration axes.
  • inspection modes may include N, F1, F2, and F3.
  • FIG. 66 assumes that there are three medicine feeders 5, but the number of medicine feeders 5 is arbitrary.
  • Mode N is a monitoring mode during normal operation. This detection mode is performed more carefully than modes F1, F2, and F3, and is a mode in which vibration states of all vibration axes (X-axis, Y-axis, and Z-axis) of each drug feeder 5 are individually inspected.
  • 66(b) and (c) are circuit diagrams for switching the vibration detection sensor according to the inspection mode.
  • the circuits shown in FIGS. 66B and 66C have an input section 100, a switch group 101, and an output section .
  • the output voltages (output signals) from the X-, Y-, and Z-axis vibration detection sensors 181 of the drug feeders (F1), (F2), and (F3) are directly or amplified.
  • X1 is the output of the X-axis vibration detection sensor of the drug feeder (F1)
  • Y1 is the output of the Y-axis vibration detection sensor of the drug feeder (F1)
  • Z1 is the drug feeder (F1).
  • X2, Y2 and Z2 are terminals to which the output of the vibration detection sensor of the drug feeder (F2) is input.
  • X3, Y3 and Z3 are terminals to which the output of the vibration detection sensor of the drug feeder (F3) is input.
  • the inspection mode N is the connection state shown in FIG. 66(b), in which the Z-axis input terminals of the drug feeders (F1), (F2), and (F3) are connected to the output terminals. .
  • an output voltage (output signal) from the Z-axis vibration detection sensor 181 of the medicine feeder (F1) is output to the output terminal S1.
  • An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F2) is output to the output terminal S2.
  • An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F3) is output to the output terminal S3.
  • the inspection mode F1 is the connection state shown in FIG. 66(c), in which the X-axis, Y-axis, and Z-axis input terminals of the drug feeder (F1) are connected to the output terminals.
  • an output voltage (output signal) from the X-axis vibration detection sensor 181 of the medicine feeder (F1) is output to the output terminal S1.
  • An output voltage (output signal) from the Y-axis vibration detection sensor 181 of the drug feeder (F1) is output to the output terminal S2.
  • An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F1) is output to the output terminal S3.
  • inspection mode F2 In inspection mode F2, the X-axis, Y-axis, and Z-axis input terminals of the medicine feeder (F2) are connected to the output terminals. In the inspection mode F3, the X-, Y-, and Z-axis input terminals of the drug feeder (F3) are connected to the output terminals.
  • the feeder section 22 described above has vibrating means 30a and 30b, a potentiometer (not shown), an actuator (not shown), a weight measurement section 24, and a vibration detection sensor 181 as electrical components.
  • the potentiometer is a sensor that can detect the amount of movement and the angle of rotation, and can detect the amount of movement of a predetermined member (for example, a member that constitutes the shutter opening/closing mechanism 55).
  • the actuator is a member that functions as a driving device that drives a predetermined member (a member that constitutes the shutter opening/closing mechanism 55), and is specifically a DC motor.
  • the vibrating means 30a, 30b, potentiometers, and actuators (not shown) are arranged so that a load is applied to the weight measuring section 24.
  • the weight measuring section 24 and the vibration detecting sensor 181 are arranged so that a load is applied to the vibration isolating means 18 (vibration isolating member 28). It is
  • the wiring member is You can connect via At this time, the actuator may be communicated with a higher control device via a motor driver.
  • the actuator may be communicated with a higher control device via a motor driver.
  • at least part of the electrical components of the feeder section 22 may be connected to a higher control device without wiring members.
  • potentiometers and actuators may be connected to a host control device by wireless power supply or wireless communication. In this way, in the case of a configuration in which connection is made to the host control device without the wiring member, it is possible to eliminate (reduce) the influence of the wiring during the weight measurement operation by the weight measurement unit 24, and the accuracy is high. Weight measurement operation becomes possible. Therefore, when performing an operation of putting a small amount of powdered medicine into the distribution tray 6 (packing a small amount of powdered medicine), etc., a more accurate operation is possible.
  • the drug feeder 5 is fixed to a feeder portion 22 having a vibrating member 16 and an intermediate plate portion (a plate portion serving as a base positioned outside the distribution plate 6; see FIG. 2 and the like). It has a weight calibration unit 21 that does not vibrate.
  • a thin and flat belt-shaped wiring member such as FFC (flexible flat cable) is used. (referred to as a member) is preferably adopted.
  • the strip-shaped wiring member is arranged in a state (orientation) extending along a rounded trajectory.
  • the portion forming the arc includes a portion that once extends upward, a portion that extends downward while moving away from the feeder portion 22 from above, and a portion that extends downward while extending in a direction approaching the feeder portion 22. may be configured.
  • the accuracy of the weight measuring operation is improved. It becomes possible to plan That is, it is possible to eliminate (reduce) the effects of changes in the tension of the wiring member due to vibration, movement of a part of the wiring member, and the like, and it is possible to improve the accuracy of the weight measurement operation.
  • the feeder section 22 includes piezoelectric elements (vibrating means 30a and 30b).
  • a D-class amplifier or an AB-class amplifier may be adopted for the oscillation circuit of the piezoelectric element.
  • invention 1 A drug feeder having a drug container for containing a powdered drug and a holding member for holding the drug container, and capable of discharging the powdered drug from the drug container, A drug feeder, wherein the drug container has a vibration detection sensor that detects vibration of the drug container.
  • the holding member has a holding-side engaging portion, The vibration detection sensor includes a sensor-side engaging portion, When the drug container is held by the holding member, the holding-side engaging portion and the sensor-side engaging portion come into contact with each other and are electrically connected to each other.
  • the drug feeder according to invention 1 which enables transmission and reception of a signal at .
  • the vibration detection sensor is capable of detecting vibration in a plurality of directions including a vertical direction and a direction crossing the vertical direction, The value of vertical vibration detected by the vibration detection sensor is amplified and output, and the value of the offset voltage for amplifying the detection value is determined based on the effect of gravity on the vibration detection sensor.
  • the vibration detection sensor is an acceleration sensor.
  • a drug dispensing device comprising the drug feeder according to any one of Inventions 1 to 5.
  • the present invention is a drug dispensing device that achieves the third goal of the Sustainable Development Goals (SDGs) of "ensuring healthy lives and promoting well-being for all at all ages". It is what you get.
  • the drug dispensing device of the present invention is a device that can be performed even by non-pharmacists such as technicians by eliminating powdered drug inspection work such as powdered drug weighing that should be performed by a qualified person such as a pharmacist. Specifically, without being conscious of the fact that it is a drug, the operator can select the number of the drug container specified based on the prescription information, or if the drug container is placed on a shelf or the like, the specified drug container can be selected by a lamp or the like.
  • Vibration-isolating member 30 Support-side horizontal portion 30a Vibrating means 30b Vibrating means 31 Support-side vertical wall portion 32 Vibration-side horizontal portion 33 Vibration-side vertical wall portion (vertical wall), 55; shutter opening/closing mechanism (opening/closing mechanism), 56; engagement piece holding portion, 61; large area side surface, 62; small area side surface, 68; Box portion 72; rectifying member 73, 473; shutter structure portion 75, 475; lid member 76; tightening member 91, 231, 491, 740; Engagement groove, 131; Engagement recess, 132; Recess, 152; Temporary receiving plate, 301; Detachment assisting member 710;

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Quality & Reliability (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Provided are a drug feeder favorably employable in a drug dispensing unit having no robot mechanism, and a drug dispensing unit employing such a drug feeder. A drug feeder 5 comprises a drug container 20 in which a powder medicine is accommodated, a container holding part 16 that holds the drug container 20, and a weight measurement means 25 for directly or indirectly measuring the weight of the drug container 20. The drug feeder 5 vibrates the drug container 20 to discharge the powder medicine from the drug container 20, and is able to detect a discharge amount of the powder medicine with the weight measurement means 25. The drug container 20 is provided with an opening/closing member for opening/closing a powder medicine discharge part, and further has an opening/closing mechanism part. The opening/closing mechanism part directly or indirectly imparts power to the opening/closing member and moves at least a part of the opening/closing member to open/close the powder medicine discharge part. The opening/closing mechanism part imparts the power to the opening/closing member when bringing the powder medicine discharge part into an open state and when bringing the powder medicine discharge part into a closed state.

Description

薬剤フィーダ及び薬剤払出し装置Drug feeder and drug dispensing device
 本発明は、散薬を所定量計量して取り出す薬剤フィーダに関するものである。本発明の薬剤フィーダは、散薬を分配する散薬分配装置に対して散薬を供給する装置として好適に使用される。
 また本発明は、薬剤フィーダを内蔵した薬剤払出し装置に関するものである。
TECHNICAL FIELD The present invention relates to a medicine feeder for weighing and taking out a predetermined amount of powdered medicine. The drug feeder of the present invention is suitably used as a device for supplying powdered drugs to a powdered drug dispensing device.
The present invention also relates to a drug dispensing device incorporating a drug feeder.
 近年、大病院や、大規模の薬局では、散薬分包装置や散薬分包機能を備えた薬剤払出し装置が導入されている。
 特許文献1に開示された旧来の薬剤払出し装置は、人手によって薬棚から処方された散薬が入った薬瓶を取り出し、天秤等の秤を使用して処方された特定の散薬の総重量を量り出す作業を行う必要があり、完全自動装置とは言いがたい。
 本出願人は、この問題に対処するため、特許文献2、3に開示された薬剤払出し装置を実用化した。
In recent years, large hospitals and large-scale pharmacies have introduced a powder medicine packaging device and a medicine dispensing device having a powder medicine packaging function.
In the conventional medicine dispenser disclosed in Patent Document 1, a medicine bottle containing prescribed powdered medicine is manually taken out from the medicine cabinet, and the total weight of the prescribed powdered medicine is weighed using a scale such as a scale. It is difficult to say that it is a fully automatic device because it is necessary to perform the work of ejecting.
In order to deal with this problem, the applicant has put into practical use the drug dispensing devices disclosed in Patent Documents 2 and 3.
 特許文献2、3に開示された薬剤払出し装置(従来技術の薬剤払出し装置)は、薬剤容器と容器載置装置とが組み合わされてなる薬剤フィーダを採用している。
 容器載置装置は、水平姿勢の振動部材と、薬剤容器の重量を測定する重量測定手段を有している。そして薬剤容器を振動部材に載置し、振動部材を振動させて前記散薬排出部から薬剤を少量ずつ排出し、重量測定手段によって薬剤の排出量を検知する。
The drug dispensing devices disclosed in Patent Documents 2 and 3 (prior art drug dispensing devices) employ a drug feeder in which a drug container and a container mounting device are combined.
The container placement device has a horizontal vibrating member and weight measuring means for measuring the weight of the drug container. Then, the drug container is placed on the vibrating member, the vibrating member is vibrated, and the drug is discharged little by little from the powdered drug discharging portion, and the discharged amount of the drug is detected by the weight measuring means.
 特許文献2、3に開示された薬剤容器は、略四角柱形状であり、横置き姿勢で容器載置装置に設置される。
 特許文献2に開示された薬剤フィーダは、略四角柱形状の薬剤容器が容器載置装置に横置きされており、薬剤フィーダとして組み合わされた状態においては、薬剤容器は水平方向の長さに比べて高さが低い。
 また、特許文献2、3に開示されている薬剤払い出しのための装置では、ロボットによって薬剤容器を所定位置に搬送し、ロボットによって薬剤容器の蓋の開閉を行っている。
The drug containers disclosed in Patent Literatures 2 and 3 have a substantially quadrangular prism shape and are installed in the container placing device in a horizontal posture.
In the drug feeder disclosed in Patent Document 2, a substantially quadrangular prism-shaped drug container is horizontally placed on a container mounting device, and when combined as a drug feeder, the drug container has a length in the horizontal direction of and low height.
Further, in the devices for dispensing drugs disclosed in Patent Documents 2 and 3, a robot transports a drug container to a predetermined position, and the robot opens and closes the lid of the drug container.
 また、特許文献4には、散薬分包機に用いる散薬供給装置が開示されている。特許文献4の散薬供給装置では、複数のカセットのそれぞれに散薬が収容されており、カセットを供給位置に移動させた後にカセット内から散薬を排出する。詳細には、カセットがスクリューと、円筒先端からなる排出口を閉塞するシャッターと、スクリューと共に回転する攪拌羽根を有しており、シャッターがばねによって強制的に閉鎖状態を維持するように構成されている。そして、供給位置にある作動装置とスクリューの回転軸後端を連結することで、スクリューが回転しながら移動する。このことにより、スクリューがシャッターを押圧し、シャッターがばねの付勢力に抗して移動することで排出口が開状態となる。その一方、スクリューと攪拌羽根が回転することで、散薬が排出口に向かって流れる。これらのことから、散薬がカセットから排出される。 In addition, Patent Document 4 discloses a powder medicine supply device used in a powder medicine packaging machine. In the powdered medicine supply device of Patent Document 4, powdered medicine is stored in each of a plurality of cassettes, and the powdered medicine is discharged from the cassette after the cassette is moved to the supply position. Specifically, the cassette has a screw, a shutter that closes a discharge port consisting of a cylindrical tip, and a stirring blade that rotates together with the screw, and the shutter is configured to be forcibly maintained in a closed state by a spring. there is By connecting the rear end of the rotating shaft of the screw to the operating device at the supply position, the screw moves while rotating. As a result, the screw presses the shutter, and the shutter moves against the biasing force of the spring, thereby opening the discharge port. On the other hand, the rotation of the screw and the stirring blade causes the powder to flow toward the discharge port. As a result, powdered medicine is ejected from the cassette.
 特許文献4の散薬供給装置では、カセットの供給位置までの移動と、供給位置からの移動を自動で実行する。また、この散薬供給装置における散薬フィーダは、上記したように、攪拌羽根とスクリューが回転することで散薬を排出するものであり、振動によって(カセット全体を振動させて)散薬を排出するものではない。また、散薬フィーダは、供給位置にある作動装置と、一つのカセットによって形成されるものであり、作動装置は、単にカセットのスクリューに対して動力を供給するものにすぎない。つまり、散薬を排出するための機構を全てカセットが有している。さらに、シャッターの閉方向への移動がバネによってなされる。即ち、閉状態を常時維持しようするシャッターに対し、一時的に開方向へ向かう力を加えることでシャッターが開くものであり、閉状態とする際には、シャッターに付与する力を解除することでシャッターを閉じる。つまり、シャッターの開度の調整がされないものである。 In the powder medicine supply device of Patent Document 4, movement of the cassette to the supply position and movement from the supply position are automatically executed. In addition, as described above, the powdered medicine feeder in this powdered medicine supply apparatus discharges the powdered medicine by rotating the stirring blade and the screw, and does not discharge the powdered medicine by vibration (by vibrating the entire cassette). . Also, the powder feeder is formed by an actuator in the feed position and one cassette, the actuator merely supplying power to the screw of the cassette. That is, the cassette has all the mechanisms for discharging the powder medicine. Furthermore, the movement of the shutter in the closing direction is made by a spring. In other words, the shutter is opened by temporarily applying a force in the opening direction to the shutter that always maintains the closed state. Close the shutter. In other words, the opening degree of the shutter is not adjusted.
特開2000-85703号公報JP-A-2000-85703 特開2018-35001号公報Japanese Patent Application Laid-Open No. 2018-35001 WO2015/076267/A1号公報WO2015/076267/A1 特開平7-132135号公報JP-A-7-132135
 特許文献2、3に開示された薬剤フィーダは、設置した際に専有する面積が大きいという問題がある。
 また特許文献2、3に開示された薬剤払出し装置は、部品点数が多いという問題がある。
 さらに、特許文献2、3には、ロボットによって薬剤容器を搬送し、薬剤容器の蓋を開閉する薬剤払出し装置が開示されているが、このような薬剤払出し装置は、装置全体が大型化する場合が多く、小規模の薬局等には導入し難いという問題があった。また、このような問題を解決するため、ロボット機構を無くし、手動によって薬剤容器を所定位置に載置するという装置を考えた場合、蓋を開閉させる機構をできるだけコンパクト化して他の部材に具備させ、装置全体の小規模化を図りたいという欲求があった。なお、この場合、手動で薬剤容器を搬送するため、人の持ちやすさを考慮することが好ましい。
 また、特許文献4に開示された薬剤払出し装置は、簡易な構造で薬剤の排出量を細かく調整するという観点から、改良の余地があった。
The drug feeders disclosed in Patent Documents 2 and 3 have a problem that they occupy a large area when installed.
In addition, the medicine dispensers disclosed in Patent Documents 2 and 3 have a problem that the number of parts is large.
Furthermore, Patent Documents 2 and 3 disclose a drug dispensing device that transports a drug container by a robot and opens and closes the lid of the drug container. There was a problem that it was difficult to introduce to small-scale pharmacies. Also, in order to solve such problems, when considering a device in which the robot mechanism is eliminated and the drug container is manually placed at a predetermined position, the mechanism for opening and closing the lid is made as compact as possible and provided in another member. , there was a desire to reduce the size of the entire apparatus. In this case, since the medicine container is manually transported, it is preferable to take into account the ease of holding the container.
Further, the medicine dispensing device disclosed in Patent Document 4 has room for improvement from the viewpoint of finely adjusting the discharge amount of the medicine with a simple structure.
 本発明は、従来技術の上記した問題点に注目し、ロボット機構を有さない薬剤払出し装置において好適に採用可能な薬剤フィーダを提供することを課題とする。また、そのような薬剤フィーダを採用した薬剤払出し装置を提供することを課題とする。 An object of the present invention is to provide a drug feeder that can be suitably employed in a drug dispensing device that does not have a robot mechanism, paying attention to the above-described problems of the prior art. Another object of the present invention is to provide a drug dispensing device that employs such a drug feeder.
 上記した課題を解決するための本発明の一つの様相は、散薬が収容される薬剤容器と、当該薬剤容器を保持する容器保持部と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記薬剤容器を振動させて前記薬剤容器から散薬を排出し、前記重量測定手段によって散薬の排出量を検知することが可能である薬剤フィーダにおいて、前記薬剤容器は、散薬排出部から散薬を外部に排出するものであり、前記散薬排出部を開閉する開閉部材を備え、開閉機構部をさらに有し、前記開閉機構部は、前記開閉部材に直接又は間接的に力を付与し、前記開閉部材の少なくとも一部を移動させて前記散薬排出部を開閉させるものであり、前記散薬排出部を開状態とする際と、閉状態とする際のそれぞれにおいて前記開閉部材に力を付与する、薬剤フィーダである。 One aspect of the present invention for solving the above-described problems is a drug container containing a powdered drug, a container holding section for holding the drug container, and directly or indirectly measuring the weight of the drug container. weight measuring means for discharging the powdered medicine from the medicine container by vibrating the medicine container, and capable of detecting the discharged amount of the powdered medicine by the weight measuring means, wherein the medicine container comprises: The powdered medicine discharging part discharges the powdered medicine to the outside, and further comprises an opening/closing member for opening and closing the powdered medicine discharging part, and further comprising an opening/closing mechanism part, wherein the opening/closing mechanism part applies a force directly or indirectly to the opening/closing member. and moves at least a part of the opening/closing member to open/close the powdered medicine discharge section. It is a drug feeder that applies force.
 本様相の薬剤フィーダでは、開閉部材を開閉させる開閉機構部が、開閉部材に対して力を付与して開閉するため、開閉部材を開く動作と閉じる動作の細かな制御が可能となる。これにより、散薬排出部の開き具合(開放度合いであり、開度)を調整することにより、排出量の細かな調整が可能となる。即ち、振動量の調整だけで排出量の調整を行う場合に比べ、さらに細かな排出量の調整が可能となる。 In the drug feeder of this aspect, the opening/closing mechanism that opens and closes the opening/closing member applies force to the opening/closing member to open/close it, so it is possible to finely control the opening/closing operation of the opening/closing member. Accordingly, by adjusting the degree of opening of the powdered medicine discharge part (the degree of opening, or the degree of opening), it is possible to finely adjust the discharge amount. That is, compared with the case where the discharge amount is adjusted only by adjusting the vibration amount, it is possible to finely adjust the discharge amount.
 上記した様相において、前記薬剤容器は、前記容器保持部に手動で保持させることが可能であり、前記容器保持部から手動で取り外すことが可能であって、前記薬剤容器を前記容器保持部から取り外すことで、前記薬剤容器が前記容器保持部及び前記開閉機構部から離反することが望ましい。 In the aspect described above, the medicament container is manually retainable in the container holding portion, is manually removable from the container holding portion, and removes the medicament container from the container holding portion. Thus, it is desirable that the drug container separates from the container holding portion and the opening/closing mechanism portion.
 本様相の薬剤フィーダは、薬剤払出し装置に採用することで、装置の小型化を図ることができる。 By adopting the drug feeder of this aspect in a drug dispensing device, it is possible to reduce the size of the device.
 上記した様相において、前記散薬排出部を開状態とするとき、前記散薬排出部の開度を段階的に調節可能であることが望ましい。 In the aspect described above, it is desirable that the degree of opening of the powdered medicine discharge section can be adjusted stepwise when the powdered medicine discharge section is placed in the open state.
 本様相によると、散薬の排出量の精密な調整が可能となる。 According to this aspect, it is possible to precisely adjust the amount of powdered medicine discharged.
 上記した様相において、前記散薬排出部は、斜め方向に延びるスリットであり、前記開閉部材は、前記散薬排出部の下方側で移動する閉鎖壁を備え、前記閉鎖壁は、前記薬剤容器の幅方向に延びた形状であり、前記開閉部材が閉方向に移動するにつれて、前記閉鎖壁と前記散薬排出部の重なり部分が大きくなり、前記散薬排出部における散薬の排出のために有効な開口幅が小さくなることが望ましい。 In the aspect described above, the powdered medicine discharge part is a slit extending in an oblique direction, the opening/closing member includes a closing wall that moves below the powdered medicine discharge part, and the closing wall extends in the width direction of the medicine container. As the opening/closing member moves in the closing direction, the overlapping portion between the closing wall and the powdered medicine discharge section increases, and the effective opening width for discharging the powdered medicine in the powdered medicine discharge section becomes smaller. It is desirable to be
 本様相においても、散薬の排出量の精密な調整が可能となる。 Even in this aspect, it is possible to precisely adjust the amount of powdered medicine discharged.
 上記した各様相において、前記容器保持部は縦壁を有し、当該縦壁が加振手段によって振動し、前記縦壁に前記薬剤容器が固定されて振動されることが望ましい。 In each aspect described above, it is desirable that the container holding portion has a vertical wall, the vertical wall is vibrated by the vibrating means, and the drug container is fixed to the vertical wall and vibrated.
 本様相の薬剤フィーダによると、薬剤フィーダを縦置き姿勢とすることができ、専有する面積を小さくできる。即ち、相当量の散薬を収容可能であり、且つ、設置した際における専有面積が小さいという効果がある。 According to the drug feeder of this aspect, the drug feeder can be placed vertically, and the area occupied can be reduced. That is, there is an effect that a considerable amount of powdered medicine can be accommodated, and the area occupied when installed is small.
 上記した各様相において、前記薬剤容器は、大面積側側面と小面積側側面を有していて、幅に対して高さが高く、底面の辺部及び/又は底面近傍の側面に前記散薬排出部があり、底面の近傍に開口を有する仕切り部材があり、散薬が前記開口を通過して前記仕切り部材と前記底面との間に入り、前記薬剤容器を振動させた際に、前記開口を通過した散薬が、仕切り板と前記底との間を移動して前記散薬排出部に至ることが望ましい。 In each aspect described above, the drug container has a large-area side surface and a small-area side surface, is taller than it is wide, and has a side portion of the bottom surface and/or a side surface near the bottom surface for discharging the powdered medicine. and a partition member having an opening in the vicinity of the bottom surface. It is desirable that the powdered medicine thus obtained moves between the partition plate and the bottom to reach the powdered medicine discharge section.
 本様相で採用する薬剤容器は、幅が狭く高さが高い。そのため従来の薬剤容器と同等の薬剤を収容可能であるにも関わらず幅が狭い。
 本様相の薬剤フィーダは、幅が狭く、小さいスペースにより多くの薬剤フィーダを並べることができる。
The medicine container adopted in this aspect has a narrow width and a high height. Therefore, the width of the container is narrow even though it can contain drugs equivalent to those of conventional drug containers.
The medicine feeder of this aspect has a narrow width, and many medicine feeders can be arranged in a small space.
 上記した各様相において、前記散薬排出部は斜め方向に延びるスリット状であることが望ましい。 In each of the aspects described above, it is desirable that the powdered medicine discharge part has a slit shape extending in an oblique direction.
 本様相によると、散薬を排出する領域を広くすることができる。 According to this aspect, it is possible to widen the area from which powdered medicine is discharged.
 上記した各様相において、前記薬剤容器は、大面積側側面と小面積側側面を有していて、幅に対して高さが高く、前記大面積側側面を開放可能であり、前記薬剤容器は、前記容器保持部に対して着脱可能であり、前記薬剤容器を前記容器保持部から外した状態で前記大面積側側面を開放して散薬を充填するものであることが望ましい。 In each aspect described above, the drug container has a large-area side surface and a small-area side surface, is taller than its width, and can open the large-area side surface, and the drug container is Preferably, the medicine container is detachable from the container holding part, and the powder medicine is filled with the large-area side surface opened in a state in which the medicine container is removed from the container holding part.
 本様相によると、散薬を薬剤容器に入れやすい。 According to this aspect, it is easy to put the powdered medicine into the medicine container.
 上記した各様相において、前記薬剤容器の高さ方向の中間部に庇状の仮受け板が設けられていることが望ましい。 In each aspect described above, it is desirable that an eaves-like temporary receiving plate is provided in the middle portion of the drug container in the height direction.
 本様相によると、上層の散薬の重量を仮受け板で支持することができ、下層の散薬が押し付けられない。そのため薬剤容器を振動させた際における散薬の移動が妨げられにくい。 According to this aspect, the weight of the powdered medicine in the upper layer can be supported by the temporary receiving plate, and the powdered medicine in the lower layer is not pressed. Therefore, movement of the powdered medicine is less likely to be hindered when the medicine container is vibrated.
 上記した各様相において、前記散薬排出部を閉じた状態で、前記開閉部材をロックするロック機構を有し、前記薬剤容器を前記容器保持部に保持させることによって前記ロック機構が解除されることが望ましい。 In each aspect described above, a locking mechanism may be provided to lock the opening/closing member in a state where the powdered medicine discharge section is closed, and the locking mechanism may be released by holding the drug container in the container holding section. desirable.
 本様相によると、薬剤容器を容器保持部から取り外した際に薬剤がこぼれにくい。 According to this aspect, the drug is less likely to spill when the drug container is removed from the container holding portion.
 上記した各様相において、前記容器保持部は縦壁を有し当該縦壁に保持部側係合部があり、前記薬剤容器は前記保持部側係合部が係合して前記薬剤容器が前記容器保持部に保持され、前記薬剤容器に係合部があり、前記容器保持部に前記係合部と係合し前記薬剤容器を前記容器保持部から離脱する方向に押圧する離脱補助部材を有することが望ましい。 In each aspect described above, the container holding portion has a vertical wall, the vertical wall has a holding portion-side engaging portion, and the drug container is engaged by the holding portion-side engaging portion so that the drug container is The drug container is held by the container holding portion, the drug container has an engaging portion, and the container holding portion has a detachment assisting member that engages with the engaging portion and presses the drug container in a direction to detach from the container holding portion. is desirable.
 本様相によると、薬剤容器を容易に容器保持部から取り外すことができる。 According to this aspect, the drug container can be easily removed from the container holding portion.
 上記した各様相において、前記薬剤容器内に前記散薬排出部に繋がる散薬通路があり、散薬は前記散薬通路を移動して前記散薬排出部から排出されるものであり、前記散薬通路には天井壁があり、前記開閉部材は、前記散薬排出部を閉鎖したときに前記散薬通路側に突出する突出部を有し、前記天井壁に前記散通路内の下に向かって突出する仕切部があり、前記開閉部材が前記散薬排出部を閉鎖したときに前記突出部が仕切部の近傍に至ることが望ましい。 In each of the above aspects, the medicine container has a powdered medicine passage connected to the powdered medicine discharge part, the powdered medicine moves in the powdered medicine passage and is discharged from the powdered medicine discharge part, and the powdered medicine passage has a ceiling wall. and the opening/closing member has a projecting portion that projects toward the powdered medicine passage when the powdered medicine discharge portion is closed, and the ceiling wall has a partition that projects downward into the dispersion passage, It is desirable that the projecting portion reaches the vicinity of the partition portion when the opening/closing member closes the powdered medicine discharge portion.
 本様相によると、開閉部材を開放状態にしたときに散薬排出部から薬剤が零れ落ちにくい。更に本様相によると、薬剤の払い出しをしている状態での散薬通路からの散薬の跳ね等の吹き出しを防止することができる。 According to this aspect, when the opening/closing member is opened, the drug is less likely to spill from the powdered drug discharge part. Furthermore, according to this aspect, it is possible to prevent the powdered medicine from splashing out from the powdered medicine passage while the medicine is being dispensed.
 上記した各様相において、錘部材を有し、前記錘部材又は前記重量測定手段又は前記薬剤容器の少なくともいずれかを昇降させる昇降手段を有し、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材の荷重が前記重量測定手段に付加されていない状態を比較して前記重量測定手段の校正、及び/又は故障検知を行うことが望ましい。 In each of the above-described aspects, a weight member is provided, and lifting means is provided for lifting and lowering at least one of the weight member, the weight measuring means, and the drug container, and the load of the weight member is applied to the weight measuring means. It is preferable to compare a state in which the load of the weight member is applied and a state in which the load of the weight member is not applied to the weight measuring means for calibration and/or failure detection of the weight measuring means.
 上記した各様相において、前記薬剤容器が、自身の振動を検知する振動検知センサを有することが望ましい。 In each aspect described above, it is desirable that the drug container has a vibration detection sensor that detects its own vibration.
 薬剤払出し装置に関する発明は、薬剤容器から所定量の散薬を取り出し、これを所定の数に分割し、さらに個別に包装して排出する薬剤払出し装置であって、薬剤投入溝が設けられ動力によって回転される分配皿を有し、当該分配皿の近傍に、上記したいずれかに記載の薬剤フィーダが複数設置され、薬剤容器から散薬を排出させて分配皿の薬剤投入溝に投入するものである。 An invention relating to a medicine dispensing device is a medicine dispensing device that takes out a predetermined amount of powdered medicine from a medicine container, divides it into a predetermined number, packs it individually, and discharges it. A plurality of drug feeders according to any one of the above are installed in the vicinity of the distribution tray, and the powdered drug is discharged from the drug container and put into the drug charging groove of the distribution tray.
 ところで、上記した従来の薬剤払出し装置は、装置全体の小型化が困難であるという点の他、散薬を払い出す動作をより速く完了させるという点において、改良の余地があった。即ち、上記した薬剤払出し装置では、散薬を払い出す動作の実行が決定すると、薬剤容器を保管している位置から供給している位置まで移動させた後、散薬の払い出しを実行する。つまり、薬剤容器を搬送するための時間が必要となり、散薬を払い出す動作を高速化するという点において、改良の余地があった。 By the way, the conventional drug dispensing device described above has room for improvement in that it is difficult to reduce the size of the entire device and that the operation of dispensing powdered medicine is completed more quickly. That is, in the medicine dispensing device described above, when the execution of the powdered medicine dispensing operation is determined, the powdered medicine is dispensed after moving the medicine container from the storage position to the dispensing position. In other words, it takes time to transport the medicine container, and there is room for improvement in terms of speeding up the operation of dispensing the powdered medicine.
 そこで、このような課題を解決するための本発明の関連発明の一つの様相は、払出される一服用分の量より多い量の散薬が一対一に割り付けされ、散薬を収容した薬剤容器と、薬剤容器を保持する載置台と、薬剤容器を振動させる振動装置とを有する複数の薬剤フィーダと、散薬を保持する投入溝を有し動力によって回転される分配皿とを有し、複数の薬剤フィーダは、分配皿の周囲に固定され、複数の薬剤フィーダの中から薬剤フィーダが選択され、選択された薬剤フィーダから一服用分の量の散薬を分配皿に払出されることを特徴とする薬剤払出し装置である。 Therefore, one aspect of the related invention of the present invention for solving such problems is a drug container in which powdered drugs in an amount larger than one dose to be dispensed are allocated one to one, and containing powdered drugs, A plurality of drug feeders having a mounting table for holding drug containers, a vibrating device for vibrating the drug containers, and a distribution plate having an input groove for holding powdered drugs and rotated by power, and a plurality of drug feeders. is fixed around a distribution tray, a drug feeder is selected from among a plurality of drug feeders, and one dose of powdered drug is dispensed from the selected drug feeder to the distribution tray. It is a device.
 また、上記関連発明における一つの様相は、環状の薬剤投入溝が設けられ動力によって回転される分配皿と、複数の薬剤フィーダを有し、前記薬剤フィーダは、散薬が収容された薬剤容器と、当該薬剤容器を保持する載置部材と、前記薬剤容器から散薬を排出させる散薬排出手段とを有し、前記各載置部材に予め決められた散薬が収容された薬剤容器が保持され、前記複数の薬剤フィーダの中から一又は複数の薬剤フィーダが選択され、選択された薬剤フィーダから所定量の散薬が分配皿に払出されることを特徴とする薬剤払出し装置である。 In addition, one aspect of the above-mentioned related invention has a distribution dish provided with an annular drug feeding groove and rotated by power, and a plurality of drug feeders, wherein the drug feeders are drug containers containing powdered drugs, a loading member for holding the drug container; and a powdered drug discharging means for discharging the powdered drug from the drug container. one or a plurality of drug feeders are selected from among the drug feeders, and a predetermined amount of powdered drug is dispensed from the selected drug feeder to a distribution tray.
 これらの様相によると、装置全体の小型化が可能であり、且つ、散薬を払い出す動作を高速化が可能となる。 According to these aspects, it is possible to reduce the size of the entire device and speed up the operation of dispensing powdered medicine.
 本発明によると、ロボット機構を有さない薬剤払出し装置において好適に採用可能な薬剤フィーダ、並びに、そのような薬剤フィーダを備えた薬剤払出し装置を提供できる。 According to the present invention, it is possible to provide a drug feeder that can be suitably employed in a drug dispensing device that does not have a robot mechanism, and a drug dispensing device equipped with such a drug feeder.
本発明の実施形態の薬剤払出し装置の斜視図であって上蓋を開いた状態を示す。It is a perspective view of the medicine dispensing device of embodiment of this invention, and shows the state which opened the upper cover. 図1の薬剤払出し装置の分配皿周辺の斜視図である。Fig. 2 is a perspective view of the periphery of a distribution plate of the medicine dispensing device of Fig. 1; 本発明の実施形態の薬剤フィーダの斜視図である。1 is a perspective view of a drug feeder of an embodiment of the invention; FIG. 図3の薬剤フィーダから情報読書手段を省略して示す斜視図である。FIG. 4 is a perspective view showing the drug feeder of FIG. 3 with information reading means omitted; 薬剤フィーダを図4とは異なる方向から観察した斜視図である。FIG. 5 is a perspective view of the drug feeder observed from a direction different from that of FIG. 4; 薬剤フィーダのフィーダ本体であって、薬剤容器を保持部材から取り外した状態の斜視図である。Fig. 10 is a perspective view of the feeder body of the drug feeder with the drug container removed from the holding member; 薬剤フィーダのフィーダ本体であって、薬剤容器を保持部材から取り外した状態の側面図である。FIG. 4 is a side view of the feeder main body of the drug feeder with the drug container removed from the holding member. 図7をモデル化して表示したフィーダ本体の側面図である。FIG. 8 is a side view of the feeder main body showing a model of FIG. 7; 薬剤フィーダのフィーダ本体であって、薬剤容器を保持部材から取り外し、図6とは異なる方向から観察した斜視図である。FIG. 7 is a perspective view of the feeder body of the drug feeder, with the drug container removed from the holding member and observed from a direction different from that in FIG. 6 ; フィーダ本体であって、薬剤容器を保持部材から取り外し、図6、図9とは異なる方向から観察した斜視図であり、シャッター開閉機構の概要を拡大して示す。FIG. 10 is a perspective view of the feeder main body, with the drug container removed from the holding member, observed from a different direction from FIGS. 6 and 9, showing an enlarged outline of the shutter opening/closing mechanism. フィーダ本体の保持部材の分解斜視図である。FIG. 4 is an exploded perspective view of a holding member of the feeder body; フィーダ本体の保持部材をさらに詳細に分解した分解斜視図である。FIG. 4 is an exploded perspective view of the holding member of the feeder body exploded in more detail; (a)、(b)、(c)は、薬剤容器をフィーダ本体に装着し、散薬を排出するに至るまでの様子を示す説明図、及びその一部の拡大断面図である。(a), (b), and (c) are an explanatory view showing a state from mounting the drug container to the feeder body to discharging the powdered drug, and an enlarged cross-sectional view of a part thereof. (a)は、左図が図10のフィーダ本体の係合用部材を示す斜視図であり、右図がシャッター開閉機構の係合片保持部56を示す斜視図である。(b)は、左図がフィーダ本体の係合片が開口内に没入している様子を示す説明図であり、右図がフィーダ本体の係合片が開口から突出している様子を示す説明図である。10A is a perspective view of the engaging member of the feeder body shown in FIG. 10, and FIG. (b) is an explanatory diagram showing a state where the engaging piece of the feeder body is retracted into the opening on the left side, and an explanatory diagram showing a state where the engaging piece of the feeder body protrudes from the opening on the right side. is. (a)は、蓋部材を開いた状態における薬剤容器の斜視図であり、(b)は、その正面図である。(a) is a perspective view of the drug container with the lid member opened, and (b) is a front view thereof. 薬剤容器に散薬を充填する際の姿勢を示す斜視図である。FIG. 4 is a perspective view showing a posture when filling powdered medicine into a medicine container. (a)、(b)、(c)は、薬剤容器の蓋部分の正面図であり、容器本体に蓋部材を固定する際の様子を示す。(a), (b), and (c) are front views of the lid portion of the drug container, showing how the lid member is fixed to the container body. (a)は、上記した薬剤容器において、蓋部材を閉じた状態の締め付け片の周辺を示す図であり、左図が斜視図、右図が平面図である。(b)は、(a)とは異なる実施形態に係る薬剤容器において、蓋部材を閉じた状態の締め付け片の周辺を示す図であり、左図が斜視図、右図が平面図である。(a) is a diagram showing the periphery of the clamping piece with the lid member closed in the drug container described above, the left diagram being a perspective view and the right diagram being a plan view. (b) is a diagram showing the periphery of a clamping piece with the lid member closed in a drug container according to an embodiment different from (a), the left diagram being a perspective view and the right diagram being a plan view. 薬剤容器のシャッターの分解斜視図である。FIG. 4 is an exploded perspective view of the shutter of the drug container; 薬剤容器のシャッターの動作を示す説明図であり、(a)は、シャッターを閉じた状態における斜視図であり、(b)は、シャッターを開いた状態における斜視図である。FIG. 4A is an explanatory view showing the operation of the shutter of the medicine container, where (a) is a perspective view with the shutter closed, and (b) is a perspective view with the shutter open. 薬剤容器の伝動部材の係合部が、シャッター開閉機構の係合部と係合した状態を示す斜視図である。FIG. 10 is a perspective view showing a state in which the engaging portion of the transmission member of the drug container is engaged with the engaging portion of the shutter opening/closing mechanism; 薬剤フィーダと分配皿の位置関係を示す説明図である。It is an explanatory view showing the positional relationship between the medicine feeder and the distribution tray. (a)は、シャッターを全開にして分配皿に薬剤を落下させた際における散薬の広がりを示す説明図であり、(b)は、シャッターを半開にして分配皿に薬剤を落下させた際における散薬の広がりを示す説明図である。(a) is an explanatory diagram showing the spread of the powdered medicine when the shutter is fully opened and the medicine is dropped onto the distribution tray, and (b) is an explanatory diagram showing the spread of the powdered medicine when the shutter is half-opened and the medicine is dropped onto the distribution tray. It is explanatory drawing which shows the spread of a powder medicine. (a)は、シャッターを全開にした際における薬剤容器の底面図であり、(b)は、シャッターを半開にした際における薬剤容器の底面図であり、(c)は、シャッターを閉じた際における薬剤容器の底面図であり、(d)は、容器本体の下部と、シャッターの斜視図である。(a) is a bottom view of the drug container when the shutter is fully opened, (b) is a bottom view of the drug container when the shutter is half-opened, and (c) is a bottom view of the drug container when the shutter is closed. is a bottom view of the medicine container in , and (d) is a perspective view of the lower part of the container body and the shutter. (a)は、シャッター部材に図19とは異なるシール部材を取り付けた様子を示す斜視図であり、下方側から見た様子を示す。(b)は、(a)のシール部材を示す斜視図であり、(c)は、(a)のシール部材を示す底面図である。(a) is a perspective view showing a state in which a sealing member different from that in FIG. 19 is attached to the shutter member, and shows a state seen from below. (b) is a perspective view showing the sealing member of (a), and (c) is a bottom view showing the sealing member of (a). 図25で示すシール部材を採用した薬剤容器を示す底面図であり、(a)は、シャッターを全開にした状態を示し、(b)は、シャッターを少し開いた状態を示し、(c)は、シャッターを閉じた状態を示す。FIG. 26 is a bottom view showing a drug container employing the sealing member shown in FIG. 25, (a) showing a state in which the shutter is fully opened, (b) showing a state in which the shutter is slightly opened, and (c). , indicates that the shutter is closed. 上記した実施形態とは異なる実施形態に係る薬剤容器の底面図であり、(a)は、シャッターを全開にした状態を示し、(b)は、シャッターを少し開いた状態を示し、(c)は、シャッターを閉じた状態を示す。FIG. 10 is a bottom view of a drug container according to an embodiment different from the above-described embodiment, where (a) shows a state in which the shutter is fully opened, (b) shows a state in which the shutter is slightly opened, and (c). indicates that the shutter is closed. 本発明の他の実施形態の薬剤フィーダの正面図である。Fig. 10 is a front view of a drug feeder according to another embodiment of the invention; 本発明のさらに他の実施形態の薬剤容器の内部を示す斜視図であり、(a)は、第二仕切のシャッターを閉じた状態を示し、(b)は、第二仕切のシャッターを開いた状態を示す。Fig. 10 is a perspective view showing the inside of a drug container according to still another embodiment of the present invention, where (a) shows a state in which the shutter of the second partition is closed, and (b) shows a state in which the shutter of the second partition is open; Indicates status. 図29に示す薬剤容器で採用するシャッターの開閉機構を示す説明図である。FIG. 30 is an explanatory view showing an opening/closing mechanism of a shutter employed in the medicine container shown in FIG. 29; 本発明の他の実施形態の、薬剤払出し装置の分配皿周辺の斜視図である。Fig. 10 is a perspective view of the periphery of the distribution tray of the drug dispensing device according to another embodiment of the present invention; 分配皿と散薬投入ホッパーの位置関係を示す説明図であり、(a)は、分配皿に散薬を撒き終えた状態を示し、(b)は、分配皿に掻き出し装置のディスクを入れた状態を示し、(c)は分配皿から散薬を掻き出す際の様子を示す。FIG. 4 is an explanatory view showing the positional relationship between the distribution tray and the powdered medicine charging hopper, where (a) shows a state in which the powdered medicine has been sprinkled on the distribution tray, and (b) shows a state in which the disk of the scraping device is placed in the distribution tray. and (c) shows how the powdered medicine is scraped out from the distribution dish. 上記した実施形態とは異なる実施形態に係る薬剤容器を示す斜視図であり、(a)は、蓋部材を閉状態とした様子を示し、(b)は、蓋部材を開状態とした様子を示す。FIG. 10 is a perspective view showing a drug container according to an embodiment different from the above-described embodiment, where (a) shows how the lid member is closed, and (b) shows how the lid member is opened; show. (a)は、図33(a)の薬剤容器を別方向からみた様子を示す斜視図であり、(b)は、(a)の薬剤容器を模式的に示す底面図である。33(a) is a perspective view showing the medicine container of FIG. 33(a) viewed from another direction, and (b) is a bottom view schematically showing the medicine container of (a). 図33(a)の薬剤容器を示す断面図であり、蓋部材と他の部分とを異なる切断面で切断した様子を示す。FIG. 33(a) is a cross-sectional view showing the drug container of FIG. 33(a), showing a state in which the lid member and other portions are cut along different cutting planes. 図33(a)の薬剤容器の示す分解斜視図である。Figure 33(a) is an exploded perspective view of the drug container of Figure 33(a); 図36の仕切り部材を示す図であって、(a)は下方からみた斜視図、(b)は正面図である。FIG. 37 shows the partition member of FIG. 36, where (a) is a perspective view from below and (b) is a front view; (a)は、図2の薬剤フィーダ及び分配皿を模式的に示す平面図であり、(b)は、図1の錠剤手撒き装置を姿勢変更させた様子を示す斜視図である。(a) is a plan view schematically showing a medicine feeder and a distribution tray in FIG. 2, and (b) is a perspective view showing a state in which the posture of the tablet hand-dispensing device in FIG. 1 is changed. (a)は、第二実施形態の薬剤フィーダをモデル化して表示した側面図であり、(b)はそのシャッター開閉機構の分解斜視図である。(a) is a side view showing a modeled medicine feeder of the second embodiment, and (b) is an exploded perspective view of the shutter opening/closing mechanism. (a)、(b)、(c)は、第二実施形態の薬剤フィーダであって、薬剤容器をフィーダ本体に装着する際の様子を示す説明図である(a), (b), and (c) of the drug feeder of the second embodiment are explanatory diagrams showing how the drug container is attached to the feeder main body. (a)、(b)、(c)は、第二実施形態の薬剤フィーダであって、薬剤容器をフィーダ本体から取り外す際の様子を示す説明図である(a), (b), and (c) of the drug feeder of the second embodiment are explanatory diagrams showing how the drug container is removed from the feeder main body. (a)は、第三実施形態の薬剤容器を示す断面図であり、(b)は、シャッターを開いた状態におけるシャッターの近傍の断面図である。(a) is a cross-sectional view showing a drug container of a third embodiment, and (b) is a cross-sectional view near the shutter when the shutter is open. 本発明のさらに他の実施形態の薬剤フィーダの正面図であり、(a)は、薬剤容器をフィーダ本体に取り付けられている状態を示し、(b)は、薬剤容器をフィーダ本体から取り外す際の状態を示す。FIG. 10 is a front view of a drug feeder according to still another embodiment of the present invention, where (a) shows a state in which a drug container is attached to the feeder body, and (b) shows a state in which the drug container is removed from the feeder body; Indicates status. 本発明のさらに他の実施形態のフィーダ本体の正面図であり、(a)は、薬剤容器をフィーダ本体に取り付けられている際におけるフィーダ本体の状態を示し、(b)は、薬剤容器をフィーダ本体から取り外す際におけるフィーダ本体の状態を示す。Fig. 10 is a front view of a feeder body according to still another embodiment of the present invention, where (a) shows the state of the feeder body when the drug container is attached to the feeder body, and (b) shows the feeder body when the drug container is attached to the feeder body; 2 shows the state of the feeder body when removed from the body. 第三実施形態の薬剤容器のシャッターの分解斜視図である。FIG. 11 is an exploded perspective view of the shutter of the drug container of the third embodiment; 図45の仕切り部材を示す図であって、(a)は下方からみた斜視図であり、(b)は正面図である。FIG. 46 shows the partition member of FIG. 45, where (a) is a perspective view from below and (b) is a front view; 仕切り部材の変形例を示す図であって、(a)はその斜視図であり、(b)は仕切り板の水平部の断面図である。It is a figure which shows the modification of a partition member, (a) is the perspective view, (b) is sectional drawing of the horizontal part of a partition plate. 電光表示の正面図である。1 is a front view of an electronic display; FIG. 上蓋の変形例を示す薬剤払出し装置の斜視図であり、(a)は、カバーが閉じられた状態を示し、(b)は、カバーが開かれた状態を示す。It is a perspective view of the medicine dispensing device showing a modification of the upper lid, (a) shows a state in which the cover is closed, and (b) shows a state in which the cover is opened. 上蓋の他の変形例を示す薬剤払出し装置の斜視図であり、(a)は、カバーが閉じられた状態を示し、(b)は、カバーが開かれた状態を示す。It is a perspective view of the drug dispensing device showing another modification of the upper lid, (a) shows a state in which the cover is closed, and (b) shows a state in which the cover is opened. 図4の重量校正部を別方向からみた様子を示す斜視図である。FIG. 5 is a perspective view showing a state in which the weight calibration unit of FIG. 4 is viewed from another direction; 図51の重量校正部の分解斜視図である。FIG. 52 is an exploded perspective view of the weight calibration unit of FIG. 51; 図51の上側ガイド部材を示す図であり、(a)は、下方側から観察した斜視図であり、(b)は断面図である。It is a figure which shows the upper guide member of FIG. 51, (a) is a perspective view observed from the downward side, (b) is sectional drawing. 図4の重量校正部を第一の状態から第二の状態に移行する際の動作を模式的に示す説明図であり、(a)~(c)の順に移行する。5A to 5C are explanatory diagrams schematically showing the operation when the weight calibration unit shown in FIG. 4 shifts from the first state to the second state, and shifts in the order of (a) to (c). (a)は、図52とは異なる実施形態に係る分銅を示す斜視図であり、(b)は、図52とは異なる実施形態に係る分銅支持部材を示す斜視図である。53A is a perspective view showing a weight according to an embodiment different from FIG. 52, and FIG. 53B is a perspective view showing a weight support member according to an embodiment different from FIG. (a)は、さらに異なる実施形態に係る薬剤フィーダを模式的に示す説明図であり、(b)は、(a)の薬剤フィーダが第一の状態から第二の状態に移行する様子を模式的に示す説明図である。(a) is an explanatory view schematically showing a drug feeder according to a further different embodiment, and (b) is a schematic diagram showing how the drug feeder in (a) shifts from the first state to the second state. It is an explanatory diagram schematically shown. 図2の掻出装置に装着することが可能な校正用器具を模式的に示す図であり、(a)は、掻出装置に装着した状態の斜視図であり、(b)は、(a)の校正用器具を分解して示す説明図である。3A is a perspective view of a calibration instrument that can be attached to the scraping device of FIG. 2, and FIG. ) is an explanatory diagram showing an exploded calibration instrument. (a)は、図57で示される校正用器具に錘部材を支持させる様子を模式的に示す説明図であり、(b)は、図57で示される校正用器具によって錘部材を振動側水平部の上に載置する様子を模式的に示す説明図である。58(a) is an explanatory diagram schematically showing how a weight member is supported by the calibration instrument shown in FIG. 57, and FIG. 58(b) is a diagram showing a vibration-side horizontal movement of the weight member by the calibration instrument shown in FIG. FIG. 10 is an explanatory view schematically showing how the device is placed on the part; さらに他の実施形態に係る薬剤フィーダを模式的に示す説明図であり、(a)は、第一の状態を示し、(b)は、第二の状態を示す。It is explanatory drawing which shows typically the medicine feeder which concerns on further another embodiment, (a) shows a 1st state, (b) shows a 2nd state. (a)は、さらに他の実施形態に係る重量校正部を薬剤払出し装置に採用した様子を模式的に示す説明図である。(b)は、左図が、第一の状態とした際の一つの錘部材の周辺を模式的に示す説明図であり、右図が、第二の状態とした際の一つの錘部材の周辺を模式的に示す説明図である。(a) is an explanatory diagram schematically showing a state in which a weight correcting unit according to still another embodiment is adopted in a drug dispensing device. (b) is an explanatory view schematically showing the periphery of one weight member when the left figure is in the first state, and the right figure is one weight member when in the second state. It is an explanatory view showing the periphery typically. さらに他の実施形態に係る薬剤払出し装置の主要部を模式的に示す説明図であり、薬剤フィーダから分配皿に散薬を排出させて故障検知動作を実行する様子を示す。FIG. 10 is an explanatory view schematically showing the main part of the medicine dispensing device according to still another embodiment, showing how powdered medicine is discharged from the medicine feeder to the distribution tray and failure detection operation is executed. 図61で示す薬剤払出し装置において、図61とは異なる故障検知動作を実行する様子を示す図である。FIG. 62 is a diagram showing how the medicine dispensing device shown in FIG. 61 performs a failure detection operation different from that in FIG. 61; 薬剤フィーダから分配皿に散薬を排出する排出動作の具体的な手順を模式的に示す説明図であり、(a)~(k)の順で排出動作を実行する。FIG. 4 is an explanatory diagram schematically showing a specific procedure of discharging operation for discharging powdered medicine from a medicine feeder to a distribution tray, and the discharging operation is executed in the order of (a) to (k). (a)は、図8で示す容器支持部をさらに簡易的なモデルとして示す斜視図であり、(b)は、図8で示す薬剤容器をさらに簡易的なモデルとして示す斜視図である。9A is a perspective view showing a simpler model of the container supporting portion shown in FIG. 8, and FIG. 9B is a perspective view showing a simpler model of the medicine container shown in FIG. 図64の振動検知センサの回路図である。FIG. 65 is a circuit diagram of the vibration detection sensor of FIG. 64; (a)は、薬剤フィーダの振動状態を検査する際における検査モードを示す論理表であり、(b)は、振動検知センサを切り替える回路図であって検査モードがNの場合の各スイッチの接続状態を示し、(c)は、振動検知センサを切り替える回路図であって検査モードがF1の場合の各スイッチの接続状態を示す。(a) is a logic table showing the inspection mode when inspecting the vibration state of the medicine feeder, and (b) is a circuit diagram for switching the vibration detection sensor, showing connection of each switch when the inspection mode is N. (c) is a circuit diagram for switching the vibration detection sensor and shows the connection state of each switch when the inspection mode is F1.
 以下さらに本発明の実施形態の薬剤払出し装置1について説明する。なお、以下の説明において、特に断りがない限り、上下の位置関係は通常の設置状態(図1の状態)を基準に説明する。理解を容易にするため、先に薬剤払出し装置1の概要と大まかな動作について説明し、その後に各部材や装置を詳細に説明する。
 本実施形態の薬剤払出し装置1は、図1で示されるように、筐体2によって囲まれており、その内部は、錠剤手撒き領域300と、散薬分割領域301と、薬剤包装領域302に分かれている。
 筐体2には、図1の様に上蓋3がある。上蓋3は、図示しないヒンジで筐体2の本体部に取り付けられている。上蓋3を閉状態とすることで、上蓋4が散薬分割領域301に属する各部材の上方を覆った状態となる。
 錠剤手撒き領域300には錠剤手撒き装置303が設けられている。この錠剤手撒き装置303は、後述する分配皿6、薬剤フィーダ5等の上方に位置する。
 錠剤手撒き装置303は公知であるから、詳細な説明を省略する。
 薬剤包装領域302には、図2に概念的に表示した様に薬剤包装装置305が内蔵されている。薬剤包装装置305は、薬剤を一服用分ずつ包装する機械であり、分包紙供給装置306(分包紙供給部)と、分包装置308(シール部)を有する。また薬剤包装装置305には、分包装置308の上方に、薬剤を投入する散薬投入ホッパー310が設けられている。
 作図の関係上、散薬投入ホッパー310を分配皿6から離れた位置に図示しているが、実際には、散薬投入ホッパー310の上端は、分配皿6の機材収納開口15内にある。
The drug dispensing device 1 according to the embodiment of the present invention will be further described below. In the following description, unless otherwise specified, the vertical positional relationship is based on the normal installation state (state shown in FIG. 1). For easy understanding, the outline and rough operation of the drug dispensing device 1 will be described first, and then each member and device will be described in detail.
As shown in FIG. 1, the drug dispensing device 1 of this embodiment is surrounded by a housing 2, and the interior is divided into a tablet hand-dispensing area 300, a powdered medicine division area 301, and a medicine packaging area 302. ing.
The housing 2 has an upper lid 3 as shown in FIG. The upper lid 3 is attached to the main body of the housing 2 with a hinge (not shown). By closing the upper lid 3 , the upper lid 4 covers the upper parts of the members belonging to the powdered medicine division area 301 .
A tablet manual distribution device 303 is provided in the tablet manual distribution area 300 . This tablet hand-dispensing device 303 is positioned above a distribution plate 6, a medicine feeder 5, etc., which will be described later.
Since the tablet manual distributing device 303 is well known, a detailed description thereof will be omitted.
The medicine packaging area 302 incorporates a medicine packaging device 305 as conceptually shown in FIG. The medicine packaging device 305 is a machine for packaging medicines for each dose, and has a packing paper supply device 306 (packaging paper feeding section) and a packing device 308 (sealing section). The drug packaging device 305 is also provided with a powdered drug charging hopper 310 above the packaging device 308 for charging the drug.
Although the powdered medicine charging hopper 310 is shown at a position away from the distribution tray 6 for drawing purposes, the upper end of the powdered medicine charging hopper 310 is actually within the equipment storage opening 15 of the distribution tray 6 .
 薬剤包装装置305は、分包紙供給装置306の本体(図示しない)の装着部に、ロールペーパーを装着して使用する。ロールペーパーは、帯状の分包紙(包装紙)を管状の芯部材に巻いてロール状にしたものである。なお、特に限定されるものではないが、本実施形態のロールペーパーは、二つ折りされた状態で帯状となった分包紙をロール状にしたものである。
 また、薬剤包装装置305は、図示しない印刷機構(印刷部)を有している。
 薬剤包装装置305では、ロールペーパーから繰り出された分包紙が印刷機構に導入され、患者名、薬剤名称、服用日時等の情報(処方に関する情報であり、提供する薬剤に関する情報)が印刷される。その後、所定の情報が印刷された分包紙は、上向きに開口された状態にされる。そして、その状態で、散薬投入ホッパー310から落下(供給)された薬剤(散薬)を受け入れる。
 さらに、薬剤を受け入れた分包紙が、シール部(分包装置308)に導入され、シール部で縦方向と横方向にシールされ、受け入れた薬剤を順次包装していく。このことにより、薬剤を一服用分内包した薬剤包装が形成され、薬剤包装が装置外部まで搬送される。
 このとき、薬剤包装が複数包連続した薬剤包装帯を形成し、装置外部まで搬送する。しかしながら、薬剤包装帯ではなく、一又は複数の個別の薬剤包装を形成し、装置外部まで搬送してもよい。
 なお、上記した横方向は、分包紙の繰出方向(送出方向)であり、縦方向は、分包紙の繰出方向と交差する(直交する)方向である。
The drug packaging device 305 is used by attaching roll paper to the attachment portion of the main body (not shown) of the packaging paper supply device 306 . The roll paper is formed by winding a band-shaped packing paper (wrapping paper) around a tubular core member to form a roll. Although not particularly limited, the roll paper of the present embodiment is a roll of packaging paper that is folded in two and has a strip shape.
In addition, the medicine packaging device 305 has a printing mechanism (printing section) (not shown).
In the drug packaging device 305, the packaging paper fed out from the roll paper is introduced into the printing mechanism, and information such as the patient name, drug name, date and time of administration (information related to prescription and information related to the drug to be provided) is printed. . After that, the packaging sheet on which the predetermined information is printed is opened upward. In this state, the medicine (powder medicine) dropped (supplied) from the powder medicine introduction hopper 310 is received.
Furthermore, the packaging paper containing the drug is introduced into the sealing section (packaging device 308) and sealed in the vertical and horizontal directions by the sealing section to sequentially package the received drugs. As a result, a drug package containing a single dose of drug is formed, and the drug package is transported to the outside of the apparatus.
At this time, a drug packaging band is formed in which a plurality of drug packages are continuously packed, and the band is conveyed to the outside of the apparatus. However, instead of the drug packaging band, one or more individual drug packages may be formed and delivered to the outside of the apparatus.
Note that the above-described horizontal direction is the delivery direction (delivery direction) of the packaging paper, and the vertical direction is the direction crossing (perpendicular to) the delivery direction of the packaging paper.
 また、上記したロールペーパーの芯部材は、識別子が装着されていてもよい。識別子は、ロールペーパーを個別に識別可能な情報(製造メーカー等に関する情報(メーカー名等)や、製造年月日等に関する情報、当該芯に巻かれたロールペーパーの種類、受注No.、出荷日、納品先の顧客情報、当該ロールペーパーが装着される分包機の機種名、機種コード、その他ID等)が記憶された記憶手段であり、例えば、ICタグ等のメモリであってもよい。また、一次元コード(バーコード)や二次元コードのようなコードであってもよく、コードを採用する場合、ラベルに付されていてもよい。
 そして、ロールペーパーを分包紙供給装置306に装着するとき、装着しようとする装置との照合、即ち、所定のロールペーパーが正しく装置に装着されようとしているか否かを判別する動作を実行してもよい。また、識別子にロールペーパーが未使用であることを識別するための情報を記憶させ、装着する際に、ロールペーパーが未使用か否かを判別する動作を実行してもよい。さらに、ロールペーパー(分包紙ロール)を分包紙供給装置306の本体に装着したときの分包紙の残量に関する情報を記憶させてもよい。また、薬剤を包装する分包動作が実行されたとき、分包動作中の適宜な時点での残量を記憶させてもよい。この残量に関する情報は、例えば、分包動作中に記憶させてもよい。この他、分包動作後に分包動作の終了時の残量を記憶させてもよい。即ち、薬剤払出し装置1を運用する際、適宜なタイミングで残量に関する情報を記憶させていってもよい。
Further, an identifier may be attached to the core member of the roll paper described above. The identifier is information that can individually identify the roll paper (information on the manufacturer, etc. (manufacturer name, etc.), information on the date of manufacture, etc., type of roll paper wound around the core, order number, shipping date , customer information of the delivery destination, the model name and model code of the packaging machine to which the roll paper is attached, other IDs, etc.), and may be, for example, a memory such as an IC tag. Also, a code such as a one-dimensional code (bar code) or a two-dimensional code may be used, and when a code is employed, it may be attached to a label.
Then, when the roll paper is loaded into the packaging paper supply device 306, an operation is executed to check with the device to be loaded, that is, to determine whether or not the predetermined roll paper is to be loaded into the device correctly. good too. Further, information for identifying that the roll paper is unused may be stored in the identifier, and an operation for determining whether the roll paper is unused may be executed when the roll paper is loaded. Further, information regarding the remaining amount of packaging paper when the roll paper (packaging paper roll) is attached to the main body of the packaging paper supply device 306 may be stored. Further, when the packaging operation of packaging the medicine is executed, the remaining amount at an appropriate time during the packaging operation may be stored. Information about this remaining amount may be stored, for example, during the packaging operation. In addition, after the packaging operation, the remaining amount at the end of the packaging operation may be stored. That is, when operating the medicine dispensing device 1, information about the remaining amount may be stored at appropriate timing.
 散薬分割領域301は、図2の様に、分配皿6が設置された領域であり、その周辺に薬剤フィーダ5と、清掃装置7が配置されている。また散薬分割領域301には、掻出装置8が設けられている。
 分配皿6及び掻出装置8は公知であり、簡単に説明する。
 分配皿6は、「凹溝」とも称され薬剤投入溝13(投入溝)が設けられた円板状の部材である。薬剤投入溝13は、分配皿6の外縁を環状に取り巻いている。分配皿6は、中央に機材収納開口15が設けられている。なお図2ではその大部分が蓋で覆われている。
 機材収納開口15に、前記した散薬投入ホッパー310が設置されている。
 分配皿6は、一定速度で回転させることができる。また所定の角度だけ回転させることもできる。
As shown in FIG. 2, the powdered medicine division area 301 is an area where the distribution tray 6 is installed, and the medicine feeder 5 and the cleaning device 7 are arranged around it. A scraping device 8 is provided in the powdered medicine dividing area 301 .
The distribution pan 6 and scraping device 8 are well known and will be briefly described.
The distribution plate 6 is a disk-shaped member provided with a medicine injection groove 13 (injection groove), which is also referred to as a "concave groove". The drug introduction groove 13 surrounds the outer edge of the distribution plate 6 in an annular shape. The distribution plate 6 is provided with an equipment storage opening 15 in the center. In addition, in FIG. 2, most of them are covered with a lid.
The above-described powdered medicine charging hopper 310 is installed in the equipment storage opening 15 .
The distribution dish 6 can be rotated at a constant speed. It can also be rotated by a predetermined angle.
 掻出装置8は、掻出用アーム17(図57(b)等参照)の先端に回転板12(図2参照)を有する。具体的には、掻出用アーム17の先端にモータによって回転駆動可能な取付基台255(図57(b)等参照)が設けられており、この取付基台255に掻き板等(図示しない)を有する回転板12が取り付けられている。すなわち、回転板12は、モータの動力によって回転する。
 掻出装置8の根本部分は、分配皿6の機材収納開口15内のターンテーブル(図示しない)の上に設置されている。そして分配皿6の中央からは、掻出装置8の掻出用アーム17が突出している。この掻出装置8は、ターンテーブルが回転することで全体が旋回可能である。また、掻出用アーム17が上下方向に揺動可能である。なお、掻出装置8は、ターンテーブルを設けず、全体が旋回しないものであって、掻出用アーム17が揺動可能であるものでもよい。
The raking device 8 has a rotary plate 12 (see FIG. 2) at the tip of a raking arm 17 (see FIG. 57(b), etc.). Specifically, a mounting base 255 (see FIG. 57(b), etc.) that can be rotated by a motor is provided at the tip of the scraping arm 17, and a scraping plate or the like (not shown) is attached to the mounting base 255. ) is mounted thereon. That is, the rotating plate 12 is rotated by the power of the motor.
A root portion of the scraping device 8 is installed on a turntable (not shown) in the equipment storage opening 15 of the distribution plate 6 . A scraping arm 17 of the scraping device 8 protrudes from the center of the distribution plate 6 . The scraping device 8 can be turned as a whole by rotating the turntable. Also, the scraping arm 17 can swing vertically. Note that the scraping device 8 may be one in which the turntable is not provided, the whole is not swivel, and the scraping arm 17 is swingable.
 ここで、本実施形態の薬剤払出し装置1は、図2で示されるように、散薬投入ホッパー310の薬剤投入口となる上部開口が分配皿6の内側に位置する。すなわち、散薬投入ホッパー310の外側で分配皿6が環状(円環状)に連続しており、平面視において分配皿6で囲まれた領域に散薬投入ホッパー310が位置する。そして、掻出装置8もまた、分配皿6の内側に位置させている。
 そして、掻出装置8によって分配皿6上の散薬を掻き出して散薬投入ホッパー310に投入する際、散薬を分配皿6の内側に向かって掻き出している。すなわち、分配皿6上の散薬を分配皿6の内側に移動させるように、回転板12を回転させて掻き板を移動させている(掻き板が分配皿6の外縁側から内縁側に向かって横断する方向で移動するように、回転板12を回転させている)。
 本実施形態では、分配皿6の内側に掻出装置8を設け、分配皿6の内側に向かって散薬を掻き出すことで、分配皿6の外側の部材数を少なくしている。すなわち、分配皿6の外側であり、薬剤フィーダ5の周辺に広いスペースを確保し、フィーダ本体10に対する薬剤容器20の着脱を手作業で行う際に作業をやり易くすると共に、薬剤払出し装置1の装置全体の小型化に寄与している。
Here, in the drug dispensing device 1 of the present embodiment, as shown in FIG. 2, the upper opening serving as the drug input port of the powdered drug input hopper 310 is positioned inside the distribution plate 6 . That is, the distribution tray 6 continues in an annular (annular) fashion outside the powdered medicine charging hopper 310, and the powdered medicine charging hopper 310 is located in an area surrounded by the distribution tray 6 in a plan view. The scraping device 8 is also positioned inside the distribution plate 6 .
When the powdered medicine on the distribution tray 6 is scraped out by the scraping device 8 and put into the powdered medicine charging hopper 310 , the powdered medicine is scraped out toward the inside of the distribution tray 6 . That is, the rotary plate 12 is rotated to move the scraping plate so as to move the powdered medicine on the distribution tray 6 to the inside of the distribution tray 6 (the scraping plate moves from the outer edge side to the inner edge side of the distribution tray 6). rotating plate 12 so as to move in the transverse direction).
In this embodiment, the scraping device 8 is provided inside the distribution tray 6 and the powdered medicine is scraped out toward the inside of the distribution tray 6, thereby reducing the number of members outside the distribution tray 6. FIG. That is, a wide space is secured around the medicine feeder 5 outside the distribution plate 6 to facilitate the work when manually attaching and detaching the medicine container 20 to and from the feeder main body 10, and at the same time, the medicine dispensing device 1 is provided with a large space. This contributes to the miniaturization of the entire device.
 薬剤フィーダ5は、図3、図4、図5の様に、フィーダ部22に重量校正部21が設けられたものである。また、薬剤フィーダ5は、後述する情報記憶手段65(図4参照)に対して情報の読み取り及び書き込みが可能な情報読書手段66(図3参照)を有する。フィーダ部22は、図4乃至図10の様に、散薬が収容される薬剤容器20と、薬剤容器20を保持するフィーダ本体10とを有している。
 フィーダ本体10は、図8の様に、機構上、容器支持部23と、重量測定部24と、土台部26に分けられる。
 容器支持部23は、図8の様に、支持台27と、振動部材16(容器保持部)及び加振手段30a,30bを有している。加振手段30a,30bは、圧電素子であり、板状を呈している。この振動部材16及び加振手段30a,30bは、薬剤容器20を振動させる振動装置でもある。
As shown in FIGS. 3, 4, and 5, the drug feeder 5 has a feeder section 22 provided with a weight calibration section 21. As shown in FIGS. The drug feeder 5 also has an information read/write means 66 (see FIG. 3) capable of reading and writing information to and from an information storage means 65 (see FIG. 4), which will be described later. 4 to 10, the feeder section 22 has a medicine container 20 containing powdered medicine and a feeder body 10 holding the medicine container 20. As shown in FIGS.
As shown in FIG. 8, the feeder body 10 is mechanically divided into a container support portion 23, a weight measurement portion 24, and a base portion 26. As shown in FIG.
As shown in FIG. 8, the container support section 23 has a support base 27, a vibrating member 16 (container holding section), and vibrating means 30a and 30b. The vibrating means 30a and 30b are piezoelectric elements and have a plate shape. The vibrating member 16 and vibrating means 30a and 30b are also vibrating devices for vibrating the drug container 20. As shown in FIG.
 支持台27及び振動部材16は、共に側面形状が「L」型の部材であり、水平部と垂直壁部を有している。
 即ち支持台27は、図7、図8、図11の様に、支持側水平部30と、支持側垂直壁部31を有している。
 振動部材16は、容器保持部としても機能するものであり、振動側水平部32と、振動側垂直壁部33(縦壁)を有している。振動側垂直壁部33には、薬剤容器20と係合する係合部(保持部側係合部であり、後述する溝状の係合部48(台形の係合部47)と、係合片(保持部側係合部)50の2つ。図10参照)が設けられている。
The support base 27 and the vibrating member 16 are both "L" shaped members having a horizontal portion and a vertical wall portion.
That is, the support table 27 has a support-side horizontal portion 30 and a support-side vertical wall portion 31, as shown in FIGS.
The vibration member 16 also functions as a container holding portion, and has a vibration-side horizontal portion 32 and a vibration-side vertical wall portion 33 (vertical wall). The vibration-side vertical wall portion 33 is provided with an engaging portion (holding portion-side engaging portion, which is a groove-shaped engaging portion 48 (trapezoidal engaging portion 47) described later) that engages with the drug container 20. Two pieces (holding portion side engaging portions) 50 (see FIG. 10) are provided.
 支持台27と、振動部材16の間が、二枚の加振手段30a,30bによって接続されている。
 振動側水平部32と支持側水平部30との間は実質的に非接触である。従って、加振手段30a,30bに通電すると、振動部材16が振動する。
The support base 27 and the vibrating member 16 are connected by two vibrating means 30a and 30b.
There is substantially no contact between the vibration-side horizontal portion 32 and the support-side horizontal portion 30 . Therefore, when the vibrating means 30a and 30b are energized, the vibrating member 16 vibrates.
 図8の様に、容器支持部23の下部に重量測定部24が配されている。重量測定部24は、重量測定手段25と防振手段18を備えている。重量測定手段25は、公知のロードセルである。防振手段18は防振部材28を有している。
 重量測定手段25の検知部に容器支持部23(支持台27、振動部材16、加振手段30a,30b)が接続されている。また土台部26は、重量測定部24の防振部材28を介して、上部の部材(支持台27、振動部材16、加振手段30a,30b)を支持している。
 容器支持部23の重量は、重量測定手段25で検知される。防振手段18の重量は、土台部26に掛かるが、重量測定手段25には掛からない。従って、容器支持部23(支持台27、振動部材16、加振手段30a,30b)の重量は、重量測定手段25によって検知される。(測定可能である)。
As shown in FIG. 8, a weight measurement section 24 is arranged below the container support section 23 . The weight measurement unit 24 includes weight measurement means 25 and vibration isolation means 18 . The weight measuring means 25 is a known load cell. The vibration isolation means 18 has a vibration isolation member 28 .
A detecting portion of the weight measuring means 25 is connected to the container supporting portion 23 (the supporting base 27, the vibrating member 16, and the vibrating means 30a and 30b). Further, the base portion 26 supports the upper members (the support base 27, the vibrating member 16, and the vibrating means 30a and 30b) via the vibration isolating member 28 of the weight measuring portion 24. As shown in FIG.
The weight of container support portion 23 is detected by weight measuring means 25 . The weight of the anti-vibration means 18 hangs on the base portion 26 but does not hang on the weight measuring means 25 . Therefore, the weight of the container support portion 23 (the support base 27, the vibrating member 16, the vibrating means 30a and 30b) is detected by the weight measuring means 25. FIG. (which is measurable).
 薬剤容器20は、散薬が充填される容器であり、その形状は、側面形状が略正方形の直方体である。
 薬剤容器20は、図6、図8、図9の様に、正面壁35と、背面壁36と、左右側面壁37と、天面壁38及び底面壁40に囲まれている。
 薬剤容器20の底面壁40であって、正面壁35近傍に開閉可能な散薬排出部11がある。
 また背面壁36の縦辺と、下部に係合部(係合溝130、係合凹部131、図6参照)がある。
The drug container 20 is a container filled with powdered medicine, and has a rectangular parallelepiped shape with substantially square side surfaces.
The drug container 20 is surrounded by a front wall 35, a rear wall 36, left and right side walls 37, a top wall 38 and a bottom wall 40, as shown in FIGS.
An openable and closable powdered medicine discharge part 11 is located near the front wall 35 of the medicine container 20 at the bottom wall 40 .
In addition, there are engagement portions (engagement groove 130 and engagement recess 131, see FIG. 6) on the vertical sides and lower portion of the rear wall 36 .
 薬剤容器20には散薬が充填され、図4、図5の様に、フィーダ本体10に固定される。即ち薬剤容器20の背面壁36が容器保持部たる振動部材16の、振動側垂直壁部33(竪壁)と接し、薬剤容器20の底面壁40の背面壁36側が振動側水平部32と接し、薬剤容器20の大部分が、片持ち状に張り出した状態で、フィーダ本体10に固定される。つまり、振動側水平部32は、薬剤容器20の少なくとも一部が載置される載置部材(載置台)でもある。
 また薬剤容器20の係合部が、それぞれ振動部材16の二か所の係合部(後述する溝状の係合部48(台形の係合部47 保持部側係合部)と、係合片(保持部側係合部)50の2つであり、図10参照)と係合している。そのため、薬剤容器20は、振動部材16と一体化されており、振動部材16と共に振動する。
The medicine container 20 is filled with powdered medicine and fixed to the feeder body 10 as shown in FIGS. That is, the back wall 36 of the drug container 20 is in contact with the vibration side vertical wall portion 33 (vertical wall) of the vibrating member 16 serving as the container holding portion, and the back wall 36 side of the bottom wall 40 of the drug container 20 is in contact with the vibration side horizontal portion 32 . , most of the drug container 20 is fixed to the feeder body 10 in a cantilevered state. In other words, the vibration-side horizontal portion 32 is also a mounting member (mounting table) on which at least part of the drug container 20 is mounted.
Further, the engaging portion of the medicine container 20 engages with two engaging portions (a groove-shaped engaging portion 48 (trapezoidal engaging portion 47 holding portion side engaging portion) described later) of the vibrating member 16, respectively. These are two of the pieces (holding portion side engaging portions) 50, and are engaged with the pieces (see FIG. 10). Therefore, the drug container 20 is integrated with the vibrating member 16 and vibrates together with the vibrating member 16 .
 ここで、2つの左右側面壁37の一方には、情報記憶手段65が取り付けられている(図4参照)。情報記憶手段65には、薬剤容器20に関する情報(薬剤容器20に収容されている散薬に関する情報)が記憶されている。例えば、収容された薬剤を特定する識別情報(薬剤名や各種コード等の情報)や、収容された薬剤の現在の残量に関する残量情報が記憶されている。情報記憶手段65に記憶された情報は、処方データ等と関連付けて使用可能な情報であり、情報記憶手段65に記憶された情報を取得することで、薬剤容器20に収容された散薬の種類を特定する動作等が可能となる。この情報記憶手段65は、ICタグ等のメモリであってもよい。また、一次元コード(バーコード)や二次元コードのようなコードであってもよく、コードを採用する場合、ラベルに付されていてもよい。 Here, information storage means 65 is attached to one of the two left and right side walls 37 (see FIG. 4). Information on the drug container 20 (information on the powdered medicine contained in the drug container 20) is stored in the information storage means 65 . For example, it stores identification information (information such as drug name and various codes) that identifies the stored medicine, and remaining amount information about the current remaining amount of the stored medicine. The information stored in the information storage means 65 is information that can be used in association with prescription data and the like. It becomes possible to perform a specified operation. This information storage means 65 may be a memory such as an IC tag. Also, a code such as a one-dimensional code (bar code) or a two-dimensional code may be used, and when a code is employed, it may be attached to a label.
 なお、薬剤フィーダ5は、上記したように、情報記憶手段65に対して情報の読み取り及び書き込みが可能な情報読書手段66(図3参照)を有する。本実施形態では、この情報読書手段66としてRFIDリーダライタを採用しており、無線通信によって情報記憶手段65に対する情報の読書が可能である。そして、情報記憶手段65からカセット情報を読み取る動作と、薬剤容器20から散薬を払い出した後に残量を書き込む(書き換える)動作が可能となっている。なお、カセット情報は、上記した薬剤容器20に関する情報であり、例えば、薬剤名と残量が挙げられる。
 この情報読書手段66は、フィーダ本体10に薬剤容器20が取り付けられた状態において、情報記憶手段65の外側となる位置であり、情報記憶手段65からやや離れた位置に配される(図3、図4参照)。なお、情報読書手段66に替わって、情報の読取と書き込みのそれぞれが可能な情報読取手段、情報書込手段等を設けることも考えられる。
The medicine feeder 5 has the information reading/writing means 66 (see FIG. 3) capable of reading and writing information to/from the information storage means 65, as described above. In this embodiment, an RFID reader/writer is employed as the information reading/writing means 66, and information can be read from/to the information storage means 65 by wireless communication. An operation of reading the cassette information from the information storage means 65 and an operation of writing (rewriting) the remaining amount after dispensing the powdered medicine from the medicine container 20 are possible. Note that the cassette information is information about the drug container 20 described above, and includes, for example, the drug name and remaining amount.
The information reading/reading means 66 is located outside the information storage means 65 when the medicine container 20 is attached to the feeder main body 10, and is arranged at a position slightly separated from the information storage means 65 (see FIGS. 3 and 5). See Figure 4). In place of the information reading/writing means 66, it is conceivable to provide an information reading means, an information writing means, etc. capable of reading and writing information respectively.
 重量校正部21は、重量測定手段25が正常であるか否かを検知するものである。重量校正部21は、図4の様に、分銅42(錘部材、校正用錘)と、分銅42が載置される分銅載置部材43(重量受部)と、分銅42を中空に持ち上げる分銅支持部材45(図51参照)を有している。
 分銅載置部材43は、フィーダ本体10の容器支持部23に取付用部材を介して固定されている。従って、分銅載置部材43の重量は、重量測定手段25に付加される。
 一方、分銅支持部材45は、フィーダ本体10の土台部26に荷重が付加されるように配されている(図51、図52参照)。従って分銅支持部材45の重量は、重量測定手段25に付加されない。
The weight calibration section 21 detects whether or not the weight measuring means 25 is normal. As shown in FIG. 4, the weight calibration unit 21 includes a weight 42 (weight member, weight for calibration), a weight mounting member 43 (weight receiver) on which the weight 42 is mounted, and a weight for lifting the weight 42 into the air. It has a support member 45 (see FIG. 51).
The weight placement member 43 is fixed to the container support portion 23 of the feeder body 10 via an attachment member. Therefore, the weight of the weight mounting member 43 is added to the weight measuring means 25. FIG.
On the other hand, the weight support member 45 is arranged so that a load is applied to the base portion 26 of the feeder body 10 (see FIGS. 51 and 52). The weight of the weight support member 45 is therefore not added to the weight measuring means 25 .
 本実施形態では、図2で示されるように、分配皿6の周囲に、薬剤フィーダ5が6基、固定されている。薬剤容器20は、正面壁35側(図6等参照)が分配皿6に向かって突き出しており、散薬排出部11は、薬剤投入溝13の真上の位置にある。 In this embodiment, six drug feeders 5 are fixed around the distribution plate 6, as shown in FIG. The drug container 20 has a front wall 35 side (see FIG. 6 and the like) protruding toward the distribution plate 6 , and the powdered drug discharge section 11 is positioned directly above the drug introduction groove 13 .
 本実施形態の薬剤払出し装置1では、あらかじめ各薬剤フィーダ5の薬剤容器20に異なる薬剤が充填されている。
 そして処方箋(処方に関する情報である処方データ)に基づき、特定の薬剤フィーダ5が駆動され、散薬が分配皿6に投入される。具体的には、図示しない制御装置の信号によって、特定の薬剤フィーダ5の加振手段30a,30bに一定周波数の電流を通電して振動を発生させ、この振動によって振動部材16(容器保持部)を振動させる。
 また振動開始と前後して分配皿6を回転させる。
In the medicine dispensing device 1 of this embodiment, the medicine container 20 of each medicine feeder 5 is filled with different medicines in advance.
Then, based on a prescription (prescription data, which is information about prescription), a specific drug feeder 5 is driven, and powdered drugs are put into the distribution tray 6 . Specifically, according to a signal from a control device (not shown), a current of a constant frequency is applied to the vibrating means 30a and 30b of a specific drug feeder 5 to generate vibration, and the vibrating member 16 (container holding portion) is caused by this vibration. to vibrate.
In addition, the distribution plate 6 is rotated before and after the start of vibration.
 また振動開始と前後して、薬剤容器20の重量が測定される。薬剤容器20の重量は、重量測定手段25の検知重量から、一定値を引いたものである。より具体的には、薬剤容器20の重量は、重量測定手段25の検知重量から、容器支持部23及び重量校正部21の一部を含む部材(重量測定手段25に対して荷重が付加される部材)の重量を引いたものである。
 散薬排出前の薬剤容器20の重量は、原重量Gとして記憶される。また薬剤容器20の重量は、常時監視される。即ち薬剤容器20の現在の重量は、現重量gとして監視される。
Also, the weight of the medicine container 20 is measured before and after the start of the vibration. The weight of the medicine container 20 is obtained by subtracting a certain value from the weight detected by the weight measuring means 25 . More specifically, the weight of the drug container 20 is calculated from the weight detected by the weight measuring means 25 by the member including the container supporting portion 23 and part of the weight calibrating portion 21 (the load is applied to the weight measuring means 25). material) is subtracted.
The weight of the medicine container 20 before the powdered medicine is discharged is stored as the original weight G. Also, the weight of the drug container 20 is constantly monitored. That is, the current weight of the drug container 20 is monitored as the current weight g.
 振動部材16が振動を開始すると、薬剤容器20が共に振動する。ここで、本実施形態では、薬剤容器20は、二か所に設けられた係合部(後述する溝状の係合部48(台形の係合部47 保持部側係合部)と、係合片50の2つであり、図10参照)によって強固に振動部材16の振動側垂直壁部33(縦壁)に接合されており、且つ振動部材16との密着度合いも高いから、薬剤容器20は、振動部材16と同一周波数で振動する。その結果、薬剤容器20に貯留された散薬が、散薬排出部11側に向かってゆっくりと移動する。 When the vibrating member 16 starts vibrating, the drug container 20 vibrates together. Here, in the present embodiment, the drug container 20 is provided with two engaging portions (a groove-shaped engaging portion 48 (trapezoidal engaging portion 47 holding portion side engaging portion) described later). 10) of the vibrating member 16, and the degree of close contact with the vibrating member 16 is high. 20 vibrates at the same frequency as vibrating member 16 . As a result, the powdered medicine stored in the medicine container 20 slowly moves toward the powdered medicine discharging part 11 side.
 そして散薬は、散薬排出部11から落下し、下の分配皿6の薬剤投入溝13に入る。 Then, the powdered medicine falls from the powdered medicine discharge part 11 and enters the medicine input groove 13 of the distribution plate 6 below.
 散薬が落下中であることは、薬剤容器20の重量が減少することによって確認される。即ち本実施形態では、散薬が薬剤容器20から落下中においても、薬剤容器20の現在の重量が、現重量gとして監視され続けている。そして振動部材16に設置直後の薬剤容器20の原重量Gと、現重量gとを比較し、散薬の落下量H(散薬の排出量であり、Gマイナスg)を常時演算している。
 そして散薬の総落下量Hが所望の重量となったところで、振動部材16の振動を停止する。
The fact that the powdered medicine is falling is confirmed by the weight of the medicine container 20 decreasing. That is, in this embodiment, the current weight of the medicine container 20 is continuously monitored as the current weight g even while the powdered medicine is falling from the medicine container 20 . The original weight G of the drug container 20 immediately after being placed on the vibrating member 16 is compared with the current weight g, and the falling amount H of the powdered medicine (the discharged amount of the powdered medicine, G minus g) is always calculated.
Then, the vibration of the vibrating member 16 is stopped when the total dropping amount H of the powder medicine reaches the desired weight.
 その後の動作は、掻出装置8の回転板12を分配皿6の薬剤投入溝13内に落とす。さらにその後、分配皿6を分配個数に応じた角度だけ回転させ、一服用分の散薬を回転板12の前面側に集める。そして回転板12を回転し、図示しない掻き板によって散薬を分配皿6の外に掻き出して、散薬投入ホッパー310に投入する。散薬投入ホッパー310から落下した散薬は、薬剤包装装置305で一服用分ずつ包装される。
 このように、本実施形態の薬剤払出し装置1は、公知の薬剤払い出し装置と同様に、薬剤を一服用分ずつ包装する分包動作が可能となっている。また、容器支持部23は、薬剤容器20から散薬を排出させる散薬排出手段として機能する。
In the subsequent operation, the rotating plate 12 of the scraping device 8 is dropped into the medicine charging groove 13 of the distribution plate 6. As shown in FIG. Furthermore, after that, the distribution plate 6 is rotated by an angle corresponding to the number of distribution, and the powdered medicine for one dose is collected on the front side of the rotary plate 12. - 特許庁Then, the rotating plate 12 is rotated, and the powdered medicine is scraped out of the distribution tray 6 by a scraping plate (not shown) and put into the powdered medicine feeding hopper 310 . The powdered medicine dropped from the powdered medicine feeding hopper 310 is packaged by the medicine packaging device 305 for each dose.
In this manner, the medicine dispensing device 1 of the present embodiment is capable of packaging the medicine by one dose in the same manner as a well-known medicine dispensing device. Further, the container support portion 23 functions as powdered medicine discharge means for discharging the powdered medicine from the medicine container 20 .
 上記した一連の薬剤排出動作は、重量校正部21の分銅支持部材45によって分銅42が持ち上げられた状態で行われる。そのため、分銅42の重量は、重量測定手段25に検知されない。
 重量測定手段25が正常であるか否かを判別する際には、分銅支持部材45を動作させて分銅42を分銅載置部材43に載せる(詳しくは後述する)。
 その結果、分銅42の重量が、重量測定手段25に掛かり、分銅42の重量が検知される。
 ここで分銅42の重量は既知であるから、分銅42を載せたことによる検知重量の増加分が、予め記憶された分銅42の重量の値と等しければ、重量測定手段25が正常であと言える。逆に、分銅42を載せたことによる検知重量の増加分が、分銅42の重量と異なっていれば、重量測定手段25が故障していると言える。即ち、重量測定手段25の校正では、分銅42を載せたことによる検知重量の増加分(分銅42の重量)を取得する重量取得工程を行う。
The series of drug discharge operations described above is performed while the weight 42 is lifted by the weight support member 45 of the weight calibration unit 21 . Therefore, the weight of the weight 42 is not detected by the weight measuring means 25 .
When determining whether or not the weight measuring means 25 is normal, the weight supporting member 45 is operated to place the weight 42 on the weight placing member 43 (details will be described later).
As a result, the weight of the weight 42 is applied to the weight measuring means 25, and the weight of the weight 42 is detected.
Here, since the weight of the weight 42 is known, it can be said that the weight measuring means 25 is normal if the increase in the detected weight due to the weight 42 being placed is equal to the value of the weight of the weight 42 stored in advance. Conversely, if the amount of increase in the detected weight due to the placement of the weight 42 is different from the weight of the weight 42, it can be said that the weight measuring means 25 is out of order. That is, in calibrating the weight measuring means 25, a weight obtaining step is performed to obtain an increase in the detected weight (the weight of the weight 42) due to placing the weight 42 thereon.
 次に、薬剤払出し装置1の各部材や装置について説明する。
(1)フィーダ本体10
 フィーダ本体10は、前記した様に、容器支持部23と、重量測定手段25と、土台部26に分けられる。
 また容器支持部23は、支持台27と、振動部材16(容器保持部)及び加振手段30a,30bを有している。
 振動部材16の外観形状は、図4乃至図12の通りであり、略「L」形状である。即ち振動部材16は、振動側水平部32と、縦壁たる振動側垂直壁部33を有している。
Next, each member and device of the drug delivery device 1 will be described.
(1) Feeder body 10
The feeder body 10 is divided into the container support portion 23, the weight measuring means 25, and the base portion 26, as described above.
Further, the container support section 23 has a support base 27, a vibrating member 16 (container holding section), and vibrating means 30a and 30b.
The external shape of the vibrating member 16 is as shown in FIGS. 4 to 12, and is substantially "L" shaped. That is, the vibration member 16 has a vibration-side horizontal portion 32 and a vibration-side vertical wall portion 33 as a vertical wall.
 振動側垂直壁部33は、図9乃至図12の様に、金属で形成された本体部63に樹脂で形成された内張り部材46が設けられたものである。
 内張り部材46は、図10の様に、全体形状が概ね長方形の板状であり、表面側に係合部47が設けられている。
 係合部47は、正面視が、長方形に近い台形である。ただし一方の斜辺の下部には膨らみ部58がある。そして当該台形形状の斜辺に相当する辺に、あり溝状の係合部(保持部側係合部)48が設けられている。
As shown in FIGS. 9 to 12, the vibration-side vertical wall portion 33 has a body portion 63 made of metal and a lining member 46 made of resin.
As shown in FIG. 10, the lining member 46 has a substantially rectangular plate shape as a whole, and has an engaging portion 47 on the surface side.
The engaging portion 47 has a trapezoidal shape that is close to a rectangle when viewed from the front. However, there is a bulging portion 58 at the bottom of one oblique side. A dovetail groove-shaped engaging portion (holding portion-side engaging portion) 48 is provided on a side corresponding to the oblique side of the trapezoidal shape.
 振動側垂直壁部33の裏面には、図11、図12の様に、四角形の凹部132が上下2か所に設けられている。また各凹部132の下辺部は、傾斜面133となっている。傾斜面133は、上辺側に比べて下辺側が奥側となる様に傾斜している。当該傾斜面133は、加振手段30a,30bを取り付ける座面として機能する。  On the rear surface of the vibration-side vertical wall part 33, as shown in Figs. Also, the lower side of each recess 132 forms an inclined surface 133 . The inclined surface 133 is inclined such that the lower side is closer to the back side than the upper side. The inclined surface 133 functions as a seating surface for mounting the vibrating means 30a and 30b.
 また係合部47の正面であって、その下部には、図10、図13の様に、略四角形の開口51が設けられている。そして当該開口51内に、係合片50が収容されている。
 係合片50は、出し入れ機構に接続されており、開口51から出没する。
10 and 13, a substantially rectangular opening 51 is provided on the front surface of the engaging portion 47 and in the lower portion thereof. An engaging piece 50 is accommodated in the opening 51 .
The engaging piece 50 is connected to the loading/unloading mechanism and projects from the opening 51 .
 振動側水平部32は、金属で作られた板状の部材である。
 振動側水平部32の一方の辺部には、図9、図10、図13の様に、シャッター開閉機構55(開閉機構部)が設けられている。シャッター開閉機構55は、薬剤容器20から散薬を定量排出するための開閉機構である。
 シャッター開閉機構55は、図10、図13の様に、係合片保持部56とアーム57によって構成されている。また、アーム57を動作(直線移動)させる動力部を有する。この動力部は、モータ等から構成されている。
 係合片保持部56は、略直方体形状であり、上面に係合部60となる凹部が設けられている。
 アーム57は、一端側が係合片保持部56に接続されており、他端側は、振動側垂直壁部33内に収容されている。
 そして、前記した出し入れ機構に接続されている。
The vibration-side horizontal portion 32 is a plate-like member made of metal.
A shutter opening/closing mechanism 55 (opening/closing mechanism portion) is provided on one side portion of the vibration-side horizontal portion 32, as shown in FIGS. The shutter opening/closing mechanism 55 is an opening/closing mechanism for discharging a fixed amount of powdered medicine from the medicine container 20 .
The shutter opening/closing mechanism 55 is composed of an engagement piece holding portion 56 and an arm 57 as shown in FIGS. It also has a power unit that operates (linearly moves) the arm 57 . This power unit is composed of a motor and the like.
The engaging piece holding portion 56 has a substantially rectangular parallelepiped shape, and has a concave portion that serves as an engaging portion 60 on the upper surface thereof.
One end of the arm 57 is connected to the engagement piece holding portion 56 , and the other end is accommodated in the vibration-side vertical wall portion 33 .
And it is connected to the loading/unloading mechanism described above.
 なお、本実施形態では、詳細に説明すると、本実施形態のフィーダ本体10は、係合用部材210(図14(a)左図参照)を有しており、この上部が係合片50を構成する。つまり、係合用部材210は、係合片50を形成する上側の係合片形成部210aと、下側の当接部210bと、これらを繋ぐ中間部210cを有する。この係合用部材210は、コイルバネ等の付勢部材により、支持側垂直壁部31から振動側垂直壁部33へ向かう方向に常時付勢されている。
 また、係合片保持部56は、側面に押圧突起部56a(図14(a)右図参照)を有する。
 そして、係合片保持部56が振動側垂直壁部33の近傍に位置した状態では、図14(b)の左図で示されるように、押圧突起部56aが当接部210bを振動側垂直壁部33に向かう方向に押圧する。このことにより、係合用部材210が付勢力に抗して押圧され、係合片50が開口51に没入された状態となる。
 対して、係合片保持部56が振動側垂直壁部33から離れた位置に移動した状態では、図14(b)の右図で示されるように、係合用部材210が付勢部材によって押圧されて移動し、係合片50が開口51から突出した状態となる。このように、係合用部材210が振動側水平部32に形成された溝(凹部)内で移動する。
In this embodiment, to explain in detail, the feeder body 10 of this embodiment has an engaging member 210 (see the left diagram of FIG. 14(a)), the upper portion of which constitutes an engaging piece 50. do. That is, the engaging member 210 has an upper engaging piece forming portion 210a that forms the engaging piece 50, a lower contact portion 210b, and an intermediate portion 210c that connects them. The engaging member 210 is constantly urged in the direction from the support-side vertical wall portion 31 toward the vibration-side vertical wall portion 33 by an urging member such as a coil spring.
In addition, the engaging piece holding portion 56 has a pressing projection portion 56a (see the right figure in FIG. 14(a)) on its side surface.
Then, when the engagement piece holding portion 56 is positioned near the vibration side vertical wall portion 33, as shown in the left diagram of FIG. It is pressed in a direction toward the wall portion 33 . As a result, the engaging member 210 is pressed against the urging force, and the engaging piece 50 is recessed into the opening 51 .
On the other hand, when the engaging piece holding portion 56 is moved away from the vibration-side vertical wall portion 33, the engaging member 210 is pressed by the biasing member as shown in the right diagram of FIG. is moved, and the engagement piece 50 protrudes from the opening 51 . Thus, the engaging member 210 moves within the groove (recess) formed in the vibration-side horizontal portion 32 .
 支持台27の外観形状は、図12、図13の通りであり、略「L」形状である。即ち支持台27は、支持側水平部30と、支持側垂直壁部31を有している。
 支持側垂直壁部31の前面側にも、図示されない傾斜面があり、当該傾斜面は、加振手段30a,30bを取り付ける座面として機能する
The external shape of the support base 27 is as shown in FIGS. 12 and 13, and is substantially "L" shaped. That is, the support base 27 has a support-side horizontal portion 30 and a support-side vertical wall portion 31 .
The support-side vertical wall portion 31 also has an inclined surface (not shown) on the front side thereof, and the inclined surface functions as a seat surface for mounting the vibrating means 30a and 30b.
 振動部材16が支持台27の上に設置され、支持側水平部30の上に振動側水平部32がある。また支持側垂直壁部31の凹面側に、振動側垂直壁部33の凸面側が面している。
 そして、支持側垂直壁部31の凹面側と、振動側垂直壁部33の凸面側の間が、二枚の加振手段30a,30bで接続されている。加振手段30a,30bは、いずれも、支持側垂直壁部31側が上、振動側垂直壁部33側が下となる方向に傾斜して取り付けられている。
 振動側水平部32と支持側水平部30との間は実質的に非接触である。
A vibrating member 16 is mounted on a support base 27 , and a vibrating horizontal portion 32 is on a supporting horizontal portion 30 . The convex side of the vibration-side vertical wall portion 33 faces the concave side of the support-side vertical wall portion 31 .
The concave side of the support-side vertical wall portion 31 and the convex side of the vibration-side vertical wall portion 33 are connected by two vibrating means 30a and 30b. Both of the vibrating means 30a and 30b are attached so that the support-side vertical wall portion 31 side is upward and the vibrating-side vertical wall portion 33 side is downward.
There is substantially no contact between the vibration-side horizontal portion 32 and the support-side horizontal portion 30 .
 重量測定部24は、重量測定手段25と防振手段18を備えている。防振手段18は、防振枠135と防振部材28によって構成されている。
 防振枠135は、図12に示すように、高部枠136と、支持台部137を有している。
 高部枠136は、平行に配された防振部材取り付け板140を有している。支持台部137は、防振部材取り付け板140の間であって、高部枠136よりも下の位置に設けられている。
 防振部材取り付け板140の四隅であって、下部側に、防振部材28が取り付けられている。
 また支持台部137の上に、重量測定手段25が固定されている。支持台部137は、高部枠136よりも下の位置にあるから、重量測定手段25の大部分は、高部枠136よりも下の位置にあるが、重量測定手段25の上面は、高部枠136よりも上の位置にある。
The weight measurement unit 24 includes weight measurement means 25 and vibration isolation means 18 . The vibration isolation means 18 is composed of a vibration isolation frame 135 and a vibration isolation member 28 .
The anti-vibration frame 135 has a high frame 136 and a support base 137, as shown in FIG.
The high frame 136 has anti-vibration member attachment plates 140 arranged in parallel. The support base portion 137 is provided at a position below the high portion frame 136 between the anti-vibration member mounting plates 140 .
The vibration isolating members 28 are attached to the four corners of the vibration isolating member mounting plate 140 on the lower side.
Also, the weight measuring means 25 is fixed on the support base portion 137 . Since the support base 137 is located below the high frame 136, most of the weight measuring means 25 is located below the high frame 136, but the upper surface of the weight measuring means 25 is located above the high frame 136. It is positioned above the frame 136 .
 土台部26は、金属で作られた板状の部材であり、中央に凹部が設けられている。
 重量測定部24の重量測定手段25の上面に、容器支持部23が固定されている。具体的には、容器支持部23の支持側水平部30が、高部枠136から突出する重量測定手段25の上面に固定されている。
 また重量測定部24の防振部材28が土台部26に設置されている。
 本実施形態では、重量測定手段25の上面に載置されているのは、容器支持部23(支持台27、振動部材16、加振手段30a,30b)であり、重量測定手段25は、これらの重量を正確に測定することができる。
The base portion 26 is a plate-like member made of metal, and has a recess in the center.
A container supporting portion 23 is fixed to the upper surface of the weight measuring means 25 of the weight measuring portion 24 . Specifically, the support-side horizontal portion 30 of the container support portion 23 is fixed to the upper surface of the weight measuring means 25 projecting from the high portion frame 136 .
A vibration isolating member 28 of the weight measuring section 24 is installed on the base section 26 .
In this embodiment, what is placed on the upper surface of the weight measuring means 25 is the container supporting portion 23 (the supporting table 27, the vibrating member 16, and the vibrating means 30a and 30b). can be accurately measured.
 本実施形態のフィーダ本体10は、薬剤容器20を保持する容器保持部と、立設状の支持部(支持側垂直壁部31)を有し、前記容器保持部は、縦部材(振動側垂直壁部33)を有し、前記支持部と前記縦部材との間に加振手段30a,30bが設けられたものである。 The feeder body 10 of this embodiment has a container holding portion that holds the drug container 20 and an upright support portion (support side vertical wall portion 31). wall portion 33), and vibrating means 30a and 30b are provided between the support portion and the vertical member.
 本実施形態のフィーダ本体10は、薬剤容器20の一つの側面側に加振手段30a,30bがある。即ち薬剤容器20と加振手段30a,30bが並立している。
 そのため加振手段30a,30bが薬剤容器20の下にあるようなレイアウトに比べて薬剤容器20を低い位置に置くことができ、薬剤容器20の散薬排出部11を分配皿6に近づけることができ、散薬の跳ねを少なくすることができる。
The feeder main body 10 of this embodiment has vibrating means 30 a and 30 b on one side of the drug container 20 . That is, the medicine container 20 and the vibrating means 30a, 30b are arranged side by side.
Therefore, compared to a layout in which the vibrating means 30a and 30b are located under the drug container 20, the drug container 20 can be placed at a lower position, and the powdered drug discharging portion 11 of the drug container 20 can be brought closer to the distribution plate 6. , can reduce splashing of powdered medicine.
(2)薬剤容器20
 次に薬剤容器20について説明する。以下の説明において、縦横の方向は、薬剤容器20がフィーダ本体10に設置された姿勢を基準とする。
 薬剤容器20は、密閉可能な容器本体70を有している。
 また薬剤容器20は、図6、図15の様に、内部に仕切り板68(仕切り部材)と、整流部材72と、シャッター構造部73を有している。
(2) Drug container 20
Next, the drug container 20 will be explained. In the following description, the vertical and horizontal directions are based on the orientation of the drug container 20 installed in the feeder main body 10 .
The drug container 20 has a sealable container body 70 .
6 and 15, the drug container 20 has a partition plate 68 (partition member), a rectifying member 72, and a shutter structure portion 73 inside.
 容器本体70の外観形状は、フィーダ本体10の容器支持部23に取り付けられた姿勢を基準として正面側(散薬排出部11側)から見ると、細長い箱状の部材である。
 容器本体70は、側面形状が略正方形の直方体である。即ち薬剤容器20は、大面積側側面61と小面積側側面62を有していて、幅Wに対して高さHが高い。
 容器本体70は、正面壁35と、背面壁36と、左右側面壁37と、天面壁38及び底面壁40が囲まれている。
 正面壁35及び背面壁36とは、小面積側側面62であり、縦長の長方形である。左右側面壁37は、正方形に近い長方形であり、大面積側側面61である。天面壁38及び底面壁40は長方形である。
The external shape of the container body 70 is an elongated box-like member when viewed from the front side (the powdered medicine discharge section 11 side) with respect to the orientation of the feeder body 10 attached to the container support portion 23 .
The container main body 70 is a rectangular parallelepiped with a substantially square side surface. That is, the drug container 20 has a large-area side surface 61 and a small-area side surface 62, and the height H is high with respect to the width W. As shown in FIG.
The container body 70 is surrounded by a front wall 35 , a rear wall 36 , left and right side walls 37 , a top wall 38 and a bottom wall 40 .
The front wall 35 and the rear wall 36 are small area side surfaces 62 and are vertically long rectangles. The left and right side walls 37 have a rectangular shape close to a square, and are large-area side surfaces 61 . The top wall 38 and bottom wall 40 are rectangular.
 背面壁36には、図6、図9の様に、一対の係合溝130と、一つの係合凹部131が設けられている。
 係合溝130は、背面壁36の左右の縦辺に沿って設けられた内側に向かって開く縦溝である。
 係合凹部131は、背面壁36の下部に設けられたくぼみである。
The rear wall 36 is provided with a pair of engaging grooves 130 and one engaging recess 131 as shown in FIGS.
The engaging grooves 130 are vertical grooves that open inward along the left and right vertical sides of the back wall 36 .
The engagement recess 131 is a depression provided in the lower portion of the rear wall 36 .
 図19の様に、正面壁35の下部から底面壁40の正面壁35側にかけての領域に、欠落部77がある。底面壁40の正面壁35側の部位は、斜めに欠落している。そのため底面壁40の正面壁35側の端部は、図24の様に斜辺となっている。本実施形態では、欠落部77の端部の傾斜は、急傾斜部150と緩傾斜部151が組み合わされたものとなっている。 As shown in FIG. 19, there is a missing portion 77 in a region from the lower portion of the front wall 35 to the bottom wall 40 on the front wall 35 side. A portion of the bottom wall 40 on the front wall 35 side is obliquely missing. Therefore, the end portion of the bottom wall 40 on the side of the front wall 35 is an oblique side as shown in FIG. In this embodiment, the slope of the end of the missing portion 77 is a combination of a steep slope portion 150 and a gentle slope portion 151 .
 容器本体70は、一面が開口した箱部71と、蓋部材75によって構成されている。
 箱部71は、容器本体70の各壁の内、一方の側面壁を除く5面を構成するものである。箱部71の開口部には図示しないパッキンが装着されている。箱部71の正面壁35の開口側には図17の様に、係合部81が設けられている。
 蓋部材75は、容器本体70の各壁の内、一方の側面壁(大面積側側面61)を構成するものである。
 蓋部材75は、箱部71の背面壁36にヒンジ120(図15(a)参照)を介して揺動可能に取り付けられている。
 蓋部材75の自由端側には、締め付け部材76が設けられている。締め付け部材76は、トグル式の締め付け手段を採用するものであり、ヒンジ121(図15(a)参照)を介して揺動可能な締め付け片78を備えている。締め付け片78の内側には、係合凹部80が設けられている。
The container body 70 is composed of a box portion 71 with one side open and a lid member 75 .
The box portion 71 constitutes five walls of the container body 70 excluding one side wall. A packing (not shown) is attached to the opening of the box portion 71 . An engaging portion 81 is provided on the opening side of the front wall 35 of the box portion 71 as shown in FIG.
The lid member 75 constitutes one of the walls of the container body 70 (the large-area side surface 61).
The lid member 75 is swingably attached to the back wall 36 of the box portion 71 via a hinge 120 (see FIG. 15(a)).
A tightening member 76 is provided on the free end side of the lid member 75 . The tightening member 76 employs toggle-type tightening means, and includes a tightening piece 78 that can swing via a hinge 121 (see FIG. 15(a)). An engaging recess 80 is provided inside the tightening piece 78 .
 蓋部材75で箱部71の開口部を閉じる際には、図17(a)の様に蓋部材75の自由端を箱部71に近づけ、締め付け片78の係合凹部80を図17(b)の様に箱部71の係合部81と当接させ、図17(c)の様に締め付け片78を正面壁35と接する程度まで倒す。
 その結果、蓋部材75の自由端側が、箱部71の開口部に引き寄せられ、蓋部材75の内面側が、箱部71のパッキンと接して容器本体70の内部が密閉される。
 また締め付け片78は、箱部71の正面壁35と略平行姿勢となる。
When closing the opening of the box portion 71 with the lid member 75, the free end of the lid member 75 is brought close to the box portion 71 as shown in FIG. ), and the clamping piece 78 is brought into contact with the front wall 35 as shown in FIG. 17(c).
As a result, the free end side of the lid member 75 is pulled toward the opening of the box portion 71 , and the inner surface side of the lid member 75 comes into contact with the packing of the box portion 71 to seal the inside of the container body 70 .
The tightening piece 78 is substantially parallel to the front wall 35 of the box portion 71 .
 ここで、本実施形態の薬剤容器20は、箱部71の開口部を閉じた状態から開いた状態とするとき、図示しない外部の装置や治具を使用することを想定している。つまり、蓋部材75の締め付け状態(ロック状態)を解除するとき、締め付け片78を手で直接操作せず、外部の装置等で姿勢変更させることを想定している。
 このため、図18(a)で示されるように、締め付け片78は、外形が略三角柱状であり、自由端側に向かうにつれて厚さが薄くなる形状としている。そして、締め付け片78は、閉じた状態で正面壁35側とは逆側となる部分に傾斜面が形成される一方で、正面壁35側の部分の一部を除いた略全体が正面壁35と隙間なく密着する。詳細には、締め付け片78の自由端側に切り欠き部78aが形成されており、この切り欠き部78aと隣接する部分(締め付け片78の基端側に位置する部分)では、正面壁35との間に微細な隙間(図示しない)が形成されている。そして、外部の装置や治具の一部を切り欠き部78aからこの隙間に挿入し、締め付け片78を姿勢変更することで締め付け状態を解除する。この切り欠き部78aや、切り欠き部78aと隣接する隙間は、一般的な成人の指が入らない大きさとしている。
Here, in the drug container 20 of the present embodiment, it is assumed that an external device or jig (not shown) is used to open the opening of the box portion 71 from the closed state. In other words, it is assumed that when releasing the tightened state (locked state) of the lid member 75, the posture is changed by an external device or the like without directly operating the tightening piece 78 by hand.
For this reason, as shown in FIG. 18(a), the tightening piece 78 has a substantially triangular prism-like outer shape, and the thickness decreases toward the free end side. The tightening piece 78 has an inclined surface on the side opposite to the front wall 35 side in the closed state. It adheres without gaps. More specifically, a notch portion 78a is formed on the free end side of the tightening piece 78, and the portion adjacent to the notch portion 78a (the portion located on the base end side of the tightening piece 78) is the front wall 35. A minute gap (not shown) is formed between them. Then, a part of an external device or jig is inserted into this gap from the notch portion 78a, and the posture of the tightening piece 78 is changed to release the tightened state. The cutout portion 78a and the gap adjacent to the cutout portion 78a are sized so that a general adult's finger cannot be inserted therein.
 しかしながら、上記した薬剤容器20に替わって、図18(b)で示されるように、締め付け状態(ロック状態)を手動で解除することを想定した薬剤容器を採用してもよい。
 この薬剤容器は、締め付け片278が上記した薬剤容器20とは異なる。したがって、締め付け状態としたとき、図18(b)で示されるように、締め付け片278と正面壁35との間に隙間279が形成される。この隙間279は、比較的大きな隙間であり、一般的な成人の指が余裕をもって入る程度の大きさとしている。
 詳細には、締め付け状態とした締め付け片278を平面視したとき、締め付け片278の正面壁35側の縁部分のうち、半分以上の部分が正面壁35から離れた位置に配される。また、図18(b)の右図で示すように、隙間279は、締め付け片278の自由端側(図18の上側)が最も広く、同基端側(図18の下側)に向かうにつれて狭くなる。
 以上のことから、使用者が隙間279に指を挿入して締め付け片278を姿勢変更することで、締め付け状態(ロック状態)の解除が可能となる。
However, instead of the drug container 20 described above, as shown in FIG. 18(b), a drug container that assumes that the tightened state (locked state) is manually released may be employed.
This medicament container differs from the medicament container 20 described above in that a clamping piece 278 is provided. Therefore, in the tightened state, a gap 279 is formed between the tightening piece 278 and the front wall 35 as shown in FIG. 18(b). This gap 279 is a relatively large gap, and is of a size that a general adult's finger can easily enter.
More specifically, when the clamping piece 278 in the clamped state is viewed from above, half or more of the edge portion of the clamping piece 278 on the side of the front wall 35 is located away from the front wall 35 . 18(b), the gap 279 is widest on the free end side of the tightening piece 278 (upper side in FIG. 18), and gradually increases toward the base end side (lower side in FIG. 18). narrow.
As described above, the tightened state (locked state) can be released by the user inserting a finger into the gap 279 to change the posture of the tightening piece 278 .
 仕切り板68(仕切り部材)は、帯状の板を折り曲げて成形されたものであり、図15の様に、接壁部141、142と大傾斜部143と、小傾斜部145と、水平部146を有している。
 仕切り板68(仕切り部材)は、中央部に水平部146あり、その両脇に大傾斜部143と小傾斜部145が形成され、さらにその両脇に接壁部141、142が形成されたものである。
The partition plate 68 (partition member) is formed by bending a belt-like plate, and as shown in FIG. have.
The partition plate 68 (partition member) has a horizontal portion 146 in the central portion, a large inclined portion 143 and a small inclined portion 145 formed on both sides thereof, and contact wall portions 141 and 142 formed on both sides thereof. is.
 水平部146は、容器本体70に設置された際に水平姿勢となるものであり、小孔(開口)146が多数設けられている。本実施形態で採用する小孔(開口)146は、容器本体70の幅W方向にのびるスリット状である。
 大傾斜部143と小傾斜部145は、容器本体70に設置された際に水平部146に向かって傾斜する姿勢となる部位であり、大傾斜部143は、小傾斜部145に比べて長い。傾斜部143、145の傾斜角度は、同等である。
 接壁部141、142は、容器本体70に設置された際に垂直姿勢となる部位である。
The horizontal portion 146 assumes a horizontal posture when installed in the container body 70, and is provided with a large number of small holes (openings) 146. As shown in FIG. The small hole (opening) 146 employed in this embodiment has a slit shape extending in the width W direction of the container body 70 .
The large inclined portion 143 and the small inclined portion 145 are portions inclined toward the horizontal portion 146 when installed on the container body 70 , and the large inclined portion 143 is longer than the small inclined portion 145 . The inclination angles of the inclined portions 143 and 145 are the same.
The contact wall portions 141 and 142 are portions that assume a vertical posture when installed on the container body 70 .
 整流部材72は、コイル状の部材である。 The rectifying member 72 is a coil-shaped member.
 シャッター構造部73は、図19に示すように、ガイド部材90と、シャッター部材91(開閉部材)と、伝動部材92及び付勢部材93によって構成されている。
 ガイド部材90は、側面形状が凹形の部材であり、上部側水平壁95と、下部側水平壁96と、両者を繋ぐ奥壁97を有している。
The shutter structure 73 is composed of a guide member 90, a shutter member 91 (opening/closing member), a transmission member 92, and a biasing member 93, as shown in FIG.
The guide member 90 is a member having a concave side surface, and has an upper horizontal wall 95, a lower horizontal wall 96, and a back wall 97 connecting the two.
 シャッター部材91は、図19、図20、図21の様に、閉鎖壁110と、ガイド壁部111と、連結壁112と、ストッパ壁113を有している。また、閉鎖壁110の上側となる位置にシール部材(パッキン)が取り付けられる。
 閉鎖壁110は、取り付けられた状態では水平姿勢となるものである。閉鎖壁110は、斜辺138を有している。
 ガイド壁部111は、閉鎖壁110に対して平行となる壁面である。連結壁112は、ガイド壁部111と閉鎖壁110を接続する垂直壁である。
 閉鎖壁110と連結壁112とガイド壁部111によって凹形が形成されている。
 ストッパ壁113は、ガイド壁部111の自由端側から垂直に立ち上がる小壁である。  
The shutter member 91 has a closing wall 110, a guide wall portion 111, a connecting wall 112, and a stopper wall 113, as shown in FIGS. A sealing member (packing) is attached to a position above the closing wall 110 .
The closing wall 110 assumes a horizontal position when installed. Closing wall 110 has a hypotenuse 138 .
The guide wall portion 111 is a wall surface parallel to the closing wall 110 . The connecting wall 112 is a vertical wall that connects the guide wall portion 111 and the closing wall 110 .
A concave shape is formed by the closing wall 110 , the connecting wall 112 and the guide wall portion 111 .
The stopper wall 113 is a small wall vertically rising from the free end side of the guide wall portion 111 .
 伝動部材92は、スティック状の部材である。本実施形態では、細長い金属板によって作られている。
 伝動部材92の一端には、シャッター側取り付け部118が設けられている。伝動部材92の他端には、切り欠き部115があり、切り欠き部115よりも先の部分が係合部116となっている。
 伝動部材92は、シャッター側取り付け部118がシャッター部材91に取り付けられており、シャッター部材91と一体となっている。
The transmission member 92 is a stick-shaped member. In this embodiment, it is made of an elongated metal plate.
A shutter-side mounting portion 118 is provided at one end of the transmission member 92 . A notch portion 115 is provided at the other end of the transmission member 92 , and a portion ahead of the notch portion 115 serves as an engaging portion 116 .
The transmission member 92 is integrated with the shutter member 91 by attaching the shutter side attachment portion 118 to the shutter member 91 .
 付勢部材93は、ばねである。 The biasing member 93 is a spring.
 仕切り板68(仕切り部材)と、整流部材72は、容器本体70内に収容されている。シャッター構造部73は、大部分が容器本体70内にあり、伝動部材92だけが容器本体70の外面に沿ってのびている。 The partition plate 68 (partition member) and the rectifying member 72 are housed inside the container body 70 . The shutter structure 73 is mostly inside the container body 70 and only the transmission member 92 extends along the outer surface of the container body 70 .
 仕切り板68(仕切り部材)は、接壁部142が、容器本体70の正面壁35の内側に固定され、接壁部141が容器本体70の背面壁36の内側に固定された状態で、容器本体70に固定されている。
 仕切り板68(仕切り部材)の傾斜部143、145と、水平部146は、あたかも容器本体70の正面壁35と背面壁36のから吊り下げられた状態となっている。仕切り板68(仕切り部材)の大傾斜部143は、正面壁35から容器本体70の中心に至る位置にある。
 水平部146は、容器本体70の底面壁40の近傍にあるが、底面壁40とは接しておらず、両者の間に散薬が通過する散薬通路117が形成されている。
The partition plate 68 (partition member) is configured such that the contact wall portion 142 is fixed inside the front wall 35 of the container body 70 and the contact wall portion 141 is fixed inside the rear wall 36 of the container body 70, and the container It is fixed to the body 70 .
The inclined portions 143 and 145 and the horizontal portion 146 of the partition plate 68 (partition member) are suspended from the front wall 35 and the rear wall 36 of the container body 70 as if they were suspended therefrom. The large inclined portion 143 of the partition plate 68 (partition member) is located from the front wall 35 to the center of the container body 70 .
The horizontal portion 146 is in the vicinity of the bottom wall 40 of the container body 70, but is not in contact with the bottom wall 40, and a powdered drug passage 117 is formed between the two through which the powdered drug passes.
 シャッター構造部73は、大傾斜部143の下部側に収容されている。
 シャッター構造部73のガイド部材90は、奥壁97を背面壁36側に向けた姿勢で配置されている。
 シャッター部材91は閉鎖壁110と連結壁112とガイド壁部111によって構成される凹形部分が、ガイド部材90の凹部と噛み合う様な姿勢となっている。即ち、シャッター部材91のガイド壁部111の下面が、ガイド部材90の下部側水平壁96と接している。
 またシャッター部材91の閉鎖壁110は、容器本体70の底面壁40の外側と接している。
The shutter structure portion 73 is accommodated on the lower side of the large inclined portion 143 .
The guide member 90 of the shutter structure 73 is arranged with the back wall 97 facing the rear wall 36 side.
The shutter member 91 is oriented such that a concave portion formed by the closing wall 110 , the connecting wall 112 and the guide wall portion 111 is engaged with the concave portion of the guide member 90 . That is, the lower surface of the guide wall portion 111 of the shutter member 91 is in contact with the lower horizontal wall 96 of the guide member 90 .
Also, the closing wall 110 of the shutter member 91 is in contact with the outside of the bottom wall 40 of the container body 70 .
 付勢部材93は、容器本体70の正面壁35の内面と、シャッター部材91のストッパ壁113の間にあり、シャッター部材91をガイド部材90の奥壁97に向かって付勢している。
 伝動部材92は、図21に示すように、前記した様に容器本体70の外にあり、側面壁に沿って背面壁36側にのびている。
The biasing member 93 is located between the inner surface of the front wall 35 of the container body 70 and the stopper wall 113 of the shutter member 91 and biases the shutter member 91 toward the inner wall 97 of the guide member 90 .
As shown in FIG. 21, the transmission member 92 is located outside the container body 70 as described above and extends along the side wall toward the rear wall 36 side.
 伝動部材92は、シャッター部材91と一体であり、伝動部材92を容器本体70の前後方向に摺動させると、シャッター部材91も直線移動する。
 シャッター部材91は、凹部がガイド部材90と、容器本体70に接しており、これらに規制されて直線移動する。
 伝動部材92が、最も背面壁36側にある際は、シャッター部材91の閉鎖壁110が、容器本体70の下部の欠落部77を覆い、散薬が排出される開口部であるところの当該欠落部77を封鎖する。
 伝動部材92が、最も正面壁35側にある際は、シャッター部材91の閉鎖壁110が、容器本体70の下部の欠落部77の傾斜辺(背面壁36側の斜辺)を離れ、容器本体70の下部が開く。
 ここで、容器本体70の欠落部77の開口端(欠落部77の底面壁40の正面壁35側の部位)は、傾斜であり、シャッター部材91の自由端も傾斜辺138であるから、散薬排出部11となる開口は、図24(a)(b)の様な斜め姿勢のスリット148となる。
 本実施形態の薬剤フィーダ5は、スリット148の幅の開き具合を調整可能であり、制御装置(図示しない)からの信号に基づいて開き具合の変更(開き具合を調整する制御)が可能となっている。この制御は、伝動部材92の移動距離の制御でもある。なお、スリット148の開き具合は、薬剤容器20から排出させる薬剤の種類(散薬の種類であり、流れ易さや粒径等)や、薬剤の排出量に応じて(基づいて)変更してもよい。
 シャッター部材91は、付勢部材93によって散薬排出部11が閉じる方向に押圧されており、伝動部材92を正面壁35側に移動させることによって散薬排出部11が開く。
The transmission member 92 is integrated with the shutter member 91 , and when the transmission member 92 is slid in the front-rear direction of the container body 70 , the shutter member 91 also linearly moves.
The recessed portion of the shutter member 91 is in contact with the guide member 90 and the container body 70, and is restricted by these to move linearly.
When the transmission member 92 is located closest to the rear wall 36, the closing wall 110 of the shutter member 91 covers the missing portion 77 in the lower portion of the container body 70 and closes the missing portion, which is the opening through which the powdered medicine is discharged. Block 77.
When the transmission member 92 is closest to the front wall 35 side, the closing wall 110 of the shutter member 91 leaves the inclined side of the missing portion 77 in the lower portion of the container body 70 (the oblique side on the side of the back wall 36 ). opens at the bottom.
Here, the opening end of the missing portion 77 of the container body 70 (the portion of the missing portion 77 on the front wall 35 side of the bottom wall 40) is inclined, and the free end of the shutter member 91 is also an inclined side 138, so that the powdered medicine The opening that serves as the discharge portion 11 is a slit 148 in an oblique posture as shown in FIGS. 24(a) and 24(b).
The drug feeder 5 of this embodiment can adjust the degree of opening of the width of the slit 148, and the degree of opening can be changed (control to adjust the degree of opening) based on a signal from a control device (not shown). ing. This control is also control of the moving distance of the transmission member 92 . The degree of opening of the slit 148 may be changed according to (based on) the type of drug to be discharged from the drug container 20 (the type of powdered drug, flowability, particle size, etc.) and the discharge amount of the drug. .
The shutter member 91 is pressed by a biasing member 93 in a direction in which the powdered medicine discharge portion 11 is closed, and the powdered medicine discharge portion 11 is opened by moving the transmission member 92 toward the front wall 35 side.
 次に、薬剤フィーダ5と分配皿6との位置関係について説明する。
 薬剤フィーダ5は、図2の様に、分配皿6の周囲に複数個並べて設置されている。
 薬剤フィーダ5は、いずれも分配皿6に対して法線方向に向いている。
 本実施形態の薬剤フィーダ5は、幅が狭いので狭い領域に多数配置することができる。このため、多数、分配皿6の周囲に並べることができる。本実施形態では、分配皿6の手前側半周部分に、薬剤フィーダ5が6個、放射状に並べられている。
 本実施形態の薬剤フィーダ5は、薬剤容器20の背面壁36をフィーダ本体10の振動側垂直壁部33で片持ち状に支持するものであるから、薬剤容器20の多くの部分は、フィーダ本体10から片持ち状に突出する。
 そして図22、図23の様に、薬剤容器20の正面壁35側に設けられた散薬排出部11の位置が、分配皿6の薬剤投入溝13の真上の位置となる。
Next, the positional relationship between the medicine feeder 5 and the distribution tray 6 will be explained.
A plurality of drug feeders 5 are arranged side by side around the distribution tray 6 as shown in FIG.
The drug feeders 5 are all oriented normal to the distribution dish 6 .
Since the drug feeder 5 of this embodiment has a narrow width, a large number of drug feeders can be arranged in a narrow area. Therefore, a large number of them can be arranged around the distribution plate 6. - 特許庁In this embodiment, six drug feeders 5 are radially arranged in the front half circumference portion of the distribution plate 6 .
Since the drug feeder 5 of this embodiment supports the back wall 36 of the drug container 20 in a cantilever manner with the vibration-side vertical wall portion 33 of the feeder main body 10, most of the drug container 20 is supported by the feeder main body. It protrudes from 10 in a cantilevered manner.
As shown in FIGS. 22 and 23, the position of the powdered medicine discharge portion 11 provided on the front wall 35 side of the medicine container 20 is the position right above the medicine introduction groove 13 of the distribution plate 6 .
 本実施形態の薬剤フィーダ5は、散薬排出部11の形状がスリット状であり、且つ薬剤容器20に対して傾斜している。そのため、散薬排出部11は、図22、図23の様に、薬剤投入溝13の幅A方向に広がりがある。 In the medicine feeder 5 of this embodiment, the powdered medicine discharge part 11 has a slit shape and is inclined with respect to the medicine container 20 . 22 and 23, the powdered medicine discharge part 11 spreads in the width A direction of the medicine feeding groove 13. As shown in FIGS.
 次に、薬剤フィーダ5の動作について説明する。
 本実施形態の薬剤払出し装置1では、前記した様に、あらかじめ各薬剤フィーダ5の薬剤容器20に異なる薬剤が充填されている。
 散薬の充填時には、薬剤容器20をフィーダ本体10から取り外し、図16の様に薬剤容器20を平置きにする。そして蓋部材75を開き、薬剤容器20の大面積側側面61側
から散薬を充填する。
 その後、蓋部材75を閉じて薬剤容器20内を密閉状態とする。
Next, the operation of drug feeder 5 will be described.
In the medicine dispensing device 1 of this embodiment, as described above, the medicine container 20 of each medicine feeder 5 is filled with different medicines in advance.
When filling the powder medicine, the medicine container 20 is removed from the feeder main body 10, and the medicine container 20 is laid flat as shown in FIG. Then, the cover member 75 is opened, and powdered medicine is filled from the large-area side surface 61 side of the medicine container 20 .
After that, the lid member 75 is closed to make the inside of the drug container 20 hermetically sealed.
 続いて、図13の様に薬剤容器20をフィーダ本体10に装着する。
 その際、フィーダ本体10は、図13(a)の様に待機状態となっている。具体的には、フィーダ本体10の出し入れ機構が収納姿勢となっており、振動側垂直壁部33の係合片50は開口51内に没入している。
 またシャッター開閉機構55は、アーム57が振動側垂直壁部33側に引き寄せられており、係合片保持部56は、振動側垂直壁部33の近傍にある。
 一方、薬剤容器20は、伝動部材92を背面壁36側に引き、容器本体70の下部の開口を封鎖しておく。
Subsequently, the drug container 20 is attached to the feeder main body 10 as shown in FIG.
At that time, the feeder main body 10 is in a standby state as shown in FIG. 13(a). Specifically, the loading/unloading mechanism of the feeder main body 10 is in the retracted posture, and the engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51 .
The arm 57 of the shutter opening/closing mechanism 55 is drawn toward the vibration-side vertical wall portion 33 , and the engagement piece holding portion 56 is located near the vibration-side vertical wall portion 33 .
On the other hand, the drug container 20 pulls the transmission member 92 toward the rear wall 36 to block the opening at the bottom of the container body 70 .
 この状態で、図13(a)の様に薬剤容器20の背面壁36をフィーダ本体10の振動側垂直壁部33に沿って上部から差し込む。
 ここで、振動側垂直壁部33には、台形の係合部47があり、当該台形形状の斜辺に相当する辺に、あり溝状の係合部(保持部側係合部)48がある。一方、容器本体70の背面壁36には、一対の係合溝130がある。
 そのため、薬剤容器20の背面壁36をフィーダ本体10の振動側垂直壁部33に沿って上部から差し込むことにより、容器本体70の係合溝130を、振動側垂直壁部33の係合部48に係合させることができる。
 なおこのとき、振動側垂直壁部33の係合片50は開口51内に没入しているから、薬剤容器20を差し込む際の障害とはならない。
In this state, the back wall 36 of the drug container 20 is inserted from above along the vibration-side vertical wall portion 33 of the feeder main body 10 as shown in FIG. 13(a).
Here, the vibration-side vertical wall portion 33 has a trapezoidal engaging portion 47, and a dovetail-shaped engaging portion (holding portion-side engaging portion) 48 is provided on a side corresponding to the oblique side of the trapezoidal shape. . On the other hand, the rear wall 36 of the container body 70 has a pair of engaging grooves 130 .
Therefore, by inserting the rear wall 36 of the drug container 20 from above along the vibration-side vertical wall portion 33 of the feeder body 10 , the engagement groove 130 of the container body 70 is engaged with the engagement portion 48 of the vibration-side vertical wall portion 33 . can be engaged.
At this time, since the engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51, it does not interfere with inserting the drug container 20. As shown in FIG.
 またこのとき、図13(b)の様に伝動部材92の係合部116をフィーダ本体10の係合片保持部56と係合させる。ここで、本実施形態では、薬剤容器20を装着するとき、上記したように、あり溝状の係合部48が薬剤容器20の移動方向を規制するガイドとして機能する。このため、薬剤容器20を係合部48に沿って移動させるだけで、薬剤容器20の装着が可能であり、且つ、伝動部材92の係合部116と係合片保持部56の係合が可能となる。つまり、伝動部材92の係合部116と係合片保持部56を係合させるために細かな位置合わせをすることなく(係合させるための作業を意識することなく)、薬剤容器20を装着するだけで自然に係合させることが可能となる。
 そして前記した様に、処方箋に基づき、特定の薬剤フィーダ5が選択されて駆動される。ここで、本実施形態では、選択された薬剤フィーダ5は、出し入れ機構が突出姿勢となり、図13(c)の様に、振動側垂直壁部33の係合片50が開口51から突出する。その結果、振動側垂直壁部33の係合片50が、薬剤容器20の背面壁36の係合凹部131と係合し、薬剤容器20が振動部材16に強固に固定される。
 また出し入れ機構が突出姿勢となることにより、図13(c)の様に、係合片保持部56が正面壁35側に移動し、伝動部材92が前方に摺動して、シャッター部材91を移動させ、容器本体70の下部の散薬排出部11が開く。
At this time, the engaging portion 116 of the transmission member 92 is engaged with the engaging piece holding portion 56 of the feeder body 10 as shown in FIG. 13(b). Here, in this embodiment, when the drug container 20 is attached, the dovetail groove-shaped engaging portion 48 functions as a guide for regulating the moving direction of the drug container 20 as described above. Therefore, the drug container 20 can be attached only by moving the drug container 20 along the engaging portion 48, and the engagement between the engaging portion 116 of the transmission member 92 and the engaging piece holding portion 56 can be achieved. It becomes possible. In other words, the drug container 20 is mounted without performing fine positioning for engaging the engaging portion 116 of the transmission member 92 and the engaging piece holding portion 56 (without being conscious of the work for engaging). It becomes possible to engage naturally only by doing.
Then, as described above, a specific drug feeder 5 is selected and driven based on the prescription. Here, in the present embodiment, the selected drug feeder 5 has the loading/unloading mechanism in a protruding posture, and the engaging piece 50 of the vibration-side vertical wall portion 33 protrudes from the opening 51 as shown in FIG. 13(c). As a result, the engagement piece 50 of the vibration-side vertical wall portion 33 engages with the engagement recess 131 of the back wall 36 of the medicine container 20 , and the medicine container 20 is firmly fixed to the vibration member 16 .
13(c), the engagement piece holding portion 56 moves toward the front wall 35, the transmission member 92 slides forward, and the shutter member 91 moves forward. It is moved to open the powdered medicine discharge part 11 at the bottom of the container body 70 .
 続いて振動部材16の振動を開始し、前記した様に、薬剤容器20が共に振動する。ここで、本実施形態では、薬剤容器20は、二か所に設けられた係合部によって強固に振動部材16に接合されており、且つ振動部材16との密着度合いも高いから、薬剤容器20は、振動部材16と同一周波数で振動する。
 本実施形態の薬剤容器20では、内部に仕切り板68(仕切り部材)が設けられており、容器本体70の中が上下に仕切られている。そして、仕切り板68の下部に、散薬が通過する空間(散薬通路117)が確保されている。
 そのため、散薬通路117内の散薬に、上部側の散薬の重量が掛かりにくく、散薬が動きやすい。
Subsequently, the vibrating member 16 starts to vibrate, and the drug container 20 vibrates together as described above. Here, in this embodiment, the drug container 20 is firmly joined to the vibrating member 16 by the engaging portions provided at two locations, and the degree of close contact with the vibrating member 16 is high. vibrates at the same frequency as the vibrating member 16 .
A partition plate 68 (partition member) is provided inside the drug container 20 of the present embodiment, and the inside of the container body 70 is partitioned vertically. A space (powder medicine passage 117 ) through which the powder medicine passes is secured in the lower part of the partition plate 68 .
Therefore, the powdered medicine in the powdered medicine passage 117 is less likely to bear the weight of the powdered medicine on the upper side, and the powdered medicine moves easily.
 本実施形態の薬剤容器20は、幅が狭いので、散薬を収容する容積を確保する必要から、高さが高い。散薬に掛かる圧力は、高さと相関する関数であり、散薬の積み重ね高さが高いほど下部側の散薬は、強い力で押し付けられる。
 そのため、仕切り板68(仕切り部材)が無ければ、底面壁40の近傍の散薬は、上部の散薬に押し付けられて固まり、動きが悪くなる懸念がある。
 本実施形態では、上部側の散薬の重量を、仕切り板68で支持するので、底面壁40の近傍の散薬が押し付けられず、振動による流れが円滑である。さらには、散薬の排出動作の際に薬剤容器20を振動させることで、薬剤容器20内の散薬は、仕切り板68(水平部146)の上側の空間である貯留空間内で攪拌される。この際、貯留された散薬の一部が大傾斜部143を上る方向に移動し、水平部146よりも上方向で、水平部146側へと移動することとなる。このため、水平部146の小孔(スリット)上において、散薬による上方から下方に押し付ける力が掛かり難く、攪拌によって流れる散薬が適切に小孔(スリット)から落下するので、散薬の円滑な排出が可能となる。
 散薬通路117内の散薬が不足すると、水平部146に設けられた小孔147から散薬通路117に散薬が落下し、散薬が散薬通路117に補充される。
Since the drug container 20 of the present embodiment has a narrow width, it is necessary to secure a volume for accommodating the powdered drug, so the height is high. The pressure applied to the powdered medicine is a function that correlates with the height of the powdered medicine.
Therefore, without the partition plate 68 (partition member), the powdered medicine in the vicinity of the bottom wall 40 is pressed against the powdered medicine on the upper side, and there is a concern that the movement of the powdered medicine may become difficult.
In this embodiment, since the weight of the powdered medicine on the upper side is supported by the partition plate 68, the powdered medicine in the vicinity of the bottom wall 40 is not pressed, and the flow due to vibration is smooth. Furthermore, by vibrating the drug container 20 during the discharge operation of the powdered drug, the powdered drug in the drug container 20 is agitated in the storage space above the partition plate 68 (horizontal portion 146). At this time, part of the stored powdered medicine moves upward on the large inclined portion 143 and moves upward from the horizontal portion 146 toward the horizontal portion 146 . For this reason, on the small holes (slits) of the horizontal portion 146, the force of the powdered medicine that presses downward from above is less likely to be applied, and the powdered medicine flowing by stirring appropriately falls from the small holes (slits), so that the powdered medicine can be discharged smoothly. It becomes possible.
When the powdered medicine in the powdered medicine passageway 117 runs short, the powdered medicine falls into the powdered medicine passageway 117 from a small hole 147 provided in the horizontal portion 146, and the powdered medicine passageway 117 is replenished with the powdered medicine.
 また本実施形態では、散薬通路117への散薬の補充は、水平部146からのみ行われる。水平部146は、水平方向には、正面壁35よりも背面壁36に近い位置にあり、排出部から離れている。
 また水平部146と正面壁35との間には、大傾斜部143があるので、散薬の進行方向の前側は、空間がより広くなっている。具体的には、空間の高さが高くなっている。そのため、散薬通路117を流れる散薬の上に空間ができる。そのため散薬は、散薬通路117を進むうちに散薬の流れが整流され、層流化が進み、高度に層流化する。
Further, in this embodiment, replenishment of the powdered medicine to the powdered medicine passage 117 is performed only from the horizontal portion 146 . The horizontal portion 146 is horizontally closer to the rear wall 36 than to the front wall 35 and away from the discharge portion.
Further, since there is a large inclined portion 143 between the horizontal portion 146 and the front wall 35, the front side in the advancing direction of the powder medicine has a wider space. Specifically, the height of the space is increased. Therefore, a space is created above the powdered medicine flowing through the powdered medicine passage 117 . Therefore, as the powdered medicine advances through the powdered medicine passage 117, the flow of the powdered medicine is rectified, laminarization progresses, and the laminarization is advanced.
 また本実施形態では、散薬通路117内の散薬が散薬排出部11側に向かって進む際、整流部材72を通過し、コイルの線の隙間を通る。そのため薬剤の流れが平滑化する。
 散薬は、シャッター部材91の散薬排出部11から落下し、下の分配皿6の薬剤投入溝13に入る。
Further, in this embodiment, when the powdered medicine in the powdered medicine passage 117 advances toward the powdered medicine discharge section 11 side, it passes through the rectifying member 72 and passes through the gaps between the wires of the coil. Therefore, the drug flow is smoothed.
The powdered medicine drops from the powdered medicine discharging portion 11 of the shutter member 91 and enters the medicine feeding groove 13 of the distribution tray 6 below.
 また本実施形態では、閉鎖壁110端面に傾斜辺138を有する構成とすることにより、有効な開度を調節することができる。
 即ち、本実施形態の薬剤フィーダ5は、散薬排出部11の形状がスリット状であり、且つ容器本体70に対して傾斜している。
 そのため、前記した様に散薬排出部11は、薬剤投入溝13の幅A方向に広がりがある。散薬は、薬剤投入溝13の幅A方向に広がりをもって落下するから、薬剤投入溝13の幅A方向にまんべんなく落下する。
 そのため、後の工程で散薬をかき寄せる際に、かき寄せた散薬の集合が崩れにくい。
Further, in this embodiment, the effective opening degree can be adjusted by providing the inclined side 138 at the end face of the closing wall 110 .
That is, in the medicine feeder 5 of this embodiment, the shape of the powdered medicine discharge part 11 is slit-shaped and inclined with respect to the container body 70 .
Therefore, as described above, the powdered medicine discharge portion 11 is widened in the width A direction of the medicine introduction groove 13 . Since the powdered medicine spreads in the direction of the width A of the medicine feeding groove 13 and falls, it falls evenly in the direction of the width A of the medicine feeding groove 13 .
Therefore, when the powdered medicine is collected in a later step, the gathered powdered medicine is less likely to collapse.
 また容器本体70の欠落部77の端部の傾斜は、急傾斜部150と緩傾斜部151が組み合わされたものとなっている。
 そのため図24(a)の様に、閉鎖壁110の移動量を大きくすると、底面壁40の全幅から散薬を落下させることができる(図23(a)参照)。
 これに対して、図24(b)の様に、閉鎖壁110の移動量が少ないと、閉鎖壁110の急傾斜部150と底面壁40の斜辺との間だけが開口するので、有効な開口幅が狭くなる(図23(b)参照)。
 散薬を大量に排出する必要がある場合には、図23(a)、図24(a)の様に、閉鎖壁110の移動量を大きくして底面壁40の全幅から散薬を落下させ、散薬の排出量が少ない場合には、、図23(b)、図24(b)の様に閉鎖壁110の移動量を少なくして狭い幅から散薬を落下させる。
Further, the slope of the end of the cutout portion 77 of the container body 70 is a combination of a steep slope portion 150 and a gentle slope portion 151 .
Therefore, as shown in FIG. 24(a), by increasing the amount of movement of the closing wall 110, the powder can be dropped from the entire width of the bottom wall 40 (see FIG. 23(a)).
On the other hand, when the amount of movement of the closing wall 110 is small as shown in FIG. The width becomes narrow (see FIG. 23(b)).
When it is necessary to discharge a large amount of powdered medicine, as shown in FIGS. 23(b) and 24(b), the amount of movement of the closing wall 110 is reduced to drop the powdered medicine from a narrow width.
 所定量の散薬が排出されると振動部材16の振動を停止する。
 その後、フィーダ本体10の出し入れ機構を引き込み側に動作させる。その結果、係合片保持部56が背面壁36側に移動し、伝動部材92が後方に摺動して、シャッター部材91を移動させ、容器本体70の下部の開口が閉じる。
 同時に、フィーダ本体10の出し入れ機構が収納姿勢となり、振動側垂直壁部33の係合片50が、薬剤容器20の係合凹部131から離脱する。
When a predetermined amount of powdered medicine is discharged, the vibration of the vibrating member 16 is stopped.
After that, the loading/unloading mechanism of the feeder main body 10 is operated to the retraction side. As a result, the engagement piece holding portion 56 moves toward the rear wall 36, the transmission member 92 slides rearward, the shutter member 91 moves, and the opening at the bottom of the container body 70 closes.
At the same time, the loading/unloading mechanism of the feeder main body 10 assumes the retracted posture, and the engagement piece 50 of the vibration-side vertical wall portion 33 disengages from the engagement concave portion 131 of the medicine container 20 .
 以下、本発明の他の実施形態について説明する。 Other embodiments of the present invention will be described below.
 上記した実施形態における薬剤容器20の内部空間の底部分(底面)、即ち、散薬排出部11と連なる散薬通路117(図15、図16等参照)の底部分(底面)を傾斜させてもよい。例えば、底面は、薬剤容器20の幅方向の片側に向かうにつれて高さが低くなるように傾斜させた傾斜面であってもよい。つまり、2つの左右側面壁37の一方側から他方側に向かうにつれて低くなるように傾斜させた傾斜面であり、例えば、蓋部材75を閉じた状態で、蓋部材75側に向かうにつれて下り勾配となるように形成してもよい。
 このような構造によると、散薬を排出させる際、散薬が薬剤容器20の幅方向の片側に集まり易くなるため、散薬を少量排出させる場合であっても正確且つ安定した排出が可能となる。
 なお、この底面を散薬排出部11に向かって下り勾配となるように形成することも考えられる。即ち、平面視で幅方向と直交する方向において、一方端側から他方端側に向かうにつれて下り勾配となるように形成することも考えられる。
The bottom portion (bottom surface) of the internal space of the drug container 20 in the above-described embodiment, that is, the bottom portion (bottom surface) of the powdered medicine passage 117 (see FIGS. 15 and 16) connected to the powdered medicine discharge portion 11 may be inclined. . For example, the bottom surface may be an inclined surface that is inclined so that the height decreases toward one side in the width direction of the drug container 20 . That is, the two left and right side walls 37 are sloped surfaces that are inclined so as to become lower from one side to the other side. It may be formed to be
According to such a structure, when discharging the powdered medicine, the powdered medicine tends to gather on one side in the width direction of the medicine container 20, so that even when discharging a small amount of the powdered medicine, accurate and stable discharge is possible.
It is also conceivable to form the bottom surface so as to slope downward toward the powdered medicine discharge portion 11 . That is, in a direction perpendicular to the width direction in a plan view, it may be formed so as to have a downward slope from one end side to the other end side.
 上記したシャッター部材91は、図25で示されるような、シール部材250を取り付けてもよい。シール部材250は、立板状の取付片部251と、取付片部251の一主面から外側に突出する平板部280とを有しており、これらが一体に形成されている。
 取付片部251は、図25(c)で示されるように、斜め方向に延びている。なお、斜め方向とは、平面視において、上記した薬剤容器20の幅方向(図25(c)の左右方向)と、排出時における散薬の流れ方向(図25(c)の上下方向)のそれぞれと傾斜する方向となる。
The shutter member 91 described above may be fitted with a seal member 250 as shown in FIG. The seal member 250 has an upright plate-like mounting piece portion 251 and a flat plate portion 280 projecting outward from one main surface of the mounting piece portion 251, which are integrally formed.
The attachment piece 251 extends obliquely as shown in FIG. 25(c). Note that the oblique directions refer to the width direction of the drug container 20 (horizontal direction in FIG. 25(c)) and the flow direction of the powdered medicine during discharge (vertical direction in FIG. 25(c)) in plan view. and the direction of inclination.
 平板部280は、薬剤容器20の幅方向(図25(c)の左右方向)において、片側から他方側に向かって第一突出片部260、第二突出片部261、第三突出片部262に区画されている。
 なお、以下のシール部材250の説明において、薬剤容器20の幅方向(図25(c)の左右方向)を左右方向とも称し、散薬の流れ方向(図25(c)の上下方向)を前後方向とも称す。このとき、図25(c)の下方を前方とする。
The flat plate portion 280 has a first protruding piece portion 260, a second protruding piece portion 261, and a third protruding piece portion 262 from one side to the other side in the width direction of the medicine container 20 (left and right direction in FIG. 25(c)). are divided into
In the following description of the sealing member 250, the width direction of the drug container 20 (horizontal direction in FIG. 25(c)) is also referred to as the lateral direction, and the flow direction of the powder medicine (vertical direction in FIG. 25(c)) is referred to as the front-rear direction. Also called At this time, let the downward direction of FIG.25(c) be the front.
 第一突出片部260、第二突出片部261、第三突出片部262は、取付片部251からの突出長さであり、取付片部251の主面と直交する方向(図25(c)の矢印Xで示す方向)における突出長さが異なる。具体的には、第一突出片部260、第二突出片部261、第三突出片部262の順で突出長さが長くなっている。
 このため、第一突出片部260の突出端面と、第二突出片部261の突出端面は段差を介して連続している。そして、第二突出片部261の突出端面は、上記した取付片部251の主面と直交する方向において、第一突出片部260の突出端面よりも後方側に位置する。そして、第三突出片部262の突出端面は、同方向において、第二突出片部261の突出端面よりもさらに後方側に位置する。
The first projecting piece portion 260, the second projecting piece portion 261, and the third projecting piece portion 262 are projecting lengths from the attachment piece portion 251, and are perpendicular to the main surface of the attachment piece portion 251 (Fig. 25(c) ) in the direction indicated by the arrow X) is different. Specifically, the projection length is increased in the order of the first projecting piece portion 260, the second projecting piece portion 261, and the third projecting piece portion 262. As shown in FIG.
Therefore, the projecting end surface of the first projecting piece portion 260 and the projecting end surface of the second projecting piece portion 261 are continuous via a step. The protruding end surface of the second protruding piece portion 261 is located on the rear side of the protruding end surface of the first protruding piece portion 260 in the direction orthogonal to the main surface of the mounting piece portion 251 described above. The protruding end face of the third protruding piece portion 262 is located further rearward than the protruding end face of the second protruding piece portion 261 in the same direction.
 なお、特に限定されるものではないが、第一突出片部260の突出端の内で最も後方に位置する部分(図中P1で示す部分)と、第三突出片部262の突出端の内で最も後方に位置する部分(図中P2で示す部分)は、前後方向の位置が同じ位置となっている。
 即ち、平板部280は、平面視形状が略台形状となる板状体に対して切り欠き状の欠落部を形成し、一部を欠落させた形状となっている。
In addition, although not particularly limited, the rearmost portion of the projecting end of the first projecting piece portion 260 (the portion indicated by P1 in the figure) and the projecting end of the third projecting piece portion 262 , the rearmost portion (the portion indicated by P2 in the figure) is at the same position in the front-rear direction.
That is, the flat plate portion 280 has a shape in which a notch-shaped missing portion is formed in a plate-like body whose plan view shape is substantially trapezoidal, and a part thereof is missing.
 このシャッター部材91は、図26で示されるように、シール部材250が薬剤容器20の内部空間(散薬通路117、図15等参照)に挿入された状態で前後(図26では左右)に移動し、散薬排出部11の開閉動作を実行する。
 具体的には、図26(a)乃至図26(c)のように、シャッター部材91を移動させて閉状態と開状態を切り替えるとき、第三突出片部262の少なくとも一部が薬剤容器20の内部に常時挿入された状態で、シャッター部材91が移動する。このため、シール部材250は、シャッター部材91を移動させる際のガイドとしても機能する。
As shown in FIG. 26, the shutter member 91 moves back and forth (left and right in FIG. 26) with the sealing member 250 inserted into the internal space of the drug container 20 (powder passage 117, see FIG. 15). , the opening/closing operation of the powdered medicine discharge unit 11 is executed.
Specifically, as shown in FIGS. 26(a) to 26(c), when the shutter member 91 is moved to switch between the closed state and the open state, at least a part of the third protruding piece 262 is positioned at the drug container 20. The shutter member 91 moves in a state of being constantly inserted into the interior of the . Therefore, the seal member 250 also functions as a guide when the shutter member 91 is moved.
 例えば、図26(a)で示されるように、シャッター部材91(閉鎖壁110)の移動量を大きくし、散薬排出部11を全開状態とする。このとき、第一突出片部260、第二突出片部261が散薬排出部11から外側に離れた位置に配される一方で、第三突出片部262の一部が散薬排出部11の内側(薬剤容器20の内部)に挿入された状態となる。
 このため、散薬排出部11のうち、第一突出片部260と離間対向する部分と、第二突出片部261と離間対向する部分の双方から散薬が排出される。また、散薬排出部11を形成する開口の一部が第三突出片部262によって閉塞される。言い換えると、散薬排出部11と第一突出片部260の間の空間と、散薬排出部11と第二突出片部261の間の空間から散薬が落下することとなる。
For example, as shown in FIG. 26( a ), the amount of movement of the shutter member 91 (closing wall 110 ) is increased to fully open the powdered medicine discharge section 11 . At this time, the first protruding piece portion 260 and the second protruding piece portion 261 are arranged at a position away from the powdered medicine discharge portion 11 to the outside, while a part of the third protruding piece portion 262 is located inside the powdered medicine discharge portion 11. (inside the medicine container 20).
Therefore, the powdered medicine is discharged from both the portion facing the first projecting piece 260 and the portion facing the second projecting piece 261 in the powdered medicine discharge portion 11 . A part of the opening forming the powdered medicine discharge part 11 is blocked by the third protruding piece part 262 . In other words, the powdered medicine falls from the space between the powdered medicine discharge portion 11 and the first projecting piece portion 260 and the space between the powdered medicine discharging portion 11 and the second projecting piece portion 261 .
 対して、図26(b)で示されるように、シャッター部材91(閉鎖壁110)の移動量を少なくし、散薬排出部11をやや開いた状態とする。このとき、第一突出片部260が散薬排出部11から外側に離れた位置に配される一方で、第二突出片部261の一部と第三突出片部262の一部が散薬排出部11の内側(薬剤容器20の内部)に挿入された状態となる。
 このため、散薬排出部11のうち、第一突出片部260と離間対向する部分が内外を連通した状態となり、この部分から散薬が排出される。また、散薬排出部11を形成する開口の一部が第二突出片部261、第三突出片部262によって閉塞される。言い換えると、散薬排出部11と第一突出片部260の間の空間から散薬が落下することとなる。このように、シャッター部材91の移動量が少ない場合、散薬の排出のために有効な開口幅が小さくなる。換言すると、散薬排出部11のうちで散薬を排出するのに有効な部分の開口面積が小さくなる。
On the other hand, as shown in FIG. 26(b), the amount of movement of the shutter member 91 (closed wall 110) is reduced, and the powdered medicine discharge section 11 is slightly opened. At this time, while the first projecting piece 260 is arranged at a position away from the powdered medicine discharge part 11, part of the second projecting piece 261 and part of the third projecting piece 262 11 (inside the drug container 20).
For this reason, the portion of the powdered medicine discharge portion 11 that faces the first projecting piece portion 260 at a distance is in a state in which the inside and outside are communicated, and the powdered medicine is discharged from this portion. A part of the opening forming the powdered medicine discharge part 11 is blocked by the second protruding piece 261 and the third protruding piece 262 . In other words, the powdered medicine falls from the space between the powdered medicine discharge part 11 and the first projecting piece part 260 . As described above, when the amount of movement of the shutter member 91 is small, the width of the opening effective for ejecting the powder medicine becomes small. In other words, the opening area of the portion of the powdered medicine discharge portion 11 that is effective for discharging the powdered medicine is reduced.
 また、図26(c)で示されるように、シャッター部材91を閉状態とすると、第一突出片部260、第二突出片部261、第三突出片部262が散薬排出部11の内側(薬剤容器20の内部)に挿入された状態となる。このことにより、散薬の排出後、シャッター部材91を閉状態とすることで、散薬を散薬排出部11の付近から奥側に押し戻すことができる。 Further, as shown in FIG. 26(c), when the shutter member 91 is closed, the first protruding piece 260, the second protruding piece 261, and the third protruding piece 262 move inside the powdered medicine discharge part 11 ( inside the medicine container 20). As a result, by closing the shutter member 91 after discharging the powdered medicine, the powdered medicine can be pushed back from the vicinity of the powdered medicine discharging portion 11 to the back side.
 以上のように、本実施形態では、散薬排出部11を段階的に開口させることが可能であり、散薬を大量に排出する必要がある場合には、図26(a)の様に、閉鎖壁110の移動量を大きくして比較的広い範囲から散薬を落下させる。そして、散薬の排出量が少ない場合には、図26(a)の様に閉鎖壁110の移動量を少なくして比較的狭い範囲から散薬を落下させる。上記した実施形態では、散薬排出部11の開放度合い(開度)を2段階で調節可能な構造としたが、3段階以上となる複数段階の調節を可能してもよい。すなわい、突出片部の数を4以上としてもよい。 As described above, in this embodiment, it is possible to open the powdered medicine discharge part 11 step by step. By increasing the amount of movement of 110, powdered medicine is dropped from a relatively wide range. When the amount of the powdered medicine discharged is small, the amount of movement of the closing wall 110 is reduced as shown in FIG. 26(a) to drop the powdered medicine from a relatively narrow range. In the above-described embodiment, the opening degree (opening degree) of the powdered medicine discharge section 11 is configured to be adjustable in two stages, but it may be adjustable in a plurality of stages such as three or more stages. That is, the number of projecting pieces may be four or more.
 また、上記した散薬排出部11の開度を段階的に調節可能な構造の他、図27のように、散薬排出部11のうちで散薬の排出のために有効な部分の開口面積(開口幅)を、シャッター部材231(開閉部材)の移動量に応じて連続的に増減させる構造としてもよい。 In addition to the above-described structure in which the degree of opening of the powdered medicine discharge unit 11 can be adjusted stepwise, as shown in FIG. ) may be continuously increased or decreased according to the amount of movement of the shutter member 231 (opening/closing member).
 本実施形態のシャッター部材231は、図27で示されるように、閉鎖壁232の平面視形状(底面視形状)が上記と異なり、略四角形状(略長方形状)となっている。つまり、閉鎖壁232は、平面視において、薬剤容器の薬剤容器の幅方向に長さを有する形状であり、最も後方側(図27では左側)の辺232aは、薬剤容器の幅方向と同方向に延びる辺である。言い換えると、最も後方側の部分に直線状に延びた部分を有する。
 対して、散薬排出部11は、斜め方向に延びている。そして、底面壁40の前端部分もまた平面視で斜め方向に延びている。なお、この底面壁40の前端部分は、底面壁40と、正面壁35側の欠落部77(図19等参照)の境界部分でもある。
In the shutter member 231 of this embodiment, as shown in FIG. 27, the planar view shape (bottom view shape) of the closing wall 232 is substantially quadrangular (substantially rectangular) unlike the above. That is, the closing wall 232 has a shape having a length in the width direction of the drug container in plan view, and the side 232a on the rearmost side (left side in FIG. 27) extends in the same direction as the width direction of the drug container. is a side extending to In other words, it has a portion extending linearly at the rearmost portion.
On the other hand, the powdered medicine discharge part 11 extends obliquely. The front end portion of the bottom wall 40 also extends obliquely in plan view. The front end portion of the bottom wall 40 is also a boundary portion between the bottom wall 40 and the missing portion 77 (see FIG. 19 and the like) on the front wall 35 side.
 そして、閉鎖壁232は、図27(a)のように全開状態としたとき、平面視で底面壁40と重ならない位置に配される。つまり、閉鎖壁232の全体が散薬排出部11及び底面壁40の前端(図27では右端)よりも前方に配される。この場合、散薬排出部11の全域から散薬が排出される。即ち、平面視(底面視)で散薬排出部11と辺232aの間に位置する空間から散薬が落下する。
 図27(a)の状態からシャッター部材231が閉方向に移動すると、図27(b)で示されるように、閉鎖壁232の一部が底面壁40の下方側に位置し、底面壁40と上下方向(図27(a)では奥行方向)で重なった状態となる。このとき、平面視において、散薬排出部11の一部(底面壁40の前端部分の一部)が辺232aよりも前方に位置し、他の部分が辺232aよりも後方に位置した状態となる。
The closing wall 232 is arranged at a position that does not overlap the bottom wall 40 in a plan view when it is in a fully open state as shown in FIG. 27(a). In other words, the entire closing wall 232 is arranged forward of the front ends (the right ends in FIG. 27) of the powdered medicine discharge portion 11 and the bottom wall 40 . In this case, the powdered medicine is discharged from the whole area of the powdered medicine discharging part 11 . That is, the powdered medicine falls from the space positioned between the powdered medicine discharge part 11 and the side 232a in plan view (bottom view).
When the shutter member 231 moves in the closing direction from the state shown in FIG. 27(a), a portion of the closing wall 232 is positioned below the bottom wall 40 and closes to the bottom wall 40 as shown in FIG. 27(b). They overlap in the vertical direction (the depth direction in FIG. 27(a)). At this time, in plan view, a portion of the powdered medicine discharge portion 11 (a portion of the front end portion of the bottom wall 40) is positioned forward of the side 232a, and the other portion is positioned rearward of the side 232a. .
 この状態では、散薬排出部11のうち、辺232aよりも後方側に位置する部分が、散薬の排出のために有効な部分となる。つまり、この辺232aよりも後方側に位置する部分と、辺232aの間に位置する空間から散薬が落下する。
 このため、シャッター部材231が閉方向に移動し、底面壁40と閉鎖壁232の重なりが大きくなるにつれ、散薬の排出のために有効な部分の開口幅が小さくなる。反対に、シャッター部材231が閉方向に移動し、底面壁40と閉鎖壁232の重なり部分が小さくなるにつれ、散薬の排出のために有効な部分の開口幅が大きくなる。
 なお、全閉状態とするときには、図27(c)で示されるように、散薬排出部11及び底面壁40の前端(図27では右端)の全体が、辺232aよりも前方に配された状態となる。
In this state, the portion of the powdered medicine discharge portion 11 located on the rear side of the side 232a becomes an effective portion for discharging the powdered medicine. That is, the powdered medicine falls from the space located between the side 232a and the part located behind the side 232a.
Therefore, as the shutter member 231 moves in the closing direction and the overlap between the bottom wall 40 and the closing wall 232 increases, the width of the opening effective for discharging the powder medicine becomes smaller. Conversely, as the shutter member 231 moves in the closing direction and the overlapping portion between the bottom wall 40 and the closing wall 232 becomes smaller, the opening width of the portion effective for discharging the powder medicine becomes larger.
When the fully closed state is achieved, as shown in FIG. 27(c), the entire front ends (right ends in FIG. 27) of the powdered medicine discharge portion 11 and the bottom wall 40 are arranged forward of the side 232a. becomes.
 上記した実施形態では、シャッター部材91の閉鎖壁110は、容器本体70の底面壁40の外側と接している。また上記した実施形態では、閉鎖壁110端面の輪郭が単純な傾斜線である。
 これに対して、シャッター部材91の閉鎖壁110を、容器本体70の底面壁40の内側と接する構成としてもよい。
In the embodiment described above, the closing wall 110 of the shutter member 91 is in contact with the outside of the bottom wall 40 of the container body 70 . Also, in the embodiment described above, the contour of the end surface of the closing wall 110 is a simple slanted line.
Alternatively, the closing wall 110 of the shutter member 91 may be configured to contact the inside of the bottom wall 40 of the container body 70 .
 シャッター部材91の閉鎖壁110を、容器本体70の底面壁40の内側と接する構成とすると、閉鎖壁110を閉じたとき、シャッター部材91の端部が、薬剤容器20の底面壁40の開口近傍に至っている散薬を、奥側に押し入れる。
 そのため、次回、閉鎖壁110を開いたときに、散薬が零れ落ちることが防がれる。
If the closing wall 110 of the shutter member 91 is configured to be in contact with the inside of the bottom wall 40 of the container body 70 , when the closing wall 110 is closed, the end of the shutter member 91 will be in the vicinity of the opening of the bottom wall 40 of the drug container 20 . Push the powdered medicine that has reached to the back side.
Therefore, the next time the closing wall 110 is opened, the powdered medicine is prevented from spilling out.
 上記した実施形態では、容器本体70の下部近傍に仕切り板68(仕切り部材)を設けたが、これに加えて、あるいは仕切り板68(仕切り部材)に代えて、図28の様に、薬剤容器の高さ方向の中間部に庇状の仮受け板152を設けてもよい。
 仮受け板152を設けることにより、上部側の散薬の重量が下の散薬にかかることを防ぐことができる。
 仮受け板152に開口が設けられていてもよい。
In the above embodiment, the partition plate 68 (partition member) is provided in the vicinity of the lower portion of the container body 70. In addition to this, or in place of the partition plate 68 (partition member), as shown in FIG. An eave-like temporary receiving plate 152 may be provided in the middle portion in the height direction of the .
By providing the temporary receiving plate 152, it is possible to prevent the weight of the powdered medicine on the upper side from being applied to the powdered medicine below.
An opening may be provided in the temporary receiving plate 152 .
 容器本体70の下部近傍に設けられた仕切り板68(仕切り部材)に加えて、図29(a)の様に、容器本体70内を仕切る第二仕切160を設けてもよい。また図29(b)の様に、第二仕切160にシャッター161を設けることが推奨される。
 シャッター161は、手動で開閉されるものである。
 第二仕切160を設けることにより、散薬の先入れ・先出を促進することができる。
In addition to the partition plate 68 (partition member) provided in the vicinity of the lower portion of the container body 70, a second partition 160 for partitioning the inside of the container body 70 may be provided as shown in FIG. 29(a). It is also recommended to provide a shutter 161 on the second partition 160 as shown in FIG. 29(b).
The shutter 161 is manually opened and closed.
By providing the second compartment 160, the first-in/first-out of the powdered medicine can be facilitated.
 薬剤容器20内の散薬は、全部使いきってから新たな散薬を薬剤容器20に補充することが望ましいが、使い残りが生じてしまう場合もある。この場合には、第二仕切160の下に、残った散薬を落とし、その後にシャッター161を閉じて薬剤容器の下部と上部を仕切る。そして、上部に散薬を充填する。そしてその後に、シャッター161を開く。そうすることにより、新しい散薬は、元の散薬の上に積まれ、古いものから排出されていくこととなる。 Although it is desirable to replenish the drug container 20 with new powdered drugs after all the powdered drugs in the drug container 20 have been used up, there are cases where leftovers occur. In this case, the remaining powdered medicine is dropped under the second partition 160, and then the shutter 161 is closed to separate the lower part and the upper part of the drug container. Then, powdered medicine is filled in the upper portion. After that, the shutter 161 is opened. By doing so, the new powdered medicine is piled on top of the original powdered medicine, and the old powdered medicine is discharged first.
 第二仕切160のシャッター161を、散薬排出部11のシャッター部材91と連動させてもよい。
 例えば図30の様に、シャッター部材91と、第二仕切160のシャッター161をばね170で連結し、シャッター部材91と、第二仕切160のシャッター161を連動させる。
 連動させるばね170は、シャッター部材91を閉方向に付勢する付勢部材93のばねよりも弱いばねであることが望ましい。
 この理由は、散薬の残量が多い場合、第二仕切160のシャッター161に散薬が詰まって第二仕切160のシャッター161が閉じなくなる場合があるためである。
 第二仕切160のシャッター161は、必ずしも全閉にする必要が無い。ばね170を弱くすることにより、第二仕切160のシャッター161を半開き状態とすることができる。
The shutter 161 of the second partition 160 may be interlocked with the shutter member 91 of the powdered medicine discharge section 11 .
For example, as shown in FIG. 30, the shutter member 91 and the shutter 161 of the second partition 160 are connected by a spring 170, and the shutter member 91 and the shutter 161 of the second partition 160 are interlocked.
The interlocking spring 170 is desirably weaker than the spring of the biasing member 93 that biases the shutter member 91 in the closing direction.
The reason for this is that when the remaining amount of powdered medicine is large, the shutter 161 of the second partition 160 may be clogged with the powdered medicine and the shutter 161 of the second partition 160 may not close.
The shutter 161 of the second partition 160 does not necessarily need to be fully closed. By weakening the spring 170, the shutter 161 of the second partition 160 can be in a half-open state.
 以上説明した薬剤容器は、側面側から直接的に散薬を充填するが、散薬を充填する面は任意である。
 例えば、薬剤容器の上面側から散薬を導入してもよい。
 また図31の様に、上面側が解放された薬剤容器172を使用してもよい。例えば、一つ又は複数のフィーダ本体10に上面側が解放された薬剤容器172を装着しておく。そして、使用頻度が少ない散薬を分包する場合、当該散薬を直接的に、上部の開口から投入し、分包する。
In the drug container described above, the powdered medicine is directly filled from the side surface, but the surface on which the powdered medicine is filled is arbitrary.
For example, powdered medicine may be introduced from the top side of the medicine container.
Also, as shown in FIG. 31, a medicine container 172 with an open upper surface may be used. For example, one or a plurality of feeder bodies 10 are attached with a drug container 172 having an open top side. When powdered medicines that are used infrequently are to be packaged, the powdered medicines are directly put in through the upper opening and packaged.
 以上説明した実施形態では、散薬投入ホッパー310は、分配皿6の機材収納開口15内に設置されている。
 ここで、散薬投入ホッパー310の開口部の高さは、図32の様に分配皿6よりもわずかに低いことが望ましい。
 散薬投入ホッパー310の開口部の高さを散薬投入ホッパー310よりも低くし、且つ回転板12を比較的ゆっくり回転させることにより、散薬を散らすことなく散薬投入ホッパー310に入れることができる。
In the embodiment described above, the powdered medicine input hopper 310 is installed inside the equipment storage opening 15 of the distribution tray 6 .
Here, it is desirable that the height of the opening of the powdered medicine charging hopper 310 is slightly lower than that of the distribution plate 6 as shown in FIG.
By making the height of the opening of the powdered medicine charging hopper 310 lower than that of the powdered medicine charging hopper 310 and rotating the rotating plate 12 relatively slowly, the powdered medicine can be put into the powdered medicine charging hopper 310 without being scattered.
 上記した薬剤フィーダ5は、上記の薬剤容器20に替わって、図33で示されるような第二実施形態の薬剤容器420を採用してもよい。第二実施形態の薬剤容器420は、上記した薬剤容器20と同様に、フィーダ本体10に対して着脱可能である。つまり、上記したフィーダ本体10と共に薬剤フィーダを構成する。 The drug feeder 5 described above may employ a drug container 420 of the second embodiment as shown in FIG. 33 instead of the drug container 20 described above. The drug container 420 of the second embodiment can be attached to and detached from the feeder body 10 in the same manner as the drug container 20 described above. That is, together with the feeder main body 10 described above, a drug feeder is configured.
 この薬剤容器420もまた、小面積側側面となる正面壁435及び背面壁436と、大面積側側面となる2つの側面壁437と、天面壁438と、底面壁440に囲まれている。つまり、この薬剤容器420もまた、縦に細長い箱状の部材となっている。また、背面壁436には、上記と同様に、係合溝130と係合凹部(係合片50と係合する凹部であり、図示しない)が形成されている。
 そして、薬剤容器420は、底面壁440のうちで正面壁435の近傍となる位置に、開閉可能な散薬排出部411(図35参照)がある。また、薬剤容器420は、シャッター構造部473を有する。
This medicine container 420 is also surrounded by a front wall 435 and a rear wall 436 as small area side surfaces, two side walls 437 as large area side surfaces, a top wall 438 and a bottom wall 440 . In other words, the drug container 420 is also a vertically elongated box-shaped member. Further, the back wall 436 is formed with the engaging groove 130 and the engaging concave portion (the concave portion that engages with the engaging piece 50, not shown) in the same manner as described above.
The medicine container 420 has an openable and closable powdered medicine discharging part 411 (see FIG. 35) at a position near the front wall 435 in the bottom wall 440 . The drug container 420 also has a shutter structure portion 473 .
 シャッター構造部473は、図34(a)で示されるように、シャッター部材491(開閉部材)と、伝動部材492を有する。即ち、ガイド部材90、付勢部材93(図19等参照)を有していない点が上記した実施形態とは異なる。そして、上記した実施形態と同様に、伝動部材492が直線移動することで、シャッター部材491が移動し、散薬排出部411が開閉する。即ち、上記した実施形態と同様に、伝動部材492の背面壁436側の一部分が外部に露出した状態となっており、薬剤容器420をフィーダ本体10に保持させることで、伝動部材492がシャッター開閉機構55と係合する。 The shutter structure 473 has a shutter member 491 (opening/closing member) and a transmission member 492, as shown in FIG. 34(a). That is, it differs from the above-described embodiment in that it does not have a guide member 90 and an urging member 93 (see FIG. 19, etc.). Then, as in the above-described embodiment, the transmission member 492 linearly moves, thereby moving the shutter member 491 and opening and closing the powdered medicine discharge section 411 . That is, as in the above-described embodiment, a portion of the transmission member 492 on the side of the rear wall 436 is exposed to the outside. engage mechanism 55;
 なお、本実施形態の薬剤容器420は、伝動部材492の中途部分を保持する保持突起部525と、係止突起部526を有している。この係止突起部526は、薬剤容器420をフィーダ本体10から取り外して持ち運ぶ際に、散薬排出部411が(シャッターが)不用意に開かないように閉鎖状態を維持するロック機構を形成する部分である。
 保持突起部525は、上下それぞれから互いに近づく方向に延びる一対の突起部分である。この保持突起部525の内側に形成された溝状部分に、伝動部材492の一部が挿通されている。
 係止突起部526は、前後に位置する板ばね部材520の平板状部分と一体に形成された突起であり、2つの平板状部分の間で側面視略V字状に延びる板状の部分である。この係止突起部526は、前後の平板状部分と共に薬剤容器420の幅方向外側に片持ち状に張り出しており、平板状部分と共に弾性変形する。この係止突起部526は、伝動部材492の上方(係合部116の上方)に形成された切欠部分(係止部)と係合することで、伝動部材492の意図しない移動を規制する。
The medicine container 420 of this embodiment has a holding protrusion 525 that holds the intermediate portion of the transmission member 492 and a locking protrusion 526 . The locking protrusion 526 forms a lock mechanism that maintains the closed state so that the powdered medicine discharging part 411 (shutter) does not open accidentally when the medicine container 420 is removed from the feeder body 10 and carried. be.
The holding protrusions 525 are a pair of protrusions extending in directions approaching each other from above and below. A portion of the transmission member 492 is inserted through a groove-shaped portion formed inside the holding protrusion 525 .
The locking protrusion 526 is a protrusion formed integrally with the flat plate-like portions of the leaf spring member 520 positioned in the front and rear, and is a plate-like portion extending in a substantially V shape in a side view between the two flat plate-like portions. be. The locking protrusion 526 projects outward in the width direction of the drug container 420 in a cantilever manner together with the front and rear flat plate-like portions, and is elastically deformed together with the flat plate-like portions. The locking protrusion 526 restricts unintended movement of the transmission member 492 by engaging with a notch portion (locking portion) formed above the transmission member 492 (above the engaging portion 116).
 そして、薬剤容器420をフィーダ本体10に取り付けることで、係止突起部526と伝動部材492との係合(ロック状態)が解除され、伝動部材492が移動可能な状態となる。具体的には、薬剤容器420がフィーダ本体10に装着されることで、上記と同様に、係合片保持部56の係合部60(図13、図14等参照)と、伝動部材492の係合部116が係合する(伝動部材492の一部である係合部116よりも後方側の部分が、係合片保持部56の係合部60に上側から挿入された状態となる)。即ち、本実施形態では、この際に、係止突起部526の後側(背面壁436側)の平板状部分が、係合部60が形成されている係合片保持部56の上面により、下方から持ち上げられた状態となる。このことにより、係止突起部526と平板状部分が共にしなるように弾性変形し、係止突起部526と伝動部材492の係合が解除される。 Then, by attaching the drug container 420 to the feeder body 10, the engagement (locked state) between the locking protrusion 526 and the transmission member 492 is released, and the transmission member 492 becomes movable. Specifically, when the drug container 420 is attached to the feeder main body 10, the engaging portion 60 of the engaging piece holding portion 56 (see FIGS. 13 and 14) and the transmission member 492 are connected in the same manner as described above. Engagement portion 116 is engaged (a portion of transmission member 492 on the rear side of engagement portion 116 is inserted into engagement portion 60 of engagement piece holding portion 56 from above). . That is, in this embodiment, at this time, the flat plate-like portion on the rear side (back wall 436 side) of the locking protrusion 526 is moved by the upper surface of the engaging piece holding portion 56 on which the engaging portion 60 is formed. It will be in a state of being lifted from below. As a result, the locking protrusion 526 and the flat plate portion are elastically deformed so that the locking protrusion 526 and the transmission member 492 are disengaged.
 本実施形態の薬剤容器420は、図33で示されるように、蓋部材475が各壁のうちで天面壁438を構成している。上面が開口した箱部471に対して蓋部材475が取り付けられ、蓋部材475がヒンジ421によって揺動可能となっている。そして、蓋部材475を開状態とすることで上側から散薬の充填が可能であり、閉状態とすることで薬剤容器420を密閉することが可能である。なお、本実施形態の薬剤容器420は、フィーダ本体10に保持させた状態のまま散薬の充填が可能となる。 In the drug container 420 of this embodiment, as shown in FIG. 33, the lid member 475 constitutes the top wall 438 among the walls. A lid member 475 is attached to a box portion 471 having an open upper surface, and the lid member 475 is swingable by means of a hinge 421 . When the lid member 475 is opened, powdered medicine can be filled from above, and when it is closed, the drug container 420 can be sealed. It should be noted that the drug container 420 of the present embodiment can be filled with the powdered drug while being held by the feeder main body 10 .
 本実施形態の蓋部材475は、図35で示されるように、蓋本体部475aと小蓋部475bを有している。そして、小蓋部475bが蓋本体部475aの下側(閉状態としたときの下側)に取り付けられ、ヒンジ421によって揺動可能となっている。
 ここで、蓋部材475は、乾燥剤等を収容可能な空間である蓋内収容部527を有している。本実施形態の蓋内収容部527には、調湿剤が収納される。そして、小蓋部475bを揺動させることで蓋内収容部527の開閉が可能となる。即ち、蓋内収容部527は、蓋本体部475aと小蓋部475bの間に形成される空間である。詳細には、蓋部材475を閉状態とし、小蓋部475bを閉状態としたとき、小蓋部475bの大部分の上方に位置する空間である。
As shown in FIG. 35, the lid member 475 of this embodiment has a lid body portion 475a and a small lid portion 475b. A small lid portion 475b is attached to the lower side of the lid main body portion 475a (the lower side when closed), and is swingable by a hinge 421. As shown in FIG.
Here, the lid member 475 has an in-lid accommodating portion 527 which is a space capable of accommodating a desiccant or the like. A humidity control agent is stored in the in-lid storage portion 527 of the present embodiment. By rocking the small lid portion 475b, the in-lid accommodation portion 527 can be opened and closed. In other words, the in-lid accommodating portion 527 is a space formed between the lid body portion 475a and the small lid portion 475b. Specifically, when the lid member 475 is closed and the small lid portion 475b is closed, the space is located above most of the small lid portion 475b.
 また、蓋部材475は、図34(a)、図35で示されるように、箱部471との連結部分とは逆側に、蓋側係止片部476を有する。蓋側係止片部476は、ヒンジ421によって揺動可能な状態で、蓋本体部475aの正面側の端部に連結される。
 蓋側係止片部476は、図35で示されるように、立てた姿勢で内側となる面に係止突起476aを有する。この係止突起476aは、蓋部材475を閉状態としたとき、正面側から背面側に向かって延びる突起であり、箱部471に形成された突起部600と係合可能な突起である。つまり、係止突起476aと突起部600は、対となる係合部であって互いに係合する。そして、これらが係合することで、蓋部材475がロック状態(強固に閉状態を維持した状態)となる。なお、箱部471には、蓋部材475を操作するための操作用切欠部601(図34(a)参照)が形成されている。この操作用切欠部601は、蓋部材475をロック状態としたとき、蓋部材475の側方(幅方向の片側側方)に位置する。
34(a) and 35, the lid member 475 has a lid-side locking piece portion 476 on the side opposite to the connecting portion with the box portion 471. As shown in FIGS. The lid-side locking piece 476 is connected to the front end of the lid main body 475a in a swingable state by means of a hinge 421. As shown in FIG.
As shown in FIG. 35, the lid-side locking piece portion 476 has a locking projection 476a on the inner surface in an upright posture. The locking projection 476 a is a projection that extends from the front side toward the back side when the lid member 475 is closed, and is a projection that can be engaged with the projection portion 600 formed on the box portion 471 . In other words, the locking projection 476a and the projection 600 are engaging portions that form a pair and engage with each other. By engaging these members, the lid member 475 is in a locked state (a state in which the closed state is maintained firmly). The box portion 471 is formed with an operation notch portion 601 (see FIG. 34(a)) for operating the lid member 475. As shown in FIG. The operation notch 601 is positioned on the side (one side in the width direction) of the lid member 475 when the lid member 475 is in the locked state.
 箱部471は、図36で示されるように、箱部本体605に対して正面側の開口部分から仕切り部材606を挿入し、押さえ板部材607を取り付け、さらにシャッター構造部473を取り付けることで形成されている。
 仕切り部材606は、平板状の本体部606aと、本体部606aの上面から上方に突出する被押さえ板部606bと、本体部606aの下面側に形成された整流部472(図37参照)を有する。
 仕切り部材606を境として下部側が散薬通路517となっている。散薬通路517は、散薬排出部411に至る通路であり、箱部471の底部と、側壁下部と、仕切り部材606で囲まれている。
As shown in FIG. 36, the box portion 471 is formed by inserting the partition member 606 into the box portion main body 605 from the opening on the front side, attaching the pressing plate member 607, and further attaching the shutter structure portion 473. It is
The partition member 606 has a flat plate-shaped main body portion 606a, a pressed plate portion 606b projecting upward from the upper surface of the main body portion 606a, and a straightening portion 472 (see FIG. 37) formed on the lower surface side of the main body portion 606a. .
A powdered medicine passage 517 is formed on the lower side of the partition member 606 . The powdered medicine passage 517 is a passage leading to the powdered medicine discharge portion 411 , and is surrounded by the bottom portion of the box portion 471 , the side wall lower portion, and the partition member 606 .
 本体部606aは、背面壁436側に連通孔形成部546を有する。連通孔形成部546は、小孔(開口)547が多数設けられる部分であり、本実施形態では、長孔列が形成されている。なお、この長孔列は、複数の長孔が前後方向に並んで形成されている。それぞれの長孔は、本体部606aを厚さ方向に貫通し、薬剤容器20の幅方向に延びている。本実施形態で採用する小孔(開口)547は、容器本体70の幅W方向にのびるスリット状である。 The main body part 606a has a communication hole forming part 546 on the rear wall 436 side. The communicating hole forming portion 546 is a portion in which a large number of small holes (openings) 547 are provided, and in this embodiment, a long hole row is formed. The row of elongated holes is formed by arranging a plurality of elongated holes in the front-rear direction. Each elongated hole penetrates the body portion 606a in the thickness direction and extends in the width direction of the drug container 20. As shown in FIG. The small hole (opening) 547 employed in this embodiment has a slit shape extending in the width W direction of the container body 70 .
 本実施形態の整流部472は、図37(a)で示されるように、複数の突起部によって構成される突起群である。整流部472に属するそれぞれの突起部は、外形が略直方体状であり、本体部606aの下面から下方(図37(a)では上面から上方)に突出している。また、それぞれの突起部は、薬剤容器420の幅方向に厚さを有し、前後方向に延びた形状となっている。
 ここで、整流部472に属する複数の突起部は、千鳥状に配列されている。つまり、整流部472は、前側の第一突起列472aと、後側(連通孔形成部546側)の第二突起列472bから構成される。それぞれの突起列では、複数(本実施形態では4つ)の突起部が、薬剤容器420の幅方向で間隔を空けて並列している。そして、第一突起列472aに属する突起部の後側部分が、第二突起列472bに属する突起部の前側部分の側方に位置する。したがって、第一突起列472aに属する突起部の一部は、後側部分が第二突起列472bに属する2つの突起部の間に配される。そして、薬剤容器20の幅方向で向かいあう位置に配された第一突起列472aに属する突起部の側面と、第二突起列472bに属する突起部の側面との間には、隙間が形成される。
 なお、図37(b)で示されるように、整流部472に属する複数の突起部は、それぞれの下端面の高さ方向における位置が異なる。即ち、突起部の配置位置が、幅方向の一方端(図10(b)では右側)に近づくにつれ、下端面の位置がより低位置となる。
The rectifying portion 472 of the present embodiment is a group of projections composed of a plurality of projections, as shown in FIG. 37(a). Each protrusion belonging to the straightening section 472 has a substantially rectangular parallelepiped outer shape and protrudes downward from the lower surface of the main body section 606a (upward from the upper surface in FIG. 37(a)). Moreover, each protrusion has a thickness in the width direction of the drug container 420 and has a shape extending in the front-rear direction.
Here, the plurality of protrusions belonging to the straightening section 472 are arranged in a zigzag pattern. That is, the rectifying portion 472 is composed of a first projection row 472a on the front side and a second projection row 472b on the rear side (on the communication hole forming portion 546 side). In each row of protrusions, a plurality of (four in this embodiment) protrusions are arranged side by side in the width direction of the drug container 420 at intervals. The rear portions of the protrusions belonging to the first protrusion row 472a are positioned to the sides of the front portions of the protrusions belonging to the second protrusion row 472b. Therefore, a portion of the protrusions belonging to the first protrusion row 472a is disposed between two protrusions whose rear portions belong to the second protrusion row 472b. A gap is formed between the side surface of the protrusion belonging to the first protrusion row 472a and the side surface of the protrusion belonging to the second protrusion row 472b, which are arranged to face each other in the width direction of the drug container 20. .
In addition, as shown in FIG. 37(b), the plurality of protrusions belonging to the rectifying portion 472 have different positions in the height direction of the respective lower end faces. That is, the position of the lower end surface becomes lower as the arrangement position of the protrusion approaches one end in the width direction (the right side in FIG. 10B).
 押さえ板部材607は、図35、図36で示されるように、2つの取付用操作部610と、押圧突起部611(図35参照)を有する。取付用操作部610は、使用者が操作することで弾性変形する摘み部である。2つの取付用操作部610は、幅方向で離れた位置にそれぞれ形成されており、いずれも幅方向外側に突出する突起部分を有する。
 ここで、図36で示されるように、箱部本体605の左右側面壁のそれぞれには、箱側係合部612が形成されている。箱側係合部612は、側面壁を貫通する孔であり、取付用操作部610の突起部分と係合する。つまり、2つの取付用操作部610と、2つの箱側係合部612が係合することで、押さえ板部材607が箱部本体605に取り付けられる。
As shown in FIGS. 35 and 36, the pressing plate member 607 has two mounting operation portions 610 and a pressing protrusion 611 (see FIG. 35). The attachment operation portion 610 is a knob that is elastically deformed by being operated by the user. The two attachment operation portions 610 are formed at positions separated in the width direction, and both have protrusions that protrude outward in the width direction.
Here, as shown in FIG. 36, box-side engaging portions 612 are formed on the left and right side walls of the box body 605 respectively. The box-side engaging portion 612 is a hole penetrating the side wall and engages with the projecting portion of the attachment operating portion 610 . In other words, the pressing plate member 607 is attached to the box body 605 by engaging the two attachment operation portions 610 and the two box side engaging portions 612 .
 押圧突起部611は、図35で示されるように、前側から後側(図35では右側から左側)に延びる突起部分であり、仕切り部材606の被押さえ板部606bに前方から当接する部分である。具体的には、突出端の面が、被押さえ板部606bの前面と面接触する。このことにより、仕切り部材606の意図しない位置ずれを防止できる。 As shown in FIG. 35, the pressing protrusion 611 is a protrusion extending from the front side to the rear side (from the right side to the left side in FIG. 35), and is the portion that contacts the pressed plate portion 606b of the partition member 606 from the front. . Specifically, the surface of the projecting end is in surface contact with the front surface of the pressed plate portion 606b. As a result, unintended displacement of the partition member 606 can be prevented.
 シャッター部材491は、図36で示されるように、閉鎖壁510(図34(b)等参照)と、ガイド壁部511と、連結壁512を有している。その一方で、上記したストッパ壁113(図19等参照)が形成されていない。また、閉鎖壁110の上側となる位置にシール部材550が取り付けられている。 The shutter member 491 has a closing wall 510 (see FIG. 34(b), etc.), a guide wall portion 511, and a connecting wall 512, as shown in FIG. On the other hand, the above-described stopper wall 113 (see FIG. 19, etc.) is not formed. A seal member 550 is attached at a position above the closing wall 110 .
 本実施形態の薬剤容器420では、図34(b)で示されるように、散薬排出部411を閉じた状態において、閉鎖壁510が底面壁440よりも前方に位置する。つまり、閉鎖壁510の一部が底面壁440と上下方向で重ならない。本実施形態では、底面壁440を散薬排出部411に近接させ、シール部材550を散薬排出部411に押し当てることで、散薬排出部411を閉状態とする。また、シール部材550を散薬排出部411から前方に離した状態とすることで、散薬排出部411を開状態とする。なお、閉じた状態としたとき、シール部材550の一部が散薬排出部411から散薬通路517に入り込んだ状態となる(図35参照)。 In the drug container 420 of the present embodiment, as shown in FIG. 34(b), the closed wall 510 is positioned forward of the bottom wall 440 when the powdered drug discharge section 411 is closed. That is, a portion of the closing wall 510 does not vertically overlap the bottom wall 440 . In this embodiment, the bottom wall 440 is brought close to the powdered medicine discharge part 411 and the sealing member 550 is pressed against the powdered medicine discharge part 411 to close the powdered medicine discharge part 411 . In addition, the powdered medicine discharger 411 is opened by separating the sealing member 550 forward from the powdered medicine discharger 411 . When closed, part of the sealing member 550 enters the powdered medicine passage 517 from the powdered medicine discharging portion 411 (see FIG. 35).
 本実施形態の薬剤容器420の内部では、図35で示されるように、平板状の部分である連通孔形成部546が、仕切板部(仕切り部材)となる。即ち、散薬を貯留する貯留空間613と、散薬通路517の境界に仕切板部(仕切り部材)が配される。散薬通路517は、散薬を排出する際に散薬が通過する部分であり、連通孔形成部546の下側に位置する空間であって、連通孔形成部546と底面壁440の間の部分を含む空間である。 Inside the drug container 420 of the present embodiment, as shown in FIG. 35, the communication hole forming portion 546, which is a plate-like portion, serves as a partition plate portion (partition member). That is, a partition plate portion (partition member) is arranged at the boundary between the storage space 613 that stores the powdered medicine and the powdered medicine passage 517 . The powdered medicine passage 517 is a portion through which the powdered medicine passes when the powdered medicine is discharged. Space.
 なお、本実施形態では、散薬通路517の底部分(底面壁440の上面)が傾斜している。具体的には、薬剤容器420の幅方向において、片側端部(図35では手前奥方向の奥側端部)に向かうにつれて下り勾配となるように傾斜している。さらに、薬剤容器420の前後方向(図35では左右方向)において、散薬排出部411に向かうにつれて下り勾配となるように傾斜している。つまり、全体として、散薬排出部411のうち、薬剤容器420の幅方向における片側端部に向かって傾斜している。
 また、整流部472に属する複数の突起部は、いずれも下端部分が散薬通路517の底部分と密着している。このため、散薬が整流部472を通過するとき、2つの突起部の間、又は、一つの突起部と薬剤容器420の側面壁437の間を通過する。つまり、散薬が整流部472を通過するとき、小さな隙間(幅の狭い流路)を通過し、薬剤の流れが平滑化される。
In addition, in this embodiment, the bottom portion (upper surface of the bottom wall 440) of the powdered medicine passage 517 is inclined. Specifically, in the width direction of the drug container 420, it slopes downward toward one side end (in FIG. 35, the back side end in the front and back direction). Furthermore, the medicine container 420 is inclined downward toward the powdered medicine discharging part 411 in the front-rear direction (horizontal direction in FIG. 35). That is, as a whole, the powdered medicine discharge part 411 is inclined toward one end in the width direction of the medicine container 420 .
Further, the lower end portions of the plurality of protrusions belonging to the rectifying portion 472 are in close contact with the bottom portion of the powdered medicine passage 517 . Therefore, when the powdered medicine passes through the straightening section 472 , it passes between two protrusions or between one protrusion and the side wall 437 of the drug container 420 . In other words, when the powdered medicine passes through the rectifying section 472, it passes through a small gap (narrow flow path), smoothing the flow of the medicine.
 連通孔形成部546は、薬剤容器420をフィーダ本体10に保持させたとき、水平姿勢となる部分である。また、仕切板となる連通孔形成部546と隣接する部分には、大傾斜部543と小傾斜部545が設けられている。 The communicating hole forming portion 546 is a portion that assumes a horizontal posture when the drug container 420 is held by the feeder body 10 . In addition, a large inclined portion 543 and a small inclined portion 545 are provided in a portion adjacent to the communication hole forming portion 546 serving as a partition plate.
 大傾斜部543と、小傾斜部545は、薬剤容器420をフィーダ本体10に保持させた際、共に連通孔形成部546に向かって傾斜する傾斜面を形成する。大傾斜部543は、小傾斜部545よりも長く、それぞれの傾斜角度は同等である。つまり、大傾斜部543と小傾斜部545の間の空間(貯留空間613の下側部分)は、連通孔形成部546に向かって収斂する。 The large inclined portion 543 and the small inclined portion 545 both form an inclined surface inclined toward the communication hole forming portion 546 when the drug container 420 is held by the feeder body 10 . The large inclined portion 543 is longer than the small inclined portion 545 and has the same inclination angle. That is, the space between the large inclined portion 543 and the small inclined portion 545 (the lower portion of the storage space 613) converges toward the communication hole forming portion 546. As shown in FIG.
 薬剤容器420から薬剤を排出する際には、フィーダ本体10に薬剤容器420を保持させた状態で散薬排出部411を開状態とし、薬剤容器420を振動させる。このとき、薬剤容器420内の散薬は、散薬通路517の散薬が排出によって少なくなると、連通孔形成部546の上側の空間である貯留空間613から散薬通路517に移動し、散薬排出部411に向かって進む。そして、散薬排出部411から排出される。
 本実施形態においても、薬剤容器420を振動させることで、散薬が貯留空間613内で攪拌される。この際、貯留された散薬の一部が大傾斜部543を上る方向に移動し、連通孔形成部546よりも上方向で、連通孔形成部546側へと移動する。つまり、上記と同様に、連通孔形成部546に対して散薬による押し付ける力が掛かり難く、散薬の円滑な排出が可能となる。
When the medicine is to be discharged from the medicine container 420 , the medicine container 420 is held by the feeder body 10 , the powdered medicine discharging part 411 is opened, and the medicine container 420 is vibrated. At this time, when the powdered medicine in the powdered medicine passage 517 is reduced due to the discharge, the powdered medicine in the medicine container 420 moves from the storage space 613 , which is the space above the communication hole forming portion 546 , to the powdered medicine passage 517 and toward the powdered medicine discharge portion 411 . to proceed. Then, it is discharged from the powdered medicine discharge part 411 .
In this embodiment as well, the powdered medicine is agitated in the storage space 613 by vibrating the medicine container 420 . At this time, part of the stored powdered medicine moves upward on the large inclined portion 543 and moves upward from the communicating hole forming portion 546 toward the communicating hole forming portion 546 side. That is, similarly to the above, it is difficult for the powdered medicine to apply a pressing force to the communication hole forming portion 546, and the powdered medicine can be discharged smoothly.
 次に、第二実施形態の薬剤フィーダ700について図39乃至図42を参照しつつ説明する。薬剤フィーダ700は、第三実施形態の薬剤容器701と、薬剤容器701を保持する第二実施形態のフィーダ本体702とを有している。
 薬剤容器701及びフィーダ本体702の基本構成と、機能は前記した薬剤容器20,172,420及びフィーダ本体10と同じであるから、改良点のみ説明する。
 本実施形態のフィーダ本体702は、薬剤容器701を取り外す際に使用する離脱補助部材705を備えている。またフィーダ本体702は、シャッター開閉機構706に、シャッター707をロックする機能が付加されている。
 一方、第三実施形態の薬剤容器701には前記した離脱補助部材705が係合する係合部710が設けられている。また薬剤容器701も散薬排出部(シャッター)711が不用意に開かないように閉鎖状態を維持するロック機構を備えているが、その構造は、前記した薬剤容器420とは異なる。
 さらに、薬剤容器701は、図42の様に、散薬排出部711及びシャッター構造部713の構造が前記した薬剤容器20,172,420とは異なる。以下、説明する。
Next, a medicine feeder 700 of a second embodiment will be described with reference to FIGS. 39 to 42. FIG. A medicine feeder 700 has a medicine container 701 of the third embodiment and a feeder body 702 of the second embodiment holding the medicine container 701 .
Since the basic structure and function of the drug container 701 and the feeder main body 702 are the same as those of the drug containers 20, 172, 420 and the feeder main body 10 described above, only improvements will be described.
The feeder main body 702 of this embodiment includes a detachment assisting member 705 used when detaching the drug container 701 . Further, the feeder main body 702 has a shutter opening/closing mechanism 706 added with a function of locking the shutter 707 .
On the other hand, the drug container 701 of the third embodiment is provided with an engaging portion 710 with which the detachment assisting member 705 is engaged. The drug container 701 also has a lock mechanism that maintains the closed state so that the powdered drug discharge section (shutter) 711 does not open unintentionally, but its structure is different from that of the drug container 420 described above.
Furthermore, as shown in FIG. 42, the drug container 701 differs from the drug containers 20, 172, and 420 described above in the structure of the powdered drug discharge portion 711 and the shutter structure portion 713. As shown in FIG. This will be explained below.
 本実施形態のフィーダ本体702では、振動部材16(容器保持部)の振動側垂直壁部33(縦壁)に、薬剤容器701を取り外す際に使用する離脱補助部材705が設けられている。
 離脱補助部材705は、図39、図40、図41の様に、水平に設けられた軸720を中心として回動するレバーであり、操作部721と作用部722を有している。
 操作部721は、上向きの弓状であり、係合用押圧部723と解除用押圧部725とを有している。
 作用部722は、爪である。
In the feeder main body 702 of this embodiment, a detachment assisting member 705 used when removing the medicine container 701 is provided on the vibration-side vertical wall portion 33 (longitudinal wall) of the vibrating member 16 (container holding portion).
39, 40, and 41, the detachment assisting member 705 is a lever that rotates around a horizontally provided shaft 720, and has an operation portion 721 and an action portion 722. As shown in FIGS.
The operating portion 721 has an upward arcuate shape, and has an engaging pressing portion 723 and a releasing pressing portion 725 .
Actuating portion 722 is a claw.
 操作部721と作用部722は、略「L」状の連結部726で結合されている。連結部726は、薬剤容器701が振動部材16(容器保持部)に装着されている状態を基準として、垂直姿勢となる縦辺部727と水平姿勢となる横辺部728を有している。そして縦辺部727と横辺部728の接続部分に軸720が相通されている。
 縦辺部727と横辺部728の接続部分であって外側の部分は、着座部731として機能する部分であり、平面である。
The operation portion 721 and the action portion 722 are connected by a substantially “L”-shaped connecting portion 726 . The connection portion 726 has a vertical side portion 727 and a horizontal side portion 728 with a state in which the drug container 701 is attached to the vibrating member 16 (container holding portion) as a reference. A shaft 720 is connected to the connecting portion between the vertical side portion 727 and the horizontal side portion 728 .
The connecting portion between the vertical side portion 727 and the horizontal side portion 728 and the outer portion functions as the seating portion 731 and is flat.
 振動側垂直壁部33(縦壁)には、ばね等の付勢部材732が設けられており、離脱補助部材705を常時付勢している。具体的には、付勢部材732は横辺部728を上方に押圧しており、離脱補助部材705を回動方向に付勢している。 A biasing member 732 such as a spring is provided on the vibration-side vertical wall portion 33 (vertical wall) to always bias the detachment assisting member 705 . Specifically, the biasing member 732 presses the horizontal side portion 728 upward, biasing the detachment assisting member 705 in the rotational direction.
 またフィーダ本体702のシャッター開閉機構706は、前記した実施形態と同様に、係合片保持部735とアーム57によって構成されている。前記した実施形態と同様に、係合片保持部735の上面に係合部60となる凹部が設けられている。
 本実施形態では、それに加えて、係合片保持部735の上面に突起物737が設けられている。突起物737は、傾斜面738を有している。傾斜面738の傾斜方向は、アーム57の突出方向側を基準として前側が低く,後方が高い。
Further, the shutter opening/closing mechanism 706 of the feeder body 702 is composed of the engagement piece holding portion 735 and the arm 57 as in the above-described embodiment. As in the above-described embodiment, a concave portion that serves as the engaging portion 60 is provided on the upper surface of the engaging piece holding portion 735 .
In this embodiment, in addition to that, a protrusion 737 is provided on the upper surface of the engaging piece holding portion 735 . Projection 737 has an inclined surface 738 . As for the inclination direction of the inclined surface 738 , the front side is lower and the rear side is higher with respect to the protruding direction side of the arm 57 .
 第三実施形態の薬剤容器701は、前記した第二実施形態の薬剤容器420と同様に、上面が開口した箱部471に対して蓋部材475が取り付けられ、蓋部材475がヒンジ421によって揺動可能となっている。
 前記した様に、薬剤容器701には前記した離脱補助部材705が係合する係合部710が設けられている。係合部710は、背面壁436に設けられた凸部である。係合部710の位置は任意であり、側面壁437や底面壁440にあってもよい。
A drug container 701 of the third embodiment has a lid member 475 attached to a box portion 471 having an open top, and the lid member 475 is pivoted by a hinge 421, similarly to the drug container 420 of the second embodiment described above. It is possible.
As described above, the drug container 701 is provided with the engaging portion 710 with which the detachment assisting member 705 engages. The engaging portion 710 is a protrusion provided on the rear wall 436 . The position of the engaging portion 710 is arbitrary, and may be on the side wall 437 or the bottom wall 440 .
 図39に示すように、シャッター構造部713は、前記した第二実施形態と同様に、シャッター707と、シャッター部材740(開閉部材)と、伝動部材741を有する。そして、伝動部材741が直線移動することで、シャッター部材740が移動し、散薬排出部711が開閉する。
 伝動部材741の上辺には、第二実施形態の薬剤容器420と同様、図39の様に、切り欠き742が設けられている。切り欠き742の前方側傾斜743は緩傾斜であり、後方側傾斜745は急傾斜である。
 また本実施形態の薬剤容器701も、板ばね部材748と、係止突起部747を有している。
 板ばね部材748は、薬剤容器701の幅方向外側に片持ち状に取り付けられている。係止突起部747は、概略三角形の部材であり、板ばね部材748に一体的に固定されている。
 係止突起部747の下面には、図39の様に前方側傾斜750と、後方側傾斜751がある。係止突起部747の前方側傾斜750は緩傾斜であり、後方側傾斜751は急傾斜である。
As shown in FIG. 39, the shutter structure 713 has a shutter 707, a shutter member 740 (opening/closing member), and a transmission member 741, as in the second embodiment. The linear movement of the transmission member 741 causes the shutter member 740 to move and the powdered medicine discharging portion 711 to open and close.
A notch 742 is provided on the upper side of the transmission member 741, as in the drug container 420 of the second embodiment, as shown in FIG. A forward slope 743 of the notch 742 is gentle, and a rear slope 745 is steep.
The drug container 701 of this embodiment also has a leaf spring member 748 and a locking protrusion 747 .
The leaf spring member 748 is attached to the outside in the width direction of the medicine container 701 in a cantilevered manner. The locking protrusion 747 is a substantially triangular member and is integrally fixed to the leaf spring member 748 .
The lower surface of the locking protrusion 747 has a forward slope 750 and a rear slope 751 as shown in FIG. A front slope 750 of the locking protrusion 747 is gentle, and a rear slope 751 is steep.
 シャッター部材740(開閉部材)は、図42の様に、散薬排出部711を閉鎖したときに薬剤容器701側に突出する突出部760を有している。
 突出部760の断面形状は、図42の様な略三角形であり、上面761が略水平であり、下面762が傾斜面である。突端部763は、略垂直面である。
 下面762が傾斜角度は、30度以下である。下面762の傾斜角度は、薬剤容器701に収容する散薬の安息角よりも小さいことが望ましい。
As shown in FIG. 42, the shutter member 740 (opening/closing member) has a protruding portion 760 that protrudes toward the drug container 701 when the powdered drug discharging portion 711 is closed.
The cross-sectional shape of the projecting portion 760 is substantially triangular as shown in FIG. 42, the upper surface 761 is substantially horizontal, and the lower surface 762 is an inclined surface. The tip portion 763 is a substantially vertical surface.
The inclination angle of the lower surface 762 is 30 degrees or less. It is desirable that the angle of inclination of the lower surface 762 is smaller than the angle of repose of the powdered medicine contained in the medicine container 701 .
 薬剤容器701内には、散薬排出部711に繋がる散薬通路517があり、散薬通路517を移動して散薬排出部711から排出される.
 本実施形態では、散薬通路517の天井壁に相当する仕切り部材620に、散薬通路517側(下側)に向かって突出する仕切部766がある(図42、図45、図46)。仕切部766の高さ(垂下量)は、1.2mm~3.0mm、もしくは、通路高さに対して、5分の1~5分の3の高さである。
 シャッター部材740(開閉部材)が散薬排出部711を閉鎖したときに突出部760の突端部763が仕切部766に極めて近づく。
 また突出部760の上面761は、散薬通路517の天井壁に相当する仕切り部材620に、極めて近づく。
 突出部760の下面762と散薬通路517の底面との間の角度Dは、散薬の安息角以下の角度をなす。
A powdered medicine passage 517 connected to a powdered medicine discharge portion 711 is provided in the medicine container 701 .
In this embodiment, a partition member 620 corresponding to the ceiling wall of the powdered medicine passage 517 has a partition portion 766 projecting toward the powdered medicine passage 517 (downward) (FIGS. 42, 45, and 46). The height (hanging amount) of the partition 766 is 1.2 mm to 3.0 mm, or 1/5 to 3/5 of the height of the passageway.
When the shutter member 740 (opening/closing member) closes the powdered medicine discharge portion 711 , the tip portion 763 of the projecting portion 760 comes very close to the partition portion 766 .
In addition, the upper surface 761 of the projecting portion 760 is extremely close to the partition member 620 corresponding to the ceiling wall of the powdered medicine passage 517 .
An angle D between the lower surface 762 of the protrusion 760 and the bottom surface of the powder passageway 517 is less than or equal to the repose angle of the powder.
 そのため、シャッター部材740(開閉部材)を開いた直後において、散薬Pの進行方向の先端の斜面の角度Eは、図42(b)の様に安息角以下の角度となっており、零れ落ちにくい。
 またシャッター部材740の突出部760の上面761と散薬通路517の天井壁との間は散薬が入り込む空間が小さいので、突出部760の上面761に散薬が乗りにくく、シャッター部材740を開いたときに、突出部760の上面761から散薬が零れ落ちにくい。
 シャッター部材740の突出部760の突端部763と仕切部766の間は散薬が入り込む空間が小さいので、突出部760の突端部763に散薬が付着しにくく、シャッター部材740を開いたときに、突出部760の突端部763から散薬が零れ落ちにくい。
Therefore, immediately after the shutter member 740 (opening/closing member) is opened, the slope angle E of the tip of the powder medicine P in the traveling direction is equal to or less than the angle of repose as shown in FIG. .
In addition, since the space between the upper surface 761 of the protruding portion 760 of the shutter member 740 and the ceiling wall of the powdered medicine passage 517 is small for the powdered medicine to enter, it is difficult for the powdered medicine to get on the upper surface 761 of the protruding portion 760, and when the shutter member 740 is opened. , the powdered medicine is less likely to spill from the upper surface 761 of the projecting portion 760 .
Since the space for the powdered medicine to enter is small between the protruding end portion 763 of the projecting portion 760 of the shutter member 740 and the partition portion 766, the powdered medicine is less likely to adhere to the protruding end portion 763 of the protruding portion 760, and when the shutter member 740 is opened, the powdered medicine is not projected. The powdered medicine is less likely to spill from the tip portion 763 of the portion 760 .
 次に、薬剤容器701をフィーダ本体702に装着する際の動作について説明する。
 薬剤容器701が取り付けられていない状態においては、フィーダ本体702は、図40(a)の様に待機状態となっている。具体的には、離脱補助部材705の横辺部728が、付勢部材732に押圧され、離脱補助部材705が全体的に傾斜姿勢となっている。振動側垂直壁部33の係合片50は開口51内に没入している。
Next, the operation when the drug container 701 is attached to the feeder main body 702 will be described.
When the drug container 701 is not attached, the feeder main body 702 is in a standby state as shown in FIG. 40(a). Specifically, the horizontal side portion 728 of the detachment assisting member 705 is pressed by the biasing member 732, and the detachment assisting member 705 is in an inclined posture as a whole. The engaging piece 50 of the vibration-side vertical wall portion 33 is recessed into the opening 51 .
 この状態で、図40(b)の様に薬剤容器701の背面壁436をフィーダ本体702の振動側垂直壁部33に沿って上部から差し込む。
 なおこの時、一旦、薬剤容器701の散薬排出部711が上になるように傾斜させてから振動側垂直壁部33に差し込むことが望ましい。こうすることにより、薬剤容器701の散薬通路517の散薬が、散薬排出部711から離れ、シャッター部材740を開いたときに、散薬が零れ落ちにくい。
In this state, as shown in FIG. 40(b), the back wall 436 of the drug container 701 is inserted along the vibration-side vertical wall portion 33 of the feeder body 702 from above.
At this time, it is desirable to once tilt the drug container 701 so that the powder discharge portion 711 of the drug container 701 faces upward, and then insert the drug container 701 into the vibration-side vertical wall portion 33 . By doing so, the powdered medicine in the powdered medicine passage 517 of the medicine container 701 is separated from the powdered medicine discharging portion 711, and when the shutter member 740 is opened, the powdered medicine is less likely to spill.
 薬剤容器701の背面壁36をフィーダ本体702の振動側垂直壁部33に沿って上部から差し込むことにより、薬剤容器701の係合溝130を、振動側垂直壁部33の係合部(保持部側係合部)48に係合させることができる。
 振動側垂直壁部33の係合片(保持部側係合部)50は開口51内に没入している。
By inserting the back wall 36 of the drug container 701 from above along the vibration-side vertical wall portion 33 of the feeder body 702 , the engagement groove 130 of the drug container 701 is engaged with the engagement portion (holding portion) of the vibration-side vertical wall portion 33 . side engaging portion) 48.
An engaging piece (holding portion side engaging portion) 50 of the vibration side vertical wall portion 33 is recessed in the opening 51 .
 薬剤容器701を差し込んでいくと、離脱補助部材705の作用部722が薬剤容器701の係合部710と接触する。
 さらに薬剤容器701を差し込んでいくと、離脱補助部材705の作用部722が薬剤容器701に押されて回動し、縦辺部727が垂直姿勢となり、横辺部728が水平姿勢となって離脱補助部材705が安定した姿勢となる。
 前記した様に、薬剤容器701を差し込んでいくことによって、離脱補助部材705を回動させることができるが、補助的に操作部721の係合用押圧部723を押して離脱補助部材705を回動させてもよい。
 いずれにしても、薬剤容器701が正しくフィーダ本体702に装着されると、離脱補助部材705の横辺部728が図40(c)のように水平姿勢となる。そのため、上から見て操作部721が水平になっていることを目視で確認することによって、確実に薬剤容器701がフィーダ本体702に装着されたことを認識することができる。
As the drug container 701 is inserted, the acting portion 722 of the detachment assisting member 705 comes into contact with the engaging portion 710 of the drug container 701 .
When the drug container 701 is further inserted, the working portion 722 of the withdrawal assisting member 705 is pushed by the drug container 701 and rotated, the vertical side portion 727 assumes a vertical posture, and the horizontal side portion 728 assumes a horizontal posture and is removed. The auxiliary member 705 assumes a stable posture.
As described above, the withdrawal assistance member 705 can be rotated by inserting the drug container 701, and the engagement pressing portion 723 of the operation portion 721 is pressed to assist the rotation of the withdrawal assistance member 705. may
In any case, when the drug container 701 is properly attached to the feeder main body 702, the horizontal side portion 728 of the detachment assisting member 705 assumes a horizontal posture as shown in FIG. 40(c). Therefore, by visually confirming that the operation portion 721 is horizontal when viewed from above, it is possible to reliably recognize that the drug container 701 is attached to the feeder main body 702 .
 薬剤容器701をフィーダ本体702から取り外す場合は、図41の矢印の様に、操作部721の解除用押圧部725を押す。その結果、離脱補助部材705が逆方向に回動して、離脱補助部材705の作用部722が上昇する。そのため、作用部722が薬剤容器701の係合部710に係合して薬剤容器701を押し上げ、薬剤容器701が上方に移動して、フィーダ本体702から外れる。 When removing the drug container 701 from the feeder main body 702, the release pressing portion 725 of the operation portion 721 is pushed as indicated by the arrow in FIG. As a result, the detachment assisting member 705 rotates in the opposite direction, and the acting portion 722 of the detachment assisting member 705 rises. Therefore, the acting portion 722 engages with the engaging portion 710 of the drug container 701 to push up the drug container 701 , and the drug container 701 moves upward and is removed from the feeder main body 702 .
 本実施形態によると、フィーダ本体702から薬剤容器701を容易に取り外すことができる。
 即ち本実施形態の薬剤払出し装置1では、薬剤フィーダ5、700が密に配置されているから、薬剤容器701間の隙間が少なく、指を入れにくい。本実施形態の薬剤フィーダ700によると、薬剤容器701の間に指を入れる必要が無いので、薬剤容器701の取り外しが容易である。
According to this embodiment, the drug container 701 can be easily removed from the feeder body 702 .
That is, in the medicine dispensing device 1 of this embodiment, since the medicine feeders 5 and 700 are densely arranged, the gaps between the medicine containers 701 are small and it is difficult to insert a finger. According to the medicine feeder 700 of this embodiment, it is not necessary to insert a finger between the medicine containers 701, so the medicine containers 701 can be easily removed.
 次に、薬剤容器701のシャッター707をロックする機構について説明する。薬剤容器701では、シャッター部材740が閉じた状態においては、伝動部材741が後退しており、伝動部材741の切り欠き742に板ばね部材748に取り付けられた係止突起部747が係合している。ここで、切り欠き742の後方側傾斜745及び係止突起部747の後方側傾斜751はともに急傾斜である。そのため、伝動部材741がシャッター707を開く方向に移動しようとしても、切り欠き742と係止突起部747の急斜面同士が係合し、伝動部材741のシャッター707を開く方向への移動が阻止される。
 そのため、薬剤容器701のシャッター707は、ロック状態となり、シャッター707は開かない。
Next, a mechanism for locking shutter 707 of drug container 701 will be described. In the drug container 701, when the shutter member 740 is closed, the transmission member 741 is retracted, and the locking protrusion 747 attached to the leaf spring member 748 is engaged with the notch 742 of the transmission member 741. there is Here, both the rearward slope 745 of the notch 742 and the rearward slope 751 of the locking protrusion 747 are steep. Therefore, even if the transmission member 741 attempts to move in the direction of opening the shutter 707, the steep slopes of the notch 742 and the locking protrusion 747 engage with each other, and the movement of the transmission member 741 in the direction of opening the shutter 707 is blocked. .
Therefore, the shutter 707 of the drug container 701 is locked, and the shutter 707 does not open.
 一方、薬剤容器701から散薬を排出すべく、係合片保持部735を正面壁35側に移動させると、係合片保持部735が移動して突起物737が薬剤容器701の係止突起部747と当接する。この時の突起物737側の当接面は、傾斜面738であり、突起物737の前進に伴って薬剤容器701の係止突起部747を板ばね部材748に抗して上に押し上げる。
 その結果、板ばね部材748に取り付けられた係止突起部747が、伝動部材741の切り欠き742を離れ、板ばね部材748に取り付けられた係止突起部747と伝動部材741の切り欠き742との係合が解除される。
 係合片保持部735が正面壁35側に移動し、伝動部材741が前方に摺動して、シャッター707を移動させ、薬剤容器701の散薬排出部711が開く。
On the other hand, when the engagement piece holding portion 735 is moved toward the front wall 35 in order to discharge the powdered medicine from the medicine container 701 , the engagement piece holding portion 735 moves and the projection 737 is engaged with the locking projection portion of the medicine container 701 . 747 abuts. The contact surface on the projection 737 side at this time is an inclined surface 738 , and as the projection 737 advances, the locking projection 747 of the medicine container 701 is pushed up against the plate spring member 748 .
As a result, the locking protrusion 747 attached to the leaf spring member 748 leaves the notch 742 of the transmission member 741, and the locking protrusion 747 attached to the leaf spring member 748 and the notch 742 of the transmission member 741 are separated. is disengaged.
The engagement piece holding portion 735 moves toward the front wall 35, the transmission member 741 slides forward, the shutter 707 moves, and the powdered medicine discharging portion 711 of the medicine container 701 opens.
 薬剤容器20(以下、他の構造の薬剤容器でもよい)の取り外しをさらに容易にする方策として、図43の様に、フィーダ本体10にばね等の付勢部材770を設け、当該付勢部材770で薬剤容器20を上方に常時付勢することが考えられる。
 本実施形態では、振動側垂直壁部33の係合片50が引き込むと、薬剤容器20を固定する規制が解除され、付勢部材770によって薬剤容器20が上方に持ち上げられる。
As a measure for further facilitating removal of the drug container 20 (hereinafter, drug containers of other structures may be used), as shown in FIG. to constantly urge the drug container 20 upward.
In the present embodiment, when the engaging piece 50 of the vibration-side vertical wall portion 33 is retracted, the restriction that fixes the drug container 20 is released, and the drug container 20 is lifted upward by the biasing member 770 .
 以上説明した実施形態では、薬剤容器20と係合する係合片50は、出し入れ機構に接続されており、シャッター開閉機構55と連動する構造となっているが、係合片50が独立して出没するような構成であってもよい。
 例えば図44の様に、ばね780で係合片50が突出する方向に付勢されており、レバー781を操作することにより、係合片50を引き入れ、薬剤容器20との係合を解消することができる。
 本実施形態によると、シャッター開閉機構55のアクチェータに頼ることなく係合片50を引き入れ、薬剤容器20をフィーダ本体から取り外すことができる。
In the embodiment described above, the engaging piece 50 that engages with the drug container 20 is connected to the loading/unloading mechanism and has a structure that interlocks with the shutter opening/closing mechanism 55. However, the engaging piece 50 is independent. It may be configured such that it appears frequently.
For example, as shown in FIG. 44, the engagement piece 50 is biased by a spring 780 in a direction in which the engagement piece 50 protrudes. be able to.
According to this embodiment, the engaging piece 50 can be pulled in and the drug container 20 can be removed from the feeder body without depending on the actuator of the shutter opening/closing mechanism 55 .
 第一実施形態の容器本体70に設けられた小孔(開口)146や、第二実施形態の容器本体70に設けられた小孔(開口)547は、いずれも容器本体70の幅W方向にのびるスリット状であるが。当該開口の形状はこの構成に限定されるものではない。
 例えば、図45、図46に示す小孔(開口)782は、容器本体70の背面壁36側から、正面壁35にのびるスリット状である。
 小孔(開口)782の平面視は、細長い三角形であり、正面壁35側に向かうにつれて開口幅が広くなっている。
 実験によると、小孔(開口)782の形状を、図45、図46の形状としたことにより、散薬の流れがより円滑なものとなった。開口の形状は図45、図46に示した形に限定されるものではない。
The small holes (openings) 146 provided in the container body 70 of the first embodiment and the small holes (openings) 547 provided in the container body 70 of the second embodiment are both arranged in the width W direction of the container body 70. Although it is in the shape of an elongated slit. The shape of the opening is not limited to this configuration.
For example, a small hole (opening) 782 shown in FIGS. 45 and 46 has a slit shape extending from the rear wall 36 side of the container body 70 to the front wall 35 .
The small hole (opening) 782 has an elongated triangular shape when viewed from above, and the width of the opening increases toward the front wall 35 side.
According to experiments, the flow of the powder medicine became smoother by making the shape of the small holes (openings) 782 as shown in FIGS. 45 and 46 . The shape of the opening is not limited to the shapes shown in FIGS.
 図46に示す仕切り部材620は、前記した様に、下面に仕切部766がある。また図46に示す仕切り部材620では、整流部621の形状が柱状である。 The partition member 620 shown in FIG. 46 has the partition portion 766 on the lower surface as described above. Further, in the partition member 620 shown in FIG. 46, the straightening portion 621 has a columnar shape.
 また図47に示す仕切り部材622の様に、上面側に凹凸625を設けてもよい。本実施形態によると、薬剤容器20内で散薬が押し固められることを防ぐことができる。
 本実施形態で採用する凹凸625は、鋸刃状や波型であり、傾斜をもっている。そのため、仕切り部材622の近傍において上部側の散薬自体の重量を逃がし、仕切り部材622の近傍の散薬が押し固められることを抑制することができる。
 凹凸の形状は鋸刃状や波型に限定されるものではなく、例えば円錐形な三角錐といった錐形でもよい。
Further, like a partition member 622 shown in FIG. 47, unevenness 625 may be provided on the upper surface side. According to this embodiment, it is possible to prevent the powdered medicine from being compacted in the medicine container 20 .
The unevenness 625 employed in this embodiment has a serrated shape or a wavy shape and has an inclination. Therefore, in the vicinity of the partition member 622, the weight of the powdered medicine itself on the upper side can be released, and the compaction of the powdered medicine in the vicinity of the partition member 622 can be suppressed.
The shape of the unevenness is not limited to a sawtooth shape or a wave shape, and may be, for example, a pyramid shape such as a conical triangular pyramid.
 以上説明した実施形態では、いずれも薬剤容器20をフィーダ本体10に取り付けて使用するものである。ここで、薬剤容器20がフィーダ本体10に正しく装着されているか否かを確認するセンサが設けられていることが望ましい。
 センサの構造は任意であるが,光電センサや近接センサの様に、物体を検知することができるものが望ましい。センサの取り付け位置は任意であるが,フィーダ本体10の振動側垂直壁部33や振動側水平部32が取り付け位置の候補としてあげられる。
In all of the embodiments described above, the drug container 20 is attached to the feeder main body 10 for use. Here, it is desirable to provide a sensor for confirming whether or not the medicine container 20 is correctly attached to the feeder main body 10 .
Although the structure of the sensor is arbitrary, a sensor capable of detecting an object, such as a photoelectric sensor or a proximity sensor, is desirable. Although the mounting position of the sensor is arbitrary, the vibrating-side vertical wall portion 33 and the vibrating-side horizontal portion 32 of the feeder body 10 are candidates for the mounting position.
 以上説明した実施形態では、薬剤容器20に情報記憶手段65としてRFIDタグが取り付けられている。RFIDタグに代わって、あるいはRFIDタグに加えて、ARマーカーを設けてもよい。ARマーカーは、あらかじめ登録しておいた写真やイラストその他の図形である。ARマーカーを印刷したラベルを薬剤容器20の見える位置に貼付する。
 ARマーカーは、カメラで認識することができる。ここで近年、薬剤の払い出し工程を監視し、後で確認することができるように、装置内にカメラが複数設置される傾向がある。例えば、薬剤フィーダ5の近くに、払い出し監視用のカメラが設置される場合がある。例えばそのカメラを利用してARマーカーを撮影し、薬剤容器20の識別を行う。
 これにより処方情報に基づく薬剤情報と照合し正しく薬剤容器がセットされているかの確認を行うことができる。
 RFIDタグは、検出距離を確保する必要があるのに対し、ARマーカーはそのような制約が少ない。また監視用カメラを、ARマーカーの撮影に兼用することができるので、RFIDタグに代わってARマーカーを採用すると、RFIDタグ読み取り用の部品を減らすことができる。
In the embodiment described above, an RFID tag is attached to the medicine container 20 as the information storage means 65 . AR markers may be provided instead of or in addition to RFID tags. AR markers are pre-registered photographs, illustrations, and other graphics. A label printed with an AR marker is attached to the drug container 20 at a visible position.
AR markers can be recognized by cameras. In recent years, there has been a tendency to install a plurality of cameras in the device so that the drug dispensing process can be monitored and confirmed later. For example, a camera for dispensing monitoring may be installed near the medicine feeder 5 . For example, the camera is used to photograph the AR marker to identify the drug container 20 .
This makes it possible to check whether the medicine container is set correctly by collating it with the medicine information based on the prescription information.
The RFID tag needs to ensure a detection distance, whereas the AR marker has less such restrictions. Moreover, since the monitoring camera can also be used for photographing the AR marker, if the AR marker is adopted instead of the RFID tag, the parts for reading the RFID tag can be reduced.
 上記した薬剤払出し装置1では、図1、図2等で示されるように、複数の薬剤フィーダ5が分配皿6の周囲に固定されている。また、これら複数の薬剤フィーダ5は、放射線状に配置されている。即ち、図38(a)で示されるように、それぞれの薬剤フィーダ5は、平面視において、自身の幅方向の中心と重なり、自身の長手方向と同方向に延びる仮想線が分配皿6の回転中心(図中P3で示す点)と重なるように配されている。
 また、上記した薬剤払出し装置1では、一つの薬剤フィーダ5の薬剤容器20内に一種類の散薬が収容されている。つまり、一つの薬剤フィーダ5の薬剤容器20と予め決められた散薬とが一対一に割り付けされている。このとき、薬剤容器20には、一服用分以上の量を収容してもよい。そして、上記した散薬を排出する動作を実行する際には、複数の薬剤フィーダ5の中から排出する散薬が割り当てられた薬剤フィーダ5が選択され、選択された薬剤フィーダから一服用分の量の散薬を排出させることが可能である。
 また、一又は複数の薬剤フィーダ5から一又は複数種類の散薬を排出させる際、選択された一又は複数の薬剤フィーダ5から所定量の散薬を分配皿6に排出(払い出し)してもよい。
In the drug dispensing device 1 described above, a plurality of drug feeders 5 are fixed around a distribution tray 6, as shown in FIGS. In addition, these multiple drug feeders 5 are arranged radially. That is, as shown in FIG. 38( a ), each drug feeder 5 overlaps its center in the width direction in a plan view, and a virtual line extending in the same direction as its longitudinal direction indicates the rotation of the distribution plate 6 . It is arranged so as to overlap with the center (the point indicated by P3 in the figure).
Further, in the medicine dispensing device 1 described above, one kind of powdered medicine is accommodated in the medicine container 20 of one medicine feeder 5 . In other words, the medicine container 20 of one medicine feeder 5 and the predetermined powdered medicine are allocated one-to-one. At this time, the drug container 20 may contain more than one dose. When executing the above-described operation of discharging the powdered medicine, the medicine feeder 5 to which the powdered medicine to be discharged is assigned is selected from among the plurality of medicine feeders 5, and the amount of one dose is supplied from the selected medicine feeder. It is possible to discharge powdered medicine.
Further, when discharging one or more types of powdered medicine from one or more medicine feeders 5 , a predetermined amount of powdered medicine may be discharged (dispensed) from one or more selected medicine feeders 5 to the distribution tray 6 .
 上記した実施形態の薬剤払出し装置1を使用し続けると、いずれかの薬剤フィーダ5において薬剤容器20内の散薬が無くなってしまう場合がある。即ち、消耗品である散薬が無くなってしまう場合がある。
 本実施形態の薬剤払出し装置1では、このような場合、使用者(薬剤師等)が薬剤容器20をフィーダ本体10から取り外し、薬剤容器20に散薬を充填した後、薬剤容器20を再度フィーダ本体10に取り付ける作業を行う。つまり、いずれかの薬剤フィーダ5で散薬が無くなった(又は無くなることが予測された)場合、報知動作等でその報知を受けた使用者が、上記の作業を行う。
 ここで、本実施形態の薬剤払出し装置1では、薬剤容器20を再度取り付ける際、薬剤容器20が元々取り付けられていたフィーダ本体10に加え、他のフィーダ本体10にも取り付けが可能である。即ち、元々のフィーダ本体10の他に薬剤容器20が取り付けられていないフィーダ本体10があれば、そのフィーダ本体10にも取り付けが可能である。つまり、再度の取り付けをする際には、その時点で薬剤容器20を保持していない全てのフィーダ本体10から選択される任意の一つに対し、薬剤容器20の取り付けが可能である。このことから、使用者が薬剤容器20をどこに取り付ければよいか考える必要がなく、上記作業が容易となる。
If the medicine dispensing device 1 of the embodiment described above continues to be used, the powdered medicine in the medicine container 20 may run out in one of the medicine feeders 5 . That is, there are cases where powdered medicine, which is a consumable item, runs out.
In the medicine dispensing device 1 of the present embodiment, in such a case, the user (pharmacist or the like) removes the medicine container 20 from the feeder main body 10, fills the medicine container 20 with powdered medicine, and then reinserts the medicine container 20 into the feeder main body 10. work to attach it to the In other words, when the powdered medicine runs out (or is predicted to run out) in any of the medicine feeders 5, the user who is notified of this by the notification operation or the like performs the above operation.
Here, in the drug dispensing device 1 of the present embodiment, when reattaching the drug container 20, the drug container 20 can be attached to another feeder body 10 in addition to the feeder body 10 to which the drug container 20 was originally attached. That is, if there is another feeder body 10 to which the medicine container 20 is not attached besides the original feeder body 10, it can be attached to that feeder body 10 as well. That is, when reattaching, the drug container 20 can be attached to any one selected from all the feeder bodies 10 that do not hold the drug container 20 at that time. As a result, the user does not have to think about where to attach the drug container 20, which facilitates the above work.
 薬剤容器の散薬排出部は、上記したように、散薬の排出のために有効な開口幅(散薬の出口幅)を変更可能であることが好ましい。例えば、上記のように、散薬排出部の開口部分のうち、閉塞されている部分を段階的又は連続的に変更可能としてもよい。このような構成とすると、振動量を可変して散薬の流量を変更する制御と組み合わせる等することが可能であり、より正確な散薬の排出動作が可能となる。 As described above, it is preferable that the powdered medicine discharge part of the medicine container can change the effective opening width (exit width of the powdered medicine) for discharging the powdered medicine. For example, as described above, the blocked portion of the opening of the powdered medicine discharge section may be changed stepwise or continuously. With such a configuration, it is possible to combine with control for changing the flow rate of the powdered medicine by varying the amount of vibration, thereby enabling a more accurate discharge operation of the powdered medicine.
 ところで、上記した薬剤払出し装置1は、小型化を想定したものである。ここで、装置全体が小型化すると、受ける衝撃が小さくても筐体2(装置全体)が傾いてしまうおそれがある。そして、薬剤払出し装置1を移動させたり、設置時に筐体2が衝撃を受けたりすることで筐体2が傾き、筐体2が傾いたまま薬剤払出し装置1を運用すると、各種動作(例えば、散薬の重量を測定する動作)で、不具合が生じてしまうおそれがある。
 そこで、上記した薬剤払出し装置1は、ジャイロセンサ(傾き検知手段であり、水平器)を備えたものであってもよい。また、ジャイロセンサが検知した情報(ジャイロセンサから発信された信号)に基づいて、筐体2の傾きを報知する傾き報知動作を実行してもよい。
 この傾き報知動作は、ジャイロセンサによって検知した装置全体の傾きが規定値を超過したことを条件として、その旨を報知する動作である。この動作は、薬剤払出し装置1の電源を投入したことを条件として実行される動作であってもよい。また、例えば、薬剤払出し装置1にスピーカ等の音声発生手段を設け、警告音(アラート)やメッセージを出力する動作であってもよい。
By the way, the drug delivery device 1 described above is intended to be miniaturized. Here, if the entire device is miniaturized, there is a risk that the housing 2 (the entire device) will tilt even if the impact received is small. Then, when the drug dispensing device 1 is moved or the housing 2 receives an impact during installation, the housing 2 tilts. operation of measuring the weight of the powdered medicine) may cause problems.
Therefore, the medicine dispensing device 1 described above may be provided with a gyro sensor (inclination detecting means, level). Further, based on information detected by the gyro sensor (signal transmitted from the gyro sensor), a tilt notification operation of notifying the tilt of the housing 2 may be executed.
This tilt notification operation is an operation for notifying that effect on the condition that the tilt of the entire device detected by the gyro sensor exceeds a specified value. This operation may be an operation that is executed on the condition that the drug dispensing device 1 is powered on. Further, for example, the medicine dispensing device 1 may be provided with a sound generating means such as a speaker, and an operation of outputting an alarm or a message may be performed.
 また傾き検知手段として、3軸加速度センサを採用することも推奨される。例えば3軸加速度センサを実装した基板を、筐体2内の水平に支持された仕切や板に取り付ける。
 3軸加速度センサは加速度の測定を目的とした慣性センサの1つで、3次元の慣性運動(直行3軸方向の並進運動)を検出することができる。3軸加速度センサは、重力、動き、振動、衝撃を測定する事ができる。
 例えば薬剤払出し装置1を所定の位置に設置し、筐体2の水平調整を行った後の3軸加速度センサの各軸に関する出力値を記憶しておく。3軸加速度センサは、重力加速度を検知することができ、垂直方向には常に重力加速度が掛かっているため、筐体2が傾くと、3軸の各検出値が変化する。
 当該検出値の変化に基づいて、筐体2の傾き具合を演算し、筐体2の傾きを検出する。どの様に姿勢を修正すれば、水平姿勢に戻るかを表示してもよい。
 逆に、3軸の各検出値の変化が一定未満である場合には、薬剤払出し装置1は傾いておらず姿勢が安定しいていると判断できる。
It is also recommended to employ a triaxial acceleration sensor as the tilt detection means. For example, a substrate on which a triaxial acceleration sensor is mounted is attached to a partition or plate that is horizontally supported inside the housing 2 .
A 3-axis acceleration sensor is one of inertial sensors for measuring acceleration, and can detect 3-dimensional inertial motion (translational motion in orthogonal 3-axis directions). A 3-axis accelerometer can measure gravity, motion, vibration, and shock.
For example, the drug dispensing device 1 is installed at a predetermined position, and the output values for each axis of the three-axis acceleration sensor after horizontal adjustment of the housing 2 are stored. The triaxial acceleration sensor can detect gravitational acceleration, and gravitational acceleration is always applied in the vertical direction. Therefore, when the housing 2 is tilted, the detection values of the three axes change.
The degree of inclination of the housing 2 is calculated based on the change in the detected value, and the inclination of the housing 2 is detected. It may be displayed how to correct the posture to return to the horizontal posture.
Conversely, when the change in each detected value of the three axes is less than a constant, it can be determined that the medicine dispensing device 1 is not tilted and its posture is stable.
 ところで、上記した薬剤フィーダ5における散薬の排出動作は、散薬排出部11を閉状態としたまま(シャッターを閉じたまま)薬剤容器20を振動させ、その後に、散薬排出部11を開状態とし、薬剤容器20を振動させて薬剤を排出させる動作でもよい。つまり、散薬排出部11を開状態として薬剤容器20を振動させる動作(以下、開状態振動動作とも称す)に先立って、散薬排出部11を閉状態として薬剤容器20を振動させる動作(以下、閉状態振動動作とも称す)を実行してもよい。
 ここで、閉状態振動動作は、開状態振動動作よりも薬剤容器20を強振動させる動作であってもよい。つまり、薬剤フィーダ5は、振動数(周波数)や振幅の大きさを変更可能な構成としてもよい。そして、閉状態振動動作を開状態振動動作よりも振動量(振動の大きさ)が大きな動作としてもよく、より単位時間当たりの振動回数が多い動作としてもよい。また、閉状態振動動作は、最も強い振動で薬剤容器20を振動させる動作、即ち、最大振動としたり、単位時間当たりの振動回数を最大としたりする動作でもよい。
 詳細に説明すると、薬剤容器20に薬剤を充填した直後等では、散薬排出部11の付近に散薬がない状態となることがある。このような状態で通常の散薬の排出動作を実行したのでは、少量の散薬を排出させる場合に時間がかかってしまう可能性がある。即ち、散薬排出部11を開いて薬剤容器20を強振動で振動させると、散薬が実際に排出され始めた際に一度に多量の散薬が落下してしまうことがある。このため、少量の排出を行う際には、薬剤容器20を強振動で振動させることが難しい。また、振動を弱くすると、散薬が実際に排出され始めるまでに長い時間が必要となってしまう。
 そこで、上記した閉状態振動動作、開状態振動動作を実行して散薬を排出させることで、上記した少量の散薬を排出させる場合においても、散薬の排出のために必要な時間を短縮できる。
By the way, the operation of discharging the powdered medicine in the medicine feeder 5 is performed by vibrating the medicine container 20 while keeping the powdered medicine discharging part 11 closed (while the shutter is closed), then opening the powdered medicine discharging part 11, An operation of vibrating the drug container 20 to discharge the drug may be employed. That is, prior to the action of vibrating the drug container 20 with the powdered medicine discharge part 11 in the open state (hereinafter also referred to as the open state vibrating action), the action of vibrating the drug container 20 with the powdered drug discharge part 11 in the closed state (hereinafter referred to as the closed state) is performed. (also referred to as state oscillation operation) may be performed.
Here, the closed-state vibrating action may be an action that vibrates the drug container 20 more strongly than the open-state vibrating action. In other words, the medicine feeder 5 may be configured to be able to change the frequency and amplitude. Then, the closed-state vibrating action may be an action with a larger vibration amount (vibration magnitude) than the open-state vibrating action, or may be an action with a larger number of vibrations per unit time. Further, the closed-state vibrating action may be an action of vibrating the drug container 20 with the strongest vibration, that is, an action of maximizing vibration or maximizing the number of vibrations per unit time.
More specifically, immediately after the medicine container 20 is filled with medicine, there may be no powdered medicine near the powdered medicine discharge section 11 . If a normal powdered medicine discharge operation is performed in such a state, it may take a long time to discharge a small amount of powdered medicine. In other words, if the powdered medicine discharge unit 11 is opened and the medicine container 20 is strongly vibrated, a large amount of powdered medicine may drop at once when the powdered medicine actually starts to be discharged. Therefore, it is difficult to strongly vibrate the drug container 20 when discharging a small amount of drug. Also, if the vibration is weakened, it takes a long time before the powdered medicine actually starts to be discharged.
Therefore, by executing the closed-state vibration operation and the open-state vibration operation to discharge the powdered medicine, it is possible to shorten the time required for discharging the powdered medicine even when discharging a small amount of the powdered medicine.
 ここで、図1、図38(b)で示されるように、上記した錠剤手撒き装置303は、全体の概形が略直方体状の部材であって、揺動可能な状態で取り付けられている。即ち、上面の升状部分の開口が上方を向く通常姿勢(図1参照)と、同開口が後方上側を向く傾斜姿勢(図38(b)参照)の間で姿勢変更が可能となっている。
 また、図1、図2で示されるように、上記した清掃装置7は、錠剤手撒き装置303の下側に配されている(図1参照)。ここで、清掃装置7は、図示しない吸引装置に接続された吸引口7aを有しており、負圧を発生させて空気と共に汚れ(残存散薬や塵等)を吸い込む装置である。詳細には、清掃装置7は、分配皿6の外側から内側に向かって延びる延設部7bを有し、この延設部7bに吸引口7aが形成されている。また、清掃装置7は、分配皿6を清掃するものであり、通常、吸引口7aが下側を向いた状態となっている。
Here, as shown in FIGS. 1 and 38(b), the above-mentioned manual tablet distributing device 303 is a member having a substantially rectangular parallelepiped shape as a whole, and is attached in a swingable state. . That is, it is possible to change the posture between a normal posture (see FIG. 1) in which the opening of the square portion on the upper surface faces upward and an inclined posture (see FIG. 38(b)) in which the opening faces upward to the rear. .
Further, as shown in FIGS. 1 and 2, the cleaning device 7 described above is arranged below the tablet manual distribution device 303 (see FIG. 1). Here, the cleaning device 7 has a suction port 7a connected to a suction device (not shown), and is a device that generates negative pressure to suck dirt (residual powdered medicine, dust, etc.) together with air. Specifically, the cleaning device 7 has an extension portion 7b extending inwardly from the outside of the distribution plate 6, and the extension portion 7b is formed with a suction port 7a. The cleaning device 7 cleans the distribution plate 6, and is normally in a state in which the suction port 7a faces downward.
 ここで、本実施形態の薬剤払出し装置1では、錠剤手撒き装置303と清掃装置7が連動する。即ち、錠剤手撒き装置303を使用時の姿勢である通常姿勢から傾斜姿勢に姿勢変更すると、図38(b)で示されるように、それに伴って清掃装置7が自動で回転動作を実行する。具体的には、この回転動作は、延設部7bが一回転する動作であり、この際の回転軸は、延設部7bの延び方向と同方向となる。このことにより、吸引口7aが下側を向いた状態から、側方(通常時を基準として側方)を向いた状態、上側を向いた状態を経て、下側を向いた状態に戻る。
 このような構成によると、清掃装置7の吸引口7aの周辺が汚れているか否かを使用者が確認しやすくなる。即ち、使用者が錠剤手撒き装置303を姿勢変更することで、図示しないセンサ等によってこの姿勢変更が検知され、清掃装置7が自動で回転を始める。このように清掃装置7が動くことで、清掃装置7に使用者の目を行き易くすることができる(使用者の注意を引き易くすることができる)。また、吸引口7aの周辺の汚れやすい部分であり、通常姿勢のままでは見え難い部分が見易くなる。つまり、吸引口7aの周辺が汚れていた場合、使用者に汚れを気付かせることができる。延いては、使用者に対し、清掃装置7に対する清掃(清掃装置7のメンテナンス)が必要か否かの判断を促すことができる。
Here, in the medicine dispensing device 1 of this embodiment, the tablet hand-dispensing device 303 and the cleaning device 7 are interlocked. That is, when the attitude of the manual tablet distributing device 303 is changed from the normal attitude, which is the attitude during use, to the tilted attitude, the cleaning device 7 automatically rotates accordingly, as shown in FIG. 38(b). Specifically, this rotating operation is an operation in which the extending portion 7b rotates once, and the axis of rotation at this time is the same direction as the extending direction of the extending portion 7b. As a result, the suction port 7a faces downward, faces sideways (sideways with respect to the normal time), faces upward, and then returns to face downward.
With such a configuration, the user can easily check whether or not the area around the suction port 7a of the cleaning device 7 is dirty. That is, when the user changes the attitude of the tablet hand-dispensing device 303, the change in attitude is detected by a sensor or the like (not shown), and the cleaning device 7 automatically starts rotating. By moving the cleaning device 7 in this way, it is possible to make it easier for the user to see the cleaning device 7 (it is possible to make it easier to draw the user's attention). In addition, the portion around the suction port 7a, which is likely to get dirty and is difficult to see in the normal posture, becomes easier to see. That is, when the area around the suction port 7a is dirty, the user can be made aware of the dirt. As a result, the user can be prompted to determine whether or not cleaning of the cleaning device 7 (maintenance of the cleaning device 7) is necessary.
 薬剤容器20の内部に水や洗浄液等を入れ、この状態で薬剤容器をフィーダ本体10に装着して薬剤容器20を振動させることによって、薬剤容器20の内部を洗浄することができる。 The inside of the drug container 20 can be washed by putting water, a cleaning liquid, etc. inside the drug container 20, attaching the drug container to the feeder main body 10 in this state, and vibrating the drug container 20.
 次に上蓋3について説明する。上蓋3には、図48のような電光表示800が設けられている。
 電光表示800は、複数の発光部802が列状に並んだ複数の発光群801aから801fがある。各発光群801aから801fは、散薬分割領域301の薬剤フィーダ5と対応している。即ち散薬分割領域301には、薬剤フィーダ5が6基設置されている。
 発光群801aは薬剤フィーダ5aに対応し、発光群801bは薬剤フィーダ5bに対応し、発光群801cは薬剤フィーダ5cに対応し、発光群801dは薬剤フィーダ5dに対応し、発光群801eは薬剤フィーダ5eに対応し、発光群801fは薬剤フィーダ5fに対応している。
 本実施形態では、発光群801a-801fは、扇状に配列されている。
 発光群801に属する発光部802は、色及び又は輝度が異なるものが混在しており、中心側から外側に向かって色等がなだらかに変化するよう段階的に配列されている。本実施形態では、中心側が淡い色であり、外側に向かうほど濃い色に発光する。
Next, the upper lid 3 will be explained. The upper lid 3 is provided with an electric display 800 as shown in FIG.
The electric display 800 has a plurality of light emitting groups 801a to 801f in which a plurality of light emitting portions 802 are arranged in a row. Each luminescence group 801 a to 801 f corresponds to a drug feeder 5 in the powdered drug dividing area 301 . That is, six drug feeders 5 are installed in the powdered drug division area 301 .
The luminous group 801a corresponds to the drug feeder 5a, the luminous group 801b corresponds to the drug feeder 5b, the luminous group 801c corresponds to the drug feeder 5c, the luminous group 801d corresponds to the drug feeder 5d, and the luminous group 801e corresponds to the drug feeder. 5e, and luminous group 801f corresponds to drug feeder 5f.
In this embodiment, the light emitting groups 801a-801f are arranged in a fan shape.
The light-emitting portions 802 belonging to the light-emitting group 801 are mixed with different colors and/or luminances, and are arranged stepwise so that the color or the like gradually changes from the center toward the outside. In this embodiment, the light is emitted in a lighter color toward the center and darker in color toward the outside.
 発光群801は、使用者が薬剤払出し装置1の動作状況を把握しやすいように電光で知らせるものである。
 薬剤払出し装置1を起動し、準備段階である場合は、準備状況に応じて発光群の発光部が順次発光してゆく。輝度や色彩が変わってもよい。例えばヒートシールのヒータの温度上昇に応じて順次発光する。錠剤手撒き装置303が準備段階である場合も同様に、準備段階に応じて発光状態が変化する。
 薬剤払出し装置1の停止時は、ヒータを冷却するためのファンを駆動し、冷却状況に応じて、発光群の発光部を消灯してゆく。発光群が複数ある場合には、発光群ごと消灯してもよい。
The light-emitting group 801 is used to notify the user of the operation status of the drug dispensing device 1 by electric light.
When the drug dispensing device 1 is started and in the preparation stage, the light emitting units of the light emitting group sequentially emit light according to the preparation state. Brightness and color may vary. For example, it emits light sequentially according to the temperature rise of the heater of the heat seal. Similarly, when the tablet manual distributing device 303 is in the preparatory stage, the light emission state changes according to the preparatory stage.
When the medicine dispensing device 1 is stopped, the fan for cooling the heater is driven, and the light-emitting units of the light-emitting group are extinguished according to the cooling condition. When there are a plurality of light emitting groups, each light emitting group may be turned off.
 また各薬剤フィーダ5における薬剤容器20の装着状況に応じて発光状況が変わる。さらに薬剤容器20の取り外し忘れの警告がなされる。
 一日の作業完了後は、薬剤容器20をフィーダ本体10から取り外すが、取り外し忘れがある場合は、該当する発光群801の発光部802を発光させて警告する。時間の経過とともに、発光させる発光部802や発光群801の数を減らしてゆくことが望ましい。発光色や輝度を変えてもよい。
In addition, the light emission state changes according to the mounting state of the drug container 20 in each drug feeder 5 . Furthermore, a warning is issued that the drug container 20 has been forgotten to be removed.
After the day's work is completed, the medicine container 20 is removed from the feeder main body 10. If the removal is forgotten, the corresponding light-emitting unit 802 of the light-emitting group 801 emits light to issue a warning. It is desirable to reduce the number of light-emitting units 802 and light-emitting groups 801 that emit light over time. The emission color and brightness may be changed.
 薬剤容器20から散薬が払い出されている場合は、対応する発光群801の発光部802が所定の順番で発光する。例えば奥から手前に向かって発光させたり、薄い色から濃い色に発光する等が考えられる。
 要求される払い出し量に対して、薬剤容器20が保有する薬剤量が足りない場合は、対応する発光群801の発光部802が通常とは異なる表示を行う。例えば、通常の場合とは逆に手前から奥に向かって発光させたり、濃い側から薄い側に向かって発光させる。
 薬剤容器20の内の薬剤がすべて払い出されてしまい、薬剤容器20が空になってしまった場合は、対応する発光群801が特定の発光状態となる。
When powdered medicine has been dispensed from the drug container 20, the corresponding light-emitting units 802 of the light-emitting group 801 emit light in a predetermined order. For example, light may be emitted from the back to the front, or light may be emitted from a light color to a dark color.
When the amount of medicine held in the medicine container 20 is insufficient for the required dispensing amount, the corresponding light-emitting section 802 of the light-emitting group 801 performs display different from usual. For example, in contrast to the usual case, light is emitted from the front toward the back, or light is emitted from the dark side toward the light side.
When all the drugs in the drug container 20 have been dispensed and the drug container 20 is empty, the corresponding light emission group 801 is in a specific light emission state.
 何らかのエラーがある場合は、明らかに異なる表示を行う。例えばすべての発光部802を赤色に発光させる。
 エラーの種類は限定されるものではなく、薬剤容器20の異常、フィーダ本体10の異常、その他の異常が考えられる。またその他の異常には錠剤手撒き装置303の異常も含まれる。
If there are any errors, it will display a distinctly different display. For example, all the light emitting units 802 are caused to emit red light.
The type of error is not limited, and may be an abnormality in the drug container 20, an abnormality in the feeder main body 10, or other abnormalities. Other abnormalities also include an abnormality in the tablet hand-dispensing device 303 .
 薬剤容器20の取り付け状況に応じて発光群801を発光させることが望ましい。
 以下に示す発光状態は例示に過ぎず、これに限定されるものではない。
 例えば薬剤容器20が取り付けられていない場合は、対応する発光群801が所定の発光状態となり、薬剤容器20が取り付けられている場合は、これとは異なる発光状態となる。例えば、薬剤容器20が取り付けられていない場合は、対応する発光群801が消灯しており、薬剤容器20が取り付けられている場合は淡い色や、輝度が低い状態で発光する。
 薬剤容器20から薬剤が払い出されている場合は、対応する発光群801が所定の発光状態となり、薬剤容器20からの払い出しを一時停止している場合は、これとは異なる発光状態となる。例えば、薬剤容器20から薬剤が払い出されている場合は、対応する発光群801の発光部802が連続点灯し、薬剤容器20からの払い出しを一時停止している場合は、対応する発光群801の発光部802が点滅する。
 薬剤容器20の払い出しが終了した場合は、発光していた発光部802が消灯する。
 特定のフィーダ本体10に薬剤容器20を設置すべき場合には、対応する発光群801が所定の発光状態となる。
It is desirable to cause the light-emitting group 801 to emit light depending on how the drug container 20 is attached.
The light emission state shown below is merely an example, and is not limited to this.
For example, when the drug container 20 is not attached, the corresponding light emission group 801 is in a predetermined light emission state, and when the drug container 20 is attached, it is in a different light emission state. For example, when the medicine container 20 is not attached, the corresponding light emitting group 801 is turned off, and when the medicine container 20 is attached, it emits light in a pale color or in a state of low brightness.
When the drug is being dispensed from the drug container 20, the corresponding light emitting group 801 is in a predetermined light emitting state, and when the dispensing from the drug container 20 is temporarily stopped, it is in a different light emitting state. For example, when the medicine is being dispensed from the medicine container 20, the corresponding light emitting group 801 of the light emitting unit 802 is lit continuously, and when the dispensing from the medicine container 20 is temporarily stopped, the corresponding light emitting group 801 flashes.
When dispensing of the drug container 20 is completed, the light-emitting part 802 that has been emitting light is extinguished.
When a drug container 20 is to be installed in a specific feeder body 10, the corresponding light-emitting group 801 is in a predetermined light-emitting state.
 また分配皿6の回転に応じて、発光群801を順に発光させてもよい。
 たとえば、yuyamaロゴに最も近い円弧の発光部802aが回転方向と同じ方向に細かく分割されて点灯点滅する。
 メンテナンス要員が、所定の操作をすることにより、薬剤払出し装置1の状況に応じて所定の発光状態となるものであってもよい。
Further, the light emitting group 801 may be caused to emit light in order according to the rotation of the distribution plate 6 .
For example, the arc-shaped light-emitting portion 802a closest to the yuyama logo is finely divided in the same direction as the rotation direction and lights up and flashes.
A predetermined light emitting state may be obtained according to the situation of the medicine dispensing device 1 by a maintenance staff performing a predetermined operation.
 上蓋3の開閉構造は、ヒンジに限定されるものでない。例えば図49、図50の様に上蓋615にカバー616、617を設けてもよい。
 図49に示したカバー616は、図49(b)の様に、奥側にスライドさせることが可能であり、カバー616を奥側に移動させて上蓋615の一部を開放することができる。  
The opening/closing structure of the upper lid 3 is not limited to hinges. For example, covers 616 and 617 may be provided on the upper lid 615 as shown in FIGS.
The cover 616 shown in FIG. 49 can be slid to the back side as shown in FIG.
 図50に示したカバー617は、図50(b)の様に、手前側にスライドさせ、さらに下側に織り込むことが可能である。図50に示したカバー617についても、カバー617の姿勢を変更して上蓋615の一部を開放することができる。 The cover 617 shown in FIG. 50 can be slid to the front side and woven further downward as shown in FIG. 50(b). As for the cover 617 shown in FIG. 50 as well, the position of the cover 617 can be changed to partially open the upper lid 615 .
 特許文献2に開示された薬剤払出し装置は、薬剤容器を多数保管する容器保管装置と、薬剤容器を搬送させるロボットと、薬剤容器を振動させて薬剤容器から薬剤を排出させる容器載置装置と、分配皿とが内蔵されている。また容器載置装置は薬剤容器の重量を測定する重量測定手段を有している。
 そして必要な薬剤容器を自動的に選び出し、ロボットで容器載置装置に載置し、薬剤容器を振動させて薬剤容器から直接分配皿に薬剤を排出する。薬剤を排出する間、重量測定手段で薬剤容器の重量を監視して薬剤の排出量を検知し、排出量が所定量に達すると振動を停止する。
 その後、ロボットを駆動して、薬剤容器を他の重量測定手段の上に移動させ、薬剤容器の重量を他の重量検知手段によって再度検知する。
 この再重量検知動作は、主として重量測定手段の故障検知を目的として実施されるものである。
 即ち、容器載置装置の重量測定手段が検知した薬剤排出後の薬剤容器の重量と、他の重量検知手段によって検知された同じ薬剤容器の重量を比較し、両者が同じであれば、重量測定手段が故障しておらず、両者の間に差異があれば、重量測定手段が故障している可能性がある。
The drug dispensing device disclosed in Patent Document 2 includes a container storage device that stores a large number of drug containers, a robot that transports the drug containers, a container placement device that vibrates the drug containers and discharges the drugs from the drug containers, A distribution plate is built in. The container placement device also has weight measuring means for measuring the weight of the drug container.
Then, the required drug container is automatically selected, placed on the container placing device by the robot, and the drug container is vibrated to discharge the drug directly from the drug container to the distribution tray. While the medicine is being discharged, the weight measuring means monitors the weight of the medicine container to detect the amount of medicine discharged, and when the amount of medicine discharged reaches a predetermined amount, the vibration is stopped.
After that, the robot is driven to move the medicine container onto another weight measuring means, and the weight of the medicine container is detected again by another weight detecting means.
This weight re-detection operation is mainly performed for the purpose of detecting a failure of the weight measuring means.
That is, the weight of the drug container after drug discharge detected by the weight measuring means of the container placing device is compared with the weight of the same drug container detected by another weight detecting means. If the means are not faulty and there is a difference between the two, the weighing means may be faulty.
 特許文献2に開示された薬剤払出し装置では、ロボットを使用して薬剤容器を他の重量測定手段に載せ替えて、重量測定手段の良否を判定するので、ロボットを動作させることが必須である。また特許文献2に開示された薬剤払出し装置では、複数の重量測定手段を使用する必要がある。 In the drug dispensing device disclosed in Patent Document 2, a robot is used to transfer the drug container to another weight measuring means to determine the quality of the weight measuring means, so it is essential to operate the robot. In addition, the medicine dispensing device disclosed in Patent Document 2 needs to use a plurality of weight measuring means.
 以下の発明は、重量測定手段の良否を判定する際に、必ずしもロボットが必要でなく、必ずしも複数の重量測定手段を使用する必要がないものとすることが可能な薬剤フィーダを提供することを課題とする。また、そのような薬剤フィーダを備えた薬剤払出し装置を提供することを課題とする。さらにまた、必ずしもロボットが必要でなく、必ずしも複数の重量測定手段を使用する必要がない薬剤フィーダの校正方法、薬剤フィーダの故障検知方法を提供することを課題とする。 An object of the invention below is to provide a drug feeder that does not necessarily require a robot and does not necessarily require the use of a plurality of weight measuring means when judging the quality of the weight measuring means. and Another object of the present invention is to provide a drug dispensing device having such a drug feeder. A further object of the present invention is to provide a drug feeder calibration method and a drug feeder failure detection method that do not necessarily require a robot and do not necessarily require the use of a plurality of weight measuring means.
 上記した課題を解決するための本発明の一つの様相は、散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記薬剤容器から散薬を排出し、前記重量測定手段によって散薬の排出量を検知することが可能である薬剤フィーダにおいて、錘部材を有し、前記錘部材又は前記重量測定手段又は前記薬剤容器の少なくともいずれかを昇降させる昇降手段を有し、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材の荷重が前記重量測定手段に付加されていない状態を比較して前記重量測定手段の校正を行う、薬剤フィーダである。 One aspect of the present invention for solving the above-described problems is a drug container containing a powdered drug, a holding member for holding the drug container, and a weight for directly or indirectly measuring the weight of the drug container. and measuring means for discharging the powdered medicine from the medicine container and detecting the discharged amount of the powdered medicine by the weight measuring means, the medicine feeder having a weight member, the weight member or the weight measuring means. and a lifting means for lifting and lowering at least one of the means and the drug container, and a state in which the load of the weight member is applied to the weight measuring means and a state in which the load of the weight member is not applied to the weight measuring means. A drug feeder for comparing conditions to calibrate said weighing means.
 本様相の薬剤フィーダによると、外部機器であるロボットや、他の重量測定手段を必ずしも必要とすることなく、重量測定手段の校正や故障検知が可能となる。 According to the drug feeder of this aspect, it is possible to calibrate the weight measurement means and detect failures without necessarily requiring a robot as an external device or other weight measurement means.
 上記した様相は、前記昇降手段は、前記錘部材を昇降させるものであり、前記錘部材が昇降して前記校正を行うことが好ましい。 In the aspect described above, the elevating means elevates the weight member, and it is preferable that the weight member elevates and performs the calibration.
 上記した好ましい様相は、重量受部を有し、前記重量受部は、前記保持部材が前記薬剤容器を保持した状態と、前記保持部材から前記薬剤容器が取り外された状態のそれぞれで、前記錘部材の荷重を受けることが可能であることがさらに好ましい。 The preferred aspect described above has a weight receiving portion, and the weight receiving portion is adapted to support the weight when the holding member holds the drug container and when the drug container is removed from the holding member. It is further preferred to be able to take the load of the member.
 この様相によると、薬剤容器を保持した状態と、薬剤容器を取り外した状態のいずれにおいても重量測定手段を校正できる。 According to this aspect, the weight measuring means can be calibrated both in a state in which the drug container is held and in a state in which the drug container is removed.
 上記した好ましい様相は、前記錘部材と、前記昇降手段と、前記錘部材の荷重を受けることが可能な重量受部を含んで形成される測定手段検査部を有し、前記測定手段検査部によって前記校正が実行されるものであり、前記測定手段検査部は、前記保持部材から側方に離れた位置に配されることがさらに好ましい。 The preferred aspect described above has a measurement means inspection section formed including the weight member, the lifting means, and a weight receiving section capable of receiving the load of the weight member, and the measurement means inspection section It is further preferable that the calibration is performed, and the measuring means inspection portion is arranged at a position laterally spaced from the holding member.
 このさらに好ましい様相によると、仮に重量測定手段の校正を実行する測定手段検査部が故障したとしても、測定手段検査部の交換やメンテナンスが容易となる。 According to this more preferable aspect, even if the measuring means inspecting part for calibrating the weight measuring means fails, replacement and maintenance of the measuring means inspecting part become easy.
 上記した好ましい様相は、重量受部を有し、前記昇降手段は、動力源であるモータと、前記モータの稼働によって回転するカムと、前記カムの上に載置される昇降部材を有し、前記昇降部材は、前記カムの上に載置された状態を維持しつつ前記カムの回転に伴って上下に移動するものであり、前記昇降部材が前記錘部材を下方から押し上げることで、前記錘部材が前記重量受部に接触した状態から、前記錘部材が前記重量受部に接触しない状態に移行することがさらに好ましい。 The preferred aspect described above has a weight receiving portion, and the lifting means includes a motor as a power source, a cam rotated by the operation of the motor, and a lifting member mounted on the cam, The elevating member moves up and down as the cam rotates while maintaining a state of being placed on the cam. It is further preferable that the state in which the member is in contact with the weight receiving portion is shifted to the state in which the weight member is not in contact with the weight receiving portion.
 このさらに好ましい様相によると、簡易な構造で重量測定手段の校正が可能である。 According to this more preferable aspect, it is possible to calibrate the weight measuring means with a simple structure.
 上記した好ましい様相は、重量受部を有し、前記重量受部は、前記保持部材の一部であり、保持した前記薬剤容器の下方側となる位置に形成され、前記錘部材を昇降させることで、前記錘部材が前記重量受部に載置され、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材が前記重量受部から上方に離れた状態とが切り替わり、前記錘部材は、前記重量受部に載置された状態と、前記重量受部から上方に離れた状態のそれぞれで、保持した前記薬剤容器よりも下方側となる位置に配される、ことがさらに好ましい。 The preferred aspect described above has a weight receiving portion, and the weight receiving portion is a part of the holding member, is formed at a position below the held drug container, and lifts and lowers the weight member. and switching between a state in which the weight member is placed on the weight receiving portion and the load of the weight member is applied to the weight measuring means and a state in which the weight member is separated upward from the weight receiving portion, The weight member may be arranged at a position below the held drug container in each of the state of being placed on the weight receiving portion and the state of being separated upward from the weight receiving portion. More preferred.
 このさらに好ましい様相によると、薬剤フィーダの配置のために必要な領域を省スペース化できるので、好ましい。 According to this more preferable aspect, it is possible to save the space required for arranging the drug feeder, which is preferable.
 上記した様相は、前記薬剤容器を手動で前記保持部材に保持させることが可能であり、前記保持部材に保持させた前記薬剤容器を手動で取り外すことが可能であることが好ましい。 In the aspect described above, it is preferable that the drug container can be manually held by the holding member, and the drug container held by the holding member can be manually removed.
 本発明の他の様相は、上記した薬剤フィーダを備えている、薬剤払出し装置である。 Another aspect of the present invention is a drug dispensing device comprising the drug feeder described above.
 かかる様相においても、ロボットや、他の重量測定手段を必ずしも必要とすることなく、重量測定手段の校正が可能となる。 Even in this aspect, it is possible to calibrate the weight measurement means without necessarily requiring a robot or other weight measurement means.
 上記した様相は、散薬を包装する薬剤包装部と、前記薬剤包装部に供給する散薬が投入されるホッパー部材と、ホッパー部材の重量を直接的又は間接的に測定するホッパー側重量測定手段を有し、前記重量測定手段の検出値に基づいて目標排出量の散薬を排出し、排出された散薬をホッパー部材に投入するものであり、前記ホッパー側重量測定手段の検出値に基づいて前記故障検知を行うことが好ましい。 The aspect described above has a medicine packaging unit for packaging powdered medicine, a hopper member into which the powdered medicine to be supplied to the medicine packaging unit is put, and a hopper-side weight measuring means for directly or indirectly measuring the weight of the hopper member. Then, a target amount of powdered medicine is discharged based on the detected value of the weight measuring means, and the discharged powdered medicine is put into the hopper member, and the failure is detected based on the detected value of the hopper side weight measuring means. It is preferable to
 かかる様相では、散薬の排出動作の際に重量測定手段が正常であったか否かを判別できため、重量測定手段が故障してしまったことに起因する問題の発生を抑制できる。 In this aspect, it is possible to determine whether or not the weight measuring means was normal during the operation of discharging the powdered medicine, so it is possible to suppress the occurrence of problems caused by the failure of the weight measuring means.
 本発明の他の様相は、散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記重量測定手段によって散薬の排出量を検出することが可能な薬剤フィーダの校正方法であって、錘部材の荷重を前記重量測定手段に付加した状態で前記重量測定手段による重量測定を行う重量取得工程を含み、前記重量取得工程で取得した重量と、予め記憶された重量とを比較して前記重量測定手段が正常であるか否かを判別する、薬剤フィーダの校正方法である。 Another aspect of the present invention comprises a medicine container containing a powdered medicine, a holding member holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container, A method for calibrating a drug feeder capable of detecting the amount of powdered medicine discharged by a weight measuring means, comprising: a weight acquisition step of performing weight measurement by the weight measuring means in a state in which a load of a weight member is applied to the weight measuring means. and comparing the weight obtained in the weight obtaining step with a pre-stored weight to determine whether or not the weight measuring means is normal.
 本発明の他の様相は、散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記重量測定手段によって散薬の排出量を検出することが可能な薬剤フィーダの故障検知方法であって、錘部材の荷重を前記重量測定手段に付加した状態で前記重量測定手段による重量測定を行う重量取得工程を含み、散薬の排出動作に先立って前記重量取得工程を行い、散薬の排出動作後にさらに前記重量取得工程を行い、散薬の排出動作に先立って行った前記重量取得工程で取得した重量と、散薬の排出動作後に行った前記重量取得工程で取得した重量とを比較し、散薬の排出動作の際に前記重量測定手段が故障していなかったか否かを判別する、薬剤フィーダの故障検知方法である。 Another aspect of the present invention comprises a medicine container containing a powdered medicine, a holding member holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container, A drug feeder failure detection method capable of detecting the amount of powdered medicine discharged by a weight measuring means, wherein the weight is measured by the weight measuring means while a load of a weight member is applied to the weight measuring means. performing the weight obtaining step prior to the operation of discharging the powdered medicine, further performing the weight obtaining step after the operation of discharging the powdered medicine, and weight obtained in the weight obtaining step performed prior to the operation of discharging the powdered medicine; A failure detection method for a medicine feeder, wherein the weight obtained in the weight obtaining step performed after the powdered medicine discharging operation is compared with the weight obtained in the weight obtaining process to determine whether or not the weight measuring means has failed during the powdered medicine discharging operation. be.
 本様相によると、外部機器であるロボットや、他の重量測定手段を必ずしも必要とすることなく、重量測定手段の校正や故障検知が可能となる。 According to this aspect, it is possible to calibrate the weight measurement means and detect failures without necessarily requiring a robot as an external device or other weight measurement means.
 上記した様相は、散薬の排出動作では、前記薬剤容器の散薬排出部を開状態として散薬の排出を行い、散薬の排出量を検出する動作では、散薬排出前の前記薬剤容器の重量を原重量として取得する動作を実行しており、前記薬剤容器の散薬排出部を開状態とする前に、散薬排出前の前記薬剤容器の重量を原重量として取得する動作を実行することが好ましい。 In the above aspect, in the operation of discharging the powdered medicine, the powdered medicine is discharged with the powdered medicine discharging portion of the medicine container in the open state. , and preferably the weight of the drug container before discharging the powdered drug is obtained as the original weight before opening the powdered drug discharging portion of the drug container.
 かかる様相によると、より精度の高い散薬の排出が可能となる。 According to this aspect, it is possible to discharge powdered medicine with higher accuracy.
 本発明は、重量測定手段の良否を判定する際に、必ずしもロボットが必要でなく、必ずしも複数の重量測定手段を使用する必要がないものとすることが可能な薬剤フィーダを提供できる。また、そのような薬剤フィーダを備えた薬剤払出し装置を提供できる。さらにまた、必ずしもロボットが必要でなく、必ずしも複数の重量測定手段を使用する必要がない薬剤フィーダの校正方法、薬剤フィーダの故障検知方法を提供できる。 The present invention can provide a drug feeder that does not necessarily require a robot and does not necessarily require the use of a plurality of weight measurement means when determining the quality of the weight measurement means. Also, it is possible to provide a drug dispensing device equipped with such a drug feeder. Furthermore, it is possible to provide a drug feeder calibration method and a drug feeder failure detection method that do not necessarily require a robot and do not necessarily require the use of a plurality of weight measuring means.
 薬剤払出し装置1では、薬剤容器20から分配皿6に散薬を排出(供給)する際、排出ムラの発生があるか否かと、排出された量に異常があるか否かを判別することで、一包分(一服用分)の分量が正しいか否かを判別する配分チェック動作を実行する。
 詳細に説明すると、散薬の排出時には、上記したように、散薬の落下量Hが常時演算され続けている。そして、この散薬の落下量Hに基づいて、分配皿6への散薬の排出速度(単位時間当たりの排出量)を演算する。ここで、単位時間当たりの排出量が規定値から外れたとき、即ち、時間当たりの排出量が極端に少なくなったり、逆に極端に多くなったりしたことが検知されたとき、排出ムラが発生したものと判別する。
 また、散薬の排出時には、散薬の排出が開始される前と、散薬の排出が完了した後のそれぞれで薬剤容器20に収容された散薬の重量を測定する。そして、排出開始前の散薬の重量から排出完了後の散薬の重量を引いた値が、排出予定量(処方に基づく目標排出量)と同じであったとき、排出量に異常がないものと判別し、反対に同じでなかったとき、排出量に異常があったものと判別する。
 排出ムラが発生したと判別された場合や、排出された量に異常があったと判別された場合、その旨を報知する報知動作を実行する。報知動作は、薬剤払出し装置1にスピーカ等の音声発生手段や、ディスプレイ等の表示装置を設け、警告音や音声の出力、メッセージの表示を実行する動作であってもよい。このことは、以下の説明における報知動作においても同様である。
In the medicine dispensing device 1, when discharging (supplying) the powdered medicine from the medicine container 20 to the distribution tray 6, it is determined whether there is uneven discharge and whether there is an abnormality in the discharged amount. An allocation check operation is performed to determine whether the amount of one package (one dose) is correct.
More specifically, when the powdered medicine is discharged, the falling amount H of the powdered medicine is constantly calculated as described above. Then, based on the falling amount H of the powdered medicine, the discharge speed (discharged amount per unit time) of the powdered medicine to the distribution tray 6 is calculated. Here, when the amount of discharge per unit time deviates from the specified value, that is, when it is detected that the amount of discharge per unit of time has become extremely small or, conversely, has become extremely large, uneven discharge occurs. It is determined that
Further, when discharging the powdered medicine, the weight of the powdered medicine contained in the medicine container 20 is measured before the discharge of the powdered medicine is started and after the discharge of the powdered medicine is completed. When the value obtained by subtracting the weight of powdered medicine after completion of discharging from the weight of powdered medicine before starting discharging is the same as the expected discharge amount (target discharge amount based on prescription), it is determined that there is no abnormality in the discharged amount. On the other hand, if they are not the same, it is determined that there is an abnormality in the amount of discharge.
When it is determined that uneven discharge has occurred, or when it is determined that there is an abnormality in the discharged amount, a notification operation is performed to notify that effect. The notification operation may be an operation in which the medicine dispensing device 1 is provided with sound generating means such as a speaker and a display device such as a display, and outputs warning sounds and voices, and displays a message. This also applies to the notification operation in the following description.
 続いて、本実施形態の特徴的な部分である重量校正部21について説明する。
 本実施形態の重量校正部21は、図51で示されるように、上記した分銅42及び分銅載置部材43と、昇降装置173(昇降手段)と、上側ガイド部材175と、制御装置176を有している。昇降装置173、上側ガイド部材175、制御装置176は、取付部材177を介して土台部26(図4参照)に固定されている。つまり、これらの荷重は土台部26に付加される。
Next, the weight calibration unit 21, which is a characteristic part of this embodiment, will be described.
As shown in FIG. 51, the weight calibration section 21 of the present embodiment includes the weight 42 and the weight placement member 43 described above, an elevating device 173 (elevating means), an upper guide member 175, and a control device 176. is doing. The lifting device 173 , the upper guide member 175 , and the control device 176 are fixed to the base portion 26 (see FIG. 4) via mounting members 177 . In other words, these loads are applied to the base portion 26 .
 なお、分銅載置部材43、取付部材177は、それぞれが容器支持部23、土台部26に対して直接、又は他部材を介して間接的に取り付けられている(図4参照)。このとき、分銅載置部材43、取付部材177は、一時締結要素を介して取り付けられる。
 ここでいう「一時締結要素」とは、締結要素の一種であり、原則的に破壊せずに取り外
しが可能な締結要素をいい、例えば、ねじ、ボルトナットの組み合わせ等であり、本実施形態では、ねじである。以上のことから、重量校正部21は、薬剤フィーダ5からの取り外しが可能(フィーダ本体10に対して着脱可能)である。
The weight placing member 43 and the mounting member 177 are directly mounted to the container supporting portion 23 and the base portion 26, respectively, or indirectly via other members (see FIG. 4). At this time, the weight placement member 43 and the attachment member 177 are attached via temporary fastening elements.
The term "temporary fastening element" as used herein refers to a type of fastening element, and in principle refers to a fastening element that can be removed without being destroyed. , is the screw. As described above, the weight calibration unit 21 can be removed from the drug feeder 5 (detachable from the feeder main body 10).
 分銅42は、図52で示されるように、外形が略球形となる金属製の錘である。
 分銅載置部材43は、平板状の受板部43aと、立板状の取付板部43bが一体に形成された部材である。取付板部43bは、取付対象物(容器支持部23や容器支持部23との間に介在する取付用部材)に添え当てる部分であり、ねじ孔を有する。
The weight 42 is a metal weight having an approximately spherical outer shape, as shown in FIG.
The weight mounting member 43 is a member in which a flat plate-like receiving plate portion 43a and an upright plate-like mounting plate portion 43b are integrally formed. The mounting plate portion 43b is a portion to be affixed to an object to be mounted (the container support portion 23 or a mounting member interposed between the container support portion 23) and has a screw hole.
 受板部43aには、係合孔部67が設けられている。係合孔部67は、開口形状が円形の貫通孔であり、受板部43aを厚さ方向(上下方向)に貫通する。また、係合孔部67は、分銅42が通過できず、分銅支持部材45が通過可能な大きさである。 An engagement hole portion 67 is provided in the receiving plate portion 43a. The engagement hole portion 67 is a through hole having a circular opening shape, and penetrates the receiving plate portion 43a in the thickness direction (vertical direction). The engagement hole 67 has a size that allows the weight support member 45 to pass through but not the weight 42 .
 昇降装置173は、図51、図52で示されるように、動力源(動力部)となるモータ83と、カム85と、分銅支持部材45(昇降部材)と、支持側ガイド部材82を有する。 As shown in FIGS. 51 and 52, the lifting device 173 has a motor 83 serving as a power source (power section), a cam 85, a weight supporting member 45 (lifting member), and a support-side guide member 82.
 カム85は、モータ83の出力軸に固定され、モータ83の稼働に伴って回転する。本実施形態では、回転中心から外周面までの距離が周方向において変化する偏心カムを採用している。
 分銅支持部材45は、図52で示されるように、上面に窪み部45aを有する縦長の略直方体状の部材である。この窪み部45aは、分銅42が載置される部分であり、換言すると、分銅42の一部と係合する係合部となる。つまり、分銅42の一部(下側部分)が略丁度嵌ることが可能な形状であり、分銅42を載置した際に分銅42の一部と接する湾曲面を有する。この湾曲面は、中心から縁部分に向かって窪み深さが浅くなる。
The cam 85 is fixed to the output shaft of the motor 83 and rotates as the motor 83 operates. This embodiment employs an eccentric cam in which the distance from the center of rotation to the outer peripheral surface changes in the circumferential direction.
As shown in FIG. 52, the weight support member 45 is a vertically elongated substantially rectangular parallelepiped member having a recess 45a on its upper surface. The recessed portion 45a is a portion on which the weight 42 is placed. In other words, it has a shape in which a part (lower part) of the weight 42 can be fitted almost exactly, and has a curved surface that comes into contact with a part of the weight 42 when the weight 42 is placed. This curved surface has a recessed depth that becomes shallower from the center toward the edge.
 支持側ガイド部材82は、平面視した外形が略四角形状となるように形成された厚板状の部材である。支持側ガイド部材82には、ガイド孔86が設けられている。ガイド孔86は、支持側ガイド部材82を厚さ方向(上下方向)に貫通する貫通孔であり、分銅支持部材45を略丁度挿通することが可能な大きさに形成されている。 The support-side guide member 82 is a thick plate-shaped member formed to have a substantially square outer shape when viewed from above. A guide hole 86 is provided in the support-side guide member 82 . The guide hole 86 is a through hole that passes through the support-side guide member 82 in the thickness direction (vertical direction), and is formed to have a size that allows the weight support member 45 to be substantially just inserted therethrough.
 上側ガイド部材175は、上下方向に厚さを有する厚板状の部材である。上側ガイド部材175の下面には、図53で示されるように、ガイド凹部88が設けられている。ガイド凹部88は、上側に底部分を有する有底孔であり、略円錐台状(略すり鉢状)となるように窪んだ窪み部分である。 The upper guide member 175 is a thick plate-like member having a thickness in the vertical direction. A guide recess 88 is provided on the lower surface of the upper guide member 175 as shown in FIG. The guide recessed portion 88 is a bottomed hole having a bottom portion on the upper side, and is a recessed portion that is recessed in a substantially truncated cone shape (substantially mortar shape).
 制御装置176は、重量校正部21の動作を制御する制御基板であり、薬剤払出し装置1の本体側の制御装置と情報の送受信が可能である。つまり、制御装置176は、CPU等の演算手段と、メモリ等の記憶手段と、I/Оポート等の通信手段を有する。なお、本体側の制御装置等の外部機器との通信は、有線通信としてもよく、無線通信としてもよい。 The control device 176 is a control board that controls the operation of the weight calibration unit 21, and can transmit and receive information to and from the control device on the main body side of the medicine dispensing device 1. That is, the control device 176 has computing means such as a CPU, storage means such as a memory, and communication means such as an I/O port. Communication with an external device such as a control device on the main body side may be wired communication or wireless communication.
 取付部材177は、図52で示されるように、立板状の取付板部87を有する本体部63aと、制御装置取付部63bを有し、本体部63aに制御装置取付部63bを取り付けた状態で土台部26に対して取り付ける。 As shown in FIG. 52, the mounting member 177 has a main body portion 63a having an upright mounting plate portion 87 and a control device mounting portion 63b. is attached to the base portion 26 with .
 続いて、重量校正部21の組み立て構造について説明する。
 図51で示されるように、取付部材177の本体部63aを挟んだ両側にモータ83とカム85が配される。本体部63aには、本体部63aの一方の主面側に配されるモータ83と、他方の主面側に配される支持側ガイド部材82及び上側ガイド部材175が取り付けられる。このとき、カム85の上方に、支持側ガイド部材82が配され、そのさらに上方に上側ガイド部材175が配される。
Next, an assembly structure of the weight calibration unit 21 will be described.
As shown in FIG. 51, a motor 83 and a cam 85 are arranged on both sides of the mounting member 177 with the body portion 63a therebetween. A motor 83 arranged on one main surface side of the main body portion 63a, and a support-side guide member 82 and an upper guide member 175 arranged on the other main surface side are attached to the main body portion 63a. At this time, the support-side guide member 82 is arranged above the cam 85, and the upper guide member 175 is arranged further above it.
 取付部材177の制御装置取付部63bは、図51、図52で示されるように、一部がカム85を回りこむように延びている。このため、カム85は、図51で示されるように、モータ83と制御装置176の間となる位置に配される。 The control device mounting portion 63b of the mounting member 177 partially extends around the cam 85 as shown in FIGS. Thus, the cam 85 is positioned between the motor 83 and the controller 176, as shown in FIG.
 分銅支持部材45は、カム85の上に載置され、ガイド孔86に挿通された状態で配される。また、受板部43aは、支持側ガイド部材82から上方に離れた位置に配され、受板部43aの上側に分銅42が配される。そして、分銅42の上側に上側ガイド部材175が配される。 The weight support member 45 is placed on the cam 85 and inserted through the guide hole 86 . Further, the receiving plate portion 43a is arranged at a position spaced upward from the supporting side guide member 82, and the weight 42 is arranged above the receiving plate portion 43a. An upper guide member 175 is arranged above the weight 42 .
 重量校正部21は、図54で示されるように、モータ83を稼働させることで、上記したように、分銅42の荷重が受板部43aに付加されない第一の状態と、分銅42の荷重が受板部43aに付加される第二の状態を切り替えることができる。 As shown in FIG. 54, the weight calibration unit 21 operates the motor 83 to obtain the first state in which the load of the weight 42 is not applied to the receiving plate portion 43a, and the load of the weight 42 as described above. The second state added to the receiving plate portion 43a can be switched.
 第一の状態は、図54(a)で示されるように、分銅42が分銅支持部材45によって持ち上げられ、受板部43aの上方に位置し、受板部43aと接触しない状態となる。即ち、分銅42は、係合孔部67の上部開口と接触しない。本実施形態では、このとき、分銅42の下側の一部が、係合孔部67の内側に位置した状態となる。
 また、第一の状態では、分銅42の上部が、上側ガイド部材175のガイド凹部88の奥まで入り込んだ状態となる。
In the first state, as shown in FIG. 54(a), the weight 42 is lifted by the weight support member 45, is positioned above the receiving plate portion 43a, and is not in contact with the receiving plate portion 43a. That is, the weight 42 does not contact the upper opening of the engaging hole 67 . In the present embodiment, at this time, a portion of the lower side of the weight 42 is positioned inside the engaging hole portion 67 .
Also, in the first state, the upper portion of the weight 42 is in a state of being deeply inserted into the guide concave portion 88 of the upper guide member 175 .
 第一の状態でモータ83が稼働し、カム85が回転すると、図54(b)、図54(c)で示されるように、分銅支持部材45が下方に移動すると共に、分銅42が分銅支持部材45に載置された状態のまま下方に移動する。そして、分銅42の一部が係合孔部67の上部開口と接触し、分銅42が受板部43aに載置された状態となる。このことにより、第一の状態(図54(a)参照)から第二の状態(図54(c)参照)に移行する。
 なお、第二の状態では、分銅支持部材45が分銅42から下方に離れた位置に配された状態、即ち、分銅42と分銅支持部材45が接触せず、分銅42と分銅支持部材45の上面との間に隙間が形成される状態とすることが好ましい。反対に、分銅42の全ての荷重を受板部43aで受けるように形成するのであれば、第二の状態で分銅42と分銅支持部材45とが接触する状態(隣接配置された状態)としてもよい。
When the motor 83 operates in the first state and the cam 85 rotates, the weight support member 45 moves downward and the weight 42 moves downward as shown in FIGS. 54(b) and 54(c). It moves downward while being placed on the member 45 . Then, a part of the weight 42 comes into contact with the upper opening of the engagement hole portion 67, and the weight 42 is placed on the receiving plate portion 43a. As a result, the first state (see FIG. 54(a)) shifts to the second state (see FIG. 54(c)).
In the second state, the weight support member 45 is positioned downwardly away from the weight 42, that is, the weight 42 and the weight support member 45 are not in contact with each other, and the upper surfaces of the weight 42 and the weight support member 45 are not in contact with each other. It is preferable to set a state in which a gap is formed between. Conversely, if all the load of the weight 42 is to be received by the receiving plate portion 43a, the weight 42 and the weight support member 45 are in contact with each other in the second state (the state in which they are arranged adjacently). good.
 第二の状態でもまた、分銅42の上部が、上側ガイド部材175のガイド凹部88の内側に位置した状態となっている。つまり、分銅42が移動可能な範囲内で上下に移動するとき、分銅42の上側の一部がガイド凹部88の内側に位置し、下側の一部が係合孔部67の内側に位置した状態が維持される。言い換えると、第一の状態、第二の状態、これらの移行途中の状態のそれぞれにおいて、分銅42は、一部がガイド凹部88の内側に常時位置し、且つ、一部が係合孔部67の内側に常時位置した状態となる。 Also in the second state, the upper portion of the weight 42 is positioned inside the guide recess 88 of the upper guide member 175 . That is, when the weight 42 moves up and down within the movable range, the upper part of the weight 42 is positioned inside the guide recess 88 and the lower part is positioned inside the engagement hole 67. state is maintained. In other words, in each of the first state, the second state, and the state in the middle of transition, the weight 42 is partly always positioned inside the guide recess 88 and partly positioned inside the engaging hole 67 . It will be in a state where it is always located inside the
 以上のことから、上側ガイド部材175と、受板部43aは、分銅42の移動時に移動範囲を規制する移動規制手段として機能すると共に、分銅42の脱落を防止する脱落防止手段としても機能する。
 なお、分銅支持部材45もまた、移動範囲内で上下方向に移動するとき、いずれかの部分がガイド孔86の内側に位置した状態となる。つまり、支持側ガイド部材82は、分銅支持部材45の移動範囲を規制する移動規制手段として機能すると共に、分銅支持部材45の脱落を防止する脱落防止手段としても機能する。
As described above, the upper guide member 175 and the receiving plate portion 43a function as movement restricting means for restricting the range of movement of the weight 42, and also function as drop-off preventing means for preventing the weight 42 from dropping off.
When the weight support member 45 also moves vertically within the range of movement, some portion of the weight support member 45 is positioned inside the guide hole 86 . In other words, the support-side guide member 82 functions as movement restricting means for restricting the movement range of the weight support member 45, and also functions as drop prevention means for preventing the weight support member 45 from dropping off.
 第二の状態から第一の状態に移行する際には、第一の状態から第二の状態に移行する際と同方向にカム85を回転させてもよく、逆方向にカム85を回転させてもよい。
 このようにカム85を回転させることで、分銅支持部材45(分銅支持部材45とカム85の接触位置)が上方へ移動し、分銅42が持ち上げられて上方に移動する。
When shifting from the second state to the first state, the cam 85 may be rotated in the same direction as when shifting from the first state to the second state, or may be rotated in the opposite direction. may
By rotating the cam 85 in this manner, the weight support member 45 (contact position between the weight support member 45 and the cam 85) moves upward, and the weight 42 is lifted and moved upward.
 本実施形態の重量校正部21によると、フィーダ部22に薬剤容器20を取り付けていない状態と、フィーダ部22に薬剤容器20を取り付けた状態のそれぞれで、重量測定手段25が正常であるか否かを判別することができる。以下、この判別動作を重量測定手段25の校正とも称す。即ち、重量測定手段25の校正とは、重量測定手段25が正しく重量を検知可能な状態であるのか、又は、何等かの理由で正しく重量を検知できない状態であるのかを確定する動作である。 According to the weight calibration unit 21 of the present embodiment, whether or not the weight measuring means 25 is normal in the state in which the drug container 20 is not attached to the feeder unit 22 and the state in which the drug container 20 is attached to the feeder unit 22 is determined. can be determined. Hereinafter, this determination operation is also referred to as calibration of the weight measuring means 25 . That is, calibration of the weight measuring means 25 is an operation to determine whether the weight measuring means 25 is in a state in which the weight can be detected correctly, or whether the weight cannot be detected correctly for some reason.
 本実施形態では、上記したように、重量測定手段25で分銅42の重量が正しく検知されたことを条件として、重量測定手段25が正しく重量を検知可能な状態であると判別する。即ち、重量校正部21を第一の状態から第二の状態に移行させると、上記したように、受板部43aに分銅42の荷重が付加される。このとき、分銅載置部材43が容器支持部23に取り付けられているので、受板部43aで分銅42の荷重を受けることで、重量測定手段25によって分銅42の重量が検知可能な状態となる。 In the present embodiment, as described above, on the condition that the weight of the weight 42 is correctly detected by the weight measuring means 25, it is determined that the weight measuring means 25 is in a state of being able to correctly detect the weight. That is, when the weight calibration section 21 is shifted from the first state to the second state, the load of the weight 42 is applied to the receiving plate section 43a as described above. At this time, since the weight mounting member 43 is attached to the container support portion 23, the load of the weight 42 is received by the receiving plate portion 43a, so that the weight of the weight 42 can be detected by the weight measuring means 25. .
 そこで、第一の状態で重量測定手段25による重量測定を行い、その後に第二の状態に移行させて重量測定手段25による重量測定を行う。そして、第二の状態で実行した2回目の重量測定の検出値(測定値)から、第一の状態で実行した1回目の重量測定の検出値を減算した値が分銅42の重量と同一となったことを条件として、分銅42の重量が正しく検知されていると判別する。 Therefore, the weight is measured by the weight measuring means 25 in the first state, and then the weight is measured by the weight measuring means 25 in the second state. Then, the value obtained by subtracting the detected value of the first weight measurement performed in the first state from the detected value (measured value) of the second weight measurement performed in the second state is the same as the weight of the weight 42. It is determined that the weight of the weight 42 is correctly detected on the condition that the weight is equal to the weight.
 この他、薬剤容器20を取り付けていない状態の校正では、例えば、以下の動作を実行してもよい。即ち、第二の状態にして重量測定手段25による重量測定を行い、検出値から基本重量を差し引いた値を算出する。
 ここで、「基本重量」とは、フィーダ部22を構成する部材のうちで重量測定手段25に荷重が掛かる部材の重量と、分銅載置部材43の重量の合計とする。また、「分銅載置部材43の重量」とは、分銅載置部材43に他部材を介して容器支持部23に取り付ける場合、この他部材の重量を含む。
 そして、検出値から基本重量を差し引いた値が分銅42の重量と同一となったことを条件として、分銅42の重量が正しく検知されていると判別する。このとき、検出値が、分銅42の重量と基本重量の合計値と同一となったことを条件として、分銅42の重量が正しく検知されていると判別してもよい。
 フィーダ部22を構成する部材のうちで重量測定手段25に荷重が掛かる部材の重量や、分銅載置部材43の重量、分銅42の重量は、他の電子天秤等で予め測定しておき、制御装置に記憶させておいてもよい。
In addition, the following operations may be performed in the calibration without the drug container 20 attached. That is, the weight is measured by the weight measuring means 25 in the second state, and the value obtained by subtracting the basic weight from the detected value is calculated.
Here, the “basic weight” is the sum of the weight of the members constituting the feeder section 22 that apply a load to the weight measuring means 25 and the weight of the weight placement member 43 . Further, "the weight of the weight placing member 43" includes the weight of the other member when the weight placing member 43 is attached to the container support portion 23 via another member.
Then, on the condition that the value obtained by subtracting the basic weight from the detected value is the same as the weight of the weight 42, it is determined that the weight of the weight 42 is correctly detected. At this time, it may be determined that the weight of the weight 42 is correctly detected on the condition that the detected value is equal to the sum of the weight of the weight 42 and the basic weight.
Among the members constituting the feeder section 22, the weight of the members to which a load is applied to the weight measuring means 25, the weight of the weight mounting member 43, and the weight of the weight 42 are measured in advance by another electronic balance or the like, and controlled. It may be stored in the device.
 この他、薬剤容器20を取り付けた状態の校正では、例えば、第二の状態で重量測定手段25による重量測定を行い、検出値から基本重量と薬剤容器20の重量の合計値を差し引いた値を算出する。そして、算出した値が分銅42の重量と同一となったことを条件として、分銅42の重量が正しく検知されていると判別する。このとき、検出値が、分銅42の重量と、基本重量と、薬剤容器20の重量の合計値と同一となったことを条件として、分銅42の重量が正しく検知されていると判別してもよい。
 なお、薬剤容器20の重量は、予め測定して制御装置に記憶させておいてもよい。また、薬剤容器20の重量は、内部に薬剤(散薬)が収容されている場合、薬剤容器20そのものの重量と、収容された薬剤の重量の合計値としてもよい。
In addition, in the calibration with the drug container 20 attached, for example, the weight is measured by the weight measuring means 25 in the second state, and the value obtained by subtracting the total value of the basic weight and the weight of the drug container 20 from the detected value is obtained. calculate. Then, on the condition that the calculated value is the same as the weight of the weight 42, it is determined that the weight of the weight 42 is correctly detected. At this time, it is determined that the weight of the weight 42 is correctly detected on the condition that the detected value is the same as the sum of the weight of the weight 42, the basic weight, and the weight of the medicine container 20. good.
The weight of the drug container 20 may be measured in advance and stored in the control device. In addition, the weight of the medicine container 20 may be the sum of the weight of the medicine container 20 itself and the weight of the contained medicine when medicine (powder medicine) is contained therein.
 本実施形態の薬剤払出し装置1では、電源を投入して1日の作業を開始する前に、それぞれの薬剤フィーダ5の重量測定手段25の校正を自動で実行する。
 加えて、分包動作を実行することが決定されると、その分包動作の実行前にそれぞれの薬剤フィーダ5の重量測定手段25の校正を自動で行う。なお、分包動作の実行前に行う校正では、全ての薬剤フィーダ5で実行する他、次に実行予定の分包動作で使用される薬剤フィーダ5のみで実行してしてもよい。
In the medicine dispensing device 1 of the present embodiment, the weighing means 25 of each medicine feeder 5 is automatically calibrated before the power is turned on and the work of the day is started.
In addition, when it is decided to perform the packaging operation, the weight measuring means 25 of each medicine feeder 5 is automatically calibrated before the packaging operation is performed. Note that the calibration performed before execution of the packaging operation may be performed for all the medicine feeders 5, or may be performed only for the medicine feeder 5 used in the packaging operation scheduled to be performed next.
 また、1日の作業開始前に実行する重量測定手段25の校正では、前日の校正で取得又は算出した値と、校正の実行時に取得又は算出した値を比較する動作を実行してもよい。例えば、前日の校正で算出した分銅42の重量の値と、電源投入後に算出した分銅42の重量の値を比較し、これらが同一である場合に、薬剤フィーダ5の重量測定手段25に異常がないものと判別してもよい。反対にこれらが同一でない場合に、薬剤フィーダ5の重量測定手段25に異常があると判別してもよい。 In addition, in the calibration of the weight measuring means 25 performed before the start of work on the day, an operation of comparing the value obtained or calculated in the previous day's calibration with the value obtained or calculated in performing the calibration may be performed. For example, the weight value of the weight 42 calculated in the previous day's calibration is compared with the weight value of the weight 42 calculated after the power is turned on. It may be determined that there is none. Conversely, if they are not the same, it may be determined that the weight measuring means 25 of the drug feeder 5 is abnormal.
 本実施形態の薬剤払出し装置1は、校正によって重量測定手段25が正しく重量の測定ができない状態である(重量測定手段25に異常がある)と判別された場合、その旨を報知する報知動作を実行してもよい。また、重量測定手段25の異常(故障)が解消されるまでの間(一定の操作等よって異常が解消されたことが入力されるまでの間)、使用者が誤って薬剤容器20をフィーダ本体10に載置(保持)しても、このフィーダ本体10による薬剤の排出ができない旨を報知する報知動作を実行してもよい。この報知動作は、薬剤容器20をフィーダ本体10に載置される都度、実行される。又は、この動作に加えて、又は替えて、フィーダ本体10が振動動作を実行しないように制御する(振動動作を実行しない設定とする)。 When it is determined by calibration that the weight measuring means 25 is incapable of correctly measuring weight (the weight measuring means 25 has an abnormality), the medicine dispensing device 1 of the present embodiment performs a notification operation to notify that effect. may be executed. In addition, until the abnormality (failure) of the weight measuring means 25 is resolved (until the fact that the abnormality has been resolved is input by a certain operation, etc.), the user may mistakenly place the medicine container 20 into the feeder body. A notification operation may be performed to notify that the medicine cannot be discharged by the feeder main body 10 even if the medicine is placed (held) on the feeder body 10 . This notification operation is performed each time the drug container 20 is placed on the feeder body 10 . Alternatively, in addition to or instead of this operation, the feeder main body 10 is controlled so as not to perform the vibrating operation (set to not perform the vibrating operation).
 本実施形態の薬剤払出し装置1では、分包動作において薬剤容器20から分配皿6に散薬を排出する際、重量測定手段25が故障してなかったか否かを判別する故障検知動作を実行可能となっている。故障検知動作は、上記した配分チェック動作に加えて実行される動作であってもよい。具体的には、薬剤フィーダ5の薬剤容器20から分配皿6に散薬を排出する際、以下の動作を実行してもよい。
 まず、薬剤容器20を保持した薬剤フィーダ5において、重量校正部21を第一の状態とする(ステップ1)。そして、薬剤容器20の重量(及び/又は内蔵された散薬の重量)を取得する(ステップ2)。続いて、重量校正部21を第一の状態から第二の状態に移行させ、分銅42の重量を検知する動作(以下、事前分銅測定動作とも称す)を実行する(ステップ3)。さらに、重量校正部21を第二の状態から第一の状態に移行させ、上記した散薬を分配皿6に排出する動作を実行する(ステップ4)。また、散薬の排出動作の実行後、薬剤容器20の重量(及び/又は内蔵された散薬の重量)を取得する(ステップ5)。さらに、重量校正部21を第一の状態から第二の状態に移行させ、分銅42の重量を検知する動作(以下、事後分銅測定動作とも称す)を実行する(ステップ6)。
In the drug dispensing device 1 of the present embodiment, when discharging the powdered drug from the drug container 20 to the distribution tray 6 in the packaging operation, it is possible to execute a failure detection operation for determining whether or not the weight measuring means 25 has failed. It's becoming The failure detection operation may be an operation performed in addition to the distribution check operation described above. Specifically, when discharging the powdered medicine from the medicine container 20 of the medicine feeder 5 to the distribution tray 6, the following operations may be performed.
First, in the drug feeder 5 holding the drug container 20, the weight calibration section 21 is set to the first state (step 1). Then, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is obtained (step 2). Subsequently, the weight calibration unit 21 is shifted from the first state to the second state, and an operation of detecting the weight of the weight 42 (hereinafter also referred to as preliminary weight measurement operation) is executed (step 3). Further, the weight calibration unit 21 is shifted from the second state to the first state, and the above-described operation of discharging the powdered medicine to the distribution tray 6 is executed (step 4). Also, after executing the operation of discharging the powdered medicine, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is obtained (step 5). Further, the weight calibration unit 21 is shifted from the first state to the second state, and an operation of detecting the weight of the weight 42 (hereinafter also referred to as post-weight measurement operation) is executed (step 6).
 そして、一連の動作の後、事前分銅測定動作(重量取得工程)と事後分銅測定動作(重量取得工程)のそれぞれで取得した分銅42の重量の値が同じであるとき、重量測定手段25が故障していなかったと判別する。このことにより、分包動作によって散薬が飛散する環境下においても、天秤(重量測定手段25)の異常を検出することが可能となり、延いては、散薬の排出動作(薬剤の払い出し)に異常がなかったか否かを検知できる。また、係る動作によると、分銅42が経年変化した場合等においても、信頼性の高い分包動作が可能となる。
 なお、故障検知動作は、上記した重量校正部21によって実行される動作に限らず、後述する重量校正部200,428,521等によって実行される動作であってもよい。また、事前分銅測定動作、事後分銅測定動作は、分銅を薬剤容器に載置して分銅の重量を検知する動作であってもよい。さらにまた、分銅の荷重が重量測定手段25に掛かる状態と掛からない状態を自動で切り替える構成にかぎらず、作業者が手動で分銅を薬剤容器20上やフィーダ本体10のいずれかの部分の上に載置し、分銅の重量を検知する動作を実行することも考えられる。
 上記のように、故障検知動作では、事前分銅測定動作と事後分銅測定動作のそれぞれで分銅42を載せたことによる検知重量の増加分を取得し、それぞれで取得した重量(増加分の重量)を比較する。事前分銅測定動作と事後分銅測定動作では、上記した校正の場合と同様に、第二の状態で行う重量測定の検出値から第一の状態で行う重量測定の検出値を減算して増加分の重量を取得してもよい。また、第二の状態で行う重量測定の検出値から基本重量と薬剤容器20の重量を減算して増加分の重量を取得してもよい。さらにまた、それぞれで分銅42の重量と基本重量と薬剤容器20の合計値(合計の重量)を取得して比較してもよい。
After the series of operations, when the weight values of the weight 42 acquired in the pre-weight measurement operation (weight acquisition step) and the post-weight measurement operation (weight acquisition step) are the same, the weight measurement means 25 fails. determine that it did not. This makes it possible to detect an abnormality in the balance (weight measuring means 25) even in an environment where the powdered medicine scatters due to the packing operation, and by extension, an abnormality in the discharge operation of the powdered medicine (dispensing of the medicine). It can be detected whether or not In addition, according to such an operation, even when the weight 42 is aged, it is possible to perform a packaging operation with high reliability.
The failure detection operation is not limited to the operation performed by the weight calibration unit 21 described above, and may be an operation performed by the weight calibration units 200, 428, 521, etc., which will be described later. Further, the pre-weight measurement operation and the post-weight measurement operation may be operations of placing the weight on the medicine container and detecting the weight of the weight. Furthermore, the configuration is not limited to the configuration in which the state in which the load of the weight is applied to the weight measuring means 25 and the state in which it is not applied are automatically switched. It is also conceivable to carry out the operation of placing and sensing the weight of the weight.
As described above, in the failure detection operation, the amount of increase in the detected weight due to the placement of the weight 42 is obtained in each of the pre-weight measurement operation and the post-weight measurement operation, and the obtained weight (increased weight) is compare. In the pre-weight measurement operation and the post-weight measurement operation, as in the calibration described above, the detected value of the weight measurement performed in the second state is subtracted from the detected value of the weight measurement performed in the first state to obtain the increment. You can get the weight. Alternatively, the increased weight may be obtained by subtracting the basic weight and the weight of the medicine container 20 from the detected value of the weight measurement performed in the second state. Furthermore, the weight of the weight 42, the basic weight, and the total value (total weight) of the drug container 20 may be obtained and compared.
 上記した実施形態では、略球状体の分銅42を採用し、略直方体状の分銅支持部材45を採用した例を示したが、本発明はこれに限るものではない。
 例えば、図55(a)で示される分銅153(錘部材)であってもよい。この分銅153は、共に略円錐台状となる上部142a及び下部142bと、その間に位置する略円板状の中央部142cを有する。即ち、分銅153の上側と下側は、テーパ状の部分であり、上方又は下方に向かうにつれて横断面の面積が小さくなる先細りした形状となっている。
 また、この分銅153を採用する場合、図55(a)で示される分銅支持部材155(昇降部材)を採用してもよい。この分銅支持部材155は、上端側に上方に凸となる湾曲面を有し、下端側に下方に凸となる湾曲面を有する縦長の部材であって、縦断面形状が略小判状となる部材である。
In the above-described embodiment, an example in which the approximately spherical weight 42 is employed and the approximately rectangular parallelepiped weight support member 45 is employed is shown, but the present invention is not limited to this.
For example, it may be a weight 153 (weight member) shown in FIG. 55(a). The weight 153 has an upper portion 142a and a lower portion 142b, both of which are substantially truncated conical, and a substantially disk-shaped central portion 142c located therebetween. That is, the upper and lower sides of the weight 153 are tapered portions, and have a tapered shape in which the area of the cross section decreases as it goes upward or downward.
Moreover, when this weight 153 is employed, a weight support member 155 (elevating member) shown in FIG. 55(a) may be employed. The weight support member 155 is a vertically long member having an upwardly convex curved surface on the upper end side and a downwardly convex curved surface on the lower end side, and has a substantially oval longitudinal cross-sectional shape. is.
 上記した実施形態では、フィーダ部22の片側側方に重量校正部21を配した例を示したが、本発明は、これに限るものではない。重量校正部21は、他方側側方に配してもよく、後方(フィーダ部22を挟んで分配皿6とは逆側となる位置であり、分配皿6側を前方としたときの後方)に配してもよい。つまり、フィーダ部22の周囲(周囲四方を含む周辺)のうちの一方に配してもよい。このとき、フィーダ部22と隣接する位置に配してもよく、フィーダ部22から水平方向にやや離れた位置に配してもよい。
 また、上記した薬剤払出し装置1では、使用者が薬剤容器20を手動でフィーダ本体10に保持させることが可能である。そして、使用者がフィーダ本体10に保持された薬剤容器20を手動で取り外すことが可能となっている。即ち、フィーダ本体10に保持させる薬剤容器20の交換(変更)を手動で行うことが可能である。
In the embodiment described above, an example in which the weight calibration section 21 is arranged on one side of the feeder section 22 has been shown, but the present invention is not limited to this. The weight calibration unit 21 may be arranged on the other side, rearward (a position on the opposite side of the distribution plate 6 with the feeder unit 22 interposed therebetween, and rearward when the distribution plate 6 side is defined as the front). may be placed in In other words, it may be arranged on one side of the periphery of the feeder section 22 (the periphery including the four sides). At this time, it may be arranged at a position adjacent to the feeder section 22 or may be arranged at a position slightly separated from the feeder section 22 in the horizontal direction.
Further, in the medicine dispensing device 1 described above, the user can manually hold the medicine container 20 in the feeder main body 10 . Then, the user can manually remove the drug container 20 held by the feeder main body 10 . That is, it is possible to manually replace (change) the medicine container 20 held by the feeder main body 10 .
 薬剤払出し装置1に採用される薬剤フィーダは、上記したものに限らず、図56で示されるような、重量校正部200(測定手段検査部)を備えた薬剤フィーダ201であってもよい。重量校正部200は、昇降装置202(昇降手段)と、錘部材203(校正用錘)と、重量受部材204(重量受部)を備えている。 The medicine feeder employed in the medicine dispensing device 1 is not limited to the one described above, and may be a medicine feeder 201 equipped with a weight calibration section 200 (measuring means inspection section) as shown in FIG. The weight calibration section 200 includes an elevating device 202 (elevating means), a weight member 203 (calibration weight), and a weight receiving member 204 (weight receiving section).
 昇降装置202は、モータ(図示しない)と、モータの稼働に伴って回転するギア215と、容器昇降部211と、錘昇降部212を有する。ギア215は、ピニオンギアであり、容器昇降部211、錘昇降部212は、それぞれ歯切りされた部分であるラック部を有する。そして、ギア215とそれぞれのラック部が係合している。このため、容器昇降部211が上昇すると錘昇降部212が下降し、容器昇降部211が下降すると錘昇降部212が上昇する。 The lifting device 202 has a motor (not shown), a gear 215 that rotates with the operation of the motor, a container lifting section 211 and a weight lifting section 212 . The gear 215 is a pinion gear, and the container elevating section 211 and the weight elevating section 212 each have a gear-cut rack portion. Gears 215 are engaged with respective rack portions. Therefore, when the container raising/lowering part 211 rises, the weight raising/lowering part 212 descends, and when the container raising/lowering part 211 descends, the weight raising/lowering part 212 rises.
 容器昇降部211は、平板状の押圧片部211aを有する。この押圧片部211aは、容器支持部23に支持された薬剤容器20に下方から接触する部分である。
 錘昇降部212は、平板状の錘支持部212aを有する。錘支持部212aには、図56(b)で示されるように、錘支持部212aを厚さ方向(上下方向)に貫通する支持用孔230が設けられている。
The container raising/lowering part 211 has a flat pressing piece 211a. The pressing piece portion 211a is a portion that contacts the drug container 20 supported by the container support portion 23 from below.
The weight raising/lowering part 212 has a plate-shaped weight support part 212a. As shown in FIG. 56(b), the weight support portion 212a is provided with a support hole 230 penetrating through the weight support portion 212a in the thickness direction (vertical direction).
 錘部材203は、上方から順に、フランジ部203a、くびれ部203b、本体部203cを有する。フランジ部203aは、支持用孔230を通過できない大きさであり、くびれ部203b及び本体部203cは、支持用孔230を通過可能な大きさである。 The weight member 203 has a flange portion 203a, a constricted portion 203b, and a body portion 203c in order from above. The flange portion 203a has a size that cannot pass through the support hole 230, and the constricted portion 203b and the body portion 203c have sizes that allow it to pass through the support hole 230. As shown in FIG.
 重量受部材204は、図56(a)で示されるように、平板状の受板部204aと、立板状の取付板部204bとを有し、支持台27に固定される部材である。 As shown in FIG. 56(a), the weight receiving member 204 is a member that has a flat plate-like receiving plate portion 204a and an upright plate-like mounting plate portion 204b, and is fixed to the support base 27. As shown in FIG.
 ここで、錘昇降部212は、図56(b)で示されるように、錘部材203を宙づりにした状態で支持可能な部材である。即ち、錘支持部212aが高位置に配されている状態で、錘部材203を支持用孔230に上方から挿入すると、フランジ部203aが引っ掛かり、フランジ部203aの下面と錘支持部212aの上面が接触した状態なる。このとき、くびれ部203bの少なくとも一部は支持用孔230の内側に位置した状態となり、錘部材203の大部分が錘支持部212aよりも下方に配され、錘部材203の下面が受板部204aの上方に離れた位置に配される。 Here, the weight raising/lowering part 212 is a member capable of supporting the weight member 203 in a suspended state, as shown in FIG. 56(b). That is, when the weight member 203 is inserted into the support hole 230 from above while the weight support portion 212a is positioned at a high position, the flange portion 203a is caught, and the lower surface of the flange portion 203a and the upper surface of the weight support portion 212a are aligned. Be in contact. At this time, at least part of the constricted portion 203b is positioned inside the support hole 230, most of the weight member 203 is disposed below the weight support portion 212a, and the lower surface of the weight member 203 is the receiving plate portion. 204a at a spaced position.
 本実施形態の重量校正部200では、錘部材203の荷重が受板部204aに付加されない第一の状態と、錘部材203の荷重が受板部204aに付加される第二の状態の間で切り替えが可能となる。 In the weight calibration unit 200 of the present embodiment, between a first state in which the load of the weight member 203 is not applied to the receiving plate portion 204a and a second state in which the load of the weight member 203 is applied to the receiving plate portion 204a, Switching is possible.
 第一の状態では、錘部材203が上記したように宙づりにされた状態で支持され、受板部204aから上方に離れた位置に配される。そして、薬剤容器20が振動部材16の振動側水平部32に載置され、押圧片部211aが薬剤容器20から下方に離れた位置に配される。 In the first state, the weight member 203 is supported in a suspended state as described above and arranged at a position spaced upward from the receiving plate portion 204a. Then, the drug container 20 is placed on the vibration-side horizontal portion 32 of the vibrating member 16, and the pressing piece 211a is arranged at a position spaced downward from the drug container 20. As shown in FIG.
 そして、第一の状態でモータが稼働し、ギア215が回転して容器昇降部211が上昇すると、押圧片部211aが薬剤容器20に下方から接触する。そして、そのまま容器昇降部211が上昇することで、薬剤容器20を上方に移動させ、押圧片部211aが薬剤容器20を持ち上げた状態となる。
 このとき、容器昇降部211の上昇に伴って錘昇降部212が下降すると、錘部材203が受板部204aに載置された状態となる。この状態から錘昇降部212がさらに下降すると、錘支持部212aの上面がフランジ部203aの下面より下方に離れた位置に配される。このことにより、第一の状態から第二の状態に移行される。また、第二の状態では、錘昇降部212(昇降装置202)の荷重が受板部204a(重量測定手段25)に付加されない。
Then, when the motor operates in the first state and the gear 215 rotates to raise the container raising/lowering part 211, the pressing piece 211a comes into contact with the drug container 20 from below. Then, the container raising/lowering part 211 is raised as it is, thereby moving the drug container 20 upward, and the pressing piece 211 a lifts the drug container 20 .
At this time, when the weight lifting portion 212 descends as the container lifting portion 211 rises, the weight member 203 is placed on the receiving plate portion 204a. When the weight raising/lowering portion 212 is further lowered from this state, the upper surface of the weight support portion 212a is arranged at a position separated below the lower surface of the flange portion 203a. This causes a transition from the first state to the second state. Further, in the second state, the load of the weight lifting section 212 (lifting device 202) is not applied to the receiving plate section 204a (weight measuring means 25).
 つまり、第一の状態では、錘部材203の荷重が重量測定手段25に付加されず、薬剤容器20の荷重が重量測定手段25に付加された状態となる。第二の状態では、錘部材203の荷重が重量測定手段25に付加され、薬剤容器20の荷重が重量測定手段25に付加されない状態となる。このため、第二の状態に移行することで、重量測定手段25の校正が可能となる。第一の状態と第二の状態の切り替えは自動で実行可能である。また、第一の状態から第二の状態への移行と、第二の状態から第一の状態への移行では、ギア215が逆方向に回転する。
 上記した実施形態では、第二の状態において薬剤容器20を持ち上げたが、必ずしも薬剤容器20を持ち上げなくてもよい。つまり、重量測定手段25の校正は、薬剤容器20を保持したまま実行してもよく、容器昇降部211は、必ずしも設けなくてもよい。
That is, in the first state, the load of weight member 203 is not applied to weight measuring means 25 and the load of medicine container 20 is applied to weight measuring means 25 . In the second state, the load of weight member 203 is applied to weight measuring means 25 and the load of drug container 20 is not applied to weight measuring means 25 . Therefore, by shifting to the second state, it is possible to calibrate the weight measuring means 25 . Switching between the first state and the second state can be performed automatically. In addition, the gear 215 rotates in the opposite direction between the transition from the first state to the second state and the transition from the second state to the first state.
In the embodiment described above, the drug container 20 is lifted in the second state, but the drug container 20 does not necessarily have to be lifted. In other words, the weight measuring means 25 may be calibrated while the drug container 20 is being held, and the container elevating section 211 may not necessarily be provided.
 ところで、1日の作業開始前に実行される重量測定手段25の校正は、図57(a)で示される校正用器具256を用いて実行してもよい。
 校正用器具256は、掻出装置8に装着して使用する器具であり、図57(b)のように、装着部材257、軸受部材252、台座部材253、係止部材254を有する。軸受部材252は、玉軸受け等のベアリングであり、係止部材254は、Cリングである。
By the way, the calibration of the weight measuring means 25, which is performed before starting work for the day, may be performed using a calibration tool 256 shown in FIG. 57(a).
The calibrating instrument 256 is an instrument used by being attached to the scraping device 8, and has a mounting member 257, a bearing member 252, a base member 253, and a locking member 254, as shown in FIG. 57(b). The bearing member 252 is a bearing such as a ball bearing, and the locking member 254 is a C-ring.
 装着部材257は、本体部251aと、連結棒部251bを有する。
 本体部251aは、円板状部263と、円環状に連続する周壁部265を有する。周壁部265は、円板状部263の縁端から厚さ方向の一方側に突出するように形成されている。そして、周壁部265に囲まれた部分に、掻出装置8の取付基台255を収容することが可能な窪み部(図示しない)が形成されている。
 この装着部材257は、上記した取付基台255に対して装着する部材である。即ち、取付基台255から回転板12を取り外した状態とし、装着部材257を取付基台255に装着する。本実施形態では、装着部材257の窪み部は、取付基台255を略丁度内嵌することが可能である。また、装着部材257の片側部分(窪み部)には、取付基台255に設けられた突起部分と係合する係合部(図示しない)が設けられている。即ち、取付基台255側の係合部である突起部分と対となる(互いに係合する)係合部である。これらが係合することで、装着部材257が取付基台255に一体的に装着固定される。
 連結棒部251bは、丸棒状の部分であり、上記した窪み部と円板状部263を挟んで逆側となる位置に形成されている。
The mounting member 257 has a body portion 251a and a connecting rod portion 251b.
The main body portion 251a has a disk-shaped portion 263 and a peripheral wall portion 265 that continues in an annular shape. The peripheral wall portion 265 is formed to protrude from the edge of the disk-shaped portion 263 to one side in the thickness direction. A recessed portion (not shown) capable of accommodating the mounting base 255 of the scraping device 8 is formed in a portion surrounded by the peripheral wall portion 265 .
The mounting member 257 is a member mounted on the mounting base 255 described above. That is, the mounting member 257 is mounted on the mounting base 255 with the rotating plate 12 removed from the mounting base 255 . In this embodiment, the recessed portion of the mounting member 257 can fit the mounting base 255 substantially exactly inside. In addition, an engaging portion (not shown) that engages with a projecting portion provided on the mounting base 255 is provided on one side portion (recess portion) of the mounting member 257 . That is, it is an engaging portion that forms a pair (engages with each other) with the projection portion that is the engaging portion on the mounting base 255 side. By engaging these members, the mounting member 257 is integrally mounted and fixed to the mounting base 255 .
The connecting rod portion 251b is a round rod-shaped portion, and is formed at a position opposite to the above-described recessed portion with the disc-shaped portion 263 interposed therebetween.
 台座部材253は、錘支持部270と、回転防止部271と、立板状の連結板部272とが一体に形成された部材である。
 錘支持部270は、平板状の部分であり、支持用孔部270aが設けられている。支持用孔部270aは、錘支持部270を厚さ方向(上下方向)に貫通する。
 回転防止部271は、上側板部271aと下側板部271bからなる2つの板状部材を有する。上側板部271aと下側板部271bは、いずれも平板状の部分であり、上下方向で離間対向するように設けられている。
 連結板部272は、長手方向の一端側で錘支持部270と連続し、他端側で回転防止部271と連続する。この連結板部272には、連結孔部272aが設けられている。連結孔部272aは、連結板部272を厚さ方向に貫通する貫通孔である。
The pedestal member 253 is a member in which a weight support portion 270, a rotation preventing portion 271, and an upright plate-like connecting plate portion 272 are integrally formed.
The weight support portion 270 is a plate-like portion and is provided with a support hole portion 270a. The support hole portion 270a penetrates the weight support portion 270 in the thickness direction (vertical direction).
The rotation preventing portion 271 has two plate-like members consisting of an upper plate portion 271a and a lower plate portion 271b. Both the upper plate portion 271a and the lower plate portion 271b are plate-shaped portions, and are provided so as to face each other with a space therebetween in the vertical direction.
The connecting plate portion 272 is continuous with the weight support portion 270 at one end in the longitudinal direction, and is continuous with the rotation preventing portion 271 at the other end. The connecting plate portion 272 is provided with a connecting hole portion 272a. The connecting hole portion 272a is a through hole penetrating through the connecting plate portion 272 in the thickness direction.
 校正用器具256が組み立てられた状態では、連結板部272の一部に軸受部材252が取り付けられ、連結孔部272aと軸受部材252の内孔に連結棒部251bが挿通される。そして、連結棒部251bのうち、連結孔部272aから一部突出した部分であり、挿入方向で先端側となる部分の一部に、係止部材254が装着される。
 以上のことから、校正用器具256は、掻出装置8に装着していない状態において、台座部材253と装着部材257とが互いに相対回転可能な状態で連結されている。即ち、連結棒部251bを回転軸として回転可能となっている。
When the calibration instrument 256 is assembled, the bearing member 252 is attached to a part of the connecting plate portion 272, and the connecting rod portion 251b is inserted through the inner hole of the bearing member 252 and the connecting hole portion 272a. A locking member 254 is attached to a portion of the connecting rod portion 251b that partially protrudes from the connecting hole portion 272a and is located on the distal end side in the insertion direction.
As described above, when the calibrating instrument 256 is not mounted on the scraping device 8, the base member 253 and the mounting member 257 are connected so as to be relatively rotatable. That is, it is rotatable around the connecting rod portion 251b as a rotation axis.
 掻出装置8に装着した状態では、図57(a)で示されるように、掻出用アーム17の延び方向で、取付基台255よりも先端側に錘支持部270が位置し、取付基台255よりも基端側に回転防止部271が位置した状態となる。このとき、回転防止部271の上側板部271aと下側板部271bの間に掻出用アーム17が位置し、上側板部271aと下側板部271bによって掻出用アーム17が挟まれた状態となる。また、取付基台255の厚さ方向における片側側方に、装着部材257と連結板部272が位置した状態となる。 When attached to the scraping device 8, as shown in FIG. 57(a), the weight supporting portion 270 is positioned on the tip side of the mounting base 255 in the extending direction of the scraping arm 17, The anti-rotation portion 271 is located on the base end side of the base 255 . At this time, the scraping arm 17 is positioned between the upper plate portion 271a and the lower plate portion 271b of the rotation preventing portion 271, and the scraping arm 17 is sandwiched between the upper plate portion 271a and the lower plate portion 271b. Become. Also, the mounting member 257 and the connecting plate portion 272 are positioned on one side of the mounting base 255 in the thickness direction.
 校正用器具256を掻出装置8に装着した状態では、上記と同様に、錘支持部270によって錘部材203を宙づりにした状態で支持可能となっている(図58(a)参照)。
 即ち、校正用器具256を用いた重量測定手段25の校正では、校正対象となる重量測定手段25を備えた薬剤フィーダ5において、予め薬剤容器20を取り外した状態としておく。そして、ターンテーブルを回転させ、掻出装置8の全体(掻出用アーム17及び取付基台255)を旋回させる。このことにより、図58(b)で示されるように、振動側水平部32の上方に錘部材203が位置した状態となる。続いて、掻出用アーム17を揺動させ、掻出用アーム17の先端側を下方に移動させることで、錘部材203を振動側水平部32の上に載置する。そのまま掻出用アーム17の先端側を下方に移動させることで、重量測定手段25に錘部材203の荷重が付加される状態とし、重量測定手段25の校正を実行する。
When the calibration instrument 256 is attached to the scraping device 8, the weight member 203 can be supported in a suspended state by the weight support portion 270 in the same manner as described above (see FIG. 58(a)).
That is, in the calibration of the weight measuring means 25 using the calibration tool 256, the drug container 20 is previously removed from the drug feeder 5 having the weight measuring means 25 to be calibrated. Then, the turntable is rotated to turn the entire scraping device 8 (scraping arm 17 and mounting base 255). As a result, the weight member 203 is positioned above the vibration-side horizontal portion 32 as shown in FIG. 58(b). Subsequently, the weight member 203 is placed on the vibration-side horizontal portion 32 by swinging the scraping arm 17 and moving the tip side of the scraping arm 17 downward. By moving the tip side of the raking arm 17 downward as it is, the load of the weight member 203 is applied to the weight measuring means 25, and the weight measuring means 25 is calibrated.
 また、校正終了後、掻出用アーム17を揺動させ、掻出用アーム17の先端側を上方に移動させることで、錘部材203を宙づりにした状態で支持し、重量測定手段25に錘部材203の荷重が付加されない状態とする。続けて、他の重量測定手段25の校正を行う場合は、掻出装置8の全体を旋回させ、上記の動作を実行する。 Further, after the calibration is completed, the scraping arm 17 is swung to move the tip side of the scraping arm 17 upward, thereby supporting the weight member 203 in a suspended state and allowing the weight measuring means 25 to carry the weight. A state is assumed in which no load is applied to the member 203 . Subsequently, when calibrating another weight measuring means 25, the entire scraping device 8 is rotated and the above operation is executed.
 また、薬剤払出し装置1で採用される薬剤フィーダは、上記したものに限らず、図59で示されるような、重量校正部428(測定手段検査部)を備えた薬剤フィーダ405であってもよい。
 本実施形態の薬剤フィーダ405は、容器支持部423(保持部材)が上記した薬剤フィーダ5とは異なる構造となっている。即ち、振動部材416の振動側水平部432には、上部が開口した凹部である錘配置部443が形成されている。また、錘配置部443の下方側には、錘配置部443と、振動部材416の下方側の空間を連通する部材配置孔446が形成されている。そして、支持台427の支持側水平部430にもまた、支持側水平部430を上下方向に貫通する部材配置孔447が形成されている。
Further, the medicine feeder employed in the medicine dispensing device 1 is not limited to the one described above, and may be a medicine feeder 405 equipped with a weight calibration section 428 (measuring means inspection section) as shown in FIG. .
The drug feeder 405 of this embodiment has a structure different from that of the drug feeder 5 described above in the container supporting portion 423 (holding member). That is, the vibration side horizontal portion 432 of the vibration member 416 is formed with a weight arrangement portion 443 which is a concave portion with an open top. A member placement hole 446 is formed below the weight placement portion 443 to communicate the space below the vibration member 416 with the weight placement portion 443 . Further, the support-side horizontal portion 430 of the support table 427 is also formed with a member arrangement hole 447 penetrating through the support-side horizontal portion 430 in the vertical direction.
 振動部材416の部材配置孔446と、支持台427の部材配置孔447は、平面視で少なくとも一部同士が重なるように形成されている。このことから、錘配置部443の下方側に部材配置空間448が形成される。部材配置空間448は、昇降装置460の一部である昇降部材445が配される空間である。 The member arrangement hole 446 of the vibrating member 416 and the member arrangement hole 447 of the support base 427 are formed so that at least parts of them overlap each other in plan view. As a result, a member placement space 448 is formed below the weight placement portion 443 . The member placement space 448 is a space in which the lifting member 445 that is part of the lifting device 460 is arranged.
 昇降装置460は、昇降部材445と、昇降部材445を昇降させる図示しない昇降機構を有する。なお、昇降機構は、動力源となるモータと、モータの回転運動を直線運動に変換する変換機構を有する。変換機構は、昇降部材445の下方に位置するカムであってもよく、昇降部材445に設けた歯切り部分とピニオンギアの組み合わせによるラックアンドピニオン機構でもよい。即ち、モータが稼働することで、昇降部材445が上下方向に移動する。 The elevating device 460 has an elevating member 445 and an elevating mechanism (not shown) that elevates the elevating member 445 . The elevating mechanism has a motor as a power source and a conversion mechanism that converts rotary motion of the motor into linear motion. The conversion mechanism may be a cam positioned below the elevating member 445, or may be a rack and pinion mechanism that combines a toothed portion provided on the elevating member 445 and a pinion gear. That is, the elevating member 445 is vertically moved by the operation of the motor.
 本実施形態の薬剤フィーダ405では、振動部材416、支持台427の下方側に昇降機構が配されている。そして、この薬剤フィーダ405の重量測定手段(図示しない)には、容器支持部423等の部材の重量が付加される一方で、昇降装置460の荷重が付加されない状態となっている。 In the drug feeder 405 of this embodiment, an elevating mechanism is arranged below the vibrating member 416 and the support base 427 . A weight measuring means (not shown) of the medicine feeder 405 is in a state where the weight of the member such as the container support portion 423 is applied, but the load of the lifting device 460 is not applied.
 錘配置部443には、略直方体状の錘部材442(校正用錘)が配置されている。錘配置部443は、容器支持部423が薬剤容器20を保持した状態としたとき、薬剤容器20の下面よりも下方に位置する。このとき、錘配置部443は、上方の全域を薬剤容器20によって覆われる。 A substantially rectangular parallelepiped weight member 442 (calibration weight) is arranged in the weight arrangement portion 443 . The weight placement portion 443 is positioned below the lower surface of the drug container 20 when the container support portion 423 holds the drug container 20 . At this time, the weight placement portion 443 is entirely covered with the drug container 20 on the upper side.
 本実施形態の薬剤フィーダ405は、錘部材442が錘配置部443の底部分から上方に離れた位置に配される第一の状態(図59(a)参照)と、錘部材442が錘配置部443の底部分に接触する第二の状態(図59(b)参照)との間で切り替えが可能となっている。そして、薬剤フィーダ405を第一の状態から第二の状態に移行させることで、重量測定手段の校正が可能となる。なお、第一の状態、第二の状態のいずれにおいても、錘部材442は、錘配置部443の内部に配される。 The drug feeder 405 of this embodiment has a first state (see FIG. 59A) in which the weight member 442 is arranged at a position separated from the bottom portion of the weight arrangement portion 443, and a state in which the weight member 442 It is possible to switch between a second state (see FIG. 59(b)) in which the bottom portion of 443 is contacted. By shifting the medicine feeder 405 from the first state to the second state, the weight measuring means can be calibrated. Note that the weight member 442 is arranged inside the weight arrangement portion 443 in both the first state and the second state.
 即ち、第一の状態では、錘部材442が昇降部材445によって持ち上げられた状態となる。このとき、錘部材442の下側部分が昇降部材445の上側部分に接触し、錘部材442が昇降部材445に載置される。このため、錘部材442の荷重が昇降部材445に付加される一方で、振動部材416に付加されない状態となる。つまり、錘部材442の荷重が薬剤フィーダ405の重量測定手段に付加されず、錘部材442の荷重が重量測定手段によって測定されない状態となる。
 この第一の状態から昇降部材445が下方に移動していくと、昇降部材445の移動に伴って錘部材442が下方に移動していく。そして、錘部材442の下側部分が錘配置部443の底部分に上方から接触する。
That is, in the first state, the weight member 442 is lifted by the elevating member 445 . At this time, the lower portion of the weight member 442 contacts the upper portion of the elevating member 445 , and the weight member 442 is placed on the elevating member 445 . Therefore, the load of the weight member 442 is applied to the lifting member 445 but not applied to the vibrating member 416 . That is, the load of weight member 442 is not applied to the weight measuring means of drug feeder 405, and the load of weight member 442 is not measured by the weight measuring means.
As the lifting member 445 moves downward from the first state, the weight member 442 moves downward along with the movement of the lifting member 445 . Then, the lower portion of the weight member 442 contacts the bottom portion of the weight arrangement portion 443 from above.
 ここで、錘部材442は、振動部材416の部材配置孔446に上方から挿入不可能な大きさ(及び/又は形状)となっている。このため、引き続き昇降部材445が下方に移動していくと、昇降部材445が錘部材442から下方に離れた位置に配される。その一方で、錘部材442は、錘配置部443の底部分に載置された状態となる。このことにより、第一の状態から第二の状態への移行が完了する。即ち、錘部材442の荷重が薬剤フィーダ405の重量測定手段に付加され、錘部材442の荷重が重量測定手段によって測定される状態となる。
 以上のように、第一の状態から第二の状態に移行させることが可能であるので、上記と同様に、重量測定手段が正しく重量を検知可能な状態であるか否かを判別する動作(重量測定手段の校正、故障検知)が可能となる。例えば、重量測定手段の校正では、第一の状態において、薬剤フィーダ405の重量測定手段による重量測定を行う。その後に、第二の状態に移行させ、薬剤フィーダ405の重量測定手段による重量測定を行う。そして、第二の状態で実行した重量測定の検出値(測定値)から、第一の状態で実行した重量測定の検出値を減算した値が錘部材442の重量と同一となったことを条件として、錘部材442の重量が正しく検知されていると判別する。即ち、重量測定手段が正しく重量を検知可能な状態であると判別する。
Here, the weight member 442 has a size (and/or shape) that cannot be inserted into the member arrangement hole 446 of the vibration member 416 from above. Therefore, when the elevating member 445 continues to move downward, the elevating member 445 is arranged at a position away from the weight member 442 downward. On the other hand, the weight member 442 is placed on the bottom portion of the weight arrangement portion 443 . This completes the transition from the first state to the second state. That is, the load of the weight member 442 is applied to the weight measuring means of the medicine feeder 405, and the load of the weight member 442 is measured by the weight measuring means.
As described above, since it is possible to shift from the first state to the second state, in the same manner as described above, the operation ( (calibration of weight measuring means, failure detection). For example, in calibration of the weight measuring means, the weight of the drug feeder 405 is measured by the weight measuring means in the first state. After that, it is shifted to the second state, and weight measurement is performed by the weight measurement means of the medicine feeder 405 . The condition is that the value obtained by subtracting the detected value of the weight measurement performed in the first state from the detected value (measured value) of the weight measurement performed in the second state is the same as the weight of the weight member 442. , it is determined that the weight of the weight member 442 is correctly detected. That is, it is determined that the weight measuring means is in a state of being able to correctly detect the weight.
 第二の状態から第一の状態に移行させる際には、上記とは逆に、昇降部材445を上方に移動させる。このことにより、昇降部材445の上側部分が錘部材442の下側部分に下方側から接触した状態となり、そのまま昇降部材445を押し上げて上方へ移動させることで、昇降部材445が持ち上げられた状態となる。 When shifting from the second state to the first state, contrary to the above, the lifting member 445 is moved upward. As a result, the upper portion of the elevating member 445 contacts the lower portion of the weight member 442 from below, and the elevating member 445 is pushed up to move upward, thereby raising the elevating member 445. Become.
 また、上記した重量校正部21に替わって、動力源となるモータと、トルクリミッターと、線状部材であるワイヤーを有し、ワイヤーによって容器支持部23の一部を上方に引っ張る引張動作が可能な重量校正部(図示しない)を設けてもよい。
 即ち、ワイヤーの長手方向の一端側を、フィーダ部22を構成する部材のうちで重量測定手段25に荷重が掛かる部材(容器支持部23等であり、以下、固定対象部材とも称す)に対して固定する。その一方で、モータとトルクリミッターを上蓋4や上部ユニット(錠剤手撒き装置303)の下側部分に固定する。
 そして、引張動作では、モータを可動してワイヤーを巻き取ることで、ワイヤーの一端が固定された固定対象部材を引っ張り、固定対象部材に鉛直上方へ向かう力を付与する。このとき、モータと、ワイヤーの一端側との間にトルクリミッターを介在させることで、固定対象部材に規定の大きさの力を付与する。
Further, instead of the weight calibration unit 21 described above, a motor as a power source, a torque limiter, and a wire as a linear member are provided, and the wire can be used to pull a portion of the container support unit 23 upward. A weight calibration unit (not shown) may be provided.
That is, one end side of the wire in the longitudinal direction is attached to a member (container support section 23 or the like, hereinafter also referred to as a fixing target member) among the members constituting the feeder section 22 where a load is applied to the weight measuring means 25. fixed. On the other hand, the motor and the torque limiter are fixed to the upper lid 4 and the lower part of the upper unit (tablet manual distributing device 303).
In the pulling operation, the wire is wound by operating the motor to pull the member to be fixed to which one end of the wire is fixed, thereby applying a vertically upward force to the member to be fixed. At this time, by interposing a torque limiter between the motor and one end of the wire, a force of a specified magnitude is applied to the member to be fixed.
 重量測定手段25の校正は、引張動作を実行していない状態での重量測定手段25の検出値と、引張動作の実行中の重量測定手段25の検出値をそれぞれ取得する。そして、引張動作を実行していない状態の検出値から、引張動作の実行中の検出値を減算し、減算した値が規定の値となったことを条件として、重量測定手段25が正しく重量を検知可能な状態であると判別する To calibrate the weight measuring means 25, the detected value of the weight measuring means 25 when the pulling action is not executed and the detected value of the weight measuring means 25 while the pulling action is being executed are obtained. Then, the detected value during execution of the pulling operation is subtracted from the detected value while the pulling operation is not being executed. determine that it is in a detectable state
 なお、薬剤容器20を保持させた状態で重量測定手段25の校正を実行する場合、ワイヤーは、薬剤容器20に固定してもよい。また、この場合、引張動作を実行していない状態での測定と、引張動作の実行中での測定では、重量が同じ薬剤容器20を保持させる。ここでいう「重量が同じ薬剤容器20」とは、内部に薬剤を収容している場合、収容した薬剤の重量を加算した薬剤容器20の重量が同じであることをいう。 It should be noted that the wire may be fixed to the drug container 20 when the weight measuring means 25 is calibrated while the drug container 20 is being held. Further, in this case, the drug container 20 having the same weight is held in the measurement when the pulling operation is not performed and the measurement when the pulling operation is performed. Here, the term "medicine container 20 having the same weight" means that the weight of the drug container 20, which is the weight of the contained drug added to the weight of the drug contained therein, is the same.
 上記した実施形態の薬剤払出し装置1は、複数(6つ)の薬剤フィーダ5を設け、それぞれの薬剤フィーダ5が個別に重量校正部21を有するものとした。即ち、一つの重量校正部21が、一つの重量測定手段25に錘(分銅42)の荷重を付加可能とした。
 しかしながら、図60で示される重量校正部521(測定手段検査部)のように、複数の重量測定手段25に錘の荷重を付加することが可能なものでもよい。
The drug delivery device 1 of the above-described embodiment is provided with a plurality (six) of drug feeders 5, and each drug feeder 5 has its own weight calibrating section 21 individually. That is, one weight calibration unit 21 can apply a load of a weight (weight 42) to one weight measurement means 25. FIG.
However, like the weight calibration section 521 (measuring means inspection section) shown in FIG.
 本実施形態では、複数のフィーダ部22に対し、一つの重量校正部521を対応付けて薬剤フィーダを構成している。
 本実施形態の重量校正部521は、図60で示されるように、モータ(図示しない)と、巻き取りプーリ501と、ワイヤー502と、複数の滑車部材503と、複数の錘部材504(校正用錘)を有している。巻き取りプーリ501と滑車部材503は、上蓋4又は上部ユニット(錠剤手撒き装置303)の下側部分に固定する。また、モータを稼働することで、巻き取りプーリ501によってワイヤー502の巻き取りが可能となる。
 なお、図60(a)では、滑車部材503、錘部材504は、作図の都合上、一部にのみ符号を付し、他への符号を省略する。
In this embodiment, one weight calibration unit 521 is associated with a plurality of feeder units 22 to configure a drug feeder.
As shown in FIG. 60, the weight calibration unit 521 of this embodiment includes a motor (not shown), a take-up pulley 501, a wire 502, a plurality of pulley members 503, and a plurality of weight members 504 (for calibration). weight). The take-up pulley 501 and the pulley member 503 are fixed to the upper lid 4 or the lower part of the upper unit (tablet manual spreading device 303). Also, by operating the motor, the wire 502 can be wound by the winding pulley 501 .
In FIG. 60(a), for the convenience of drawing, the pulley member 503 and the weight member 504 are only partly numbered, and the other parts are omitted.
 また、それぞれのフィーダ部22の上方に、それぞれ別の滑車部材503及び錘部材504が配されている。そして、ワイヤー502が巻き取りプーリ501にしっかり巻き取られた状態と、ワイヤー502の巻き取りを緩めた状態とを切り替えることで、錘部材504が薬剤容器20の上面から上方に離れた位置に配された第一の状態と、錘部材504が薬剤容器20に載置された第二の状態を切り替えることができる。 Separate pulley members 503 and weight members 504 are arranged above the respective feeder portions 22 . By switching between a state in which the wire 502 is tightly wound around the take-up pulley 501 and a state in which the wire 502 is loosely wound, the weight member 504 is arranged at a position away from the upper surface of the drug container 20 . The first state in which the weight member 504 is placed and the second state in which the weight member 504 is placed on the drug container 20 can be switched.
 ここで、図60(b)で示されるように、錘部材504は、内部空間部530を有している。内部空間部530は、下方が開放され、環状に連続する周壁部分で周囲を囲まれた空間である。また、錘部材504の上部には、外部と内部空間部530を連通するワイヤー挿通孔531が設けられている。ワイヤー挿通孔531は、内部空間部530よりも細く形成されている。 Here, as shown in FIG. 60(b), the weight member 504 has an internal space 530. The internal space portion 530 is a space that is open at the bottom and surrounded by a peripheral wall portion that continues in an annular shape. A wire insertion hole 531 that communicates the interior space 530 with the outside is provided in the upper portion of the weight member 504 . The wire insertion hole 531 is formed narrower than the internal space portion 530 .
 ワイヤー502のうち、滑車部材503から垂れ下がる部分の先端には、掛止部材532が取り付けられている。掛止部材532は、錘部材504の下側から内部空間部530内に入れることが可能であり、ワイヤー挿通孔531を通過できない大きさ(及び/又は形状)となっている。そして、図60(b)で示されるように、内部空間部530内に掛止部材532を配した状態とし、滑車部材503から垂れ下がるワイヤー502が、ワイヤー挿通孔531を経て内部空間部530内まで延び、掛止部材532と連続した状態としている。 A hooking member 532 is attached to the tip of the portion of the wire 502 that hangs down from the pulley member 503 . The locking member 532 can be inserted into the internal space 530 from below the weight member 504 and has a size (and/or shape) that prevents it from passing through the wire insertion hole 531 . Then, as shown in FIG. 60(b), the hooking member 532 is arranged in the internal space 530, and the wire 502 hanging down from the pulley member 503 extends into the internal space 530 through the wire insertion hole 531. It extends and is in a continuous state with the hooking member 532 .
 したがって、第一の状態であるときにワイヤー502の巻き取りが緩められると、掛止部材532が下方に移動し、それに伴って錘部材504が下方に移動していく。そして、錘部材504の下端部分が薬剤容器20に上方から接触する。この状態で掛止部材532がさらに下方に移動することで、掛止部材532が内部空間部530で錘部材504の上部から下方に離れた状態となり、内部空間部530の天井壁部分に接触しない状態となる。このことから、錘部材504が薬剤容器20に載置され、第二の状態に移行する。
 第二の状態では、錘部材504の荷重が重量測定手段25に付加される一方で、掛止部材532とワイヤー502の荷重が重量測定手段25に付加されない状態となる。
Therefore, when the winding of the wire 502 is loosened in the first state, the hooking member 532 moves downward, and the weight member 504 moves downward accordingly. Then, the lower end portion of weight member 504 comes into contact with drug container 20 from above. In this state, the locking member 532 moves further downward, so that the locking member 532 is separated downward from the upper portion of the weight member 504 in the internal space 530 and does not contact the ceiling wall portion of the internal space 530. state. As a result, the weight member 504 is placed on the medicine container 20, and the state is shifted to the second state.
In the second state, the load of weight member 504 is applied to weight measuring means 25 while the load of hooking member 532 and wire 502 is not applied to weight measuring means 25 .
 反対に、第二の状態でワイヤー502を巻き取ることで、掛止部材532が上方に移動し、内部空間部530内で錘部材504の上部に下方側から接触する。そして、掛止部材532がそのまま上方に移動することで、錘部材504が上方に移動し、錘部材504の下端部分が薬剤容器20から上方に離れた状態となり、第一の状態に移行する。
 上記のように、第一の状態から第二の状態に移行させることが可能であるので、上記と同様に、フィーダ部22の重量測定手段が正しく重量を検知可能な状態であるか否かを判別する動作(重量測定手段の校正、故障検知)が可能となる。例えば、重量測定手段の校正では、第一の状態において、フィーダ部22の重量測定手段による重量測定を行う。その後に、第二の状態に移行させ、フィーダ部22の重量測定手段による重量測定を行う。そして、第二の状態で実行した重量測定の検出値(測定値)から、第一の状態で実行した重量測定の検出値を減算した値が錘部材504の重量と同一となったことを条件として、錘部材504の重量が正しく検知されていると判別する。即ち、重量測定手段が正しく重量を検知可能な状態であると判別する。
Conversely, by winding the wire 502 in the second state, the hook member 532 moves upward and contacts the upper portion of the weight member 504 within the internal space 530 from below. As the hooking member 532 moves upward, the weight member 504 moves upward, and the lower end portion of the weight member 504 separates upward from the drug container 20, thereby shifting to the first state.
Since it is possible to shift from the first state to the second state as described above, whether or not the weight measuring means of the feeder section 22 is in a state in which the weight can be detected correctly is checked in the same manner as described above. It becomes possible to perform discriminating operations (calibration of weight measuring means, failure detection). For example, in the calibration of the weight measuring means, the weight is measured by the weight measuring means of the feeder section 22 in the first state. After that, it is shifted to the second state, and the weight measurement by the weight measurement means of the feeder section 22 is performed. The condition is that the value obtained by subtracting the detected value of the weight measurement performed in the first state from the detected value (measured value) of the weight measurement performed in the second state is the same as the weight of the weight member 504. , it is determined that the weight of the weight member 504 is correctly detected. That is, it is determined that the weight measuring means is in a state of being able to correctly detect the weight.
 本実施形態の重量校正部521では、複数の錘部材504を同時に昇降することが可能である。即ち、複数のフィーダ部22の重量測定手段25に、それぞれ別の錘部材504の荷重が付加される状態と、複数の重量測定手段25に錘部材504の荷重が付加されない状態の切り替えが可能である。
 また、上記した掛止部材532に替わって、ワイヤー502の先端(滑車部材503から垂れ下がる部分の先端)に、電磁石等の錘保持手段を設けてもよい。即ち、電磁石に通電して錘を吸着し、錘を持ち上げることで第一の状態としてもよい。また、錘を薬剤容器20に載置した状態で電磁石への通電を停止し、錘を保持しない状態とした上で、ワイヤー502の先端をやや上方に移動して第二の状態としてもよい。
 さらにまた、上記した例では、フィーダ部22の薬剤容器20に錘部材504を載置した。即ち、薬剤容器20を錘部材504の荷重を受ける重量受部としても機能させたが、校正を行う際にそれぞれのフィーダ部22で薬剤容器20を予め取り外しておき、容器支持部23に錘部材504を載置してもよい。
The weight calibration unit 521 of the present embodiment can raise and lower a plurality of weight members 504 at the same time. That is, it is possible to switch between a state in which the load of the weight member 504 is applied to each of the weight measuring means 25 of the plurality of feeder portions 22 and a state in which the weight member 504 does not apply the load to the weight measuring means 25 . be.
Further, instead of the hooking member 532 described above, a weight holding means such as an electromagnet may be provided at the tip of the wire 502 (the tip of the portion hanging down from the pulley member 503). That is, the first state may be obtained by energizing the electromagnet to attract the weight and lifting the weight. Alternatively, the current to the electromagnet may be stopped while the weight is placed on the drug container 20, and the weight may not be held.
Furthermore, in the above example, the weight member 504 is placed on the medicine container 20 of the feeder section 22 . In other words, the drug container 20 is made to function as a weight receiving portion that receives the load of the weight member 504. However, when performing calibration, the drug container 20 is previously removed from each feeder portion 22, and the weight member is attached to the container support portion 23. 504 may be placed.
 また、上記した薬剤フィーダは、昇降装置によって容器支持部23が上下に昇降するように形成してもよい。このとき、容器支持部23は、薬剤容器20を支持した状態のまま昇降させてもよい。そして、薬剤容器20及び容器支持部23が上方に位置するとき、これらの荷重が重量測定手段25に付加されず、上側に位置する支持側水平部30の下面と重量測定手段25の間に大きな空隙が形成されるようにしてもよい。
 この場合、人が手で錘部材を重量測定手段25に載置することで、重量測定手段25の校正が可能となる。
Further, the drug feeder described above may be formed so that the container support portion 23 can be moved up and down by an elevating device. At this time, the container support part 23 may be moved up and down while supporting the drug container 20 . When the drug container 20 and the container support portion 23 are positioned upward, the load is not applied to the weight measuring means 25, and a large amount of pressure is applied between the lower surface of the support-side horizontal portion 30 positioned above and the weight measuring means 25. A void may be formed.
In this case, the weight measuring means 25 can be calibrated by manually placing the weight member on the weight measuring means 25 .
 上記した実施形態では、フィーダ部22の片側側方に重量校正部21を配し、分銅42を分銅載置部材43に載置して重量測定手段25の校正を実行する例を示した。しかしながら、薬剤払出し装置1に採用可能な薬剤フィーダ5は、これに限るものではない。
 例えば、フィーダ部22の両側方にそれぞれカムを配した昇降装置を設け、分銅等の錘部材を上下させ、錘部材が振動側水平部32に載置された状態と、錘部材が振動側水平部32から上方に離れた位置に配された状態を切り替えてもよい。
 この場合、フィーダ本体10から薬剤容器20を取り外して重量測定手段25の校正を実行する。そして、フィーダ部22の片側側方から他方側側方まで延びる部材であり、錘部材を支持する錘支持部材を昇降装置の本体から着脱可能に形成する。即ち、フィーダ本体10に薬剤容器20を支持させる際には、錘支持部材を取り外した状態とする。錘支持部材は、上記のように錘部材を宙づりにした状態で支持可能としてもよい。
In the above-described embodiment, the weight calibration section 21 is arranged on one side of the feeder section 22, and the weight 42 is placed on the weight placement member 43 to calibrate the weight measuring means 25. As shown in FIG. However, the medicine feeder 5 that can be employed in the medicine dispensing device 1 is not limited to this.
For example, an elevating device having cams arranged on both sides of the feeder section 22 is provided to move a weight member such as a weight up and down. You may switch the state arrange|positioned in the position away from the part 32 upwards.
In this case, the drug container 20 is removed from the feeder body 10 and the weight measuring means 25 is calibrated. A weight supporting member, which is a member extending from one side of the feeder portion 22 to the other side and supports the weight member, is detachably formed from the main body of the lifting device. That is, when the drug container 20 is supported by the feeder main body 10, the weight supporting member is removed. The weight support member may be capable of supporting the weight member in a suspended state as described above.
 上記した実施形態の薬剤払出し装置1では、複数(例えば3つ)の薬剤フィーダ5の下方に、この複数の薬剤フィーダ5の荷重が付加される下側重量測定手段を設けてもよい。
 このような構成によると、複数の薬剤フィーダ5の全てで薬剤容器20の重量が正しく検知されているか否かを判別することが可能となる。
 即ち、それぞれの薬剤フィーダ5で薬剤容器20の重量を測定し、複数(3つ)の薬剤容器20の重量の合計値を算出する。また、下側重量測定手段によって検出した値から、薬剤容器20以外の部材(それぞれのフィーダ本体10や重量校正部21の重量の値等)を減算することで、複数(3つ)の薬剤容器20の重量の合計値を算出する。
 さらに、複数の重量測定手段25の検出値に基づいて算出した複数(3つ)の薬剤容器20の重量の合計値と、下側重量測定手段の検出値に基づいて算出した複数(3つ)の薬剤容器20の重量の合計値とを比較する。そして、比較動作の結果、合計値にずれが生じていない場合、複数(3つ)の薬剤フィーダ5の全てで薬剤容器20の重量が正しく検知されていると判別する。また、反対にずれが生じていた場合、複数(3つ)の薬剤フィーダ5のいずれかで薬剤容器20の重量が正しく測定されていないものと判別する。
 以上のように、上記構成によると、薬剤容器20を移動させることなく、薬剤容器20の重量の二重チェックが可能となる。なお、同様に、複数の重量測定手段25でそれぞれ別の分銅42の重量測定を行ってその合計値を算出すると共に、下側重量測定手段で複数の分銅42の重量の合計値を算出し、これらを比較して重量測定手段25の校正を実行してもよい。
In the drug dispensing device 1 of the above-described embodiment, a lower weight measuring means to which the load of the plurality of drug feeders 5 is applied may be provided below the plurality of (for example, three) drug feeders 5 .
With such a configuration, it is possible to determine whether or not the weight of the drug container 20 is correctly detected in all of the plurality of drug feeders 5 .
That is, the weight of each drug container 20 is measured in each drug feeder 5, and the total weight of the plurality (three) of drug containers 20 is calculated. Further, by subtracting the members other than the drug container 20 (such as the weight values of the feeder main body 10 and the weight calibration unit 21) from the values detected by the lower weight measuring means, a plurality of (three) drug containers Calculate the total value of the 20 weights.
Furthermore, the total value of the weights of the plurality (three) of drug containers 20 calculated based on the detection values of the plurality of weight measurement means 25 and the plurality (three) calculated based on the detection values of the lower weight measurement means is compared with the total value of the weight of the drug container 20 of As a result of the comparison operation, if there is no difference in the total value, it is determined that the weight of the drug container 20 is correctly detected by all of the plurality (three) of drug feeders 5 . Conversely, if there is a deviation, it is determined that the weight of the drug container 20 is not correctly measured by any of the plurality (three) of drug feeders 5 .
As described above, according to the above configuration, it is possible to double-check the weight of the drug container 20 without moving the drug container 20 . Similarly, a plurality of weight measuring means 25 measure the weights of different weights 42 and calculate the total value thereof, and the lower weight measuring means calculates the total value of the weights of the plurality of weights 42, By comparing these, the weight measuring means 25 may be calibrated.
 上記した薬剤払出し装置1は、外部の上位制御装置と共に、薬剤払出しシステムを構築して運用してもよい。このとき、薬剤払出し装置1と上位制御装置との間で信号の送受信を可能とする。また、上位制御装置は、ディスプレイ等の表示装置を有する構成とする。
 そして、1日の作業を開始する前に薬剤払出し装置1の電源を投入したとき(以下作業開始時とも称す)、薬剤フィーダ5の校正が必要か否かの判定作業を実行してもよい。
The medicine dispensing device 1 described above may construct and operate a medicine dispensing system together with an external host controller. At this time, it is possible to transmit and receive signals between the drug dispensing device 1 and the host controller. Also, the host controller is configured to have a display device such as a display.
Then, when the medicine dispensing device 1 is turned on before starting work for the day (hereinafter also referred to as start of work), it may be determined whether the medicine feeder 5 needs to be calibrated.
 具体的に説明すると、作業開始時において、それぞれの薬剤フィーダ5に測定用容器(測定用部材)を保持させた状態としておく。なお、それぞれの測定用容器は、予め行った測定等によって重量を取得しておき、制御装置に記憶させておく。
 そして、それぞれの薬剤フィーダ5において、重量測定手段25のゼロ点と測定用容器の重量の検出値を比較する比較動作を実行する。例えば、それぞれの薬剤フィーダ5において、保持している測定用容器の重量の検出値から、予め記憶した保持している測定用容器の重量の値を引いた値を算出する。
 続いて、それぞれの薬剤フィーダ5で実行された比較動作で算出した値を比較する。そして、それぞれの薬剤フィーダ5で算出された値が全て同一でない場合に、薬剤払出し装置1から上位制御装置に対してその旨を示す信号を送信する。上位制御装置は、この信号を受信すると、使用者に重量測定手段25の校正を実行するように促す報知動作を実行する。
 即ち、それぞれの薬剤フィーダ5で算出した値が全て同一でない場合に、薬剤フィーダ5の校正が必要であると判定し、薬剤フィーダ5の校正を促す報知動作を実行する。
Specifically, at the start of the operation, each medicine feeder 5 is held in a state of holding a measurement container (measurement member). It should be noted that the weight of each container for measurement is obtained by measurement or the like performed in advance, and is stored in the control device.
Then, in each drug feeder 5, a comparison operation is performed to compare the zero point of the weight measuring means 25 and the detected weight of the container for measurement. For example, in each drug feeder 5, a value is calculated by subtracting a previously stored value of the weight of the held measurement container from the detected value of the weight of the held measurement container.
Subsequently, the values calculated by the comparison operations performed in each drug feeder 5 are compared. Then, when the values calculated by the respective medicine feeders 5 are not all the same, the medicine dispensing device 1 transmits a signal to that effect to the host controller. When the host controller receives this signal, it performs a notification operation to prompt the user to calibrate the weight measuring means 25 .
That is, when the values calculated by the respective medicine feeders 5 are not all the same, it is determined that the medicine feeders 5 need to be calibrated, and a notification operation to prompt the calibration of the medicine feeders 5 is performed.
 上記した一連の動作は、作業開始時に上位制御装置から薬剤払出し装置1に送信された信号に基づいて実行される動作であってもよい。即ち、薬剤払出し装置1の電源を入れることで、自動で実行される動作であってもよい。この他、分包動作の実行毎、所定回数(複数回)の分包動作を実行する毎、所定時間の経過毎、といった具合に定期的に上位制御装置から信号を送信し、実行される動作であってもよい。
 測定用容器は、空の薬剤容器20や、散薬が収容された薬剤容器20であってもよい。即ち、分包動作で使用される薬剤容器20であってもよい。また、それぞれの薬剤フィーダ5で保持される測定用容器は、重さが異なるものであってもよい。
The series of operations described above may be operations executed based on a signal transmitted from the host controller to the drug dispensing device 1 at the start of work. That is, the operation may be automatically executed by turning on the medicine dispensing device 1 . In addition, a signal is periodically transmitted from the host control device such as each time the packaging operation is performed, every time the packaging operation is performed a predetermined number of times (multiple times), and every time a predetermined time elapses. may be
The measurement container may be an empty drug container 20 or a drug container 20 containing powdered medicine. That is, it may be the medicine container 20 used in the packaging operation. Further, the measurement containers held by the respective drug feeders 5 may have different weights.
 上記した薬剤払出し装置1は、電源を常時入れた状態で運用してもよい。また、薬剤払出し装置1の本体の電源を切った状態としても、薬剤フィーダ5の電源が常時入った状態となるようにしてもよい。これらの場合、それぞれの薬剤フィーダ5の重量測定手段25の検出値を常時監視し続けることで、重量測定手段25に異常があるか否かを検知する動作を実行してもよい。即ち、時間当たりの重量の値の変化が予測される変化ではなかった場合(規定値が維持されなかった等)に、重量測定手段25に異常があると判別してもよい。
 つまり、時間を横軸とし、検出値(重量の値)を縦軸とした波形グラフにおいて、波形が所定の範囲を外れて大きく乱れた場合、重量測定手段25に異常があると判別してもよい。同様に、重量測定手段25の検出値を常時監視し続けることで、薬剤容器20が取り外されたか否か、外乱振動が発生しているか否か等を検知してもよい。
 なお、異常が検知された場合、その旨を報知する報知動作を実行してもよい。また、その際、薬剤払出し装置1に設けられた表示装置等に上記のグラフ等、時間の経過に対する検出値の変化を示す情報を表示してもよい。
The drug dispensing device 1 described above may be operated in a state where the power is always on. Further, even when the main body of the medicine dispensing device 1 is turned off, the medicine feeder 5 may be always turned on. In these cases, the detection value of the weight measuring means 25 of each medicine feeder 5 may be constantly monitored to detect whether or not the weight measuring means 25 is abnormal. That is, it may be determined that the weight measuring means 25 has an abnormality when the change in the value of the weight per hour is not a predicted change (eg, the specified value is not maintained).
That is, in a waveform graph in which the horizontal axis is time and the vertical axis is the detected value (weight value), if the waveform is greatly disturbed outside a predetermined range, it is determined that there is an abnormality in the weight measuring means 25. good. Similarly, by continuously monitoring the detection value of the weight measuring means 25, it is possible to detect whether or not the drug container 20 has been removed, whether or not disturbance vibration has occurred, and the like.
Note that when an abnormality is detected, a notification operation may be performed to notify that effect. Also, at that time, information indicating changes in detected values over time, such as the above-described graph, may be displayed on a display device or the like provided in the medicine dispensing device 1 .
 上記した薬剤払出し装置1では、図61で示されるように、散薬投入ホッパー310の重量を検知することが可能なホッパー側重量測定手段560を設けてもよい。このホッパー側重量測定手段560は、分包装置308の一部であり、散薬投入ホッパー310を固定する台部材に設けてもよい。また、散薬投入ホッパー310の重量を検知する際には、ホッパー側重量測定手段560の検出値から、ホッパー側重量測定手段560に荷重が掛かる部材のうちで、散薬投入ホッパー310とは異なる部材の重量を引くことで、重量の値を取得してもよい。また、散薬投入ホッパー310の上部開口を閉塞する上側蓋部材と、下部開口を閉塞する下側蓋部材とを設けてもよい。この場合、上側蓋部材と下側蓋部材は、それぞれの開口の開状態と閉状態を切り替え可能な部材とする。さらに下側蓋部材は、散薬投入ホッパー310と一体に設けてもよい。そして、下側蓋部材を閉状態とし、散薬投入ホッパー310に散薬を投入することで、散薬投入ホッパー310の内部に散薬を一時的に留めることが可能なものとしてもよい。このとき、散薬投入ホッパー310に投入された散薬の重量をホッパー側重量測定手段560によって検知可能とする。 In the drug dispensing device 1 described above, as shown in FIG. 61, a hopper-side weight measuring means 560 capable of detecting the weight of the powdered drug charging hopper 310 may be provided. The hopper-side weight measuring means 560 is a part of the packaging device 308 and may be provided on a base member to which the powdered medicine charging hopper 310 is fixed. Further, when detecting the weight of the powdered medicine charging hopper 310, the detected value of the hopper-side weight measuring means 560 determines the weight of the member different from the powdered medicine charging hopper 310 among the members on which the load is applied to the hopper-side weight measuring means 560. A weight value may be obtained by subtracting the weight. Also, an upper lid member that closes the upper opening of the powdered medicine introduction hopper 310 and a lower lid member that closes the lower opening may be provided. In this case, the upper lid member and the lower lid member are members capable of switching between an open state and a closed state of their respective openings. Furthermore, the lower lid member may be provided integrally with the powdered medicine introduction hopper 310 . The powdered medicine may be temporarily retained inside the powdered medicine feeding hopper 310 by putting the powdered medicine into the powdered medicine feeding hopper 310 with the lower lid member closed. At this time, the weight of the powdered medicine charged into the powdered medicine charging hopper 310 can be detected by the hopper-side weight measuring means 560 .
 ホッパー側重量測定手段560を設ける構成とした場合、以下のような故障検知動作を実行してもよい。
 具体的に説明すると、上記したように、薬剤フィーダ5の薬剤容器20から分配皿6に散薬を排出する。これと前後して、処方データに基づき、一包分の散薬の重量を取得する。例えば、21包分として分配皿6に63gの散薬を排出した場合、一包分の散薬の重量は、3g(63/21)となる。
 そして、下側蓋部材によって下部開口を閉状態とした散薬投入ホッパー310に対し、通常の分包動作と同様に一包分の散薬を投入する。続いて、ホッパー側重量測定手段560の検出値に基づいて、散薬投入ホッパー310に投入された散薬の重量を取得する。
When the hopper-side weight measuring means 560 is provided, the following failure detection operation may be performed.
Specifically, powdered medicine is discharged from the medicine container 20 of the medicine feeder 5 to the distribution tray 6 as described above. Around this time, the weight of a package of powdered medicine is obtained based on the prescription data. For example, when 63 g of powdered medicine is discharged to the distribution tray 6 as 21 packets, the weight of one packet of powdered medicine is 3 g (63/21).
Then, one packet of the powdered medicine is put into the powdered medicine injection hopper 310 whose lower opening is closed by the lower cover member in the same manner as the normal packaging operation. Subsequently, based on the detection value of the hopper-side weight measuring means 560, the weight of the powdered medicine charged into the powdered medicine charging hopper 310 is acquired.
 続いて、予め取得した一包分の散薬の重量と、ホッパー側重量測定手段560に基づいて取得した散薬投入ホッパー310に投入された散薬の重量を比較する。そして、比較動作の結果、これらが同一である場合、重量測定手段25が故障していなかったと判別する。反対に、比較した重量が同一でなかった場合、重量測定手段25が故障していたと判別する。
 ここで、図61で示されるように、一つの薬剤フィーダ5から散薬が排出されたのであれば、この薬剤フィーダ5の重量測定手段25が故障していたか否かが判別される。対して、複数の薬剤フィーダ5から散薬が排出されたのであれば、複数の薬剤フィーダ5の全てで重量測定手段25が故障していなかったか否かが判別される。即ち、比較した重量が同一であった場合、複数の薬剤フィーダ5の全てで重量測定手段25が故障していなかったと判別される。対して、比較した重量が同一でなかった場合、いずれか一以上の薬剤フィーダ5に属する重量測定手段25が故障していたと判別する。
 なお、上記した一包分の重量は、重量測定手段25の検出値に基づいて算出される値であってもよい。即ち、重量測定手段25の検出値に基づいて総排出量を算出し、総排出量から一包分の重量を算出してもよい。
Subsequently, the weight of one package of powdered medicine obtained in advance and the weight of the powdered medicine put into the powdered medicine feeding hopper 310 obtained based on the hopper-side weight measuring means 560 are compared. If the result of the comparison operation is that they are the same, it is determined that the weight measuring means 25 has not failed. Conversely, if the compared weights are not the same, it is determined that the weight measuring means 25 has failed.
Here, as shown in FIG. 61, if powdered medicine is discharged from one medicine feeder 5, it is determined whether or not the weight measuring means 25 of this medicine feeder 5 is out of order. On the other hand, if the powdered medicine is discharged from a plurality of medicine feeders 5, it is determined whether or not the weight measuring means 25 of all the medicine feeders 5 are out of order. That is, if the compared weights are the same, it is determined that the weight measuring means 25 of all of the plurality of drug feeders 5 have not failed. On the other hand, if the compared weights are not the same, it is determined that the weight measuring means 25 belonging to one or more drug feeders 5 has failed.
Note that the weight of one package may be a value calculated based on the detected value of the weight measuring means 25 . That is, the total discharge amount may be calculated based on the detected value of the weight measuring means 25, and the weight of one package may be calculated from the total discharge amount.
 また、故障検知動作によって重量測定手段25が故障していたと判別された場合、その旨を報知する報知動作を実行してもよい。また、報知動作では、重量測定手段25の校正を促す動作を含んでいてもよい。例えば、故障検知動作で故障していると判別された(又は故障が疑われる)薬剤フィーダ5の校正を促す動作を実行してもよく、薬剤払出し装置1に属する(分配皿6に対応付けられた)全ての薬剤フィーダ5の校正を促す動作を実行してもよい。 In addition, when it is determined that the weight measuring means 25 is out of order by the failure detection operation, a notification operation to notify that fact may be executed. Further, the notification operation may include an operation to prompt calibration of the weight measuring means 25 . For example, an operation may be executed to prompt calibration of the medicine feeder 5 determined to be out of order (or suspected to be out of order) by the failure detection operation, and belongs to the medicine dispensing device 1 (associated with the distribution tray 6). b) an operation to prompt calibration of all drug feeders 5 may be executed.
 また、故障検知動作は、図62で示されるように、薬剤フィーダ5から分配皿6に排出した散薬を一点あるいは極狭い領域に積み上げて実行する動作であってもよい。
 即ち、この故障検知動作が開始されると、薬剤フィーダ5から分配皿6に一服用分の散薬が排出される。この間、分配皿6の回転を停止させるか、あるいは、分配皿6を極小さな回転速度で回転させる。このため、排出された散薬が分配皿6の一点あるいは極狭い領域に積み上げられて散薬集合570が形成される。つまり、散薬集合570は、分配皿6の一部となる狭い範囲に山のように積み上がった散薬の集まり(散薬の山)である。
Further, as shown in FIG. 62, the failure detection operation may be performed by stacking the powdered medicine discharged from the medicine feeder 5 to the distribution tray 6 at one point or in an extremely narrow area.
That is, when this failure detection operation is started, one dose of powdered medicine is discharged from the medicine feeder 5 to the distribution tray 6 . During this time, the rotation of the distribution plate 6 is stopped, or the distribution plate 6 is rotated at a very low rotational speed. For this reason, the discharged powdered medicine is piled up at one point or in a very narrow area of the distribution tray 6 to form a powdered medicine assembly 570 . In other words, the powdered medicine set 570 is a collection of powdered medicines piled up like a mountain in a narrow range that is part of the distribution tray 6 (a pile of powdered medicines).
 複数の薬剤フィーダ5の重量測定手段25を対象に故障検知動作を実行する場合、それぞれから一包分の散薬を排出し、分配皿6の複数個所に散薬集合570を形成する。これと前後して、処方データに基づき、それぞれの薬剤フィーダ5から排出される散薬の一包分の重量、即ち、それぞれの散薬集合570を作成する際に目標排出量となる重量を取得する。
 続いて、分配皿6を小さな速度で回転させ、一の散薬集合570aを散薬投入ホッパー310に近接する位置まで移動させた後、この散薬集合570aを散薬投入ホッパー310に投入する。このとき、散薬投入ホッパー310の下部開口を閉状態としておき、ホッパー側重量測定手段560の検出値に基づいて、散薬投入ホッパー310に投入された散薬の重量を取得する。
When executing the failure detection operation for the weight measuring means 25 of a plurality of drug feeders 5 , one package of powdered drugs is discharged from each of them to form powdered drug aggregates 570 at a plurality of locations on the distribution tray 6 . Around this time, based on the prescription data, the weight of one package of the powdered medicine discharged from each medicine feeder 5, that is, the weight that becomes the target discharge amount when creating each powdered medicine group 570, is obtained.
Subsequently, the distribution tray 6 is rotated at a low speed to move one powdered drug set 570 a to a position close to the powdered drug charging hopper 310 , and then this powdered drug set 570 a is charged to the powdered drug charging hopper 310 . At this time, the lower opening of the powdered medicine charging hopper 310 is kept closed, and the weight of the powdered medicine charged into the powdered medicine charging hopper 310 is obtained based on the detection value of the hopper-side weight measuring means 560 .
 そして、散薬投入ホッパー310に投入した散薬(散薬集合570a)の重量と、投入した散薬の目標排出量(散薬集合570aを形成する際の目標排出量)であった一包分の重量を比較する。そして、比較動作の結果、これらが同一である場合、この散薬を排出した薬剤フィーダ5の重量測定手段25が故障していなかったと判別する。反対にこれらが同一でなかった場合、この散薬を排出した薬剤フィーダ5の重量測定手段25が故障していたものと判別する。
 例えば、一の薬剤フィーダ5で目標排出量を3gとして散薬を排出して散薬集合570aを作成したのであれば、散薬投入ホッパー310に投入された散薬の重量が3gであるのか否かを判別する。そして、3gであった場合、一の薬剤フィーダ5に属する重量測定手段25が故障していなかったと判別する、といった具合である。
Then, the weight of the powdered medicine (powder medicine set 570a) fed into the powdered medicine feeding hopper 310 is compared with the weight of one package that was the target discharge amount of the fed powdered medicine (target discharge amount when forming the powdered medicine set 570a). . As a result of the comparison operation, if they are the same, it is determined that the weight measuring means 25 of the medicine feeder 5 that discharged this powdered medicine was not out of order. Conversely, if they are not the same, it is determined that the weight measuring means 25 of the drug feeder 5 that has discharged this powdered drug has failed.
For example, if one medicine feeder 5 discharges powdered medicine with a target discharge amount of 3 g to create the powdered medicine set 570a, it is determined whether or not the weight of the powdered medicine fed into the powdered medicine feeding hopper 310 is 3 g. . Then, if it is 3 g, it is determined that the weight measuring means 25 belonging to one drug feeder 5 has not failed.
 続いて、散薬投入ホッパー310の下部開口を開状態とし、散薬投入ホッパー310内から散薬(散薬集合570a)を排出する。その後、分配皿6を小さな速度で回転させることで、他の一の散薬集合570bを散薬投入ホッパー310に近接する位置まで移動させ、この散薬集合570bを散薬投入ホッパー310に投入する。なお、この投入動作に先立って散薬投入ホッパー310の下部開口を閉状態としておく。そして、上記と同様に、ホッパー側重量測定手段560の検出値に基づいて、散薬投入ホッパー310に投入された散薬(散薬集合570b)の重量を取得する。 Subsequently, the lower opening of the powdered medicine charging hopper 310 is opened, and the powdered medicine (the powdered medicine set 570a) is discharged from the inside of the powdered medicine charging hopper 310. After that, by rotating the distribution tray 6 at a low speed, another powdered medicine set 570b is moved to a position close to the powdered medicine feeding hopper 310, and this powdered medicine set 570b is fed into the powdered drug feeding hopper 310. Prior to this charging operation, the lower opening of the powdered drug charging hopper 310 is closed. Then, in the same manner as described above, based on the detection value of the hopper-side weight measuring means 560, the weight of the powdered medicine (powder medicine set 570b) fed into the powdered medicine feeding hopper 310 is acquired.
 そして、上記と同様に、散薬投入ホッパー310に投入した散薬(散薬集合570b)の重量と、投入した散薬の目標排出量(散薬集合570aを形成する際の目標排出量)であった一包分の重量を比較する。このことにより、この散薬を排出した薬剤フィーダ5の重量測定手段25が故障していなかったと判別する。以下同様に、複数の薬剤フィーダ5のそれぞれに対し、重量測定手段25が故障していたか否かを判別していく。
 この故障検知動作は、複数の薬剤フィーダ5の重量測定手段25を対象とする動作に限らず、一つの薬剤フィーダ5の重量測定手段25を対象とする動作としてもよい。
 なお、上記した故障検知動作では、重量測定手段25の検出値に基づいて算出した値(排出量)と、ホッパー側重量測定手段560の検出値に基づいて算出した値(投入量)を比較する動作を実行してもよい。
 また、上記の例では、薬剤フィーダ5から分配皿6に排出した散薬を使用して故障検知動作を実行した。しかしながら、故障検知動作は、散薬に替わって、清掃用の薬品(清掃剤)、食品、賦形剤等を使用してもよい。即ち、薬剤とは異なる粉体を使用してもよい。賦形剤は、製剤前の分量を増やすために加えられる添加剤であり、所謂増量剤である。また、ここでいう「食品」は、澱粉、重曹等、人が経口摂取しても問題のないものを含むものとし、以下も同様である。散薬に替わってこれらを使用する場合、これらを上記の薬剤容器20に収容した検知動作用容器を使用する。
Then, in the same manner as described above, the weight of the powdered medicine (powder medicine set 570b) fed into the powdered medicine feeding hopper 310 and the target discharge amount of the fed powdered medicine (target discharge amount when forming the powdered medicine set 570a) for one package Compare the weight of From this, it is determined that the weight measuring means 25 of the drug feeder 5 that discharged this powdered drug was not out of order. Similarly, it is determined whether or not the weight measuring means 25 is out of order for each of the plurality of drug feeders 5 .
This failure detection operation is not limited to an operation targeting the weight measuring means 25 of a plurality of drug feeders 5 , and may be an operation targeting the weight measuring means 25 of one drug feeder 5 .
In the failure detection operation described above, the value (discharge amount) calculated based on the detection value of the weight measuring means 25 and the value (input amount) calculated based on the detection value of the hopper-side weight measuring means 560 are compared. Actions may be performed.
Further, in the above example, the failure detection operation was performed using powdered medicine discharged from the medicine feeder 5 to the distribution tray 6 . However, the failure detection operation may use cleaning chemicals (cleaning agents), foods, excipients, etc., instead of the powdered medicine. That is, a powder different from the drug may be used. An excipient is an additive added to increase the volume before formulation, and is a so-called bulking agent. The term "food" as used herein includes starch, sodium bicarbonate, and other foods that can be taken orally by humans, and the same applies to the following. When these are used in place of the powdered medicines, a container for detection operation containing these in the medicine container 20 is used.
 上記したように、ホッパー側重量測定手段560を設けた構成とした場合、以下のようなホッパーの取付判別動作を実行してもよい。
 このホッパーの取付判別動作は、散薬投入ホッパー310が台部材に装着されているか否かを判別する動作である。詳細には、散薬投入ホッパー310を着脱する際の重量変化をホッパー側重量測定手段560によって検知する。即ち、ホッパー側重量測定手段560の検出値に基づき、散薬投入ホッパー310の荷重がホッパー側重量測定手段560に付加されているか否かを判別する。そして、散薬投入ホッパー310の荷重が付加されていると判別された場合、散薬投入ホッパー310が取り付けられた状態であるとする。反対に、散薬投入ホッパー310の荷重が付加されていないと判別された場合、散薬投入ホッパー310が取り外された状態であるとする。
 上記したホッパーの取付判別動作によると、散薬投入ホッパー310を検知するためのセンサや、散薬投入ホッパー310に検知用の配線等を設けることなく、散薬投入ホッパー310の装着の有無を検知できる。
As described above, when the hopper-side weight measuring means 560 is provided, the following hopper attachment determination operation may be performed.
This hopper attachment determination operation is an operation for determining whether or not the powdered medicine introduction hopper 310 is attached to the base member. Specifically, the hopper-side weight measuring means 560 detects the weight change when the powdered medicine charging hopper 310 is attached and detached. That is, based on the detection value of the hopper-side weight measuring means 560, it is determined whether or not the load of the powdered medicine charging hopper 310 is applied to the hopper-side weight measuring means 560. Then, when it is determined that the load of the powdered medicine charging hopper 310 is applied, it is assumed that the powdered medicine charging hopper 310 is attached. Conversely, if it is determined that no load is applied to the powdered medicine charging hopper 310, it is assumed that the powdered medicine charging hopper 310 has been removed.
According to the hopper attachment determination operation described above, it is possible to detect whether or not the powdered medicine charging hopper 310 is attached without providing a sensor for detecting the powdered medicine charging hopper 310 or wiring for detection in the powdered drug charging hopper 310 .
 上記したように、ホッパー側重量測定手段560を設けた構成とした場合、以下のようなホッパーの清掃動作を実行してもよい。
 まず、ホッパーの基本的な清掃動作について説明する。上記した薬剤払出し装置1では、分包動作の実行後であって、続いて行う分包動作の実行前に散薬投入ホッパー310の清掃動作を実行する。
 散薬投入ホッパー310の清掃動作として、下部開口を閉状態とした散薬投入ホッパー310内に清掃用の薬品又は食品(以下、単に清掃剤とする)を投入し、その後に上部開口を閉状態とし、散薬投入ホッパー310内の吸引を行う吸引清掃動作がある。吸引清掃動作では、吸引の後半で下側蓋部材を開閉させてもよく、この際に、エアーノズルから下側蓋部材の外側に空気を吹き付けてもよい。また、清掃動作として、図示しない集塵装置により、散薬投入ホッパー310に付着した薬剤等を除去する集塵動作がある。なお、集塵装置は、負圧を発生させて空気と共に塵を吸い込むものであり、特に限定されるものではないが、バキュームポンプや集塵袋を備えたものでもよい。さらにまた、清掃動作として、バイブレータやノッカー等により、散薬投入ホッパー310を叩打する、又は振動させる振動清掃動作がある。薬剤払出し装置1の清掃動作では、吸引清掃動作、集塵動作、振動清掃動作から選択される一以上を実行する。
As described above, when the hopper-side weight measuring means 560 is provided, the following hopper cleaning operation may be performed.
First, the basic cleaning operation of the hopper will be explained. In the medicine delivery device 1 described above, the cleaning operation of the powdered medicine introduction hopper 310 is executed after execution of the packaging operation and before execution of the subsequent packaging operation.
As a cleaning operation of the powdered medicine charging hopper 310, a cleaning chemical or food (hereinafter simply referred to as a cleaning agent) is charged into the powdered medicine charging hopper 310 with the lower opening closed, and then the upper opening is closed, There is a suction cleaning operation that provides suction within the powdered drug input hopper 310 . In the suction cleaning operation, the lower lid member may be opened and closed in the latter half of the suction, and at this time, air may be blown from the air nozzle to the outside of the lower lid member. Further, as the cleaning operation, there is a dust collection operation for removing the medicine or the like adhering to the powdered medicine introduction hopper 310 by a dust collector (not shown). The dust collector generates negative pressure to suck in dust together with air, and is not particularly limited, but may be equipped with a vacuum pump or a dust bag. Furthermore, as the cleaning operation, there is a vibrating cleaning operation in which the powdered medicine charging hopper 310 is hit or vibrated by a vibrator, a knocker, or the like. In the cleaning operation of the drug dispensing device 1, one or more selected from a suction cleaning operation, a dust collection operation, and a vibration cleaning operation is performed.
 ここで、散薬投入ホッパー310に付着する散薬には、種類によって清掃動作で落ち難いものがある。また、薬剤払出し装置1の設置場所の湿度等に起因して清掃動作で散薬が落ち難い場合がある。
 そこで、本実施形態の薬剤払出し装置1では、分包動作を実行した後に清掃動作を実行する際、分包動作の実行前、分包動作の実行後(清掃動作の実行前)、清掃動作の実行後のそれぞれで、散薬投入ホッパー310の重量を測定する動作を実行する。即ち、散薬投入ホッパー310に散薬が付着すると、ホッパー側重量測定手段560によって測定される散薬投入ホッパー310の重量の値が大きくなる。そこで、分包動作の前後の重量差を取得する(検出値を比較する)ことで、分包動作によって散薬投入ホッパー310に散薬がどの程度付着したのか判別できる。また、分包動作の実行前の重量の値と、清掃動作の実行後の重量の値とを比較することで、清掃動作が適切に実行できたか否か、即ち、散薬が落とし切れているか否かを判別できる。このことから、分包動作前と清掃動作後の検出値を比較することで清掃動作の評価が可能となる。
Here, depending on the type of the powdered medicine adhering to the powdered medicine feeding hopper 310, there are some that are difficult to remove by the cleaning operation. In addition, it may be difficult to remove the powdered medicine by the cleaning operation due to the humidity of the place where the medicine dispensing device 1 is installed.
Therefore, in the medicine dispensing device 1 of the present embodiment, when performing the cleaning operation after performing the packaging operation, before the packaging operation is performed, after the packaging operation is performed (before the cleaning operation is performed), and when the cleaning operation is performed. After each execution, the operation of weighing the powdered medicine input hopper 310 is executed. That is, when powdered medicine adheres to the powdered medicine charging hopper 310, the value of the weight of the powdered medicine charging hopper 310 measured by the hopper-side weight measuring means 560 increases. Therefore, by acquiring the weight difference before and after the packaging operation (comparing the detected values), it is possible to determine how much powdered medicine has adhered to the powdered medicine introduction hopper 310 due to the packaging operation. In addition, by comparing the weight value before execution of the packaging operation and the value of weight after execution of the cleaning operation, it is possible to determine whether the cleaning operation was properly performed, that is, whether the powdered medicine was completely removed. can determine whether Therefore, the cleaning operation can be evaluated by comparing the detection values before the packaging operation and after the cleaning operation.
 そして、薬剤払出し装置1では、上記したホッパー側重量測定手段560の検出値に基づいて清掃動作を実行する。例えば、分包動作前と分包動作後の検出値を比較し、多量の散薬が付着していた場合、清掃剤の量を多くする、叩打の強さを強くする、叩打の回数を多くする、集塵装置の吸い込み強さを強くする、吸い込み時間を長くする等して清掃動作を実行する。反対に、散薬があまり付着していなかった場合、清掃剤の量を少なくする、叩打の強さを弱くする・・・等して清掃動作を実行する。つまり、ホッパー側重量測定手段560の検出値に基づいて、実行する清掃動作の内容(清掃剤の量、吸引動作等の各種動作の実行長さ(実行時間)、叩打の回数、間隔、強さ、集塵動作の強さ等)を変更する。また、上記したホッパー側重量測定手段560の検出値に基づいて、清掃動作の後に再度清掃動作を実行するのか否かを決定する。そして、再度清掃動作を実行する場合、続いて行う清掃動作の内容もまた、ホッパー側重量測定手段560の検出値に基づいて決定する。言い換えると、ホッパー側重量測定手段560の検出値に基づき、清掃動作の実行回数が決定され、一又は複数回実行するそれぞれの清掃動作の内容が決定される。清掃動作の実行回数は、1度の清掃動作の実行毎に続けて清掃動作を実行するか否かを決定する他、初回の清掃動作の実行前に何回実行するかを決定してもよく、二回目以降の清掃動作の実行前に後何回実行するかを決定してもよい。清掃動作の内容も同様に、1度の清掃動作の実行毎に続けて行う清掃動作の内容を決定する他、適宜のタイミングで実行内容を決定してもよい。 Then, the drug dispensing device 1 performs a cleaning operation based on the detection value of the hopper-side weight measuring means 560 described above. For example, compare the detected values before and after the packaging operation, and if a large amount of powdered medicine is adhered, increase the amount of cleaning agent, increase the strength of hitting, and increase the number of times of hitting. , the suction strength of the dust collector is increased, the suction time is lengthened, and the like to perform the cleaning operation. Conversely, if the powdered medicine is not very attached, the cleaning operation is performed by reducing the amount of cleaning agent, weakening the strength of tapping, and so on. That is, based on the detected value of the hopper-side weight measuring means 560, the details of the cleaning operation to be performed (the amount of cleaning agent, the length (execution time) of various operations such as the suction operation, the number of tapping, the interval, the strength, etc.) , strength of dust collecting operation, etc.). Further, based on the detection value of the hopper-side weight measuring means 560 described above, it is determined whether or not the cleaning operation is to be performed again after the cleaning operation. When the cleaning operation is performed again, the content of the subsequent cleaning operation is also determined based on the detection value of the hopper-side weight measuring means 560 . In other words, based on the detection value of the hopper-side weight measuring means 560, the number of times the cleaning operation is performed is determined, and the content of each cleaning operation to be performed once or multiple times is determined. The number of cleaning operations to be performed may be determined whether or not the cleaning operation is to be performed continuously each time the cleaning operation is performed, or may be determined how many times to perform the cleaning operation before the first cleaning operation is performed. , the number of times to perform the cleaning operation may be determined before the second and subsequent cleaning operations are performed. As for the contents of the cleaning operation, similarly, the contents of the cleaning operation to be performed successively each time the cleaning operation is performed may be determined, or the contents of the cleaning operation may be determined at an appropriate timing.
 また、清掃動作を実行した後、すでに実行した清掃動作の評価に関する情報(以下、清掃評価情報とも称す)を制御装置等の記憶手段に記憶させてもよい。清掃評価情報は、清掃対象となる散薬の種類の情報、実行時の湿度の情報、実行した清掃動作の内容に関する情報等と関連付けて記憶される情報であってもよい。そして、清掃動作が実行される度、清掃評価情報やその関連情報に基づき、よりよい評価となるように内容を変更して清掃動作を実行してもよい。このような構成によると、薬剤払出し装置1の運用を長く続ける程に清掃動作の精度が向上する。 Further, after the cleaning operation is performed, information regarding the evaluation of the already performed cleaning operation (hereinafter also referred to as cleaning evaluation information) may be stored in a storage means such as a control device. The cleaning evaluation information may be information stored in association with information on the type of powdered medicine to be cleaned, information on humidity at the time of execution, information on the details of the cleaning operation performed, and the like. Then, each time the cleaning operation is performed, the cleaning operation may be performed with the content changed so as to obtain a better evaluation based on the cleaning evaluation information and related information. According to such a configuration, the longer the operation of the medicine dispensing device 1 is continued, the more the accuracy of the cleaning operation is improved.
 上記したように、掻出装置8は、取付基台255に回転板12を取り付けて使用する。ここで、ホッパー側重量測定手段560を設けた構成とした場合、以下のような装着判別動作を実行してもよい。
 装着判別動作は、掻出装置8に後付けで装着する部材(本実施形態では回転板12)が正しく装着されているか否かを判別する動作である。具体的には、散薬投入ホッパー310の下部開口を閉状態とし、分配皿6から一包分の散薬を散薬投入ホッパー310に投入する動作を実行する。そして、ホッパー側重量測定手段560によって散薬投入ホッパー310に投入した散薬の重量が正しく検知されたことを条件として、掻出装置8に回転板12が正しく装着されていると判別する。反対に、散薬投入ホッパー310に投入した散薬の重量が正しく検知されなかった場合に、掻出装置8に回転板12が正しく装着されていない状態であると判別する。
 装着判別動作は、分包動作の実行時に並行して実行される動作であってもよい。即ち、分包動作において分配皿6から散薬投入ホッパー310に散薬を投入したとき、回転板12が正しく装着されているか否かを判別してもよい。この場合、回転板12が正しく装着されていない状態であると判別された場合、実行中の分包動作を中止してもよい。また、回転板12が正しく装着されていない旨を報知する報知動作を実行してもよい。
 なお、装着判別動作は、分包動作とは別に実行される動作であってもよく、例えば、分包動作の実行前に薬剤フィーダ5から分配皿6に散薬を排出して実行してもよい。また、装着判別動作は、上記した故障検知動作と並行して実行される動作であってもよい。即ち、散薬投入ホッパー310に投入した散薬の重量が正しく検知された場合、回転板12が正しく装着されており、この散薬を排出した薬剤フィーダ5の重量測定手段25が故障していなかったと判別する。対して、散薬の重量が正しく検知されなかった場合、回転板12が正しく装着されていないか、散薬を排出した薬剤フィーダ5の重量測定手段25が故障していたものと判別する。
As described above, the scraping device 8 is used with the rotary plate 12 attached to the mounting base 255 . Here, when the hopper-side weight measuring means 560 is provided, the following attachment determination operation may be performed.
The attachment determination operation is an operation for determining whether or not a member (rotary plate 12 in this embodiment) to be attached to the scraping device 8 afterward is correctly attached. Specifically, the operation of closing the lower opening of the powdered medicine charging hopper 310 and charging one package of the powdered medicine from the distribution tray 6 into the powdered medicine charging hopper 310 is executed. Then, on condition that the weight of the powdered medicine thrown into the powdered medicine feeding hopper 310 is correctly detected by the hopper-side weight measuring means 560, it is determined that the rotary plate 12 is correctly mounted on the scraping device 8. Conversely, when the weight of the powdered medicine put into the powdered medicine injection hopper 310 is not detected correctly, it is determined that the rotating plate 12 is not properly attached to the scraping device 8 .
The attachment determination operation may be an operation that is executed in parallel with the packaging operation. That is, it may be determined whether or not the rotating plate 12 is correctly mounted when the powdered medicine is put into the powdered medicine injection hopper 310 from the distribution tray 6 in the packing operation. In this case, if it is determined that the rotary plate 12 is not correctly attached, the packaging operation that is being performed may be stopped. Also, a notification operation may be performed to notify that the rotating plate 12 is not correctly mounted.
The attachment determination operation may be performed separately from the packing operation. For example, the powdered medicine may be discharged from the medicine feeder 5 to the distribution tray 6 before the packaging operation is performed. . Also, the attachment determination operation may be an operation executed in parallel with the failure detection operation described above. That is, when the weight of the powdered medicine put into the powdered medicine feeding hopper 310 is correctly detected, it is determined that the rotating plate 12 is correctly mounted and the weight measuring means 25 of the medicine feeder 5 that has discharged this powdered medicine is not out of order. . On the other hand, if the weight of the powdered medicine is not correctly detected, it is determined that the rotating plate 12 is not properly mounted or the weight measuring means 25 of the medicine feeder 5 that has discharged the powdered medicine is out of order.
 ここで、上記した薬剤払出し装置1(図1等参照)では、薬剤フィーダ5の薬剤容器20から分配皿6に散薬を排出するとき、上記したように、排出に先立って事前分銅測定動作を実行する。そして、重量校正部21を第二の状態から第一の状態に移行させ、散薬を分配皿6に排出する動作を実行する。そして、散薬の排出動作の実行後、薬剤容器20の重量(及び/又は内蔵された散薬の重量)を取得する。さらに、事後分銅測定動作を実行している。 Here, in the medicine dispensing device 1 (see FIG. 1, etc.), when discharging the powdered medicine from the medicine container 20 of the medicine feeder 5 to the distribution tray 6, as described above, prior to discharge, the preliminary weight measurement operation is performed. do. Then, the weight calibration unit 21 is shifted from the second state to the first state, and the operation of discharging the powdered medicine to the distribution tray 6 is executed. After executing the operation of discharging the powdered medicine, the weight of the medicine container 20 (and/or the weight of the contained powdered medicine) is acquired. Furthermore, a post weight measurement operation is executed.
 また、散薬の排出動作では、上記したように、薬剤容器20の重量を測定する動作を実行する。即ち、フィーダ部22における振動部材16の振動開始と前後して、薬剤容器20の重量が測定され、散薬の落下中においても薬剤容器20の現在の重量を現重量gとして監視し続ける。そして、振動部材16に設置直後の薬剤容器20の原重量Gと現重量gとを比較して散薬の落下量Hを常時演算し、散薬の総落下量Hが所望の重量となったところで、振動部材16の振動を停止している。 Also, in the operation of discharging the powdered medicine, the operation of measuring the weight of the medicine container 20 is executed as described above. That is, the weight of the medicine container 20 is measured before and after the vibrating member 16 in the feeder section 22 starts to vibrate, and the current weight of the medicine container 20 is continuously monitored as the current weight g even while the powdered medicine is falling. Then, the original weight G and the current weight g of the drug container 20 immediately after being placed on the vibrating member 16 are compared to constantly calculate the falling amount H of the powdered medicine, and when the total falling amount H of the powdered medicine reaches the desired weight, Vibration of the vibrating member 16 is stopped.
 ここで、上記した散薬の排出動作では、薬剤容器20の下方側に設けられた開口を開状態とする前の重量を薬剤容器20の原重量Gとして取得してもよい(ゼロ点としてもよい)。散薬の落下量Hが一定以上となり、所望の重量に近づいた(又は所望の重量となった)とき、振動部材16の振動を停止し、薬剤容器20の開口を開状態としたまま所定時間だけ待機する待機動作を実行してもよい。このとき、原重量Gと待機動作を実行後に取得した現重量gを比較して演算した散薬の落下量Hを、最終的に分配皿6に排出した散薬の量(散薬の排出量)としてもよい。
 以下、このような排出動作で分配皿6に散薬を排出する際の具体的な手順につき、薬剤容器20をフィーダ本体10に取り付けて保持させ、散薬の排出動作を実行した後、薬剤容器20をフィーダ本体10から取り外す場合を例に挙げて詳細に説明する。
Here, in the operation of discharging the powdered medicine described above, the weight of the medicine container 20 before the opening provided on the lower side of the medicine container 20 is opened may be obtained as the original weight G of the medicine container 20 (it may be set as a zero point). ). When the drop amount H of the powdered medicine reaches a certain level or more and approaches the desired weight (or reaches the desired weight), the vibration of the vibrating member 16 is stopped, and the opening of the medicine container 20 is kept open for a predetermined period of time. A waiting operation of waiting may be performed. At this time, the falling amount H of the powdered medicine calculated by comparing the original weight G and the current weight g obtained after the execution of the standby operation can also be used as the amount of the powdered medicine finally discharged to the distribution tray 6 (discharge amount of the powdered medicine). good.
Hereinafter, regarding a specific procedure for discharging the powdered medicine to the distribution tray 6 by such a discharging operation, the medicine container 20 is attached to the feeder main body 10 and held, and after executing the powdered medicine discharging operation, the medicine container 20 is removed. A case of removing from the feeder main body 10 will be described in detail as an example.
 まず、図63で示されるように、薬剤容器20をフィーダ本体10に取り付けて保持させる(ステップ1、図63(a)参照)。次に、重量校正部21を第一の状態から第二の状態に移行させ、分銅42の重量を検知する動作(事前分銅測定動作)を実行する(ステップ2、図63(b)参照)。次に、重量校正部21を第二の状態から第一の状態に移行させる(ステップ3、図63(c)参照)。次に、薬剤容器20を開状態とする前の重量を薬剤容器20の原重量Gとして取得し、ゼロ点取りを行う(ステップ4、図63(d)参照)。次に、薬剤容器20を開状態とする(ステップ5、図63(e)参照)。振動部材16を振動させて散薬の排出(払い出し)を行う(ステップ6、図63(f)参照)。待機動作を実行し、原重量Gと待機動作後に取得した現重量gを比較して最終的な散薬の排出量を取得する(ステップ7、図63(g)参照)。薬剤容器20の開口を閉状態とする(ステップ8、図63(h)参照)。重量校正部21を第一の状態から第二の状態に移行させ、分銅42の重量を検知する動作(事後分銅測定動作)を実行する(ステップ9、図63(i)参照)。なお、このとき、上記と同様に、事前分銅測定動作と事後分銅測定動作のそれぞれで取得した分銅42の重量の値が同じであるとき、重量測定手段25が故障していなかったと判別する。続いて、重量校正部21を第二の状態から第一の状態に移行させる(ステップ10、図63(j)参照)。薬剤容器20をフィーダ本体10から取り外す(ステップ11、図63(k)参照)。 First, as shown in FIG. 63, the drug container 20 is attached to and held by the feeder body 10 (step 1, see FIG. 63(a)). Next, the weight calibration unit 21 is shifted from the first state to the second state, and the operation of detecting the weight of the weight 42 (preliminary weight measurement operation) is executed (step 2, see FIG. 63(b)). Next, the weight calibration unit 21 is shifted from the second state to the first state (step 3, see FIG. 63(c)). Next, the weight before opening the drug container 20 is acquired as the original weight G of the drug container 20, and zero point is taken (step 4, see FIG. 63(d)). Next, the drug container 20 is opened (step 5, see FIG. 63(e)). The vibrating member 16 is vibrated to discharge (pay out) the powdered medicine (step 6, see FIG. 63(f)). The standby operation is executed, and the original weight G and the current weight g obtained after the standby operation are compared to obtain the final discharge amount of the powder medicine (step 7, see FIG. 63(g)). The opening of the drug container 20 is closed (step 8, see FIG. 63(h)). The weight calibration unit 21 is shifted from the first state to the second state, and the operation of detecting the weight of the weight 42 (post weight measurement operation) is executed (step 9, see FIG. 63(i)). At this time, similarly to the above, when the weight values of the weight 42 obtained in the pre-weight measurement operation and the post-weight measurement operation are the same, it is determined that the weight measurement means 25 has not failed. Subsequently, the weight calibration unit 21 is shifted from the second state to the first state (step 10, see FIG. 63(j)). The drug container 20 is removed from the feeder body 10 (step 11, see FIG. 63(k)).
 上記したように散薬の排出動作を実行することで、意図しない散薬の落下に起因する散薬の排出量の測定誤差(払い出し誤差)の発生を抑制できる。
 詳細に説明すると、薬剤容器20を開状態とすると、開状態に移行させる動作に伴ってシャッター部材91等に付着した薬剤が落下してしまう可能性がある。また、薬剤容器20内の散薬排出部(開口)近傍からの薬剤の落下が万一発生してしまうことも考えられる。したがって、薬剤容器20を開状態とする前にゼロ点取りを行うことで、これらのような意図しない散薬の落下に起因する落下分の誤差の発生を抑制できる。
 即ち、シャッター部材91を開いて開状態とした後にゼロ点取りを行うと、開状態に移行させる際に上記した薬剤(散薬)の落下が発生してしまった場合、排出した薬剤の重量が分包量(本来排出すべき排出量)と相違してしまう可能性がある。つまり、ゼロ点取りの前に落下してしまった散薬の分だけ排出量が多くなってしまう可能性がある。
 これに対し、上記の手順で散薬の排出動作を実行することで、より正確な散薬の排出が可能となる。つまり、上記した実施形態によると、故障検知動作によって重量測定手段が故障することに起因する問題の発生が可能であり、且つ、排出量の測定誤差の発生を防止(抑制)可能であるため、精度の高い散薬の排出が可能となる。
By executing the operation of discharging the powdered medicine as described above, it is possible to suppress the occurrence of measurement error (dispensing error) in the discharged amount of the powdered medicine due to unintended dropping of the powdered medicine.
More specifically, when the drug container 20 is opened, there is a possibility that the drug adhering to the shutter member 91 or the like may drop as the drug container 20 is moved to the open state. In addition, it is conceivable that the drug may fall from the vicinity of the powdered drug discharge portion (opening) in the drug container 20 by any chance. Therefore, by performing the zero point before opening the drug container 20, it is possible to suppress the occurrence of errors due to the unintended dropping of the powdered medicine.
That is, if the shutter member 91 is opened and the zero point is taken after the shutter member 91 is opened, and the drug (powder drug) is dropped when the shutter member 91 is shifted to the open state, the weight of the discharged drug is divided and packaged. There is a possibility that it will be different from the amount (emission amount that should be emitted originally). In other words, there is a possibility that the discharge amount will increase by the amount of the powdered medicine that has fallen before the zero point is taken.
On the other hand, by executing the operation of discharging the powdered medicine according to the procedure described above, it becomes possible to discharge the powdered medicine more accurately. In other words, according to the above-described embodiment, it is possible to cause a problem caused by the failure of the weight measuring means due to the failure detection operation, and it is possible to prevent (suppress) the occurrence of measurement errors in the amount of discharge. It is possible to discharge powdered medicine with high accuracy.
 上記した実施形態は次の発明の実施形態である。
  [発明1]
 散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記薬剤容器から散薬を排出し、前記重量測定手段によって散薬の排出量を検出することが可能である薬剤フィーダにおいて、
 錘部材を有し、前記錘部材又は前記重量測定手段又は前記薬剤容器の少なくともいずれかを昇降させる昇降手段を有し、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材の荷重が前記重量測定手段に付加されていない状態を比較して前記重量測定手段の校正、及び/又は故障検知を行う、薬剤フィーダ。
The above-described embodiment is an embodiment of the following invention.
[Invention 1]
a drug container containing a powdered drug, a holding member for holding the drug container, and weight measuring means for directly or indirectly measuring the weight of the drug container, discharging the powdered drug from the drug container, In the drug feeder capable of detecting the discharge amount of the powdered drug by the weight measuring means,
a state in which a load of the weight member is applied to the weight measurement means; A drug feeder that performs calibration and/or failure detection of said weight measuring means by comparing a state in which no member load is applied to said weight measuring means.
  [発明2]
 前記昇降手段は、前記錘部材を昇降させるものであり、前記錘部材が昇降して前記校正、及び/又は前記故障検知を行う、発明1に記載の薬剤フィーダ。
[Invention 2]
The medicine feeder according to invention 1, wherein the elevating means elevates the weight member, and the weight member elevates to perform the calibration and/or the failure detection.
  [発明3]
 重量受部を有し、
 前記重量受部は、前記保持部材が前記薬剤容器を保持した状態と、前記保持部材から前記薬剤容器が取り外された状態のそれぞれで、前記錘部材の荷重を受けることが可能である、発明2に記載の薬剤フィーダ。
[Invention 3]
having a weight receiving part,
Invention 2, wherein the weight receiving portion can receive the load of the weight member in each of a state in which the holding member holds the drug container and a state in which the drug container is removed from the holding member. A drug feeder as described in .
  [発明4]
 前記錘部材と、前記昇降手段と、前記錘部材の荷重を受けることが可能な重量受部を含んで形成される測定手段検査部を有し、
 前記測定手段検査部によって前記校正、及び/又は前記故障検知が実行されるものであり、前記測定手段検査部は、前記保持部材の周辺に配される、発明2又は3に記載の薬剤フィーダ。
[Invention 4]
a measurement means inspection unit including the weight member, the elevating means, and a weight receiving portion capable of receiving the load of the weight member;
The medicine feeder according to invention 2 or 3, wherein the calibration and/or the failure detection are performed by the measuring means inspecting part, and the measuring means inspecting part is arranged around the holding member.
  [発明5]
 重量受部を有し、
 前記昇降手段は、動力源であるモータと、前記モータの稼働によって回転するカムと、前記カムの上に載置される昇降部材を有し、
 前記昇降部材は、前記カムの上に載置された状態を維持しつつ前記カムの回転に伴って上下に移動するものであり、
 前記昇降部材が前記錘部材を下方から押し上げることで、前記錘部材が前記重量受部に接触した状態から、前記錘部材が前記重量受部に接触しない状態に移行する、発明2乃至4のいずれかに記載の薬剤フィーダ。
[Invention 5]
having a weight receiving part,
The elevating means has a motor as a power source, a cam rotated by the operation of the motor, and an elevating member mounted on the cam,
The elevating member moves up and down with the rotation of the cam while maintaining a state of being placed on the cam,
According to any one of Inventions 2 to 4, wherein the lifting member pushes up the weight member from below, thereby shifting from a state in which the weight member is in contact with the weight receiving portion to a state in which the weight member does not contact the weight receiving portion. A drug feeder according to any one of the above.
  [発明6]
 重量受部を有し、
 前記重量受部は、前記保持部材の一部であり、保持した前記薬剤容器の下方側となる位置に形成され、
 前記錘部材を昇降させることで、前記錘部材が前記重量受部に載置され、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材が前記重量受部から上方に離れた状態とが切り替わり、
 前記錘部材は、前記重量受部に載置された状態と、前記重量受部から上方に離れた状態のそれぞれで、保持した前記薬剤容器よりも下方側となる位置に配される、発明2又は3に記載の薬剤フィーダ。
[Invention 6]
having a weight receiving part,
The weight receiving portion is a part of the holding member and is formed at a position below the held drug container,
By moving the weight member up and down, the weight member is placed on the weight receiving portion, the load of the weight member is applied to the weight measuring means, and the weight member moves upward from the weight receiving portion. The separated state is switched,
Invention 2, wherein the weight member is disposed at a position lower than the held drug container in each of the state of being placed on the weight receiving portion and the state of being separated upward from the weight receiving portion. Or the drug feeder according to 3.
  [発明7]
 前記薬剤容器を手動で前記保持部材に保持させることが可能であり、前記保持部材に保持させた前記薬剤容器を手動で取り外すことが可能である、発明1乃至6のいずれかに記載の薬剤フィーダ。
[Invention 7]
The drug feeder according to any one of Inventions 1 to 6, wherein the drug container can be manually held by the holding member, and the drug container held by the holding member can be manually removed. .
  [発明8]
 発明1乃至7のいずれかに記載の薬剤フィーダを備えている、薬剤払出し装置。
[Invention 8]
A drug dispensing device comprising the drug feeder according to any one of Inventions 1 to 7.
  [発明9]
 散薬を包装する薬剤包装部と、前記薬剤包装部に供給する散薬が投入されるホッパー部材と、ホッパー部材の重量を直接的又は間接的に測定するホッパー側重量測定手段を有し、
 前記重量測定手段の検出値に基づいて目標排出量の散薬を排出し、排出された散薬をホッパー部材に投入するものであり、前記ホッパー側重量測定手段の検出値に基づいて前記故障検知を行う、発明8に記載の薬剤払出し装置。
[Invention 9]
A medicine packaging unit for packaging powdered medicine, a hopper member into which the powdered medicine to be supplied to the medicine packaging unit is put, and a hopper-side weight measuring means for directly or indirectly measuring the weight of the hopper member,
A target discharge amount of powdered medicine is discharged based on the detected value of the weight measuring means, and the discharged powdered medicine is put into a hopper member, and the failure detection is performed based on the detected value of the hopper side weight measuring means. , the drug delivery device according to the invention 8.
  [発明10]
 散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記重量測定手段によって散薬の排出量を検出することが可能な薬剤フィーダの校正方法であって、
 錘部材の荷重を前記重量測定手段に付加した状態で前記重量測定手段による重量測定を行う重量取得工程を含み、
 前記重量取得工程で取得した重量と、予め記憶された重量とを比較して前記重量測定手段が正常であるか否かを判別する、薬剤フィーダの校正方法。
[Invention 10]
A medicine container containing a powdered medicine, a holding member for holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container, wherein the weight measuring means discharges the powdered medicine. A method for calibrating a drug feeder capable of detecting
a weight acquisition step of measuring the weight by the weight measuring means with the load of the weight member applied to the weight measuring means;
A method of calibrating a drug feeder, wherein the weight obtained in the weight obtaining step is compared with a prestored weight to determine whether or not the weight measuring means is normal.
  [発明11]
 散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記重量測定手段によって散薬の排出量を検出することが可能な薬剤フィーダの故障検知方法であって、
 錘部材の荷重を前記重量測定手段に付加した状態で前記重量測定手段による重量測定を行う重量取得工程を含み、
 散薬の排出動作に先立って前記重量取得工程を行い、
 散薬の排出動作後にさらに前記重量取得工程を行い、
 散薬の排出動作に先立って行った前記重量取得工程で取得した重量と、散薬の排出動作後に行った前記重量取得工程で取得した重量とを比較し、散薬の排出動作の際に前記重量測定手段が故障していなかったか否かを判別する、薬剤フィーダの故障検知方法。
[Invention 11]
A medicine container containing a powdered medicine, a holding member for holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container, wherein the weight measuring means discharges the powdered medicine. A drug feeder failure detection method capable of detecting
a weight acquisition step of measuring the weight by the weight measuring means with the load of the weight member applied to the weight measuring means;
performing the weight acquisition step prior to the operation of discharging the powdered medicine;
Further performing the weight acquisition step after the powder medicine discharging operation,
The weight obtained in the weight obtaining step performed prior to the powdered medicine discharging operation is compared with the weight obtained in the weight obtaining step performed after the powdered medicine discharging operation, and the weight measuring means performs the powdered medicine discharging operation. A drug feeder failure detection method for determining whether or not a drug feeder has failed.
  [発明12]
 散薬の排出動作では、前記薬剤容器の散薬排出部を開状態として散薬の排出を行い、散薬の排出量を検出する動作では、散薬排出前の前記薬剤容器の重量を原重量として取得する動作を実行しており、前記薬剤容器の散薬排出部を開状態とする前に、散薬排出前の前記薬剤容器の重量を原重量として取得する動作を実行する、発明11に記載の薬剤フィーダの故障検知方法。
[Invention 12]
In the operation of discharging the powdered medicine, the powdered medicine is discharged by opening the powdered medicine discharging portion of the medicine container, and in the operation of detecting the amount of discharged powdered medicine, the weight of the medicine container before discharging the powdered medicine is obtained as the original weight. A failure detection of a drug feeder according to invention 11, wherein an operation of acquiring the weight of the drug container before discharging the powdered drug as the original weight is executed before opening the powdered drug discharging portion of the drug container. Method.
 従来の薬剤払出し装置では、薬剤フィーダから散薬を排出させる際の振動を正確に検知するという観点から改良の余地があった。  Conventional medicine dispensers had room for improvement from the viewpoint of accurately detecting vibrations when discharging powdered medicine from the medicine feeder.
 以下に説明する本発明は、散薬を排出させる際の振動を正確に検知することが可能な薬剤フィーダを提供することを課題とする。また、そのような薬剤フィーダを備えた薬剤払出し装置を提供することを課題とする。 An object of the present invention described below is to provide a drug feeder capable of accurately detecting vibrations when discharging powdered drugs. Another object of the present invention is to provide a drug dispensing device having such a drug feeder.
 上記課題を解決するための本発明の一つの様相は、散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材を有し、前記薬剤容器から散薬を排出することが可能である薬剤フィーダにおいて、前記薬剤容器が、自身の振動を検知する振動検知センサを有する、薬剤フィーダである。 One aspect of the present invention for solving the above-mentioned problems is a medicine which has a medicine container in which a powdered medicine is stored and a holding member which holds the medicine container, and is capable of discharging the powdered medicine from the medicine container. In the feeder, the drug container is a drug feeder having a vibration detection sensor for detecting vibration of the drug container.
 本様相の薬剤フィーダは、散薬が収容された薬剤容器が振動検知センサを有しており、散薬を排出させる際、自身の振動検知センサで自身の振動を検知できる。即ち、排出される散薬に近い位置で、排出させる際の振動の検知が可能となり、検知精度を高めることができる。 In the drug feeder of this aspect, the drug container containing the powdered drug has a vibration detection sensor, and when discharging the powdered drug, its own vibration detection sensor can detect its own vibration. That is, it is possible to detect the vibration at the time of discharging at a position close to the powdered medicine to be discharged, and the detection accuracy can be improved.
 上記した様相は、前記保持部材は、保持側係合部を有し、前記振動検知センサは、センサ側係合部を備え、前記薬剤容器を前記保持部材に保持させることで、前記保持側係合部と前記センサ側係合部が接触して電気的に接続された状態となり、前記振動検知センサと他の回路との間で信号の送受信が可能となることが好ましい。 In the aspect described above, the holding member has a holding-side engaging portion, the vibration detection sensor has a sensor-side engaging portion, and the drug container is held by the holding member so that the holding-side engaging portion is held by the holding member. It is preferable that the joint portion and the sensor-side engaging portion are brought into contact with each other to be electrically connected, so that signals can be transmitted and received between the vibration detection sensor and other circuits.
 この様相によると、薬剤容器から外部に配線部材を延ばしたりすることなく振動の検知が可能となるので、保持部材に対する薬剤容器の着脱を煩雑化することなく検知精度を高くすることができる。 According to this aspect, it is possible to detect vibration without extending the wiring member from the medicine container to the outside, so that the detection accuracy can be improved without complicating attachment and detachment of the medicine container to and from the holding member.
 上記した好ましい様相は、前記薬剤容器が前記保持部材に保持されているか否かを判別する装着検知動作を実行するものであり、前記装着検知動作は、前記振動検知センサから出力された信号が他の回路に入力されたことを条件として、前記薬剤容器が前記保持部材に保持されていると判別することがさらに好ましい。 In the preferred aspect described above, a mounting detection operation for determining whether or not the drug container is held by the holding member is executed. It is further preferable to determine that the drug container is held by the holding member on the condition that the signal is input to the circuit of .
 この様相によると、薬剤容器が保持されたか否かを検知するセンサ等を別途設けることなく薬剤容器の装着検知動作が可能となるため、製造コストの低減を図ることができる。 According to this aspect, it is possible to detect the attachment of the drug container without separately providing a sensor or the like for detecting whether or not the drug container is held, so that the manufacturing cost can be reduced.
 上記した様相は、前記振動検知センサは、鉛直方向と、鉛直方向と交わる方向を含む複数方向の振動の検知が可能であり、前記振動検知センサによる鉛直方向の振動の検出値を増幅して出力するものであり、検出値を増幅するオフセット電圧の値は、前記振動検知センサへの重力の影響に基づいて決定されるものであり、鉛直方向の振動の検出値と、鉛直方向と交わる方向の振動の検出値とを増幅する前記オフセット電圧の値が同じであることが好ましい。 In the aspect described above, the vibration detection sensor is capable of detecting vibrations in a plurality of directions including the vertical direction and a direction crossing the vertical direction, and the vibration detection value in the vertical direction by the vibration detection sensor is amplified and output. The value of the offset voltage that amplifies the detected value is determined based on the effect of gravity on the vibration detection sensor. It is preferable that the value of the offset voltage for amplifying the vibration detection value is the same.
 この様相によると、安価な構成で、精度の高い振動検知が可能となる。 According to this aspect, it is possible to detect vibrations with high precision with an inexpensive configuration.
 上記した様相は、前記振動検知センサが加速度センサであることが好ましい。 In the aspect described above, it is preferable that the vibration detection sensor is an acceleration sensor.
 本発明の他の様相は、上記した薬剤フィーダを備えている、薬剤払出し装置である。 Another aspect of the present invention is a drug dispensing device comprising the drug feeder described above.
 かかる様相においても、散薬の排出させる際の振動の検知精度を高めることができる。 Even in such an aspect, it is possible to improve the detection accuracy of the vibration when discharging the powdered medicine.
 本発明は、散薬を排出させる際の振動を正確に検知することが可能な薬剤フィーダを提供できる。また、そのような薬剤フィーダを備えた薬剤払出し装置を提供できる。 The present invention can provide a drug feeder that can accurately detect vibrations when discharging powdered drugs. Also, it is possible to provide a drug dispensing device equipped with such a drug feeder.
 本実施形態の薬剤フィーダ5は、特徴的な構成として、図64で示されるように、薬剤容器20の振動を検知する振動検知手段180が設けられている。この振動検知手段180は、薬剤容器20と一体に設けられた振動検知センサ181を有している。そして、薬剤容器20を容器支持部23に保持させることで薬剤容器20の振動を電気信号として検出可能となっている。 The drug feeder 5 of the present embodiment is provided with vibration detection means 180 for detecting vibration of the drug container 20 as shown in FIG. 64 as a characteristic configuration. The vibration detection means 180 has a vibration detection sensor 181 provided integrally with the medicine container 20 . By holding the drug container 20 on the container support portion 23, the vibration of the drug container 20 can be detected as an electric signal.
 本実施形態では、振動検知センサ181として、3軸の振動を検知可能な加速度センサを採用している。詳細には、水平面と平行な方向に延びる軸であって互いに直角となる2つの軸をX軸、Y軸とし、その2つの軸に対して垂直な方向に延びる軸をZ軸として、X軸、Y軸、Z軸からなる3軸の検知を可能としている。つまり、本実施形態では、3軸加速度センサにおいて、1つの軸を鉛直方向(上下方向)の検知が可能な状態とし、他の軸を水平面と平行な方向の検知が可能な状態としている。 In this embodiment, an acceleration sensor capable of detecting three-axis vibration is used as the vibration detection sensor 181 . Specifically, two axes extending in a direction parallel to the horizontal plane and perpendicular to each other are defined as the X axis and the Y axis, and an axis extending in a direction perpendicular to the two axes is defined as the Z axis. , Y-axis, and Z-axis. In other words, in the present embodiment, one axis of the three-axis acceleration sensor is in a state capable of detecting in the vertical direction (vertical direction), and the other axis is in a state capable of detecting in a direction parallel to the horizontal plane.
 この振動検知センサ181は、振動部材16(フィーダ本体10)に設けられたコネクタピン182(保持側係合部、図64(a)参照)と接触するコネクタ接触部71aを有する。コネクタ接触部71a(センサ側係合部)は、金属製で外形が平板状となる部分であり、本実施形態では、複数(3つ)設けられている。
 振動検知センサ181は、センサを構成する基板のうち、コネクタ接触部71aが外部に露出し、他の大半の部分が外部から視認できない状態で取り付けられている。詳細には、薬剤容器20の背面壁36に設けられた複数の貫通孔のそれぞれからコネクタ接触部71aが外部に露出し、他の部分が外部に露出しない状態で取り付けられている。
The vibration detecting sensor 181 has a connector contact portion 71a that contacts a connector pin 182 (holding side engaging portion, see FIG. 64(a)) provided on the vibrating member 16 (feeder body 10). The connector contact portion 71a (sensor-side engaging portion) is a portion made of metal and having a flat plate-like outer shape.
The vibration detection sensor 181 is mounted on a substrate constituting the sensor such that the connector contact portion 71a is exposed to the outside and most of the other portions are invisible from the outside. Specifically, the connector contact portion 71a is exposed to the outside from each of the plurality of through holes provided in the back wall 36 of the drug container 20, and the other portions are attached so as not to be exposed to the outside.
 以上のことから、薬剤容器20を容器支持部23に正しく保持させることで、振動検知センサ181のコネクタ接触部71aとコネクタピン182が接触し、これらが電気的に接続された状態となる。即ち、コネクタ接触部71aとコネクタピン182は、電気的に接続が可能な対となる係合部として機能する。
 そして、コネクタ接触部71aとコネクタピン182が電気的に接続されることで、振動検知センサ181と図示しない制御装置(以下容器支持部23側の回路(通信回路、給電回路、信号処理回路等を含む回路)という)が電気的に接続された状態となる。このことから、振動検知センサ181への給電や、振動検知センサ181と容器支持部23側の回路との間での信号の送受信が可能となる。つまり、振動検知センサ181が容器支持部23側に設けられた外部の回路と信号線及び給電線となる部材を介して接続された状態となる。
As described above, when the drug container 20 is properly held by the container support portion 23, the connector contact portion 71a of the vibration detection sensor 181 and the connector pin 182 come into contact with each other and are electrically connected. That is, the connector contact portion 71a and the connector pin 182 function as a pair of engaging portions that can be electrically connected.
By electrically connecting the connector contact portion 71a and the connector pin 182, the vibration detection sensor 181 and the control device (not shown) (hereinafter, circuits on the container support portion 23 side (communication circuit, power supply circuit, signal processing circuit, etc.) are connected. circuit) are electrically connected. As a result, it is possible to supply power to the vibration detection sensor 181 and to transmit and receive signals between the vibration detection sensor 181 and the circuit on the container support portion 23 side. In other words, the vibration detection sensor 181 is connected to the external circuit provided on the container support portion 23 side through the members serving as the signal line and the power supply line.
 なお、コネクタピン182は、一部又は全体が内外に出退可能な状態で振動部材16(容器支持部23)に取り付けてもよい。例えば、振動側水平部32に内外に出退可能なトリガー片を設け、薬剤容器20を振動側水平部32に載置したとき、トリガー片が下方側に押し込まれ、それと連動してコネクタピン182が突出する構造としてもよい。即ち、薬剤容器20を保持させたときに外部に突出するようにしてもよい。
 また、本実施形態では、保持側係合部としてコネクタピン182を採用したが、本発明はこれに限るものではない。外形が突起状(棒状や針状)となる端子に限らず、例えば、平板状の部分であってもよい。即ち、振動検知センサ181の端子部分(コネクタ接触部71a)と対となる端子部分であって、電気的な接触が可能であればよい。
Note that the connector pin 182 may be attached to the vibrating member 16 (container support portion 23) in such a manner that a part or the whole of the connector pin 182 can move in and out. For example, the vibration-side horizontal portion 32 is provided with a trigger piece that can move in and out. It is good also as a structure which protrudes. That is, it may protrude to the outside when the medicine container 20 is held.
Further, in this embodiment, the connector pin 182 is used as the holding side engaging portion, but the present invention is not limited to this. The external shape of the terminal is not limited to a projecting (rod-like or needle-like) shape, and may be, for example, a plate-like portion. That is, it is sufficient that it is a terminal portion that forms a pair with the terminal portion (connector contact portion 71a) of the vibration detection sensor 181 and that is capable of electrical contact.
 本実施形態の薬剤フィーダ5は、薬剤容器20が容器支持部23に正しく取り付けられているか否か(正しく保持されているか否か)を判別する装着判別動作が可能である。
 装着判別動作は、振動検知センサ181から容器支持部23側の回路に入力電圧(入力信号)が入力されたことを条件として、薬剤容器20が容器支持部23に正しく取り付けられていると判別する。反対に、容器支持部23側の回路に入力電圧(入力信号)が入力されなかった場合、コネクタ接触部71aとコネクタピン182が正しく接触していない可能性が高い。そこで、この場合には、薬剤容器20が正しく取り付けられていないものと判別する。
The drug feeder 5 of the present embodiment is capable of an attachment determination operation for determining whether or not the drug container 20 is correctly attached to the container support portion 23 (whether or not it is correctly held).
The attachment determination operation determines that the drug container 20 is properly attached to the container support portion 23 on the condition that an input voltage (input signal) is input from the vibration detection sensor 181 to the circuit on the container support portion 23 side. . Conversely, if the input voltage (input signal) is not input to the circuit on the container support portion 23 side, there is a high possibility that the connector contact portion 71a and the connector pin 182 are not in proper contact. Therefore, in this case, it is determined that the drug container 20 is not correctly attached.
 ここで、振動検知センサ181からの出力電圧(出力信号)が入力電圧(入力信号)として外部の回路に入力されるとき、採用した加速度センサの種類によっては、入力電圧を増幅する必要が生じる。例えば、振動検知センサ181にスケールが大きい(検知感度が低い)アナログ出力式の加速度センサを採用した場合等では、薬剤容器20が最大の振動をした場合でも、入力電圧が僅かな変化しかしない可能性がある。この場合、入力電圧を増幅しないと正確な振動の検知が困難となる。
 ところが、3軸の各軸にオフセット電圧(オフセット調整用の回路)を設けて入力電圧を増幅したのでは、回路構成が高価になってしまうという問題が生じる。また、この場合、各軸を補正するオフセット電圧にはバラつきがあり、温度特性や重力等の周辺環境からも影響を受けるおそれがある。オフセット電圧が設定値からずれて増幅波形が測定レンジから振り切れてしまうことを防止する方法として、振動検知センサ181のセンサ基板をボリューム調整が可能なものとする方法が考えられるが、出荷時に調整が必要となるので好ましくない。
 この課題を解決する方策として、3軸の振動検知センサ181の信号を増幅する際のオフセット電圧を同じ電圧とし、さらにオフセット電圧を、増幅波形が測定レンジから振り切らない程度に設定することが推奨される。
 ここで、振動検知センサ181からの出力電圧が最大となるのは、3軸のセンサ軸の内、鉛直方向(上下方向)の振動を検知するものである。そのため、振動検知センサ181を増幅する際のオフセット電圧を、3軸のセンサ軸の内、鉛直方向(上下方向)の振動を検知する振動検知センサ181の増幅信号が、測定レンジに収まる範囲で高いものとする。
Here, when the output voltage (output signal) from the vibration detection sensor 181 is input to an external circuit as an input voltage (input signal), the input voltage needs to be amplified depending on the type of acceleration sensor employed. For example, if an analog output acceleration sensor with a large scale (low detection sensitivity) is used as the vibration detection sensor 181, even if the drug container 20 vibrates at its maximum, the input voltage may change only slightly. have a nature. In this case, accurate vibration detection becomes difficult unless the input voltage is amplified.
However, providing an offset voltage (offset adjustment circuit) for each of the three axes to amplify the input voltage raises a problem that the circuit configuration becomes expensive. Further, in this case, the offset voltage for correcting each axis has variations, and may be affected by surrounding environment such as temperature characteristics and gravity. As a method of preventing the offset voltage from deviating from the set value and the amplified waveform from swinging out of the measurement range, it is conceivable to make the sensor substrate of the vibration detection sensor 181 capable of adjusting the volume. It is not desirable because it is necessary.
As a measure to solve this problem, it is recommended to use the same offset voltage when amplifying the signals of the 3-axis vibration detection sensor 181, and to set the offset voltage to such an extent that the amplified waveform does not exceed the measurement range. be.
Here, the maximum output voltage from the vibration detection sensor 181 is detected in the vertical direction (vertical direction) among the three sensor axes. Therefore, the offset voltage when amplifying the vibration detection sensor 181 is high as long as the amplified signal of the vibration detection sensor 181 that detects vibration in the vertical direction (vertical direction) among the three sensor axes falls within the measurement range. shall be
 そこで、本実施形態の薬剤フィーダ5では、3軸のセンサ軸の1つであるZ軸を鉛直方向(上下方向)の検知が可能な状態とし、検知時における重力の影響を低減させている。即ち、重力の影響による検出値の誤差を少なくすることで、誤差分を含めて増幅した際の影響を小さくしている。
 さらに、Z軸での検出値を補正するオフセット電圧の値に重力の影響を反映している。
Therefore, in the medicine feeder 5 of the present embodiment, the Z-axis, which is one of the three sensor axes, is set in a state in which detection in the vertical direction (vertical direction) is possible, thereby reducing the influence of gravity during detection. That is, by reducing the error in the detected value due to the influence of gravity, the influence of the amplification including the error is reduced.
Furthermore, the effect of gravity is reflected in the value of the offset voltage that corrects the detected value on the Z axis.
 詳細には、予め薬剤容器20を振動させない状態とし、Z軸を鉛直方向の検知が可能な状態として、所定の温度範囲(例えば、0℃乃至40℃)で測定を行う。この測定により、所定の電源電圧(例えば3V)でのZ軸の検出値における重力1g当たりの影響(発生する誤差の大きさであり、出力電圧の変化)を取得する。本発明者が薬剤フィーダ5を振動させない静止時において、それぞれ重力1g、0g、-1gの影響下でZ軸の検出値の測定(電圧測定)を行った結果、下記表1のような結果が得られた。
 このように、それぞれの重力の影響下で、Z軸の増幅前の検出値と、増幅後の検出値を測定することで、所定の重力の影響により発生する検出値の誤差の大きさ、誤差の大きさに対する増幅後の影響が取得できる。なお、「誤差の大きさに対する増幅後の影響」は、増幅後の検出値の誤差の大きさであり、増幅後の検出値(出力電圧)の変化量である。本発明者が行った測定では、増幅後の検出値が重力1g当たり最大で0.2V程度変化してしまうことが判明した。
Specifically, the medicine container 20 is set in advance to a state in which vibration is not performed, the Z-axis is set to a state in which vertical detection is possible, and the measurement is performed in a predetermined temperature range (for example, 0° C. to 40° C.). By this measurement, the influence (magnitude of generated error, change in output voltage) per 1 g of gravity in the Z-axis detection value at a predetermined power supply voltage (for example, 3 V) is obtained. When the present inventor measured the Z-axis detection value (voltage measurement) under the influence of gravity of 1 g, 0 g, and -1 g when the drug feeder 5 was stationary without vibrating, the results were as shown in Table 1 below. Got.
In this way, by measuring the detected value of the Z-axis before amplification and the detected value after amplification under the influence of each gravity, the magnitude of the error in the detection value caused by the influence of the predetermined gravity and the error The post-amplification effect on the magnitude of is obtained. The "effect after amplification on the magnitude of the error" is the magnitude of the error in the detected value after amplification and the amount of change in the detected value (output voltage) after amplification. According to the measurement conducted by the present inventor, it was found that the detected value after amplification changes by a maximum of about 0.2 V per 1 g of gravity.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
 そして、取得した増幅後の検出値の変化量と、入力された回路における測定レンジに基づき、Z軸の検出値を補正する(出力電圧に含ませる)オフセット電圧の値を決定する。具体的には、図65におけるR1、R2の抵抗値を調整し、バイアス電圧を調整することで、オフセット電圧の値を決定する。 Then, the value of the offset voltage for correcting the Z-axis detection value (included in the output voltage) is determined based on the acquired amount of change in the detection value after amplification and the measurement range of the input circuit. Specifically, the value of the offset voltage is determined by adjusting the resistance values of R1 and R2 in FIG. 65 and adjusting the bias voltage.
 さらに、本実施形態では、X軸、Y軸の検出値をオフセット電圧で補正するとき、図65で示されるように、X軸、Y軸の検出値を補正するオフセット電圧の値を、上記したZ軸の検出値を補正するオフセット電圧の値に合わせた値とする。即ち、図65で示されるように、本実施形態では、X軸、Y軸、Z軸からなる3軸それぞれの検出値を補正(増幅)する増幅回路(オペアンプ)を備えている。そして、3軸それぞれの検出値の補正に同様のオフセット調整用の回路(オフセット調整用のオペアンプ)を使用する。
 ここで、検出値を補正するオフセット電圧の値は、上記したように、重力の影響を反映した値である。X軸、Y軸の検出値は、重力の影響を受けないので、Z軸の検出値と同じオフセット電圧で補正すると、Z軸の補正時よりも設定値がずれてしまう。しかしながら、X軸、Y軸方向の振幅は、Z軸方向の振幅よりも少ないため、Z軸に合わせたオフセット電圧としても(Z軸と同様のバイアス電圧を基準にしても)測定レンジを外れてしまう等の問題が発生する可能性は低い。
 つまり、本実施形態の振動検知センサ181は、出力電圧を増幅する増幅回路を有しており、3軸それぞれの検出値を補正するオフセット電圧をZ軸の検出値を補正する上で適切なオフセット電圧に合わせている。このように、オフセット電圧を最も振動することが予測される軸(Z軸)に合わせることで最大振動を精度よく検出できる。なお、X軸の検出値とY軸の検出値もまた、それぞれ別に、上記したZ軸のように予め行った測定等に基づいて補正することが検知精度を向上させる上で好ましい。しかしながら、上記したように、3軸それぞれを別途補正すると製造コストが増加してしまうという問題が生じる。そこで、上記したように、X軸、Y軸の検出値をZ軸に合わせて補正しても問題の発生する可能性が低く、十分な検知精度を発揮させることが可能であると考えられたため、X軸、Y軸の検出値をZ軸に合わせて補正している。
 以上のことから、本実施形態によると、安価な回路構成で精度の高い振動検知が可能となる。
Furthermore, in the present embodiment, when the X-axis and Y-axis detection values are corrected with offset voltages, the values of the offset voltages for correcting the X-axis and Y-axis detection values are set to the values described above as shown in FIG. The Z-axis detection value is adjusted to the value of the offset voltage to be corrected. That is, as shown in FIG. 65, in this embodiment, an amplifier circuit (operational amplifier) is provided for correcting (amplifying) detection values for each of the three axes, ie, the X-axis, Y-axis, and Z-axis. Then, similar offset adjustment circuits (offset adjustment operational amplifiers) are used to correct the detected values of the three axes.
Here, the value of the offset voltage for correcting the detected value is a value reflecting the influence of gravity as described above. Since the X-axis and Y-axis detection values are not affected by gravity, if the same offset voltage as the Z-axis detection value is used for correction, the set values will deviate from the Z-axis correction. However, since the amplitudes in the X-axis and Y-axis directions are smaller than the amplitudes in the Z-axis direction, even if the offset voltage matched to the Z-axis (even if the same bias voltage as the Z-axis is used as a reference), the measurement range will be out of range. It is unlikely that problems such as storage will occur.
In other words, the vibration detection sensor 181 of the present embodiment has an amplifier circuit that amplifies the output voltage, and the offset voltage for correcting the detection value of each of the three axes is an offset voltage suitable for correcting the detection value of the Z axis. matched to the voltage. In this manner, the maximum vibration can be detected with high accuracy by aligning the offset voltage with the axis (Z-axis) that is expected to vibrate the most. In order to improve the detection accuracy, it is preferable to correct the X-axis detection value and the Y-axis detection value separately based on the measurement performed in advance as in the case of the Z-axis. However, as described above, if each of the three axes is corrected separately, there arises a problem that the manufacturing cost increases. Therefore, as described above, even if the detection values of the X-axis and Y-axis are corrected in accordance with the Z-axis, there is a low possibility that problems will occur, and it is possible to exhibit sufficient detection accuracy. , X-axis, and Y-axis detection values are corrected according to the Z-axis.
As described above, according to the present embodiment, it is possible to detect vibration with high precision with an inexpensive circuit configuration.
 振動検知手段180による振動状態の監視は、全ての振動軸(X軸、Y軸、Z軸)に対して常時行ってもよいが、代表的な振動軸に対してのみ常時監視し、何らかの異常が検知された場合や、始業前等の定期的な時刻に、全ての振動軸を対象として振動状態を確認してもよい。 The vibration detection means 180 may constantly monitor the vibration state for all vibration axes (X-axis, Y-axis, Z-axis). is detected, or at a regular time such as before starting work, the vibration state may be checked for all vibration axes.
 例えば図66(a)に示すように、検査モードとしてN、F1、F2、F3があってもよい。なお、説明を容易にするために、図66は、薬剤フィーダ5が3台の場合を想定しているが、薬剤フィーダ5の数は任意である。
 モードNは、通常運転中の監視モードである。モードF1、F2、F3より慎重に行われる検知モードであり、各薬剤フィーダ5の全ての振動軸(X軸、Y軸、Z軸)の振動状態を個別に検査するモードである。
 図66(b)(c)は、検査モードに応じて振動検知センサを切り替える回路図である。図66(b)(c)に示す回路は、入力部100と、スイッチ群101と、出力部102を有している。
 入力部100には、各薬剤フィーダ(F1)、(F2)、(F3)のそれぞれのX軸、Y軸、Z軸の振動検知センサ181からの出力電圧(出力信号)が直接又は増幅されて入力される。
 即ち、X1は、薬剤フィーダ(F1)のX軸の振動検知センサの出力であり、Y1は、薬剤フィーダ(F1)のY軸の振動検知センサの出力であり、Z1は、薬剤フィーダ(F1)のZ軸の振動検知センサの出力が入力される端子である。同様に、X2、Y2、Z2は、薬剤フィーダ(F2)の振動検知センサの出力が入力される端子である。同様に、X3、Y3、Z3は、薬剤フィーダ(F3)の振動検知センサの出力が入力される端子である。
For example, as shown in FIG. 66(a), inspection modes may include N, F1, F2, and F3. For ease of explanation, FIG. 66 assumes that there are three medicine feeders 5, but the number of medicine feeders 5 is arbitrary.
Mode N is a monitoring mode during normal operation. This detection mode is performed more carefully than modes F1, F2, and F3, and is a mode in which vibration states of all vibration axes (X-axis, Y-axis, and Z-axis) of each drug feeder 5 are individually inspected.
66(b) and (c) are circuit diagrams for switching the vibration detection sensor according to the inspection mode. The circuits shown in FIGS. 66B and 66C have an input section 100, a switch group 101, and an output section .
In the input unit 100, the output voltages (output signals) from the X-, Y-, and Z-axis vibration detection sensors 181 of the drug feeders (F1), (F2), and (F3) are directly or amplified. is entered.
That is, X1 is the output of the X-axis vibration detection sensor of the drug feeder (F1), Y1 is the output of the Y-axis vibration detection sensor of the drug feeder (F1), and Z1 is the drug feeder (F1). is a terminal to which the output of the Z-axis vibration detection sensor is input. Similarly, X2, Y2 and Z2 are terminals to which the output of the vibration detection sensor of the drug feeder (F2) is input. Similarly, X3, Y3 and Z3 are terminals to which the output of the vibration detection sensor of the drug feeder (F3) is input.
 検査モードNは、図66(b)に示す接続状態であり、各薬剤フィーダ(F1)、(F2)、(F3)のZ軸の入力端子が、出力端子に接続される様になっている。
 図66(b)に示す接続状態においては、出力端子S1に薬剤フィーダ(F1)のZ軸の振動検知センサ181からの出力電圧(出力信号)が出力される。また出力端子S2に薬剤フィーダ(F2)のZ軸の振動検知センサ181からの出力電圧(出力信号)が出力される。出力端子S3に薬剤フィーダ(F3)のZ軸の振動検知センサ181からの出力電圧(出力信号)が出力される。
The inspection mode N is the connection state shown in FIG. 66(b), in which the Z-axis input terminals of the drug feeders (F1), (F2), and (F3) are connected to the output terminals. .
In the connection state shown in FIG. 66(b), an output voltage (output signal) from the Z-axis vibration detection sensor 181 of the medicine feeder (F1) is output to the output terminal S1. An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F2) is output to the output terminal S2. An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F3) is output to the output terminal S3.
 検査モードF1は、図66(c)に示す接続状態であり、薬剤フィーダ(F1)のX軸、Y軸、Z軸の入力端子が、出力端子に接続される様になっている。
 図66(c)に示す接続状態においては、出力端子S1に薬剤フィーダ(F1)のX軸の振動検知センサ181からの出力電圧(出力信号)が出力される。また出力端子S2に薬剤フィーダ(F1)のY軸の振動検知センサ181からの出力電圧(出力信号)が出力される。出力端子S3に薬剤フィーダ(F1)のZ軸の振動検知センサ181からの出力電圧(出力信号)が出力される。
 他の検査モードにおけるスイッチの接続状況の図示は省略するが、検査モードF2では、薬剤フィーダ(F2)のX軸、Y軸、Z軸の入力端子が、出力端子に接続される。また検査モードF3では、薬剤フィーダ(F3)のX軸、Y軸、Z軸の入力端子が、出力端子に接続される。
The inspection mode F1 is the connection state shown in FIG. 66(c), in which the X-axis, Y-axis, and Z-axis input terminals of the drug feeder (F1) are connected to the output terminals.
In the connection state shown in FIG. 66(c), an output voltage (output signal) from the X-axis vibration detection sensor 181 of the medicine feeder (F1) is output to the output terminal S1. An output voltage (output signal) from the Y-axis vibration detection sensor 181 of the drug feeder (F1) is output to the output terminal S2. An output voltage (output signal) from the Z-axis vibration detection sensor 181 of the drug feeder (F1) is output to the output terminal S3.
Although illustration of switch connections in other inspection modes is omitted, in inspection mode F2, the X-axis, Y-axis, and Z-axis input terminals of the medicine feeder (F2) are connected to the output terminals. In the inspection mode F3, the X-, Y-, and Z-axis input terminals of the drug feeder (F3) are connected to the output terminals.
 上記したフィーダ部22は、電気的な構成機器として、加振手段30a,30bと、ポテンショメータ(図示しない)と、アクチュエータ(図示しない)と、重量測定部24と、振動検知センサ181を有している。
 なお、ポテンショメータは、移動量や回転角を検知可能なセンサであり、所定の部材(例えば、シャッター開閉機構55を構成する部材)の移動量を検知可能となっている。アクチュエータは、所定の部材(シャッター開閉機構55を構成する部材)を駆動させる駆動装置として機能する部材であり、具体的には、DCモータである。
 なお、加振手段30a,30b、ポテンショメータ、アクチュエータ(図示しない)は、重量測定部24に荷重が負荷されるように配されている。そして、これら加振手段30a,30b、ポテンショメータ、アクチュエータ(図示しない)に加え、重量測定部24、振動検知センサ181は、防振手段18(防振部材28)に荷重が負荷されるように配されている。
The feeder section 22 described above has vibrating means 30a and 30b, a potentiometer (not shown), an actuator (not shown), a weight measurement section 24, and a vibration detection sensor 181 as electrical components. there is
The potentiometer is a sensor that can detect the amount of movement and the angle of rotation, and can detect the amount of movement of a predetermined member (for example, a member that constitutes the shutter opening/closing mechanism 55). The actuator is a member that functions as a driving device that drives a predetermined member (a member that constitutes the shutter opening/closing mechanism 55), and is specifically a DC motor.
The vibrating means 30a, 30b, potentiometers, and actuators (not shown) are arranged so that a load is applied to the weight measuring section 24. As shown in FIG. In addition to these vibrating means 30a and 30b, potentiometers, and actuators (not shown), the weight measuring section 24 and the vibration detecting sensor 181 are arranged so that a load is applied to the vibration isolating means 18 (vibration isolating member 28). It is
 ここで、上記したフィーダ部22の電気的な構成機器は、上位の制御装置(薬剤払出し装置1の筐体2内に配された本体の制御装置、図示しない)と接続するとき、配線部材を介して接続してもよい。このとき、アクチュエータは、上位の制御装置との間にモータドライバを介してもよい。
 この他、上記したフィーダ部22の電気的な構成機器の少なくとも一部は、配線部材を介さずに上位の制御装置と接続してもよい。例えば、ポテンショメータ、アクチュエータを無線給電、無線通信方式によって上位の制御装置と接続してもよい。
 このように、配線部材を介さずに上位の制御装置と接続する構成とした場合、重量測定部24による重量測定動作の際に配線による影響を無くす(低減させる)ことが可能となり、精度の高い重量測定動作が可能となる。したがって、少量の散薬を分配皿6に投入する(少量の散薬を分包する)動作を実行する場合等において、より精度の高い動作が可能となる。
Here, when the electrical components of the feeder section 22 described above are connected to a higher control device (control device of the main body arranged in the housing 2 of the medicine dispensing device 1, not shown), the wiring member is You can connect via At this time, the actuator may be communicated with a higher control device via a motor driver.
In addition, at least part of the electrical components of the feeder section 22 may be connected to a higher control device without wiring members. For example, potentiometers and actuators may be connected to a host control device by wireless power supply or wireless communication.
In this way, in the case of a configuration in which connection is made to the host control device without the wiring member, it is possible to eliminate (reduce) the influence of the wiring during the weight measurement operation by the weight measurement unit 24, and the accuracy is high. Weight measurement operation becomes possible. Therefore, when performing an operation of putting a small amount of powdered medicine into the distribution tray 6 (packing a small amount of powdered medicine), etc., a more accurate operation is possible.
 薬剤フィーダ5は、図4等で示されるように、振動部材16を有するフィーダ部22と、中板部分(分配皿6の外側に位置する土台となる板部分、図2等参照)に固定されて振動しない重量校正部21を有する。ここで、上記したフィーダ部22の電気的な構成機器と上位の制御装置とを配線を介して接続する場合、FFC(フレキシブルフラットケーブル)のような薄く扁平な帯状の配線部材(以下、帯状配線部材と称す)を採用することが好ましい。また、帯状配線部材は、丸みを帯びた軌道で延びた状態(姿勢)として配することが好ましい。即ち、下方に向かって直線的に延ばすのではなく、円弧を描きつつ延ばすことが好ましい。このとき、円弧をなす部分は、一旦上方に延びる部分と、上方からフィーダ部22から離れる方向に延びつつ下方に延びる部分と、フィーダ部22に近づく方向に延びつつ下方に延びる部分とを含んで構成されていてもよい。
 このように、円弧状に(ループして)延びた部分が形成された状態とすると、振動部材16を振動させつつ重量測定部24による重量測定動作を実行するとき、重量測定動作の精度の向上を図ることが可能となる。即ち、振動による配線部材の張力の変化や、配線部材の一部の移動等の影響を無くす(低減させる)ことが可能となり、重量測定動作の精度の向上を図ることが可能となる。
As shown in FIG. 4 and the like, the drug feeder 5 is fixed to a feeder portion 22 having a vibrating member 16 and an intermediate plate portion (a plate portion serving as a base positioned outside the distribution plate 6; see FIG. 2 and the like). It has a weight calibration unit 21 that does not vibrate. Here, when connecting the electrical components of the feeder section 22 and the host controller via wiring, a thin and flat belt-shaped wiring member (hereinafter referred to as belt-shaped wiring) such as FFC (flexible flat cable) is used. (referred to as a member) is preferably adopted. Moreover, it is preferable that the strip-shaped wiring member is arranged in a state (orientation) extending along a rounded trajectory. That is, it is preferable to extend while drawing an arc instead of extending downward linearly. At this time, the portion forming the arc includes a portion that once extends upward, a portion that extends downward while moving away from the feeder portion 22 from above, and a portion that extends downward while extending in a direction approaching the feeder portion 22. may be configured.
In this way, when the arc-shaped (looped) extended portion is formed, when the vibrating member 16 is vibrated and the weight measuring section 24 performs the weight measuring operation, the accuracy of the weight measuring operation is improved. It becomes possible to plan That is, it is possible to eliminate (reduce) the effects of changes in the tension of the wiring member due to vibration, movement of a part of the wiring member, and the like, and it is possible to improve the accuracy of the weight measurement operation.
 上記したように、フィーダ部22は、圧電素子(加振手段30a,30b)を備えている。ここで、この圧電素子の振動回路には、D級アンプを採用してもよく、AB級アンプを採用してもよい。しかしながら、AB級アンプを採用することが、振動動作をより適切に制御する上で好ましい。即ち、AB級アンプを採用することで、散薬を分配皿6に投入する動作の精度を向上させることができる。 As described above, the feeder section 22 includes piezoelectric elements (vibrating means 30a and 30b). Here, a D-class amplifier or an AB-class amplifier may be adopted for the oscillation circuit of the piezoelectric element. However, it is preferable to employ a class AB amplifier for better control of the oscillatory behavior. That is, by employing a class AB amplifier, it is possible to improve the accuracy of the operation of putting powdered medicine into the distribution tray 6 .
 上記した実施形態は次の発明の実施形態である。
  [発明1]
 散薬が収容される薬剤容器と、前記薬剤容器を保持する保持部材を有し、前記薬剤容器から散薬を排出することが可能である薬剤フィーダにおいて、
 前記薬剤容器が、自身の振動を検知する振動検知センサを有する、薬剤フィーダ。
  [発明2]
 前記保持部材は、保持側係合部を有し、
 前記振動検知センサは、センサ側係合部を備え、
 前記薬剤容器を前記保持部材に保持させることで、前記保持側係合部と前記センサ側係合部が接触して電気的に接続された状態となり、前記振動検知センサと他の回路との間で信号の送受信が可能となる、発明1に記載の薬剤フィーダ。
  [発明3]
 前記薬剤容器が前記保持部材に保持されているか否かを判別する装着検知動作を実行するものであり、
 前記装着検知動作は、前記振動検知センサから出力された信号が他の回路に入力されたことを条件として、前記薬剤容器が前記保持部材に保持されていると判別する、発明2に記載の薬剤フィーダ。
  [発明4]
 前記振動検知センサは、鉛直方向と、鉛直方向と交わる方向を含む複数方向の振動の検知が可能であり、
 前記振動検知センサによる鉛直方向の振動の検出値を増幅して出力するものであり、検出値を増幅するオフセット電圧の値は、前記振動検知センサへの重力の影響に基づいて決定されるものであり、
 鉛直方向の振動の検出値と、鉛直方向と交わる方向の振動の検出値とを増幅する前記オフセット電圧の値が同じである、発明1乃至3のいずれかに記載の薬剤フィーダ。
  [発明5]
 前記振動検知センサが加速度センサである、発明1乃至4のいずれかに記載の薬剤フィーダ。
  [発明6]
 発明1乃至5のいずれかに記載の薬剤フィーダを備えている、薬剤払出し装置。
The above-described embodiment is an embodiment of the following invention.
[Invention 1]
A drug feeder having a drug container for containing a powdered drug and a holding member for holding the drug container, and capable of discharging the powdered drug from the drug container,
A drug feeder, wherein the drug container has a vibration detection sensor that detects vibration of the drug container.
[Invention 2]
The holding member has a holding-side engaging portion,
The vibration detection sensor includes a sensor-side engaging portion,
When the drug container is held by the holding member, the holding-side engaging portion and the sensor-side engaging portion come into contact with each other and are electrically connected to each other. The drug feeder according to invention 1, which enables transmission and reception of a signal at .
[Invention 3]
a mounting detection operation for determining whether or not the drug container is held by the holding member;
The drug according to invention 2, wherein the attachment detection operation determines that the drug container is held by the holding member on condition that the signal output from the vibration detection sensor is input to another circuit. feeder.
[Invention 4]
The vibration detection sensor is capable of detecting vibration in a plurality of directions including a vertical direction and a direction crossing the vertical direction,
The value of vertical vibration detected by the vibration detection sensor is amplified and output, and the value of the offset voltage for amplifying the detection value is determined based on the effect of gravity on the vibration detection sensor. can be,
The medicine feeder according to any one of inventions 1 to 3, wherein the value of the offset voltage for amplifying the detected value of vibration in the vertical direction and the detected value of vibration in the direction crossing the vertical direction are the same.
[Invention 5]
The drug feeder according to any one of Inventions 1 to 4, wherein the vibration detection sensor is an acceleration sensor.
[Invention 6]
A drug dispensing device comprising the drug feeder according to any one of Inventions 1 to 5.
 本願発明は、薬剤を調剤する装置であり、「あらゆる年齢のすべての人々の健康的な生活を確保し、福祉を推進する」という持続可能な開発目標(SDGs)の第3の目標を達成し得るものである。
 本発明の薬剤払い出し装置は、薬剤師のような有資格者が実施すべき散薬秤量等の散薬監査作業を無くすことで、テクニシャン等の非薬剤師においても実施できる装置である。具体的には、作業者は薬剤であることを意識することなく、処方情報に基づいて指定された薬剤容器の番号、または棚等に配置されている場合はランプ等で指定された薬剤容器を取り出して、薬剤払い出し装置に載置するだけで、処方に必要な分包作業を確実に実行し完了できるものである。これにより、有資格者である薬剤師は調剤作業という対物業務から、患者と向き合う対人業務にシフトできると共に、必要な調剤作業を非薬剤師等で実施できることから、「あらゆる年齢のすべての人々の健康的な生活を確保し、福祉を推進する」という持続可能な開発目標(SDGs)の第3の目標を達成し得るものである。
 また本発明は、人件費を低減し、経済生産性を向上させることができる。これによっても、持続可能な開発目標(SDGs)の達成に貢献できる。
The present invention is a drug dispensing device that achieves the third goal of the Sustainable Development Goals (SDGs) of "ensuring healthy lives and promoting well-being for all at all ages". It is what you get.
The drug dispensing device of the present invention is a device that can be performed even by non-pharmacists such as technicians by eliminating powdered drug inspection work such as powdered drug weighing that should be performed by a qualified person such as a pharmacist. Specifically, without being conscious of the fact that it is a drug, the operator can select the number of the drug container specified based on the prescription information, or if the drug container is placed on a shelf or the like, the specified drug container can be selected by a lamp or the like. Only by taking out the drug and placing it on the drug dispensing device, the packaging work required for the prescription can be reliably performed and completed. As a result, qualified pharmacists can shift from pharmacist-oriented work such as dispensing work to person-to-person work in which they face patients. The third goal of the Sustainable Development Goals (SDGs), which is to ensure decent livelihoods and promote well-being, can be achieved.
The present invention can also reduce labor costs and improve economic productivity. This will also contribute to the achievement of the Sustainable Development Goals (SDGs).
1;薬剤払出し装置、5;薬剤フィーダ、6;分配皿、8;掻出装置、10;フィーダ本体、11,411;散薬排出部、13;薬剤投入溝、16;振動部材(容器保持部)、18;防振手段、20,172,420,701;薬剤容器、22;フィーダ部、23;容器支持部、24;重量測定部、25;重量測定手段、26;土台部、27;支持台、28;防振部材、30;支持側水平部、30a;加振手段、30b;加振手段、31;支持側垂直壁部、32;振動側水平部、33;振動側垂直壁部(縦壁)、55;シャッター開閉機構(開閉機構部)、56;係合片保持部、61;大面積側側面、62;小面積側側面、68;仕切り板、70;容器本体、71,471;箱部、72;整流部材、73,473;シャッター構造部、75,475;蓋部材、76;締め付け部材、91,231,491,740;シャッター部材(開閉部材)、110,232,510;閉鎖壁、117,517;散薬通路、130;係合溝、131;係合凹部、132;凹部、152;仮受け板、301;散薬分割領域、302;薬剤包装領域、310;散薬投入ホッパー
705;離脱補助部材、710;係合部、760:突出部、766;仕切部
1; drug dispensing device, 5; drug feeder, 6; distribution plate, 8; scraping device, 10; feeder body, 11, 411; , 18; vibration isolating means, 20, 172, 420, 701; drug container, 22; feeder section, 23; container supporting section, 24; weight measuring section, 25; Vibration-isolating member 30 Support-side horizontal portion 30a Vibrating means 30b Vibrating means 31 Support-side vertical wall portion 32 Vibration-side horizontal portion 33 Vibration-side vertical wall portion (vertical wall), 55; shutter opening/closing mechanism (opening/closing mechanism), 56; engagement piece holding portion, 61; large area side surface, 62; small area side surface, 68; Box portion 72; rectifying member 73, 473; shutter structure portion 75, 475; lid member 76; tightening member 91, 231, 491, 740; Engagement groove, 131; Engagement recess, 132; Recess, 152; Temporary receiving plate, 301; Detachment assisting member 710; engaging portion 760: projecting portion 766; partitioning portion

Claims (15)

  1.  散薬が収容される薬剤容器と、当該薬剤容器を保持する容器保持部と、前記薬剤容器の重量を直接的または間接的に測定する重量測定手段とを有し、前記薬剤容器を振動させて前記薬剤容器から散薬を排出し、前記重量測定手段によって散薬の排出量を検知することが可能である薬剤フィーダにおいて、
     前記薬剤容器は、散薬排出部から散薬を外部に排出するものであり、前記散薬排出部を開閉する開閉部材を備え、
     開閉機構部をさらに有し、
     前記開閉機構部は、前記開閉部材に直接又は間接的に力を付与し、前記開閉部材の少なくとも一部を移動させて前記散薬排出部を開閉させるものであり、前記散薬排出部を開状態とする際と、閉状態とする際のそれぞれにおいて前記開閉部材に力を付与する、薬剤フィーダ。
    A medicine container containing a powdered medicine, a container holding part for holding the medicine container, and weight measuring means for directly or indirectly measuring the weight of the medicine container, wherein the medicine container is vibrated to cause the weight of the medicine container to be measured. In a medicine feeder capable of discharging powdered medicine from a medicine container and detecting the discharged amount of the powdered medicine by the weight measuring means,
    The drug container discharges the powdered medicine to the outside from the powdered medicine discharge part, and includes an opening and closing member for opening and closing the powdered medicine discharge part,
    further having an opening/closing mechanism,
    The opening/closing mechanism section applies a force directly or indirectly to the opening/closing member to move at least a part of the opening/closing member to open/close the powdered medicine discharge section. a drug feeder that applies a force to the opening/closing member when closing and when closing.
  2.  前記薬剤容器は、前記容器保持部に手動で保持させることが可能であり、前記容器保持部から手動で取り外すことが可能であって、
     前記薬剤容器を前記容器保持部から取り外すことで、前記薬剤容器が前記容器保持部及び前記開閉機構部から離反する、請求項1に記載の薬剤フィーダ。
    The drug container can be manually held in the container holding part and can be manually removed from the container holding part,
    2. The drug feeder according to claim 1, wherein removing the drug container from the container holding part separates the drug container from the container holding part and the opening/closing mechanism.
  3.  前記散薬排出部を開状態とするとき、前記散薬排出部の開度を段階的に調節可能である、請求項1又は2に記載の薬剤フィーダ。 The medicine feeder according to claim 1 or 2, wherein the opening degree of the powdered medicine discharge part can be adjusted stepwise when the powdered medicine discharge part is opened.
  4.  前記散薬排出部は、斜め方向に延びるスリットであり、
     前記開閉部材は、前記散薬排出部の下方側で移動する閉鎖壁を備え、
     前記閉鎖壁は、前記薬剤容器の幅方向に延びた形状であり、前記開閉部材が閉方向に移動するにつれて、前記閉鎖壁と前記散薬排出部の重なり部分が大きくなり、前記散薬排出部における散薬の排出のために有効な開口幅が小さくなる、請求項1又は2に記載の薬剤フィーダ。
    The powder medicine discharge part is a slit extending in an oblique direction,
    The opening/closing member includes a closing wall that moves below the powdered medicine discharge unit,
    The closing wall has a shape extending in the width direction of the drug container, and as the opening/closing member moves in the closing direction, the overlapping portion between the closing wall and the powdered medicine discharge section increases, and the powdered medicine in the powdered medicine discharge section increases. 3. A drug feeder according to claim 1 or 2, wherein the effective opening width for the discharge of is reduced.
  5.  前記容器保持部は縦壁を有し、当該縦壁が加振手段によって振動し、前記縦壁に前記薬剤容器が固定されて振動される、請求項1乃至4のいずれかに記載の薬剤フィーダ。 The medicine feeder according to any one of claims 1 to 4, wherein said container holding part has a vertical wall, said vertical wall is vibrated by a vibrating means, and said medicine container is fixed to said vertical wall and vibrated. .
  6.  前記薬剤容器は、大面積側側面と小面積側側面を有していて、幅に対して高さが高く、底面の辺部及び/又は底面近傍の側面に前記散薬排出部があり、
     底面の近傍に開口を有する仕切り部材があり、散薬が前記開口を通過して前記仕切り部、仕切り板と前記底との間を移動して前記散薬排出部に至る、請求項1乃至5のいずれかに記載の薬剤フィーダ。
    The drug container has a large-area side surface and a small-area side surface, is taller than it is wide, and has the powdered medicine discharge part on the side of the bottom surface and/or the side surface near the bottom surface,
    6. A partition member having an opening in the vicinity of the bottom surface, and the powdered medicine passes through the opening and moves between the partition part, the partition plate and the bottom to reach the powdered medicine discharge part. A drug feeder according to any one of the above.
  7.  前記散薬排出部は斜め方向に延びるスリット状である、請求項1乃至6のいずれかに記載の薬剤フィーダ。 The medicine feeder according to any one of claims 1 to 6, wherein said powdered medicine discharge part has a slit shape extending in an oblique direction.
  8.  前記薬剤容器は、大面積側側面と小面積側側面を有していて、幅に対して高さが高く、前記大面積側側面を開放可能であり、
     前記薬剤容器は、前記容器保持部に対して着脱可能であり、前記薬剤容器を前記容器保持部から外した状態で前記大面積側側面を開放して散薬を充填するものである、請求項1乃至7のいずれかに記載の薬剤フィーダ。
    The drug container has a large-area side surface and a small-area side surface, is taller than the width, and can open the large-area side surface,
    2. The medicine container is detachable with respect to the container holding part, and in a state in which the medicine container is detached from the container holding part, the large-area side surface is opened and the powdered medicine is filled. 8. A drug feeder according to any one of 1 to 7.
  9.  前記薬剤容器の高さ方向の中間部に庇状の仮受け板が設けられている、請求項1乃至8のいずれかに記載の薬剤フィーダ。 The drug feeder according to any one of claims 1 to 8, wherein an eave-like temporary receiving plate is provided in the middle part of the drug container in the height direction.
  10.  前記散薬排出部を閉じた状態で、前記開閉部材をロックするロック機構を有し、前記薬剤容器を前記容器保持部に保持させることによって前記ロック機構が解除される請求項1乃至9のいずれかに記載の薬剤フィーダ。 10. The device according to any one of claims 1 to 9, further comprising a locking mechanism for locking the opening/closing member in a state in which the powdered medicine discharge part is closed, and the locking mechanism is released by holding the medicine container in the container holding part. A drug feeder as described in .
  11.  前記容器保持部は縦壁を有し当該縦壁に保持部側係合部があり、前記薬剤容器は前記保持部側係合部が係合して前記薬剤容器が前記容器保持部に保持され、
     前記薬剤容器に係合部があり、前記容器保持部に前記係合部と係合し前記薬剤容器を前記容器保持部から離脱する方向に押圧する離脱補助部材を有する請求項1乃至10のいずれかに記載の薬剤フィーダ。
    The container holding portion has a vertical wall, and the vertical wall has a holding portion side engaging portion, and the drug container is held by the container holding portion by engaging the holding portion side engaging portion. ,
    11. The drug container according to any one of claims 1 to 10, wherein the drug container has an engaging portion, and the container holding portion has a detachment assisting member that engages with the engaging portion and presses the drug container in a direction to separate from the container holding portion. A drug feeder according to any one of the above.
  12.  前記薬剤容器内に前記散薬排出部に繋がる散薬通路があり、散薬は前記散薬通路を移動して前記散薬排出部から排出されるものであり、前記散薬通路には天井壁があり、
     前記開閉部材は、前記散薬排出部を閉鎖したときに前記散薬通路側に突出する突出部を有し、
     前記天井壁に前記散薬通路内の下に向かって突出する仕切部があり、前記開閉部材が前記散薬排出部を閉鎖したときに前記突出部が仕切部の近傍に至る請求項1乃至11のいずれかに記載の薬剤フィーダ。
    The medicine container has a powdered medicine passage leading to the powdered medicine discharge part, the powdered medicine moves in the powdered medicine passage and is discharged from the powdered medicine discharge part, the powdered medicine passage has a ceiling wall,
    The opening/closing member has a projecting portion that projects toward the powdered medicine passage when the powdered medicine discharge portion is closed,
    12. The ceiling wall according to any one of claims 1 to 11, wherein the ceiling wall has a partition projecting downward into the powdered medicine passage, and the projection reaches the vicinity of the partition when the opening/closing member closes the powdered medicine discharge part. A drug feeder according to any one of the above.
  13.  錘部材を有し、前記錘部材又は前記重量測定手段又は前記薬剤容器の少なくともいずれかを昇降させる昇降手段を有し、前記錘部材の荷重が前記重量測定手段に付加された状態と、前記錘部材の荷重が前記重量測定手段に付加されていない状態を比較して前記重量測定手段の校正、及び/又は故障検知を行う、請求項1乃至12のいずれかに記載の薬剤フィーダ。 a state in which a load of the weight member is applied to the weight measurement means; 13. The medicine feeder according to any one of claims 1 to 12, wherein calibration and/or failure detection of said weight measuring means are performed by comparing a state in which no member load is applied to said weight measuring means.
  14.  前記薬剤容器が、自身の振動を検知する振動検知センサを有する、請求項1乃至13のいずれかに記載の薬剤フィーダ。 The drug feeder according to any one of claims 1 to 13, wherein the drug container has a vibration detection sensor that detects its own vibration.
  15.  薬剤容器から所定量の散薬を取り出し、これを所定の数に分割し、さらに個別に包装して排出する薬剤払出し装置であって、
     薬剤投入溝が設けられ動力によって回転される分配皿を有し、
     当該分配皿の近傍に、請求項1乃至14のいずれかに記載の薬剤フィーダが複数設置され、薬剤容器から散薬を排出させて分配皿の薬剤投入溝に投入する、薬剤払出し装置。
    A drug dispensing device that takes out a predetermined amount of powdered medicine from a drug container, divides it into a predetermined number, and further packs and discharges it individually,
    Having a distribution dish provided with a drug input groove and rotated by power,
    15. A medicine dispensing device, wherein a plurality of medicine feeders according to any one of claims 1 to 14 are installed in the vicinity of the distribution tray, and powdered medicine is discharged from the medicine container and put into the medicine feeding groove of the distribution tray.
PCT/JP2022/016202 2021-04-27 2022-03-30 Drug feeder and drug dispensing unit WO2022230590A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020237025091A KR20240004218A (en) 2021-04-27 2022-03-30 Medicine feeder and medicine dispensing device
CN202280020256.1A CN117120013A (en) 2021-04-27 2022-03-30 Medicine feeder and medicine dispensing device

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP2021075383 2021-04-27
JP2021075382 2021-04-27
JP2021-075385 2021-04-27
JP2021075385 2021-04-27
JP2021-075382 2021-04-27
JP2021-075383 2021-04-27
JP2022049908A JP2022169440A (en) 2021-04-27 2022-03-25 Drug feeder, drug delivery device, drug feeder calibration method, and drug feeder failure detection method
JP2022-049908 2022-03-25
JP2022049907A JP2022169439A (en) 2021-04-27 2022-03-25 Medicine feeder and medicine put-out device
JP2022049906A JP7345092B2 (en) 2021-04-27 2022-03-25 Drug feeder and drug dispensing device
JP2022-049906 2022-03-25
JP2022-049907 2022-03-25

Publications (1)

Publication Number Publication Date
WO2022230590A1 true WO2022230590A1 (en) 2022-11-03

Family

ID=83847427

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/016202 WO2022230590A1 (en) 2021-04-27 2022-03-30 Drug feeder and drug dispensing unit

Country Status (3)

Country Link
KR (1) KR20240004218A (en)
TW (1) TW202246127A (en)
WO (1) WO2022230590A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013129451A (en) * 2011-12-22 2013-07-04 Hitachi Aloka Medical Ltd Powder medicine dispensing device
JP2016202909A (en) * 2015-04-20 2016-12-08 株式会社湯山製作所 Medicine dispensing apparatus
WO2017159819A1 (en) * 2016-03-18 2017-09-21 株式会社湯山製作所 Drug dispensing device and drug dispensing program
JP2020127832A (en) * 2013-11-22 2020-08-27 株式会社湯山製作所 Medicine put-out device
JP2020147375A (en) * 2014-09-24 2020-09-17 株式会社湯山製作所 Medicine feeder, container mounting device of medicine feeder and medicine pay-out device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07132135A (en) 1993-09-11 1995-05-23 Tokyo Shokai:Kk Powder medicine supply device
JP4057159B2 (en) 1998-09-10 2008-03-05 株式会社湯山製作所 Powder distribution device
CN104583079B (en) 2012-09-19 2016-10-26 株式会社汤山制作所 Medicine feeder and point medicine device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013129451A (en) * 2011-12-22 2013-07-04 Hitachi Aloka Medical Ltd Powder medicine dispensing device
JP2020127832A (en) * 2013-11-22 2020-08-27 株式会社湯山製作所 Medicine put-out device
JP2020147375A (en) * 2014-09-24 2020-09-17 株式会社湯山製作所 Medicine feeder, container mounting device of medicine feeder and medicine pay-out device
JP2016202909A (en) * 2015-04-20 2016-12-08 株式会社湯山製作所 Medicine dispensing apparatus
WO2017159819A1 (en) * 2016-03-18 2017-09-21 株式会社湯山製作所 Drug dispensing device and drug dispensing program

Also Published As

Publication number Publication date
KR20240004218A (en) 2024-01-11
TW202246127A (en) 2022-12-01

Similar Documents

Publication Publication Date Title
JP7256975B2 (en) drug dispenser
JP6308395B2 (en) Drug feeder and drug dispensing device
JP2024022635A (en) Medicine feeder
JP7117680B2 (en) drug dispenser
JP2005535525A (en) Vacuum tablet dispensing cassette and counter
JP6798639B2 (en) Tablet packaging device
JP7113413B2 (en) Drug dispensing device, powdered drug weighing device and drug packaging system
JP7137771B2 (en) Powder weighing device and drug packaging system
JP2016202909A (en) Medicine dispensing apparatus
JP6990358B2 (en) Drug dispensing device and drug dispensing method
WO2015041220A1 (en) Drug cassette and drug packaging device
WO2022230590A1 (en) Drug feeder and drug dispensing unit
KR102642474B1 (en) Dispensing canisters for packaging pharmaceuticals via robotic technology
JP7345092B2 (en) Drug feeder and drug dispensing device
CN117120013A (en) Medicine feeder and medicine dispensing device
JP2023160919A (en) Medicine feeder and medicine put-out device
JP2022169440A (en) Drug feeder, drug delivery device, drug feeder calibration method, and drug feeder failure detection method
JP2024019144A (en) Medicine dispensing device
JP2022169439A (en) Medicine feeder and medicine put-out device
JP2019094171A (en) Powder and granular material supply device
JP2019094173A (en) Powder and granular material supply device
JP7212851B2 (en) Powder drug dispensing business support system
JP2022044537A (en) Medicine packaging apparatus
JP2019094172A (en) Powder and granular material supply device
JP2010143597A (en) Packaging apparatus

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22795506

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22795506

Country of ref document: EP

Kind code of ref document: A1